index,trialid,source_register,date_registration,date_enrollement,retrospective_registration,normed_spon_names,recruitment_status,phase,study_type,countries,public_title,study_category,intervention,target_enrollment,primary_completion_date,full_completion_date,web_address,results_type,results_publication_date,results_link,last_refreshed_on,first_seen,cross_registrations
0,ChiCTR2000029953,ChiCTR,17/02/2020,01/02/2020,TRUE,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Construction and Analysis of Prognostic Predictive Model of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,400,Not Available,01/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=49217,No Results,No Results,No Results,17/02/2020,08/03/2020,None
1,NCT04251871,ClinicalTrials.gov,28/01/2020,22/01/2020,TRUE,Beijing 302 Hospital,Recruiting,Not Applicable,Interventional,China,Treatment and Prevention of Traditional Chinese Medicines (TCMs) on 2019-nCoV Infection,Traditional Medicine (Unspecified),Traditional Medicine,150,22/01/2021,22/01/2021,https://clinicaltrials.gov/show/NCT04251871,No Results,No Results,No Results,17/02/2020,08/03/2020,None
2,NCT04260594,ClinicalTrials.gov,06/02/2020,07/02/2020,FALSE,Jieming QU,Not Recruiting,Phase 4,Interventional,No Country Given,Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus,Drug,Umifenovir,380,01/07/2020,30/12/2020,https://clinicaltrials.gov/show/NCT04260594,No Results,No Results,No Results,17/02/2020,08/03/2020,None
3,ChiCTR2000029949,ChiCTR,16/02/2020,16/02/2020,FALSE,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for the Effectiveness of Extracorporeal Membrane Oxygenation in Patients with Severe Novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,40,Not Available,28/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49181,No Results,No Results,No Results,17/02/2020,08/03/2020,None
4,NCT04252885,ClinicalTrials.gov,30/01/2020,28/01/2020,TRUE,Guangzhou 8th People's Hospital,Recruiting,Phase 4,Interventional,China,The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection,Drug,Lopinavir/ritonavir vs. umifenovir,125,30/05/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04252885,Pre-Print Article,23/03/2020,https://doi.org/10.1101/2020.03.19.20038984,17/02/2020,18/03/2020,None
5,NCT04255940,ClinicalTrials.gov,03/02/2020,20/01/2020,TRUE,Qilu Hospital of Shandong University,Recruiting,Not Applicable,Observational,China,2019-nCoV Outbreak and Cardiovascular Diseases,Clinical Presentation,No Intervention,12000,30/04/2020,30/04/2020,https://clinicaltrials.gov/show/NCT04255940,No Results,No Results,No Results,17/02/2020,08/03/2020,None
6,ChiCTR2000029935,ChiCTR,16/02/2020,06/02/2020,TRUE,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,A Single-arm Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19),Drug,Chloroquine,100,Not Available,06/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=49607,No Results,No Results,No Results,17/02/2020,08/03/2020,None
7,ChiCTR2000029947,ChiCTR,16/02/2020,01/03/2020,FALSE,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Qingyi No. 4 Compound in the treatment of Convalescence Patients of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,200,Not Available,01/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49599,No Results,No Results,No Results,17/02/2020,18/03/2020,None
8,ChiCTR2000029850,ChiCTR,15/02/2020,15/02/2020,FALSE,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Study on convalescent plasma treatment for severe patients with novel coronavirus pneumonia (COVID-19),ATMP,Plasma,20,Not Available,15/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=49533,No Results,No Results,No Results,17/02/2020,08/03/2020,None
9,NCT04261426,ClinicalTrials.gov,06/02/2020,10/02/2020,FALSE,Peking Union Medical College Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia,ATMP,Immunoglobulin,80,30/04/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04261426,No Results,No Results,No Results,17/02/2020,08/03/2020,None
10,NCT04261907,ClinicalTrials.gov,06/02/2020,07/02/2020,FALSE,The First Affiliated Hospital of Zhejiang University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection,Drug,Combination: ASC09 + ritonavir vs. lopinavir/ritonavir,160,31/05/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04261907,No Results,No Results,No Results,17/02/2020,08/03/2020,None
11,NCT04260308,ClinicalTrials.gov,03/02/2020,03/02/2020,FALSE,Huazhong University of Science and Technology,Recruiting,Not Applicable,Observational,China,A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia,Other (psych),No Intervention,30000,15/04/2020,20/04/2020,https://clinicaltrials.gov/show/NCT04260308,Pre-Print Article,06/03/2020,https://doi.org/10.1101/2020.03.03.20030874,17/02/2020,18/03/2020,None
12,ChiCTR2000029883,ChiCTR,16/02/2020,17/02/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,A comparative study on the sensitivity of nasopharyngeal and oropharyngeal swabbing for the detection of SARS-CoV-2 by real-time PCR,Diagnostics,Diagnostic Test or Assessment,200,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49549,No Results,No Results,No Results,17/02/2020,08/03/2020,None
13,ChiCTR2000029896,ChiCTR,16/02/2020,31/01/2020,TRUE,Affiliated Hospital of Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Evaluate the effectiveness of Traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,100,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49432,No Results,No Results,No Results,17/02/2020,18/03/2020,None
14,ChiCTR2000029814,ChiCTR,14/02/2020,14/02/2020,FALSE,Children's Hospital of Fudan University,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Integrated Chinese and Western Medicine in the Treatment of Children with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,30,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49387,No Results,No Results,No Results,17/02/2020,08/03/2020,None
15,ChiCTR2000029941,ChiCTR,16/02/2020,01/03/2020,FALSE,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for Traditional Chinese Medicine in the treatment for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,200,Not Available,01/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49596,No Results,No Results,No Results,17/02/2020,08/03/2020,None
16,ChiCTR2000029811,ChiCTR,14/02/2020,20/02/2020,FALSE,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Clinical Study for Anti-aging Active Freeze-dried Powder Granules in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,60,Not Available,20/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=49355,No Results,No Results,No Results,17/02/2020,08/03/2020,None
17,ChiCTR2000029939,ChiCTR,16/02/2020,10/02/2020,TRUE,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,"A Single-blind, Randomized, Controlled Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19)",Drug,Chloroquine,100,Not Available,06/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=49612,No Results,No Results,No Results,17/02/2020,08/03/2020,None
18,ChiCTR2000029869,ChiCTR,15/02/2020,10/02/2020,TRUE,Huangshi Hospital of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategy",Traditional Medicine + Western Medicine,Traditional Medicine,300,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49486,No Results,No Results,No Results,17/02/2020,08/03/2020,None
19,ChiCTR2000029805,ChiCTR,14/02/2020,12/02/2020,TRUE,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics of severe novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,31/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=49188,No Results,No Results,No Results,17/02/2020,08/03/2020,None
20,ChiCTR2000029810,ChiCTR,14/02/2020,16/02/2020,FALSE,Shenzhen Second People's Hospital,Recruiting,Not Applicable,Diagnostic test,China,Clinical study of a novel high sensitivity nucleic acid assay for novel coronavirus pneumonia (COVID-19) based on CRISPR-cas protein,Diagnostics,Diagnostic Test or Assessment,10000,Not Available,20/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49407,No Results,No Results,No Results,17/02/2020,08/03/2020,None
21,ChiCTR2000029867,ChiCTR,15/02/2020,15/02/2020,FALSE,"Beijing You'an Hospital, Capital Medical University",Recruiting,Phase 4,Interventional,China,"The efficacy and safety of carrimycin treatment in patients with novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",Drug,Carrimycin vs. lopinavir/ritonavir,520,Not Available,28/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=49514,No Results,No Results,No Results,17/02/2020,08/03/2020,None
22,ChiCTR2000029907,ChiCTR,16/02/2020,16/02/2020,FALSE,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Study for construction and assessment of early warning score of the clinical risk of novel coronavirus (COVID-19) infected patients,Clinical Presentation,No Intervention,1000,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49587,No Results,No Results,No Results,17/02/2020,08/03/2020,None
23,ChiCTR2000029789,ChiCTR,13/02/2020,15/02/2020,FALSE,The First Affiliated Hospital of He'nan University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,100,Not Available,30/06/2021,http://www.chictr.org.cn/showproj.aspx?proj=49348,No Results,No Results,No Results,17/02/2020,08/03/2020,None
24,ChiCTR2000029849,ChiCTR,15/02/2020,01/02/2020,TRUE,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Interventional,China,Application of Regulating Intestinal Flora in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),ATMP,Intestinal microbiome,60,Not Available,01/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=49530,No Results,No Results,No Results,17/02/2020,08/03/2020,None
25,ChiCTR2000029905,ChiCTR,16/02/2020,10/02/2020,TRUE,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,A medical records based study of novel coronavirus pneumonia (COVID-19) and influenza virus co-infection,Clinical Presentation,No Intervention,271,Not Available,15/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49595,No Results,No Results,No Results,17/02/2020,08/03/2020,None
26,ChiCTR2000029782,ChiCTR,13/02/2020,30/01/2020,TRUE,Zhejiang Provincial People's Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical study for the changes in mental state of medical staff in the department of radiotherapy in a comprehensive tertiary hospital in Zhejiang Province during the epidemic of novel coronavirus infection (COVID-19),Other (psych),No Intervention,27,Not Available,29/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49445,No Results,No Results,No Results,17/02/2020,08/03/2020,None
27,ChiCTR2000029779,ChiCTR,13/02/2020,14/02/2020,FALSE,Wuxi People's Hospital,Recruiting,Not Applicable,Diagnostic test,China,Study for the key issues of the diagnosis and treatment of novel coronavirus pneumonia (COVID-19) based on the medical imaging,Clinical Presentation,No Intervention,0,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49378,No Results,No Results,No Results,17/02/2020,08/03/2020,None
28,ChiCTR2000029870,ChiCTR,15/02/2020,15/02/2020,FALSE,Jiangsu Institute of Parasitic Diseases,Recruiting,Not Applicable,Diagnostic test,China,Evaluation of Rapid Diagnostic Kit (IgM/IgG) for Novel Coronavirus Pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,500,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49563,No Results,No Results,No Results,17/02/2020,08/03/2020,None
29,ChiCTR2000029822,ChiCTR,14/02/2020,07/02/2020,TRUE,Nanjing Second Hospital,Recruiting,Not Applicable,Interventional,No Country Given,A randomized controlled trial for honeysuckle decoction in the treatment of patients with novel coronavirus (COVID-19) infection,Traditional Medicine (Drug),Traditional Medicine,110,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49502,No Results,No Results,No Results,17/02/2020,08/03/2020,None
30,ChiCTR2000029855,ChiCTR,15/02/2020,15/02/2020,FALSE,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,"A randomized, open and controlled clinical trial for traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Unspecified),Traditional Medicine,180,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49543,No Results,No Results,No Results,17/02/2020,08/03/2020,None
31,ChiCTR2000029815,ChiCTR,14/02/2020,01/02/2020,TRUE,Guangdong Provincial Hospital of Chinese Medicine,Recruiting,Not Applicable,Observational,China,Psychological survey of frontline medical staff in various regions of China during the epidemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,800,Not Available,15/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49346,No Results,No Results,No Results,17/02/2020,18/03/2020,None
32,ChiCTR2000029764,ChiCTR,13/02/2020,16/02/2020,FALSE,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Imaging Features and Mechanisms of Novel Coronavirus Pneumonia (COVID-19): a Multicenter Study,Clinical Presentation,No Intervention,100,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49388,No Results,No Results,No Results,17/02/2020,08/03/2020,None
33,ChiCTR2000029778,ChiCTR,13/02/2020,14/02/2020,FALSE,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Clinical Study for Traditional Chinese Medicine Combined With Western Medicine in Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,600,Not Available,13/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49422,No Results,No Results,No Results,17/02/2020,08/03/2020,None
34,ChiCTR2000029853,ChiCTR,15/02/2020,16/02/2020,FALSE,People's Hospital of Guangshan County,Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,20,Not Available,16/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49532,No Results,No Results,No Results,17/02/2020,08/03/2020,None
35,ChiCTR2000029813,ChiCTR,14/02/2020,14/02/2020,FALSE,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Tanreqing Capsules in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,72,Not Available,14/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49425,No Results,No Results,No Results,17/02/2020,08/03/2020,None
36,ChiCTR2000029777,ChiCTR,13/02/2020,05/02/2020,TRUE,Huangshi Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategy",Traditional Medicine + Western Medicine,Traditional Medicine,160,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49380,No Results,No Results,No Results,17/02/2020,08/03/2020,None
37,ChiCTR2000029806,ChiCTR,14/02/2020,12/02/2020,TRUE,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,Immunomodulatory Therapy for Severe Novel Coronavirus Pneumonia (COVID-19),Drug,PD1 vs. thymosin,120,Not Available,31/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=49161,No Results,No Results,No Results,17/02/2020,08/03/2020,None
38,ChiCTR2000029695,ChiCTR,10/02/2020,01/03/2020,FALSE,Shenzhen Third People's Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Early Detection of Novel Coronavirus Pneumonia (COVID-19) Based on a Novel High-Throughput Mass Spectrometry Analysis With Exhaled Breath,Diagnostics,Diagnostic Test or Assessment,300,Not Available,31/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=49219,No Results,No Results,No Results,17/02/2020,08/03/2020,None
39,ChiCTR2000029776,ChiCTR,13/02/2020,11/02/2020,TRUE,The First Affiliated Hospital of Wenzhou Medical University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Polyinosinic-Polycytidylic Acid Injection in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Polyinosinic-polycytidylic acid,40,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49342,No Results,No Results,No Results,17/02/2020,08/03/2020,None
40,ChiCTR2000029790,ChiCTR,13/02/2020,17/02/2020,FALSE,Shanghai Pulmonary Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for the integration of traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,120,Not Available,31/10/2020,http://www.chictr.org.cn/showproj.aspx?proj=49453,No Results,No Results,No Results,17/02/2020,08/03/2020,None
41,ChiCTR2000029656,ChiCTR,09/02/2020,14/02/2020,FALSE,Wuhan Pulmonary Hosptial,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of low-dose corticosteroids in hospitalized patients with novel coronavirus pneumonia (COVID-19)",Drug,Corticosteroids,100,Not Available,14/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49086,No Results,No Results,No Results,17/02/2020,08/03/2020,None
42,ChiCTR2000029788,ChiCTR,13/02/2020,01/03/2020,FALSE,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with novel coronavirus pneumonia (COVID-19): a randomized controlled trial,Traditional Medicine (Unspecified),Traditional Medicine,60,Not Available,30/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49452,No Results,No Results,No Results,17/02/2020,08/03/2020,None
43,ChiCTR2000029742,ChiCTR,11/02/2020,10/02/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, parallel controlled trial for the efficacy and safety of Sodium Aescinate Injection in the treatment of patients with pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,90,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49297,No Results,No Results,No Results,17/02/2020,08/03/2020,None
44,ChiCTR2000029765,ChiCTR,13/02/2020,10/02/2020,TRUE,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)",Drug,Tocilizumab,188,Not Available,10/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49409,No Results,No Results,No Results,17/02/2020,08/03/2020,None
45,ChiCTR2000029626,ChiCTR,07/02/2020,17/02/2020,FALSE,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Basic Science,China,Immune Repertoire (TCR & BCR) Evaluation and Immunotherapy Research in Peripheral Blood of Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,20,Not Available,01/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49170,No Results,No Results,No Results,17/02/2020,08/03/2020,None
46,ChiCTR2000029741,ChiCTR,11/02/2020,12/02/2020,FALSE,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Phase 4,Interventional,China,"Efficacy of Chloroquine and Lopinavir/ Ritonavir in mild/general novel coronavirus (CoVID-19) infections: a prospective, open-label, multicenter randomized controlled clinical study",Drug,Lopinavir/ritonavir vs. chloroquine,112,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49263,No Results,No Results,No Results,17/02/2020,08/03/2020,None
47,ChiCTR2000029763,ChiCTR,12/02/2020,13/02/2020,FALSE,China Academy of Chinese Medical Sciences; Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,"The efficacy of traditional chinese medicine on Novel Coronavirus Pneumonia (COVID-19) patients treated in square cabin hospital: a prospective, randomized controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,408,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49408,No Results,No Results,No Results,17/02/2020,08/03/2020,None
48,ChiCTR2000029839,ChiCTR,15/02/2020,10/02/2020,TRUE,Ningbo First Hospital,Recruiting,Not Applicable,Observational,China,"An observational study on the clinical characteristics, treatment and outcome of novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,100,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49439,No Results,No Results,No Results,17/02/2020,08/03/2020,None
49,ChiCTR2000029637,ChiCTR,08/02/2020,07/02/2020,TRUE,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,An observational study for Xin-Guan-1 formula  in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,10/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49127,No Results,No Results,No Results,17/02/2020,08/03/2020,None
50,ChiCTR2000029624,ChiCTR,07/02/2020,08/02/2020,FALSE,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Observational,China,A real world study for traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,500,Not Available,07/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=49132,No Results,No Results,No Results,17/02/2020,08/03/2020,None
51,ChiCTR2000029821,ChiCTR,14/02/2020,14/02/2020,FALSE,Deyang Integrated Traditional Chinese and Western Medicine Hospital,Not Recruiting,Not Applicable,Prevention,China,Based on Delphi Method to Preliminarily Construct a Recommended Protocol for the Prevention of Novel Coronavirus Pneumonia (COVID-19) in Deyang Area by Using Chinese Medicine Technology and its Clinical Application Evaluation,Traditional Medicine (Unspecified),Traditional Medicine,400,Not Available,01/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49306,No Results,No Results,No Results,17/02/2020,08/03/2020,None
52,ChiCTR2000029758,ChiCTR,12/02/2020,03/02/2020,TRUE,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Cohort Study of Novel Coronavirus Pneumonia (COVID-19) Critical Ill Patients,Clinical Presentation,No Intervention,100,Not Available,01/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=49295,Pre-Print Article,06/03/2020,https://doi.org/10.1101/2020.03.22.20041277,17/02/2020,08/03/2020,None
53,ChiCTR2000029636,ChiCTR,08/02/2020,09/02/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Efficacy and safety of aerosol inhalation of vMIP in the treatment of novel coronavirus pneumonia (COVID-19): a single arm clinical trial,ATMP,Vaccine,40,Not Available,30/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=49215,No Results,No Results,No Results,17/02/2020,08/03/2020,None
54,ChiCTR2000029819,ChiCTR,14/02/2020,11/02/2020,TRUE,"Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University",Recruiting,Phase 4,Interventional,China,Ba-Bao-Dan in the adjuvant therapy of novel coronavirus pneumonia (COVID-19) patients,Traditional Medicine (Drug),Traditional Medicine,80,Not Available,11/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49490,No Results,No Results,No Results,17/02/2020,08/03/2020,None
55,ChiCTR2000029756,ChiCTR,12/02/2020,15/02/2020,FALSE,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,Clinical study of nebulized Xiyanping injection in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,238,Not Available,15/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=49222,No Results,No Results,No Results,17/02/2020,08/03/2020,None
56,ChiCTR2000029804,ChiCTR,14/02/2020,12/02/2020,TRUE,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Prognosis,China,Clinical Application of ECMO in the Treatment of Patients with Very Serious Respiratory Failure due to novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,100,Not Available,31/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=49178,No Results,No Results,No Results,17/02/2020,08/03/2020,None
57,ChiCTR2000029601,ChiCTR,06/02/2020,01/02/2020,TRUE,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Community based prevention and control for Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,Traditional Medicine (Other),Traditional Medicine,400,Not Available,01/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=48988,No Results,No Results,No Results,17/02/2020,08/03/2020,None
58,ChiCTR2000029589,ChiCTR,05/02/2020,06/02/2020,FALSE,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Recruiting,Not Applicable,Interventional,China,"An open, prospective, multicenter clinical study for the efficacy and safety of Reduning injection in the treatment of ovel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,60,Not Available,31/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=49104,No Results,No Results,No Results,17/02/2020,08/03/2020,None
59,ChiCTR2000029769,ChiCTR,13/02/2020,15/02/2020,FALSE,Enze Hospital of Taizhou Enze Medical Center (Group),Not Recruiting,Not Applicable,Interventional,China,Babaodan Capsule used for the adjuvant treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,40,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49415,No Results,No Results,No Results,17/02/2020,08/03/2020,None
60,ChiCTR2000029747,ChiCTR,11/02/2020,11/02/2020,FALSE,The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Effect evaluation and prognosis of Chinese medicine based on Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,200,Not Available,10/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=49287,No Results,No Results,No Results,17/02/2020,08/03/2020,None
61,ChiCTR2000029578,ChiCTR,05/02/2020,06/02/2020,FALSE,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, sing-arm trial",Traditional Medicine (Unspecified),Traditional Medicine,1000,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49080,No Results,No Results,No Results,17/02/2020,08/03/2020,None
62,ChiCTR2000029569,ChiCTR,04/02/2020,05/02/2020,FALSE,Xiangyang First People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trial,ATMP,Cells (mononuclear),30,Not Available,30/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=49062,No Results,No Results,No Results,17/02/2020,08/03/2020,None
63,ChiCTR2000029768,ChiCTR,13/02/2020,12/02/2020,TRUE,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,"A randomized, open, controlled trial for diammonium glycyrrhizinate enteric-coated capsules combined with vitamin C tablets in the treatment of common novel coronavirus pneumonia (COVID-19) in the basic of clinical standard antiviral treatment to evaluate the safety and efficiency",Drug,Combination: Diammonium glycyrrhizinate + vitamin C,60,Not Available,12/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49131,No Results,No Results,No Results,17/02/2020,08/03/2020,None
64,ChiCTR2000029542,ChiCTR,03/02/2020,03/02/2020,FALSE,Sun Yat sen Memorial Hospital of Sun Yat sen University,Recruiting,Phase 4,Interventional,China,Study for the efficacy of chloroquine in patients with novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,20,Not Available,30/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=48968,No Results,No Results,No Results,17/02/2020,08/03/2020,None
65,ChiCTR2000029518,ChiCTR,03/02/2020,04/02/2020,FALSE,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,140,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=48860,No Results,No Results,No Results,17/02/2020,08/03/2020,None
66,ChiCTR2000029754,ChiCTR,12/02/2020,10/02/2020,TRUE,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Study for the Effect of Novel Coronavirus Pneumonia (COVID-19) on the Health of Different People,Clinical Presentation,No Intervention,1500,Not Available,10/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=49370,No Results,No Results,No Results,17/02/2020,08/03/2020,None
67,ChiCTR2000029739,ChiCTR,11/02/2020,12/02/2020,FALSE,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Parallel Controlled Clinical Study of Hydrogen-Oxygen Nebulizer to Improve the Symptoms of Patients With Novel Coronavirus Pneumonia (COVID-19)",Drug,Combination: Hydrogen + Oxygen vs Oxygen,440,Not Available,31/08/2021,http://www.chictr.org.cn/showproj.aspx?proj=49283,No Results,No Results,No Results,17/02/2020,08/03/2020,None
68,ChiCTR2000029517,ChiCTR,03/02/2020,04/02/2020,FALSE,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for suspected novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,100,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=48861,No Results,No Results,No Results,17/02/2020,08/03/2020,None
69,ChiCTR2000029751,ChiCTR,12/02/2020,01/02/2020,TRUE,The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,350,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49354,No Results,No Results,No Results,17/02/2020,08/03/2020,None
70,ChiCTR2000029539,ChiCTR,03/02/2020,04/02/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of Lopinavir-Ritonavir in patients with mild novel coronavirus pneumonia (COVID-19)",Drug,Lopinavir/ritonavir,328,Not Available,02/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=48991,No Results,No Results,No Results,17/02/2020,08/03/2020,None
71,ChiCTR2000029732,ChiCTR,10/02/2020,10/02/2020,FALSE,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Impact of vitamin D deficiency on prognosis of patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,156,Not Available,10/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49302,No Results,No Results,No Results,17/02/2020,08/03/2020,None
72,ChiCTR2000029495,ChiCTR,02/02/2020,03/02/2020,FALSE,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine, Psychological Intervention and Investigation of Mental Health for Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period",Traditional Medicine (Other),Traditional Medicine,90,Not Available,31/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=48971,No Results,No Results,No Results,17/02/2020,08/03/2020,None
73,ChiCTR2000029735,ChiCTR,10/02/2020,26/01/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Risks of Death and Severe cases in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,500,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49279,No Results,No Results,No Results,17/02/2020,08/03/2020,None
74,ChiCTR2000029639,ChiCTR,08/02/2020,10/02/2020,FALSE,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Interventional,China,"Study for Mental health and psychological status of doctors, nurses and patients in novel coronavirus pneumonia (COVID-19) designated hospital and effect of interventions",Other (psych),No Intervention,192,Not Available,30/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=49187,No Results,No Results,No Results,17/02/2020,18/03/2020,None
75,ChiCTR2000029734,ChiCTR,10/02/2020,08/02/2020,TRUE,The First People's Hospital of Huaihua,Recruiting,Not Applicable,Observational,China,Epidemiological investigation and clinical characteristics analysis of novel coronavirus pneumonia (COVID-19),Clinical Presentation (Epidemiology),No Intervention,40,Not Available,07/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=48868,Pre-Print Article,06/03/2020,https://doi.org/10.1101/2020.03.04.20026005,17/02/2020,08/03/2020,None
76,ChiCTR2000029462,ChiCTR,02/02/2020,01/02/2020,TRUE,The First Affiliated Hospital of He'nan University of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Study for clinical characteristics and distribution of TCM syndrome of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,200,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=48922,No Results,No Results,No Results,17/02/2020,08/03/2020,None
77,ChiCTR2000029493,ChiCTR,02/02/2020,03/02/2020,FALSE,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine for Pulmonary Fibrosis, Pulmonary Function and Quality of Life in Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period: a Randomized Controlled Trial",Traditional Medicine (Unspecified),Traditional Medicine,100,Not Available,31/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=48931,No Results,No Results,No Results,17/02/2020,08/03/2020,None
78,ChiCTR2000029628,ChiCTR,07/02/2020,07/02/2020,FALSE,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,A clinical observational study for Xin-Guan-2 formula in the treatment of suspected novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,10/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49155,No Results,No Results,No Results,17/02/2020,08/03/2020,None
79,ChiCTR2000029438,ChiCTR,01/02/2020,04/02/2020,FALSE,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Phase 4,Interventional,China,A randomized controlled trial of integrated TCM and Western Medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,100,Not Available,01/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=48911,No Results,No Results,No Results,17/02/2020,08/03/2020,None
80,ChiCTR2000029621,ChiCTR,07/02/2020,07/02/2020,FALSE,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Phase 4,Interventional,China,Clinical study of arbidol hydrochloride tablets in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Umifenovir,380,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49165,No Results,No Results,No Results,17/02/2020,08/03/2020,None
81,ChiCTR2000029625,ChiCTR,07/02/2020,17/02/2020,FALSE,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Diagnostic test,China,Construction of Early Warning and Prediction System for Patients with Severe / Critical Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,80,Not Available,01/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49177,No Results,No Results,No Results,17/02/2020,08/03/2020,None
82,ChiCTR2000029432,ChiCTR,01/02/2020,01/02/2020,FALSE,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,A Real World Study for the Efficacy and Safety of Large Dose Tanreqing Injection in the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,72,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=48881,No Results,No Results,No Results,17/02/2020,08/03/2020,None
83,ChiCTR2000029609,ChiCTR,06/02/2020,10/02/2020,FALSE,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Phase 4,Interventional,China,"A prospective, open-label, multiple-center study for the efficacy of chloroquine phosphate in patients with novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine vs. lopinavir/ritonavir,205,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49145,No Results,No Results,No Results,17/02/2020,08/03/2020,None
84,ChiCTR2000029436,ChiCTR,01/02/2020,01/02/2020,FALSE,The First Hospital of He'nan University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A single arm study for evaluation of integrated traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,100,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=48884,No Results,No Results,No Results,17/02/2020,08/03/2020,None
85,ChiCTR2000029602,ChiCTR,06/02/2020,01/02/2020,TRUE,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Clinical study for community based prevention and control strategy of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,Clinical Presentation (Epidemiology),No Intervention,600,Not Available,01/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=48985,No Results,No Results,No Results,17/02/2020,08/03/2020,None
86,ChiCTR2000029431,ChiCTR,01/02/2020,29/01/2020,TRUE,Affiliated Zhongshan Hospital of Dalian University,Recruiting,Not Applicable,Interventional,China,Clinical study for the remedy of M1 macrophages target in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,45,Not Available,31/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=48907,Pre-Print Article,14/04/2020,https://doi.org/10.1101/2020.04.07.20054767,17/02/2020,08/03/2020,None
87,ChiCTR2000029606,ChiCTR,07/02/2020,25/01/2020,TRUE,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Clinical Study for Human Menstrual Blood-Derived Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (stem cells),63,Not Available,31/12/2022,http://www.chictr.org.cn/showproj.aspx?proj=49146,No Results,No Results,No Results,17/02/2020,08/03/2020,None
88,ChiCTR2000029600,ChiCTR,06/02/2020,30/01/2020,TRUE,The Third People's Hospital of Shenzhen,Recruiting,Not Applicable,Interventional,China,Clinical study for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Combination: Favipiravir + interferon alpha vs. interferon alpha + lopinavir/ritonavir + interferon alpha vs. interferon alpha,90,Not Available,29/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49042,Journal Article,18/03/2020,https://doi.org/10.1016/j.eng.2020.03.007,17/02/2020,08/03/2020,None
89,ChiCTR2000029605,ChiCTR,07/02/2020,06/02/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of ovel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,400,Not Available,05/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=49051,No Results,No Results,No Results,17/02/2020,18/03/2020,None
90,ChiCTR2000029418,ChiCTR,30/01/2020,03/02/2020,FALSE,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Chinese Herbal medicine for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Drug),Traditional Medicine,42,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=48886,Pre-Print Article,01/04/2020,https://doi.org/10.1101/2020.03.27.20044974,17/02/2020,08/03/2020,None
91,ChiCTR2000029572,ChiCTR,05/02/2020,05/02/2020,FALSE,Xiangyang First People's Hospital,Recruiting,Not Applicable,Interventional,China,Safety and efficacy of umbilical cord blood mononuclear cells in the treatment of severe and critically novel coronavirus pneumonia(COVID-19): a randomized controlled clinical trial,ATMP,Cells (mononuclear),30,Not Available,30/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=41760,No Results,No Results,No Results,17/02/2020,08/03/2020,None
92,ChiCTR2000029603,ChiCTR,06/02/2020,06/02/2020,FALSE,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,"A Randomized, Open-Label, Multi-Centre Clinical Trial Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Confirmed Cases of Novel Coronavirus Pneumonia (COVID-19)",Drug,Combination: ASCO9 + ritonavir vs. lopinavir/ritonavir,160,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49075,No Results,No Results,No Results,17/02/2020,08/03/2020,None
93,ChiCTR2000029559,ChiCTR,04/02/2020,31/01/2020,TRUE,Renmin Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19),Drug,Hydroxychloroquine,300,Not Available,29/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=48880,Pre-Print Article,31/03/2020,https://doi.org/10.1101/2020.03.22.20040758,17/02/2020,08/03/2020,None
94,NCT04259892,ClinicalTrials.gov,05/02/2020,04/02/2020,TRUE,INSERM,Recruiting,Not Applicable,Observational,France,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection,Clinical Presentation,No Intervention,300,04/10/2020,04/02/2021,https://clinicaltrials.gov/show/NCT04259892,No Results,No Results,No Results,24/02/2020,08/03/2020,None
95,NCT04268537,ClinicalTrials.gov,08/02/2020,10/02/2020,FALSE,"Southeast University, China",Not Recruiting,Phase 2,Interventional,No Country Given,Immunoregulatory Therapy for 2019-nCoV,Drug,PD1 vs. thymosin,120,30/04/2020,31/10/2020,https://clinicaltrials.gov/show/NCT04268537,No Results,No Results,No Results,24/02/2020,08/03/2020,None
96,ChiCTR2000029558,ChiCTR,04/02/2020,29/01/2020,TRUE,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Diagnosis and Treatment of Novel Coronavirus Pneumonia (COVID-19) in Sichuan Province,Traditional Medicine + Western Medicine,Traditional Medicine,200,Not Available,01/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=48792,No Results,No Results,No Results,17/02/2020,08/03/2020,None
97,ChiCTR2000029544,ChiCTR,03/02/2020,04/02/2020,FALSE,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,"A randomized controlled trial for the efficacy and safety of Baloxavir Marboxil, Favipiravir tablets in novel coronavirus pneumonia (COVID-19) patients who are still positive on virus detection under the current antiviral therapy",Drug,Combination: baloxavir + marboxil vs. favipiravir,30,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49013,No Results,No Results,No Results,17/02/2020,08/03/2020,None
98,ChiCTR2000030173,ChiCTR,24/02/2020,17/02/2020,TRUE,"Hunan yuanpin Cell Biotechnology Co., Ltd",Not Recruiting,Not Applicable,Interventional,China,Key techniques of umbilical cord mesenchymal stem cells for the treatment of novel coronavirus pneumonia (COVID-19) and clinical application demonstration,ATMP,Cells (mesenchymal),60,Not Available,17/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49229,No Results,No Results,No Results,25/02/2020,08/03/2020,None
99,ChiCTR2000029548,ChiCTR,04/02/2020,04/02/2020,FALSE,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,"Randomized, open-label, controlled trial for evaluating of the efficacy and safety of Baloxavir Marboxil, Favipiravir, and Lopinavir-Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19) patients",Drug,Combination: baloxavir + marboxil vs. favipiravir vs. lopinavir/ritonavir,30,Not Available,03/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49015,No Results,No Results,No Results,17/02/2020,08/03/2020,None
100,ChiCTR2000029541,ChiCTR,03/02/2020,10/02/2020,FALSE,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A randomised, open, controlled trial for darunavir/cobicistat or Lopinavir/ritonavir combined with thymosin a1 in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Combination: darunavir + cobicistat vs. lopinavir/ritonavir,100,Not Available,01/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=48992,No Results,No Results,No Results,17/02/2020,08/03/2020,None
101,ChiCTR2000030179,ChiCTR,24/02/2020,24/02/2020,FALSE,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Interventional,China,Experimental study of novel coronavirus pneumonia rehabilitation plasma therapy severe novel coronavirus pneumonia (COVID-19),ATMP,Plasma,100,Not Available,24/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50059,No Results,No Results,No Results,25/02/2020,08/03/2020,None
102,ChiCTR2000029461,ChiCTR,02/02/2020,03/02/2020,FALSE,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Integrated Traditional Chinese Medicine and Western Medicine in the Treatment of Common Type Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,100,Not Available,31/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=48927,No Results,No Results,No Results,17/02/2020,08/03/2020,None
103,ChiCTR2000029487,ChiCTR,02/02/2020,10/02/2020,FALSE,Wuhan Hospital of Integrated Traditional Chinese and Western Medicine,Not Recruiting,Not Applicable,Prevention,China,Clinical Study for Gu-Biao Jie-Du-Ling in Preventing of Novel Coronavirus Pneumonia (COVID-19) in Children,Traditional Medicine (Drug),Traditional Medicine,200,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=48965,No Results,No Results,No Results,17/02/2020,08/03/2020,None
104,ChiCTR2000030164,ChiCTR,24/02/2020,24/02/2020,FALSE,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Observational,China,A cross-sectional study of novel coronavirus pneumonia (COVID-19) patients in ICU,Clinical Presentation,No Intervention,10,Not Available,24/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49983,No Results,No Results,No Results,25/02/2020,08/03/2020,None
105,ChiCTR2000030166,ChiCTR,24/02/2020,25/02/2020,FALSE,The Fifth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,"Randomized, parallel control, open trial for Qing-Wen Bai-Du-Yin combined with antiviral therapy in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,20,Not Available,14/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49696,No Results,No Results,No Results,25/02/2020,08/03/2020,None
106,ChiCTR2000029460,ChiCTR,02/02/2020,02/02/2020,FALSE,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,The effect of shadowboxing for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,Other (exercise),Exercise,100,Not Available,31/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=48930,No Results,No Results,No Results,17/02/2020,08/03/2020,None
107,ChiCTR2000029468,ChiCTR,02/02/2020,01/02/2020,TRUE,"Institute of Emergency Medicine and Disaster Medicine Sichuan People's Hospital, Sichuan Academy of Medical Sciences",Not Recruiting,Not Applicable,Interventional,China,A real-world  study for lopinavir/ritonavir (LPV/r) and emtritabine (FTC) / Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Combination: Lopinavir/ritonavir + emtricitabine + tenofovir vs. lopinavir/ritonavir,120,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=48919,No Results,No Results,No Results,17/02/2020,08/03/2020,None
108,ChiCTR2000029459,ChiCTR,02/02/2020,03/02/2020,FALSE,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,The effect of pulmonary rehabilitation for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,Other (physio),Physio,100,Not Available,31/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=48929,No Results,No Results,No Results,17/02/2020,08/03/2020,None
109,ChiCTR2000029437,ChiCTR,01/02/2020,03/02/2020,FALSE,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Observational,China,A single arm study for combination of traditional Chinese and Western Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,300,Not Available,01/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=48913,No Results,No Results,No Results,17/02/2020,08/03/2020,None
110,ChiCTR2000030118,ChiCTR,23/02/2020,24/02/2020,FALSE,Shenzhen National Medicine Inheritance Medical Research Institute co. LTD,Not Recruiting,Not Applicable,Interventional,China,A clinical study for ''Huo-Shen'' particles in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,120,Not Available,29/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49594,No Results,No Results,No Results,25/02/2020,08/03/2020,None
111,ChiCTR2000030113,ChiCTR,23/02/2020,22/02/2020,TRUE,The Third People's Hospital of Shenzhen,Recruiting,Not Applicable,Interventional,No Country Given,Randomized controlled trial for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19) with poorly responsive ritonavir/ritonavir,Drug,Favipiravir vs. ritonavir,30,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49988,No Results,No Results,No Results,25/02/2020,08/03/2020,None
112,ChiCTR2000029439,ChiCTR,01/02/2020,02/02/2020,FALSE,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Interventional,China,Combination of traditional Chinese medicine and western medicine in the treatment of common type novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,120,Not Available,31/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=48904,No Results,No Results,No Results,17/02/2020,08/03/2020,None
113,ChiCTR2000029435,ChiCTR,01/02/2020,01/02/2020,FALSE,Wuhan First Hospital,Not Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-19) in high risk population,Traditional Medicine (Unspecified),Traditional Medicine,120,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=48827,No Results,No Results,No Results,17/02/2020,08/03/2020,None
114,ChiCTR2000030116,ChiCTR,23/02/2020,01/02/2020,TRUE,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Interventional,China,Safety and effectiveness of human umbilical cord mesenchymal stem cells in the treatment of acute respiratory distress syndrome of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),16,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49901,No Results,No Results,No Results,25/02/2020,08/03/2020,None
115,ChiCTR2000029381,ChiCTR,27/01/2020,24/01/2020,TRUE,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Phase 4,Interventional,China,A prospective comparative study for Xue-Bi-Jing injection in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,400,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=48768,No Results,No Results,No Results,17/02/2020,08/03/2020,None
116,ChiCTR2000029430,ChiCTR,01/02/2020,03/02/2020,FALSE,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Observational,China,Study for the TCM syndrome characteristics of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,600,Not Available,01/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=48902,No Results,No Results,No Results,17/02/2020,08/03/2020,None
117,ChiCTR2000030096,ChiCTR,23/02/2020,17/02/2020,TRUE,Peking University First Hospital,Not Recruiting,Not Applicable,Observational,China,Study for establishment of correlation between virological dynamics and clinical features in noveal coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,120,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49794,No Results,No Results,No Results,25/02/2020,08/03/2020,None
118,ChiCTR2000030093,ChiCTR,23/02/2020,01/03/2020,FALSE,The Second Hospital of Shanxi Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for application of simplified cognitive-behavioral therapy for related emergency psychological stress reaction of medical providers working in the position of treatment and control of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,60,Not Available,31/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=49932,No Results,No Results,No Results,25/02/2020,08/03/2020,None
119,ChiCTR2000029400,ChiCTR,29/01/2020,29/01/2020,FALSE,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Clinical Controlled Trial for Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,60,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=48824,No Results,No Results,No Results,17/02/2020,08/03/2020,None
120,ChiCTR2000030094,ChiCTR,23/02/2020,01/03/2020,FALSE,Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,"Effects of novel coronavirus pneumonia (COVID-19) on menstruation, TCM body construction and psychological state for female at different ages",Traditional Medicine (Unspecified),Traditional Medicine,200,Not Available,28/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=49970,No Results,No Results,No Results,25/02/2020,08/03/2020,None
121,ChiCTR2000030084,ChiCTR,22/02/2020,24/02/2020,FALSE,The First Hospital of Shanxi Medical University,Recruiting,Not Applicable,Interventional,China,A multicenter study for efficacy of intelligent psychosomatic adjustment system intervention in the treatment of novel coronavirus pneumonia (COVID-19) patients with mild to moderate anxiety and depression,Other (psych),Psychological,180,Not Available,01/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=49952,No Results,No Results,No Results,25/02/2020,08/03/2020,None
122,ChiCTR2000030185,ChiCTR,24/02/2020,24/02/2020,FALSE,West China Hospital of Sichuan University,Recruiting,Not Applicable,Diagnostic test,China,"The Value of Critical Care Ultrasound in Rapid Screening, Diagnosis, Evaluation of Effectiveness and Intensive Prevention of Novel Coronavirus Pneumonia (COVID-19)",Diagnostics,Diagnostic Test or Assessment,40,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50058,No Results,No Results,No Results,25/02/2020,08/03/2020,None
123,ChiCTR2000030167,ChiCTR,24/02/2020,02/03/2020,FALSE,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,Clinical Trial for Recombinant Human Interleukin-2 in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Interleukin-2,80,Not Available,01/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=49567,No Results,No Results,No Results,25/02/2020,08/03/2020,None
124,ChiCTR2000030046,ChiCTR,21/02/2020,07/02/2020,TRUE,"The First People's Hospital of Jiangxia District, Wuhan (Union Jiangnan Hospital)",Recruiting,Not Applicable,Interventional,China,A single arm trial to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of novel coronavirus pneumonia patient (COVID-19),ATMP,Plasma,10,Not Available,07/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49861,Journal Article,06/04/2020,https://doi.org/10.1073/pnas.2004168117,25/02/2020,08/03/2020,None
125,ChiCTR2000030043,ChiCTR,21/02/2020,21/02/2020,FALSE,Peking University Third Hospital,Not Recruiting,Phase 4,Interventional,China,"Shen-Fu injection in the treatment of severe novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",Traditional Medicine (Drug),Traditional Medicine,300,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49866,No Results,No Results,No Results,25/02/2020,08/03/2020,None
126,ChiCTR2000030165,ChiCTR,24/02/2020,24/02/2020,FALSE,Tianjin University,Recruiting,Not Applicable,Interventional,China,Clinical study for ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Ozone,60,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49947,No Results,No Results,No Results,25/02/2020,08/03/2020,None
127,NCT04269525,ClinicalTrials.gov,07/02/2020,06/02/2020,TRUE,ZhiYong Peng,Recruiting,Phase 2,Interventional,China,Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia,ATMP,Cells (mesenchymal),10,30/04/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04269525,No Results,No Results,No Results,24/02/2020,08/03/2020,None
128,ChiCTR2000030188,ChiCTR,24/02/2020,15/02/2020,TRUE,Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital,Recruiting,Not Applicable,Interventional,China,Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,120,Not Available,30/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50025,No Results,No Results,No Results,25/02/2020,08/03/2020,None
129,ChiCTR2000030041,ChiCTR,21/02/2020,25/02/2020,FALSE,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A single-arm, single-center clinical trial for Azivudine tablets in the treatment of adult novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,40,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49891,No Results,No Results,No Results,25/02/2020,08/03/2020,None
130,ChiCTR2000030030,ChiCTR,20/02/2020,20/02/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for acute kidney injury in novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,2000,Not Available,01/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=49841,No Results,No Results,No Results,25/02/2020,08/03/2020,None
131,ChiCTR2000030117,ChiCTR,23/02/2020,15/02/2020,TRUE,Shanghai Public Health Clinical Center,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, parallel controlled trial for the evaluation of the effectiveness and safety of Xiyanping injection in the treatment of common type novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,348,Not Available,14/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=49762,No Results,No Results,No Results,25/02/2020,08/03/2020,None
132,ChiCTR2000030034,ChiCTR,21/02/2020,07/02/2020,TRUE,Tongde Hospital of Zhejiang Province,Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19): a multicentre, randomized controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,132,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49647,No Results,No Results,No Results,25/02/2020,08/03/2020,None
133,ChiCTR2000030170,ChiCTR,24/02/2020,15/02/2020,TRUE,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Study for safety and efficacy of Jakotinib hydrochloride tablets in the treatment severe and acute exacerbation patients of novel coronavirus pneumonia (COVID-19),Drug,Jakotinib,16,Not Available,31/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=50017,No Results,No Results,No Results,25/02/2020,08/03/2020,None
134,ChiCTR2000030115,ChiCTR,23/02/2020,27/02/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A clinical research for the changes of Blood cortisol ACTH level and adrenal morphology in blood cortisol to guide the application of individualized hormone in severe novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,50,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49964,No Results,No Results,No Results,25/02/2020,08/03/2020,None
135,ChiCTR2000030032,ChiCTR,21/02/2020,10/02/2020,TRUE,Xi'an Chest Hospital,Recruiting,Not Applicable,Observational,China,Study on ultrasonographic manifestations of new type of novel coronavirus pneumonia (covid-19) in non-critical stage of pulmonary lesions,Clinical Presentation,No Intervention,20,Not Available,28/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49816,No Results,No Results,No Results,25/02/2020,08/03/2020,None
136,ChiCTR2000030138,ChiCTR,24/02/2020,24/02/2020,FALSE,Chinese PLA General Hospital,Not Recruiting,Phase 2,Interventional,China,Clinical Trial for Human Mesenchymal Stem Cells in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (mesenchymal),60,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50004,No Results,No Results,No Results,25/02/2020,08/03/2020,None
137,ChiCTR2000030092,ChiCTR,23/02/2020,12/02/2020,TRUE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Assessment of cardiac function in patients with Novel Coronavirus Pneumonia (COVID-19) by echocardiography and its new techniques,Clinical Presentation,No Intervention,800,Not Available,12/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=49880,No Results,No Results,No Results,25/02/2020,08/03/2020,None
138,ChiCTR2000030137,ChiCTR,24/02/2020,24/02/2020,FALSE,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Observational,China,Humanistic Care in Healthcare Workers in Novel Coronavirus Pneumonia (COVID-19),Other,Humanistic Care,130,Not Available,15/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50007,No Results,No Results,No Results,25/02/2020,08/03/2020,None
139,ChiCTR2000030090,ChiCTR,22/02/2020,22/02/2020,FALSE,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,A Prospective Randomized Controlled Trial for Home Exercise Prescription Intervention During Epidemic of Novel Coronary Pneumonia (COVID-19) in College Students,Other (exercise),Exercise,400,Not Available,22/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49910,No Results,No Results,No Results,25/02/2020,08/03/2020,None
140,ChiCTR2000030016,ChiCTR,19/02/2020,04/02/2020,TRUE,Guangxi Medical University,Recruiting,Phase 4,Interventional,China,Basic and clinical study of inhalation of inactivated mycobacterium vaccine in the treatment of Novel coronavirus pneumonia (COVID-19),ATMP,Vaccine,60,Not Available,31/12/2022,http://www.chictr.org.cn/showproj.aspx?proj=49799,No Results,No Results,No Results,25/02/2020,08/03/2020,None
141,ChiCTR2000030136,ChiCTR,24/02/2020,24/02/2020,FALSE,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,China,Humanistic Care in Patients With Novel Coronavirus Pneumonia (COVID-19),Other,Humanistic Care,130,Not Available,15/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50005,No Results,No Results,No Results,25/02/2020,18/03/2020,None
142,ChiCTR2000030029,ChiCTR,21/02/2020,20/02/2020,TRUE,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19),Drug,Suramin,20,Not Available,30/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49824,No Results,No Results,No Results,25/02/2020,08/03/2020,None
143,ChiCTR2000030058,ChiCTR,22/02/2020,10/03/2020,FALSE,Renmin Hospital of Wuhan University,Not Recruiting,Phase 3,Interventional,China,"A multicenter, randomized, double-blind, controlled clinical trial for leflunomide in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Leflunomide,200,Not Available,30/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49831,No Results,No Results,No Results,25/02/2020,08/03/2020,None
144,ChiCTR2000030102,ChiCTR,23/02/2020,24/02/2020,FALSE,Tianjin Huanhu Hospital,Recruiting,Not Applicable,Interventional,China,A multicenter randomized controlled trial for ozone autohemotherapy in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Ozone,180,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49747,No Results,No Results,No Results,25/02/2020,08/03/2020,None
145,ChiCTR2000030007,ChiCTR,19/02/2020,03/02/2020,TRUE,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Multicenter randomized controlled trial for rhG-CSF in the treatment of novel coronavirus pneumonia (COVID-19),Drug,G-CSF,200,Not Available,10/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49619,No Results,No Results,No Results,25/02/2020,08/03/2020,None
146,ChiCTR2000030056,ChiCTR,22/02/2020,23/02/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the effect of early endotracheal intubation on the outcome of novel coronavirus pneumonia (COVID-19) patients,Other (physical),Endotracheal Intubation,100,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49904,No Results,No Results,No Results,25/02/2020,08/03/2020,None
147,ChiCTR2000030027,ChiCTR,20/02/2020,20/02/2020,FALSE,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with Novel coronavirus pneumonia (COVID-19) and its effect on spermatogenesis: a randomized controlled trial,Traditional Medicine (Unspecified),Traditional Medicine,60,Not Available,18/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=49852,No Results,No Results,No Results,25/02/2020,08/03/2020,None
148,ChiCTR2000030089,ChiCTR,22/02/2020,28/02/2020,FALSE,Shanghai Changzheng Hospital,Not Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of Adalimumab Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),Drug,Adalimumab,60,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49889,No Results,No Results,No Results,25/02/2020,08/03/2020,None
149,ChiCTR2000030033,ChiCTR,21/02/2020,24/02/2020,FALSE,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,A study for the intervention of Xiangxue antiviral oral solution and Wu-Zhi-Fang-Guan-Fang on close contacts of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,828,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49703,No Results,No Results,No Results,25/02/2020,08/03/2020,None
150,ChiCTR2000030000,ChiCTR,19/02/2020,16/02/2020,TRUE,The Ninth Hospital of Nanchang,Recruiting,Phase 4,Interventional,China,"An open, controlled clinical trial for evaluation of ganovo combined with ritonavir and integrated traditional Chinese and Western medicine in the treatment of novel coronavirus infection (COVID-19)",Traditional Medicine + Western Medicine,Traditional Medicine,50,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49748,No Results,No Results,No Results,25/02/2020,18/03/2020,None
151,ChiCTR2000030017,ChiCTR,20/02/2020,17/02/2020,TRUE,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,Feature of Multiple Organs in Ultrasound Investigation for Clinical Management and Prognostic Evaluation of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,200,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49798,No Results,No Results,No Results,25/02/2020,08/03/2020,None
152,ChiCTR2000030088,ChiCTR,22/02/2020,01/03/2020,FALSE,The Sixth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,Umbilical cord Wharton's Jelly derived mesenchymal stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),40,Not Available,31/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=49902,No Results,No Results,No Results,25/02/2020,08/03/2020,None
153,ChiCTR2000030015,ChiCTR,20/02/2020,19/02/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Basic Science,China,Study for the correlation between the incidence and outcome of novel coronary pneumonia (COVID-2019) and ovarian function in women,Clinical Presentation,No Intervention,300,Not Available,19/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49800,Pre-Print Article,30/03/2020,https://doi.org/10.1101/2020.03.26.20043943,25/02/2020,08/03/2020,None
154,ChiCTR2000029956,ChiCTR,17/02/2020,18/02/2020,FALSE,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Chinese Medicine Promotes Rehabilitation Recommendations after 2019 Novel Coronavirus Infection (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,120,Not Available,01/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=49618,No Results,No Results,No Results,25/02/2020,08/03/2020,None
155,ChiCTR2000030012,ChiCTR,19/02/2020,19/02/2020,FALSE,"The First People's Hospital of Chenzhou, Institute of Translational Medicine,University of South China",Not Recruiting,Not Applicable,Interventional,China,Development of anti-2019-nCoV therapeutic antibody from the recovered novel coronavirus pneumonia patients (COVID-19),ATMP,Antibody,20,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49718,No Results,No Results,No Results,25/02/2020,08/03/2020,None
156,ChiCTR2000030087,ChiCTR,22/02/2020,12/02/2020,TRUE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical study for the diagnostic value of pulmonary ultrasound for novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,800,Not Available,12/02/2023,http://www.chictr.org.cn/showproj.aspx?proj=49919,No Results,No Results,No Results,25/02/2020,08/03/2020,None
157,ChiCTR2000030008,ChiCTR,19/02/2020,12/02/2020,TRUE,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Correalation between anxiety as well as depression and gut microbiome among staff of hospital during the novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),No Intervention,100,Not Available,12/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=49426,No Results,No Results,No Results,25/02/2020,08/03/2020,None
158,ChiCTR2000029781,ChiCTR,13/02/2020,14/02/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open and controlled trial for the efficacy and safety of Kang-Bing-Du granules in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,160,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49138,No Results,No Results,No Results,25/02/2020,08/03/2020,None
159,ChiCTR2000030086,ChiCTR,22/02/2020,24/02/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Study for the effects on medical providers' infection rate and mental health after performing different anesthesia schemes in cesarean section for novel coronavirus pneumonia (COVID-19) puerperae,Clinical Presentation,No Intervention,210,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49934,No Results,No Results,No Results,25/02/2020,08/03/2020,None
160,ChiCTR2000030006,ChiCTR,19/02/2020,19/02/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Ozone,60,Not Available,19/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49737,No Results,No Results,No Results,25/02/2020,08/03/2020,None
161,ChiCTR2000029740,ChiCTR,11/02/2020,11/02/2020,FALSE,The First Hospital of Peking University,Recruiting,Phase 4,Interventional,China,Efficacy of therapeutic effects of hydroxycholoroquine in novel coronavirus pneumonia (COVID-19) patients(randomized open-label control clinical trial),Drug,Hydroxychloroquine,78,Not Available,29/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49317,No Results,No Results,No Results,25/02/2020,08/03/2020,None
162,ChiCTR2000030010,ChiCTR,19/02/2020,19/02/2020,FALSE,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled, trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia patients (COVID-19)",ATMP,Plasma,100,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49777,No Results,No Results,No Results,25/02/2020,08/03/2020,None
163,ChiCTR2000030001,ChiCTR,19/02/2020,15/02/2020,TRUE,Health commission of Heilongjiang province,Recruiting,Phase 3,Interventional,China,"The efficacy and safety of Triazavirin for 2019 novel coronary pneumonia (COVID-19): a multicenter, randomized, double blinded, placebo-controlled trial",Drug,Triazavirin,240,Not Available,28/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49723,No Results,No Results,No Results,25/02/2020,08/03/2020,None
164,ChiCTR2000030054,ChiCTR,22/02/2020,22/02/2020,FALSE,Zhongshan Hospital Affiliated to Xiamen University,Not Recruiting,Not Applicable,Interventional,China,"A prospective, open label, randomized, control trial for chloroquine or hydroxychloroquine in patients with mild and common novel coronavirus pulmonary (COVIP-19)",Drug,Combination: Chloroquine vs. hydroxychloroquine,100,Not Available,21/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49869,No Results,No Results,No Results,25/02/2020,08/03/2020,None
165,ChiCTR2000029999,ChiCTR,19/02/2020,20/02/2020,FALSE,Shanghai 10th People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A clinical study for probiotics in the regulation of intestinal function and microflora structure of novel coronavirus pneumonia (COVID-19),Supplement,Probiotics,60,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49717,No Results,No Results,No Results,25/02/2020,18/03/2020,None
166,ChiCTR2000030039,ChiCTR,21/02/2020,31/05/2020,FALSE,Affiliated Hospital of Xuzhou Medical University,Recruiting,Not Applicable,Interventional,China,Clinical study for infusing convalescent plasma to treat patients with new coronavirus pneumonia (COVID-19),ATMP,Plasma,90,Not Available,01/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49544,No Results,No Results,No Results,25/02/2020,08/03/2020,None
167,ChiCTR2000029992,ChiCTR,18/02/2020,17/02/2020,TRUE,Zhongshan Hospital Affiliated to Xiamen University,Not Recruiting,Phase 4,Interventional,China,"A prospective, randomized, open label, controlled trial for chloroquine and hydroxychloroquine in patients with severe novel coronavirus pneumonia (COVID-19)",Drug,Combination: Chloroquine + hydroxychloroquine,100,Not Available,20/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49574,No Results,No Results,No Results,25/02/2020,08/03/2020,None
168,ChiCTR2000029996,ChiCTR,20/02/2020,20/02/2020,FALSE,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2,Interventional,China,"A randomized, open-label, controlled trial for the efficacy and safety of Farpiravir Tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19)",Drug,Favipiravir,60,Not Available,20/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49510,No Results,No Results,No Results,25/02/2020,08/03/2020,None
169,ChiCTR2000030021,ChiCTR,20/02/2020,20/02/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based analysis for the clinical characteristics of novel coronavirus pneumonia (COVID-19) in immunocompromised patients,Clinical Presentation,No Intervention,10,Not Available,29/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49690,No Results,No Results,No Results,25/02/2020,08/03/2020,None
170,NCT04270383,ClinicalTrials.gov,11/02/2020,15/02/2020,FALSE,Beijing Children's Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,Clinical Presentation,No Intervention,500,31/12/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04270383,No Results,No Results,No Results,02/03/2020,08/03/2020,None
171,NCT04275947,ClinicalTrials.gov,17/02/2020,14/02/2020,TRUE,Chinese Alliance Against Lung Cancer,Recruiting,Not Applicable,Observational,China,The COVID-19 Mobile Health Study (CMHS),Diagnostics,Diagnostic Test or Assessment,450,30/04/2020,31/05/2020,https://clinicaltrials.gov/show/NCT04275947,No Results,No Results,No Results,02/03/2020,08/03/2020,None
172,ChiCTR2000029990,ChiCTR,18/02/2020,30/01/2020,TRUE,"Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences",Recruiting,Phase 1/Phase 2,Interventional,China,Clinical trials of mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),120,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49674,Journal Article,13/03/2020,https://doi.org/10.14336/AD.2020.0228,25/02/2020,18/03/2020,None
173,ChiCTR2000029995,ChiCTR,19/02/2020,20/02/2020,FALSE,Shanghai General Hospital of Shanghai Jiaotong University,Recruiting,Not Applicable,Observational,China,Study on anxiety of different populations under novel coronavirus (COVID-19) infection,Other (psych),No Intervention,200,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49418,No Results,No Results,No Results,25/02/2020,08/03/2020,None
174,ChiCTR2000030020,ChiCTR,20/02/2020,06/02/2020,TRUE,"Second Hospital of University of South China, Hengyang",Recruiting,Not Applicable,Interventional,China,The clinical application and basic research related to mesenchymal stem cells to treat novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),20,Not Available,05/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=49812,No Results,No Results,No Results,25/02/2020,08/03/2020,None
175,ChiCTR2000029981,ChiCTR,18/02/2020,18/02/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Diagnostic test,China,Study for nucleic acid detection of novel coronavirus pneumonia (COVID-2019) in female vaginal secretions,Diagnostics,Diagnostic Test or Assessment,60,Not Available,18/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49692,Pre-Print Article,03/03/2020,https://doi.org/10.1101/2020.02.26.20028225,25/02/2020,08/03/2020,None
176,ChiCTR2000030019,ChiCTR,20/02/2020,28/02/2020,FALSE,"Zhongshan Hospital, Fudan University",Not Recruiting,Not Applicable,Observational,China,"The COVID-19 Mobile Health Study (CMHS), a large-scale clinical observational registration study using nCapp",Clinical Presentation,No Intervention,600,Not Available,31/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=49768,No Results,No Results,No Results,25/02/2020,08/03/2020,None
177,ChiCTR2000030420,ChiCTR,01/03/2020,01/03/2020,FALSE,"Institute of Integrative Medicine of Dalian Medical University, Dalian, China",Not Recruiting,Not Applicable,Interventional,China,A Clinical Trial Study for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,Other (psych),Psychological,60,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50286,No Results,No Results,No Results,02/03/2020,08/03/2020,None
178,ChiCTR2000029974,ChiCTR,18/02/2020,09/02/2020,TRUE,"Qingdao East Sea Pharmaceutical Co., Ltd.",Recruiting,Not Applicable,Interventional,China,"A prospective, multicenter, open-label, randomized, parallel-controlled trial for probiotics to evaluate efficacy and safety in patients infected with 2019 novel coronavirus pneumonia (COVID-19)",Supplement,Probiotics,300,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49321,No Results,No Results,No Results,25/02/2020,08/03/2020,None
179,ChiCTR2000030004,ChiCTR,19/02/2020,20/02/2020,FALSE,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Effect of Novel Coronavirus Pneumonia (COVID-19) on the Mental Health of College Students,Other (psych),No Intervention,150000,Not Available,31/01/2023,http://www.chictr.org.cn/showproj.aspx?proj=49783,No Results,No Results,No Results,25/02/2020,18/03/2020,None
180,ChiCTR2000029994,ChiCTR,18/02/2020,19/02/2020,FALSE,Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Liu-Zi-Jue Qigong and Acupressure Therapy for Pulmonary Function and Quality of Life in Patient with Severe novel coronavirus pneumonia (COVID-19): A Randomized Controlled Trial,Traditional Medicine (Drug),Traditional Medicine,200,Not Available,19/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49309,No Results,No Results,No Results,25/02/2020,08/03/2020,None
181,ChiCTR2000030390,ChiCTR,01/03/2020,01/01/2020,TRUE,Key Laboratory of Ministry of Industry and Information Technology of Biomedical Engineering and Translational Medicine,Recruiting,Not Applicable,Diagnostic test,China,Research and Development of Diagnostic Assistance Decision Support System for novel coronavirus pneumonia (COVID-19) Based on Big Data Technology,Diagnostics,Diagnostic Test or Assessment,3000,Not Available,01/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50224,No Results,No Results,No Results,02/03/2020,08/03/2020,None
182,ChiCTR2000030003,ChiCTR,19/02/2020,19/02/2020,FALSE,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Optimization Protocal of Integrated Traditional Chinese and Western Medicine in the Treatment for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,480,Not Available,01/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=49770,No Results,No Results,No Results,25/02/2020,08/03/2020,None
183,ChiCTR2000029803,ChiCTR,14/02/2020,20/02/2020,FALSE,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A prospective, randomized, open-label, controlled clinical study to evaluate the preventive effect of hydroxychloroquine on close contacts after exposure to the Novel Coronavirus Pneumonia (COVID-19)",Drug,Hydroxychloroquine vs. Umeprevir,320,Not Available,20/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=49428,No Results,No Results,No Results,25/02/2020,08/03/2020,None
184,ChiCTR2000030363,ChiCTR,29/02/2020,23/02/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"Novel Coronavirus Infected Disease (COVID-19) in children: epidemiology, clinical features and treatment outcome",Clinical Presentation (Epidemiology),No Intervention,120,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49984,No Results,No Results,No Results,02/03/2020,08/03/2020,None
185,ChiCTR2000030002,ChiCTR,19/02/2020,15/02/2020,TRUE,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Phase 4,Interventional,China,Clinical study of novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Tranilast,60,Not Available,30/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=49738,No Results,No Results,No Results,25/02/2020,08/03/2020,None
186,ChiCTR2000029780,ChiCTR,13/02/2020,14/02/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of Shen-Qi Fu-Zheng injection in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,160,Not Available,09/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49220,No Results,No Results,No Results,25/02/2020,08/03/2020,None
187,ChiCTR2000029989,ChiCTR,18/02/2020,20/02/2020,FALSE,Chinese PLA General Hospital,Not Recruiting,Phase 4,Interventional,China,A randomized controlled Trial for therapeutic efficacy of Recombinant Human Interferon alpha 1b Eye Drops in the treatment of elderly with novel coronavirus pneumonia (COVID-19),Drug,Interferon alfa,300,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49720,No Results,No Results,No Results,25/02/2020,08/03/2020,None
188,ChiCTR2000030322,ChiCTR,28/02/2020,01/02/2020,TRUE,Xinyang Central Hospital,Recruiting,Not Applicable,Observational,China,Identification and Clinical Treatment of Severe novel coronavirus pneumonia (COVID-19) Patients,Clinical Presentation,No Intervention,210,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50240,No Results,No Results,No Results,02/03/2020,08/03/2020,None
189,ChiCTR2000029978,ChiCTR,18/02/2020,21/02/2020,FALSE,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,186,Not Available,31/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=49702,No Results,No Results,No Results,25/02/2020,08/03/2020,None
190,ChiCTR2000029988,ChiCTR,18/02/2020,13/02/2020,TRUE,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Clinical Study of Chloroquine Phosphate in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),Drug,Chloroquine,80,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49218,No Results,No Results,No Results,25/02/2020,08/03/2020,None
191,ChiCTR2000030314,ChiCTR,28/02/2020,28/02/2020,FALSE,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Interventional,No Country Given,Traditional Chinese medicine Ma-Xing-Shi-Gan-Tang and Sheng-Jiang-San in the treatment of children with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,40,Not Available,28/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50248,No Results,No Results,No Results,02/03/2020,18/03/2020,None
192,NCT04275245,ClinicalTrials.gov,06/02/2020,03/02/2020,TRUE,Tang-Du Hospital,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia,Drug,Mepolizumab,20,31/12/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04275245,Pre-Print Article,24/03/2020,https://doi.org/10.1101/2020.03.21.20040691,02/03/2020,08/03/2020,None
193,NCT04275388,ClinicalTrials.gov,17/02/2020,14/02/2020,TRUE,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,Not Recruiting,Not Applicable,Interventional,No Country Given,Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia,Traditional Medicine (Drug),Traditional Medicine,348,14/05/2020,14/12/2021,https://clinicaltrials.gov/show/NCT04275388,No Results,No Results,No Results,02/03/2020,18/03/2020,None
194,ChiCTR2000029985,ChiCTR,18/02/2020,10/02/2020,TRUE,Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital,Recruiting,Not Applicable,Observational,China,Study for mental health status and influencing factors of nurses during epidemic prevention of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,1853,Not Available,29/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49711,No Results,No Results,No Results,25/02/2020,18/03/2020,None
195,ChiCTR2000029960,ChiCTR,17/02/2020,28/02/2020,FALSE,The First Affiliated Hospital of Hu'nan University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Comparative study for integrate Chinese and conventional medicine the the treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,Traditional Medicine + Western Medicine,Traditional Medicine,100,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49639,No Results,No Results,No Results,25/02/2020,08/03/2020,None
196,ChiCTR2000030305,ChiCTR,28/02/2020,09/03/2020,FALSE,Li Caixia,Not Recruiting,Not Applicable,Observational,China,Multiomics study and emergency plan optimization of spleen strengthening clearing damp and stomach therapy combined with antiviral therapy for novel coronavirus pneumonia (COVID-19),Genomics,No Intervention,20,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50223,No Results,No Results,No Results,02/03/2020,08/03/2020,None
197,ChiCTR2000029972,ChiCTR,17/02/2020,17/02/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the Efficacy of Ultra Short Wave Electrotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Other (physical),Ultra short wave electrotherapy,40,Not Available,17/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49664,No Results,No Results,No Results,25/02/2020,08/03/2020,None
198,NCT04279197,ClinicalTrials.gov,15/02/2020,15/02/2020,FALSE,ShuGuang Hospital,Recruiting,Phase 2,Interventional,China,Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu,Traditional Medicine (Drug),Traditional Medicine,136,01/12/2022,01/12/2022,https://clinicaltrials.gov/show/NCT04279197,No Results,No Results,No Results,02/03/2020,08/03/2020,None
199,NCT04280588,ClinicalTrials.gov,20/02/2020,22/02/2020,FALSE,The First Affiliated Hospital of Fujian Medical University,Recruiting,Phase 2,Interventional,China,Fingolimod in COVID-19,Drug,Fingolimod,30,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04280588,No Results,No Results,No Results,02/03/2020,08/03/2020,None
200,ChiCTR2000029954,ChiCTR,17/02/2020,30/04/2020,FALSE,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",Traditional Medicine (Drug),Traditional Medicine,300,Not Available,10/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49402,No Results,No Results,No Results,25/02/2020,08/03/2020,None
201,ChiCTR2000030260,ChiCTR,26/02/2020,27/02/2020,FALSE,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Interventional,China,Clinical study for individualized nutritional assessment and supportive treatment of novel coronavirus pneumonia (COVID-19) patients in Tibetan Plateau,Other (nutrition),Nutrition,20,Not Available,26/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=50130,No Results,No Results,No Results,02/03/2020,08/03/2020,None
202,ChiCTR2000030255,ChiCTR,26/02/2020,01/03/2020,FALSE,Shanghai University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Jing-Yin Granule in the treatment of novel coronavirus pneumonia (COVID-19) wind-heat syndrome,Traditional Medicine (Drug),Traditional Medicine,300,Not Available,31/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=50089,No Results,No Results,No Results,02/03/2020,08/03/2020,None
203,NCT04279899,ClinicalTrials.gov,18/02/2020,01/02/2020,TRUE,Children's Hospital of Fudan University,Recruiting,Not Applicable,Observational,China,The Investigation of the Neonates With or With Risk of COVID-19,Clinical Presentation,No Intervention,100,30/11/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04279899,No Results,No Results,No Results,02/03/2020,18/03/2020,None
204,ChiCTR2000030433,ChiCTR,01/03/2020,01/03/2020,FALSE,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Phase 1,Interventional,China,Application of Rehabilitation and Lung Eight-segment Exercise in Home Rehabilitation of Survivors from novel coronavirus pneumonia (COVID-19),Other (physio),Physio,80,Not Available,01/10/2020,http://www.chictr.org.cn/showproj.aspx?proj=50273,No Results,No Results,No Results,02/03/2020,08/03/2020,None
205,ChiCTR2000030432,ChiCTR,01/03/2020,02/03/2020,FALSE,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Not Applicable,Interventional,China,Application of rehabilitation and Lung eight-segment exercise in front-line nurses in the prevention of novel coronavirus pneumonia (COVID-19) epidemic,Other (physio),Physio,80,Not Available,27/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50268,No Results,No Results,No Results,02/03/2020,08/03/2020,None
206,ChiCTR2000029959,ChiCTR,17/02/2020,25/01/2020,TRUE,"West China Second Hospital, Sichuan University",Recruiting,Not Applicable,Observational,China,Clinical observation and research of  Severe acute respiratory syndrome coronavirus 2(COVID-19) infection in perinatal newborns,Clinical Presentation,No Intervention,30,Not Available,01/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=49636,No Results,No Results,No Results,25/02/2020,08/03/2020,None
207,ChiCTR2000030253,ChiCTR,26/02/2020,27/02/2020,FALSE,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Phase 1,Diagnostic test,China,Exploration and Research for a new method for detection of novel coronavirus (COVID-19) nucleic acid,Diagnostics,Diagnostic Test or Assessment,30,Not Available,26/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=50143,No Results,No Results,No Results,02/03/2020,08/03/2020,None
208,ChiCTR2000030418,ChiCTR,01/03/2020,01/03/2020,FALSE,The First Affiliated Hospital of Fujian Medical University,Recruiting,Not Applicable,Interventional,China,Application of rehabilitation lung exercise eight-segment exercise in patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio,80,Not Available,01/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=50341,No Results,No Results,No Results,02/03/2020,08/03/2020,None
209,ChiCTR2000030398,ChiCTR,01/03/2020,27/02/2020,TRUE,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, placebo-controlled trial for evaluation of  the efficacy and safety of bismuth potassium citrate capsules in the treatment of patients with novel coronavirus pneumonia (COVID-19).",Drug,Bismuth potassium citrate,340,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50173,No Results,No Results,No Results,02/03/2020,08/03/2020,None
210,ChiCTR2000030386,ChiCTR,18/02/2020,01/03/2020,FALSE,Hunan University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for moxibustion in the preventing of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,1000,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50323,No Results,No Results,No Results,02/03/2020,18/03/2020,None
211,ChiCTR2000030219,ChiCTR,25/02/2020,21/01/2020,TRUE,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for evaluation of integrated traditional Chinese and Western Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,120,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50110,No Results,No Results,No Results,02/03/2020,08/03/2020,None
212,ChiCTR2000030382,ChiCTR,17/02/2020,01/03/2020,FALSE,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Construction and application of non-contact doctor-patient interactive diagnosis and treatment mode of moxibustion therapy for novel coronary pneumonia (COVID-19) based on mobile internet,Traditional Medicine (Other),Traditional Medicine,50,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50325,No Results,No Results,No Results,02/03/2020,18/03/2020,None
213,ChiCTR2000030389,ChiCTR,01/03/2020,29/02/2020,TRUE,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,A Comparative Study for the Effectiveness of ''triple energizer treatment'' Method in Repairing Lung Injury in Patients with Novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,120,Not Available,23/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50278,No Results,No Results,No Results,02/03/2020,08/03/2020,None
214,ChiCTR2000030091,ChiCTR,23/02/2020,22/02/2020,TRUE,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,A prospective randomized controlled trial for the home exercise prescription intervention in nursing students during epidemic of novel coronary pneumonia (COVID-19),Other (exercise),Exercise,200,Not Available,22/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49914,No Results,No Results,No Results,02/03/2020,08/03/2020,None
215,ChiCTR2000030387,ChiCTR,01/03/2020,01/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical observation and research of multiple organs injury in severe patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,130,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50329,No Results,No Results,No Results,02/03/2020,08/03/2020,None
216,ChiCTR2000029866,ChiCTR,15/02/2020,17/02/2020,FALSE,Enze Hospital of Taizhou Enze Medical Center (Group),Recruiting,Not Applicable,Diagnostic test,China,Early warning prediction of patients with severe novel coronavirus pneumonia (COVID-19) based on multiomics,Genomics,No Intervention,120,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49519,No Results,No Results,No Results,25/02/2020,08/03/2020,None
217,ChiCTR2000030334,ChiCTR,28/02/2020,19/02/2020,TRUE,Nanjing Second Hospital,Recruiting,Not Applicable,Diagnostic test,China,microRNA as a marker for early diagnosis of novel coronavirus infection (COVID-19),Diagnostics,Diagnostic Test or Assessment,25,Not Available,19/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49491,No Results,No Results,No Results,02/03/2020,08/03/2020,None
218,ChiCTR2000030263,ChiCTR,26/02/2020,20/02/2020,TRUE,Beijing Geriatric Hospital,Not Recruiting,Not Applicable,Epidemiological research,China,Investigation and analysis of psychological status of hospital staff during the novel coronavirus pneumonia (COVID-19) epidemic,Other (psych),No Intervention,200,Not Available,20/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50140,No Results,No Results,No Results,02/03/2020,18/03/2020,None
219,ChiCTR2000030333,ChiCTR,28/02/2020,04/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"A randomized, open-label controlled trial for the efficacy and safety of Pirfenidone in patients with severe and critical novel coronavirus pneumonia (COVID-19)",Drug,Pirfenidone,292,Not Available,07/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=48801,No Results,No Results,No Results,02/03/2020,08/03/2020,None
220,ChiCTR2000030261,ChiCTR,26/02/2020,01/03/2020,FALSE,Wuxi Fifth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A study for the key technology of mesenchymal stem cells exosomes atomization in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),26,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49963,No Results,No Results,No Results,02/03/2020,08/03/2020,None
221,ChiCTR2000029975,ChiCTR,18/02/2020,24/02/2020,FALSE,The First Hospital of Jilin University,Not Recruiting,Phase 4,Interventional,China,Single arm study for exploration of chloroquine phosphate aerosol inhalation in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,10,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49592,No Results,No Results,No Results,02/03/2020,08/03/2020,None
222,ChiCTR2000030317,ChiCTR,28/02/2020,01/03/2020,FALSE,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical study for a new type of Gastroscope isolation mask for preventing and controlling the novel coronavirus pneumonia (COVID-19) Epidemic period,Other (physical),Gastroscope mask,300,Not Available,30/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=50247,No Results,No Results,No Results,02/03/2020,08/03/2020,None
223,ChiCTR2000030218,ChiCTR,25/02/2020,22/01/2020,TRUE,The Fifth People's Hospital of Ganzhou,Recruiting,Not Applicable,Interventional,China,Study of Pinavir / Ritonavir Tablets (Trade Name: Kelizhi) Combined with Xiyanping Injection for Novel Coronavirus Pneumonia (COVID-19),Drug,Lopinavir/ritonavir (+ Tradtional Medicine),80,Not Available,25/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50115,No Results,No Results,No Results,02/03/2020,08/03/2020,None
224,ChiCTR2000030315,ChiCTR,28/02/2020,01/01/2020,TRUE,Affiliated Hospital of Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,120,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50255,No Results,No Results,No Results,02/03/2020,08/03/2020,None
225,ChiCTR2000029900,ChiCTR,16/02/2020,17/02/2020,FALSE,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Research for Risks Associated with Novel Coronavirus Pneumonia (COVID-19) in the Hospital Workers and Nosocomial  Prevention and Control Strategy,Clinical Presentation,No Intervention,200,Not Available,29/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=49377,No Results,No Results,No Results,02/03/2020,08/03/2020,None
226,ChiCTR2000030283,ChiCTR,27/02/2020,27/02/2020,FALSE,Xianning Central Hospital,Recruiting,Not Applicable,Observational,China,Correlation between imaging characteristics and laboratory tests of new coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50119,No Results,No Results,No Results,02/03/2020,08/03/2020,None
227,ChiCTR2000030265,ChiCTR,26/02/2020,24/02/2020,TRUE,The First Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for continuous renal replacement therapy with adsorption filter in the treatment of the novel coronavirus pneumonia (COVID-19),Other (renal),Renal replacement therapy,30,Not Available,23/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=49691,No Results,No Results,No Results,02/03/2020,08/03/2020,None
228,ChiCTR2000030264,ChiCTR,26/02/2020,28/02/2020,FALSE,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,ICU healthcare personnel burnout investigation during the fight against novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,1000,Not Available,01/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50161,No Results,No Results,No Results,02/03/2020,08/03/2020,None
229,ChiCTR2000030215,ChiCTR,25/02/2020,26/02/2020,FALSE,"The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang University",Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy of Kangguan No. 1-3 prescription in the treatment of novel coronavirus pneumonia (COVID19),Traditional Medicine (Drug),Traditional Medicine,120,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50107,No Results,No Results,No Results,02/03/2020,08/03/2020,None
230,NCT04286503,ClinicalTrials.gov,25/02/2020,23/02/2020,TRUE,"Beijing You'an Hospital, Capital Medical University",Not Recruiting,Phase 4,Interventional,No Country Given,The Clinical Study of Carrimycin on Treatment Patients With COVID-19,Drug,Carrimycin vs. lopinavir/ritonavir or Umifenovir or chloroquine,520,28/02/2021,28/02/2021,https://clinicaltrials.gov/show/NCT04286503,No Results,No Results,No Results,09/03/2020,08/03/2020,None
231,ChiCTR2000030581,ChiCTR,08/03/2020,02/02/2020,TRUE,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,The immediate psychological impact of novel coronavirus pneumonia (COVID-19) outbreak on medical students in anesthesiology and how the cope,Other (psych),No Intervention,192,Not Available,02/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=50394,No Results,No Results,No Results,09/03/2020,08/03/2020,None
232,ChiCTR2000029865,ChiCTR,15/02/2020,20/02/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Descriptive study on the clinical characteristics and outcomes of novel coronavirus pneumonia (COVID-19) in cardiovascular patients,Prognosis,No Intervention,1200,Not Available,20/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49545,No Results,No Results,No Results,25/02/2020,08/03/2020,None
233,ChiCTR2000030196,ChiCTR,25/02/2020,20/02/2020,TRUE,Central South Hospital of Wuhan University,Not Recruiting,Phase 2,Interventional,China,"A multicenter, single arm, open label trial for the efficacy and safety of CMAB806 in the treatment of cytokine release syndrome of novel coronavirus pneumonia (COVID-19)",Drug,Tocilizumab,60,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49883,No Results,No Results,No Results,02/03/2020,08/03/2020,None
234,ChiCTR2000029386,ChiCTR,29/01/2020,29/01/2020,FALSE,Chongqing Public Health Medical Center,Recruiting,Not Applicable,Interventional,China,Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: a randomized controlled trial,Drug,Corticosteroids,48,Not Available,29/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=48777,No Results,No Results,No Results,02/03/2020,08/03/2020,None
235,ChiCTR2000030574,ChiCTR,07/03/2020,08/03/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Research on peripheral immunity function monitoring and its clinical application in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,500,Not Available,08/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=49953,No Results,No Results,No Results,09/03/2020,08/03/2020,None
236,ChiCTR2000030022,ChiCTR,20/02/2020,22/02/2020,FALSE,The First Affiliated Hospital of Anhui Medical University,Not Recruiting,Phase 4,Interventional,China,"A parallel, randomized controlled clinical trial for the efficacy and safety of Pediatric Huatanzhike granules (containing ipecacuanha tincture) in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,100,Not Available,22/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49797,No Results,No Results,No Results,02/03/2020,08/03/2020,None
237,ChiCTR2000030556,ChiCTR,07/03/2020,15/03/2020,FALSE,Anhui Cancer Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical study of nano-nose and its extended technology in diagnosis of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,200,Not Available,01/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50672,No Results,No Results,No Results,09/03/2020,08/03/2020,None
238,ChiCTR2000029851,ChiCTR,15/02/2020,19/02/2020,FALSE,"Zhongshan Hospital, Fudan University",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of Alpha lipoic acid (iv) in the treatment of patients of severe novel coronavirus pneumonia (COVID-19)",Supplement,Alpha lipoic acid,68,Not Available,10/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49534,Pre-Print Article,21/04/2020,https://doi.org/10.1101/2020.04.15.20066266,25/02/2020,08/03/2020,None
239,NCT04276987,ClinicalTrials.gov,16/02/2020,15/02/2020,TRUE,Ruijin Hospital,Not Recruiting,Phase 1,Interventional,No Country Given,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,ATMP,Cells (mesenchymal),30,31/05/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04276987,No Results,No Results,No Results,09/03/2020,18/03/2020,None
240,ChiCTR2000030593,ChiCTR,08/03/2020,10/03/2020,FALSE,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Observational,China,"Novel coronavirus pneumonia (COVID-19) antiviral related liver dysfunction: a multicenter, retrospective, observational study",Clinical Presentation,No Intervention,150,Not Available,09/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50228,No Results,No Results,No Results,09/03/2020,08/03/2020,None
241,ChiCTR2000030013,ChiCTR,19/02/2020,20/02/2020,FALSE,Chinese PLA General Hospital,Not Recruiting,Phase 4,Interventional,China,A prospective clinical study for recombinant human interferon alpha 1b spray in the prevention of novel coronavirus (COVID-19) infection in highly exposed medical staffs.,Drug,Interferon alfa,450,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49796,No Results,No Results,No Results,02/03/2020,08/03/2020,None
242,ChiCTR2000030542,ChiCTR,06/03/2020,09/03/2020,FALSE,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,"A clinical study about the diagnosis and prognosis evaluation of novel coronacirus pneumonia (COVID-19) based on viral genome, host genomic sequencing, relative cytokines and other laboratory indexes.",Genomics,No Intervention,600,Not Available,30/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=50608,Pre-Print Article,21/03/2020,https://doi.org/10.1101/2020.03.18.20035816,09/03/2020,08/03/2020,None
243,ChiCTR2000030559,ChiCTR,07/03/2020,07/03/2020,FALSE,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Observational,China,A medical records based study for the safety of artificial liver cluster nursing in critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,12,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50583,No Results,No Results,No Results,09/03/2020,08/03/2020,None
244,ChiCTR2000030557,ChiCTR,07/03/2020,10/03/2020,FALSE,The Third Affiliated Hospital of the Second Military Medical University,Recruiting,Not Applicable,Observational,China,"A retrospective study on virus typing, Hematological Immunology and case Review of novel coronavirus infected and convalescent patients (COVID-19)",Clinical Presentation,No Intervention,1030,Not Available,10/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=50667,No Results,No Results,No Results,09/03/2020,08/03/2020,None
245,NCT04273529,ClinicalTrials.gov,14/02/2020,20/02/2020,FALSE,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia,Drug,Thalidomide,100,30/05/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04273529,No Results,No Results,No Results,02/03/2020,08/03/2020,None
246,NCT04273581,ClinicalTrials.gov,14/02/2020,18/02/2020,FALSE,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19,Drug,Combination: thalidomide + corticosteroids,40,30/04/2020,30/05/2020,https://clinicaltrials.gov/show/NCT04273581,No Results,No Results,No Results,02/03/2020,08/03/2020,None
247,ChiCTR2000029991,ChiCTR,18/02/2020,18/02/2020,FALSE,The First Affiliated Hospital of Nanchang University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for the safety and efficiency of Kesuting syrup and Keqing capsule in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,72,Not Available,18/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=49666,No Results,No Results,No Results,02/03/2020,08/03/2020,None
248,ChiCTR2000030543,ChiCTR,06/03/2020,14/02/2020,TRUE,Central Theater General Hospital of PLA,Recruiting,Not Applicable,Observational,China,Detection of coronavirus in simultaneously collecting tears and throat swab samples collected from the patients with novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,35,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50541,No Results,No Results,No Results,09/03/2020,08/03/2020,None
249,ChiCTR2000030540,ChiCTR,06/03/2020,08/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Research for the mechanism of improvement of novel coronavirus pneumonia (COVID-19) patients' pulmonary exudation by continuous renal replacement therapy,Other (renal),Renal replacement therapy,152,Not Available,08/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50658,No Results,No Results,No Results,09/03/2020,08/03/2020,None
250,ChiCTR2000029755,ChiCTR,12/02/2020,15/02/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, open, parallel-controlled clinical trial on the efficacy and safety of Jingyebaidu granules in treating novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,120,Not Available,30/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49301,No Results,No Results,No Results,02/03/2020,08/03/2020,None
251,ChiCTR2000030541,ChiCTR,06/03/2020,06/03/2020,FALSE,"Xiamen Medical College,Shijiazhuang Medical College",Not Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-19) epidemic survey of medical students in various provinces and municipalities throughout the country,Clinical Presentation,No Intervention,1300,Not Available,13/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50623,No Results,No Results,No Results,09/03/2020,08/03/2020,None
252,ChiCTR2000030492,ChiCTR,04/03/2020,04/03/2020,FALSE,The First Affiliated Hospital of Hu'nan University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Retrospective study for integrate Chinese and conventional medicine  treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,Traditional Medicine + Western Medicine,Traditional Medicine,200,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50549,No Results,No Results,No Results,09/03/2020,08/03/2020,None
253,ChiCTR2000029728,ChiCTR,10/02/2020,15/02/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A Retrospective Study for Preventive Medication in Tongji Hospital During the Epidemic of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,500,Not Available,30/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49250,No Results,No Results,No Results,02/03/2020,08/03/2020,None
254,ChiCTR2000030490,ChiCTR,04/03/2020,01/02/2020,TRUE,Huo-Shen-Shan Hospital,Recruiting,Not Applicable,Interventional,No Country Given,To evaluate the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsules combined with hydrogen-rich water in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Combination: diammonium glycyrrhizinate + hydrogen,100,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50487,No Results,No Results,No Results,09/03/2020,08/03/2020,None
255,ChiCTR2000030518,ChiCTR,05/03/2020,29/02/2020,TRUE,The Second Affiliated Hospital of Wenzhou Medical University,Recruiting,Not Applicable,Interventional,China,"Zedoary Turmeric Oil for Injection in the treatment of Novel Coronavirus Pneumonia (COVID-19): a randomized, open, controlled trial",Traditional Medicine (Drug),Traditional Medicine,60,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50586,No Results,No Results,No Results,09/03/2020,08/03/2020,None
256,ChiCTR2000030481,ChiCTR,03/03/2020,01/03/2020,TRUE,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,The clinical value of corticosteroid therapy timing in the treatment of novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,Drug,Corticosteroids,200,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50453,No Results,No Results,No Results,09/03/2020,08/03/2020,None
257,ChiCTR2000029387,ChiCTR,29/01/2020,25/01/2020,TRUE,Chongqing Public Health Medical Center,Recruiting,Not Applicable,Interventional,China,"Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia",Drug,"Combination: ribavirin + interferon alfa
vs. lopinavir/ritonavir + interferon alfa
vs. ribavirin + interferon alfa vs. lopinavir/ritonavir",108,Not Available,25/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=48782,No Results,No Results,No Results,02/03/2020,08/03/2020,None
258,ChiCTR2000030491,ChiCTR,04/03/2020,03/03/2020,TRUE,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,A medical records based study for Comparing Differences of Clinical Features and Outcomes of Novel Coronavirus Pneumonia (COVID-19) Patients between Sichuan Province and Wuhan City,Clinical Presentation,No Intervention,100,Not Available,01/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=50552,No Results,No Results,No Results,09/03/2020,08/03/2020,None
259,ChiCTR2000030489,ChiCTR,04/03/2020,01/02/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Epidemiological research,China,Study for the route of ocular surface transmission of novel coronavirus pneumonia (COVID-19) infection and related eye diseases,Clinical Presentation,No Intervention,1000,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50490,Pre-Print Article,16/03/2020,https://doi.org/10.1101/2020.03.12.20034678,09/03/2020,08/03/2020,None
260,NCT04281693,ClinicalTrials.gov,20/02/2020,01/02/2020,TRUE,Affiliated Hospital to Academy of Military Medical Sciences,Not Recruiting,Not Applicable,Interventional,China,A New Screening Strategy for 2019 Novel Coronavirus Infection,Diagnostics,Diagnostic Test or Assessment,230,01/03/2020,01/03/2020,https://clinicaltrials.gov/show/NCT04281693,No Results,No Results,No Results,09/03/2020,18/03/2020,None
261,NCT04282902,ClinicalTrials.gov,10/02/2020,04/02/2020,TRUE,Huilan Zhang,Recruiting,Phase 3,Interventional,China,A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection,Drug,Pirfenidone,294,30/04/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04282902,No Results,No Results,No Results,09/03/2020,18/03/2020,None
262,ChiCTR2000030467,ChiCTR,02/03/2020,01/03/2020,TRUE,"Dalian Medical University, Dalian, China.",Not Recruiting,Not Applicable,Interventional,China,A Randomized  Controlled Trial  for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,Traditional Medicine + Western Medicine,Traditional Medicine,60,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50378,No Results,No Results,No Results,09/03/2020,08/03/2020,None
263,ChiCTR2000030484,ChiCTR,03/03/2020,02/02/2020,TRUE,Hubei Shiyan Taihe hospital,Not Recruiting,Not Applicable,Interventional,China,HUMSCs and Exosomes Treating Patients with Lung Injury following Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (mesenchymal),90,Not Available,31/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=50263,No Results,No Results,No Results,09/03/2020,18/03/2020,None
264,NCT04284046,ClinicalTrials.gov,22/02/2020,31/01/2020,TRUE,Shanghai General Hospital of Shanghai Jiaotong University,Not Recruiting,Not Applicable,Observational,China,CT Scores Predict Mortality in 2019-nCoV Pneumonia,Prognosis,No Intervention,39,18/02/2020,18/02/2020,https://clinicaltrials.gov/show/NCT04284046,No Results,No Results,No Results,09/03/2020,18/03/2020,None
265,NCT04285190,ClinicalTrials.gov,19/02/2020,26/02/2020,FALSE,"Tasly Pharmaceuticals, Inc.",Not Recruiting,Not Applicable,Interventional,No Country Given,The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19,Traditional Medicine (Drug),Traditional Medicine,120,15/06/2020,15/09/2020,https://clinicaltrials.gov/show/NCT04285190,No Results,No Results,No Results,09/03/2020,18/03/2020,None
266,ChiCTR2000030482,ChiCTR,03/03/2020,06/03/2020,FALSE,Peking University First Hospital,Not Recruiting,Not Applicable,Observational,China,"A Multicenter, Long- term Follow-up and Registration Study for Myocardial Injury and Prognosis of Novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,8000,Not Available,31/12/2023,http://www.chictr.org.cn/showproj.aspx?proj=50353,No Results,No Results,No Results,09/03/2020,08/03/2020,None
267,ChiCTR2000030475,ChiCTR,03/03/2020,04/03/2020,FALSE,Chinese Academy of Medical Sciences Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Interventional,China,Cytosorb in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),Other (physical),Extracorporeal blood purification ,19,Not Available,25/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50452,No Results,No Results,No Results,09/03/2020,08/03/2020,None
268,NCT04279782,ClinicalTrials.gov,15/02/2020,20/01/2020,TRUE,"Third Affiliated Hospital, Sun Yat-Sen University",Recruiting,Not Applicable,Observational,China,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,Clinical Presentation,No Intervention,100,31/01/2021,28/02/2021,https://clinicaltrials.gov/show/NCT04279782,No Results,No Results,No Results,02/03/2020,18/03/2020,None
269,NCT04279795,ClinicalTrials.gov,19/02/2020,20/01/2020,TRUE,"Third Affiliated Hospital, Sun Yat-Sen University",Recruiting,Not Applicable,Observational,China,Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations,Clinical Presentation,No Intervention,20,31/01/2021,28/02/2021,https://clinicaltrials.gov/show/NCT04279795,No Results,No Results,No Results,02/03/2020,18/03/2020,None
270,ChiCTR2000030627,ChiCTR,08/03/2020,01/02/2020,TRUE,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Interventional,China,Study for using the healed novel coronavirus pneumonia (COVID-19) patients plasma in the treatment of severe critical cases,ATMP,Plasma,30,Not Available,30/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50727,No Results,No Results,No Results,09/03/2020,08/03/2020,None
271,ChiCTR2000030464,ChiCTR,02/03/2020,03/03/2020,FALSE,"The Third Xiangya Hospital, Central South University",Recruiting,Not Applicable,Epidemiological research,No Country Given,Study for the clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,200,Not Available,01/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50382,No Results,No Results,No Results,09/03/2020,08/03/2020,None
272,ChiCTR2000030163,ChiCTR,24/02/2020,25/02/2020,FALSE,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Observational,China,A Medical Based Retrospective Real World Study for Assessment of Effectiveness of Comprehensive Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,256,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50031,No Results,No Results,No Results,09/03/2020,08/03/2020,None
273,ChiCTR2000030579,ChiCTR,08/03/2020,15/02/2020,TRUE,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Risk Factors for Outcomes of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,200,Not Available,01/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50692,No Results,No Results,No Results,09/03/2020,08/03/2020,None
274,ChiCTR2000029580,ChiCTR,05/02/2020,31/01/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"Severe novel coronavirus pneumonia (COVID-19) patients treated with ruxolitinib in combination with mesenchymal stem cells: a prospective, single blind, randomized controlled clinical trial",Drug (+ ATMP),Ruxolimab + Cells (mesenchymal),70,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49088,No Results,No Results,No Results,09/03/2020,08/03/2020,None
275,ChiCTR2000030578,ChiCTR,08/03/2020,07/03/2020,TRUE,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical Prediction and Intervention of Pulmonary Function Impairment in Patients with Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,40,Not Available,01/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=50690,No Results,No Results,No Results,09/03/2020,08/03/2020,None
276,ChiCTR2000030564,ChiCTR,07/03/2020,15/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Psychological Intervention of Children with Novel Coronavirus Disease (COVID-19),Other (psych),Psychological,120,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50653,No Results,No Results,No Results,09/03/2020,08/03/2020,None
277,ChiCTR2000029993,ChiCTR,18/02/2020,20/02/2020,FALSE,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,A pilot study for Integrated Chinese and Western Medicine in the treatment of non-critical novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,40,Not Available,20/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49435,No Results,No Results,No Results,09/03/2020,08/03/2020,None
278,ChiCTR2000030544,ChiCTR,06/03/2020,24/02/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the risk factors of critically ill patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,1500,Not Available,01/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=50134,No Results,No Results,No Results,09/03/2020,08/03/2020,None
279,ChiCTR2000029638,ChiCTR,08/02/2020,03/02/2020,TRUE,West China Hospital of Sichuan University,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of 2019 Novel Coronavirus (2019-nCoV) Infected Pneumonia",Drug,Interferon,100,Not Available,01/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49224,No Results,No Results,No Results,09/03/2020,08/03/2020,None
280,NCT04292327,ClinicalTrials.gov,23/02/2020,01/01/2020,TRUE,Fujian Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus,Clinical Presentation,No Intervention,400,30/04/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04292327,No Results,No Results,No Results,16/03/2020,18/03/2020,None
281,NCT04295551,ClinicalTrials.gov,03/03/2020,14/03/2020,FALSE,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,Not Recruiting,Not Applicable,Interventional,No Country Given,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe),Traditional Medicine (Drug),Traditional Medicine,80,14/07/2020,14/04/2021,https://clinicaltrials.gov/show/NCT04295551,No Results,No Results,No Results,16/03/2020,08/03/2020,None
282,ChiCTR2000030493,ChiCTR,04/03/2020,04/03/2020,FALSE,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,"Survey for sleep, anxiety and depression status of Chinese residents during the outbreak of novel coronavirus infected disases (COVID-19)",Other (psych),No Intervention,1300,Not Available,03/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=50547,No Results,No Results,No Results,09/03/2020,18/03/2020,None
283,ChiCTR2000029579,ChiCTR,05/02/2020,31/01/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,The investigation of cytokine expression profile of novel coronavirus pneumonia (COVID-19) and its clinical significance,Clinical Presentation,No Intervention,200,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49045,No Results,No Results,No Results,09/03/2020,08/03/2020,None
284,ChiCTR2000030442,ChiCTR,02/03/2020,05/03/2020,FALSE,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,No Country Given,"Combination of Tocilizumab, IVIG and CRRT in severe patients with novel coronavirus pneumonia (COVID-19)",Drug (+ ATMP + Other (renal)),Combination: Tocilizumab + immunoglobulin + renal replacement therapy,100,Not Available,15/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50380,No Results,No Results,No Results,02/03/2020,18/03/2020,None
285,NCT04296643,ClinicalTrials.gov,03/03/2020,01/04/2020,FALSE,McMaster University,Not Recruiting,Not Applicable,Interventional,No Country Given,Medical Masks vs N95 Respirators for COVID-19,Other (device),Masks,576,01/12/2020,01/01/2021,https://clinicaltrials.gov/show/NCT04296643,No Results,No Results,No Results,16/03/2020,18/03/2020,None
286,NCT04299711,ClinicalTrials.gov,04/03/2020,15/10/2020,FALSE,University of Macau,Not Recruiting,Not Applicable,Observational,No Country Given,Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019,Other (psych),No Intervention,3428,15/11/2020,15/03/2022,https://clinicaltrials.gov/show/NCT04299711,No Results,No Results,No Results,16/03/2020,18/03/2020,None
287,ChiCTR2000030424,ChiCTR,01/03/2020,02/03/2020,FALSE,Henan Provincial People's Hospital,Not Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,30,Not Available,02/05/2022,http://www.chictr.org.cn/showproj.aspx?proj=50174,No Results,No Results,No Results,02/03/2020,08/03/2020,None
288,ChiCTR2000029308,ChiCTR,23/01/2020,10/01/2020,TRUE,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,"A randomized, controlled open-label trial to evaluate the efficacy and safety of lopinavir-ritonavir in hospitalized patients with novel coronavirus pneumonia (COVID-19)",Drug,Lopinavir/ritonavir,160,Not Available,10/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=48684,Journal Article,18/03/2020,doi.org/10.1056/NEJMoa2001282,09/03/2020,08/03/2020,None
289,ChiCTR2000030897,ChiCTR,16/03/2020,10/02/2020,TRUE,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,Evaluation of the effect of taking Newgen beta-gluten probiotic composite powder to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19),Supplement,Probiotics,20,Not Available,01/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=50462,No Results,No Results,No Results,16/03/2020,18/03/2020,None
290,ChiCTR2000030391,ChiCTR,01/03/2020,01/03/2020,FALSE,Lishui Central Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based analysis for antiviral therapy effect on novel coronavirus pneumonia COVID-19 patients,Clinical Presentation,No Intervention,100,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=30796,Pre-Print Article,29/04/2020,https://doi.org/10.1101/2020.04.25.20079079,02/03/2020,08/03/2020,None
291,ChiCTR2000030480,ChiCTR,03/03/2020,03/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"Randomized, open, blank controlled trial for the efficacy and safety of recombinant human interferon alpha 1beta in the treatment of Wuhan patients with novel coronavirus pneumonia (COVID-19)",Drug,Interferon alfa,328,Not Available,03/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=50470,No Results,No Results,No Results,09/03/2020,08/03/2020,None
292,NCT04298814,ClinicalTrials.gov,26/02/2020,07/03/2020,FALSE,Tongji Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia,Other (physical),Endotracheal Intubation,120,30/05/2020,30/07/2020,https://clinicaltrials.gov/show/NCT04298814,No Results,No Results,No Results,16/03/2020,18/03/2020,None
293,ChiCTR2000030898,ChiCTR,16/03/2020,27/01/2020,TRUE,The Affiliated Hospital to Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Evaluation on the effect of Chushifangyi prescription in preventing novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,1000,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50780,No Results,No Results,No Results,16/03/2020,18/03/2020,None
294,ChiCTR2000030892,ChiCTR,16/03/2020,06/03/2020,TRUE,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Pirfenidone in the Treatment of Severe Post-Novel Coronavirus Pneumonia (COVID-19) Fibrosis: a prospective exploratory experimental medical study,Drug,Pirfenidone,40,Not Available,30/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51118,No Results,No Results,No Results,16/03/2020,18/03/2020,None
295,ChiCTR2000030327,ChiCTR,28/02/2020,21/01/2020,TRUE,The Second Affiliated hospital of Anhui Medical University,Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,200,Not Available,08/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50214,No Results,No Results,No Results,02/03/2020,08/03/2020,None
296,ChiCTR2000030325,ChiCTR,28/02/2020,28/02/2020,FALSE,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Observational,China,A survey of mental health of first-line medical service providers and construction of crisis intervention model for novel coronavirus pneumonia (COVID-19) in Xiangyang,Other (psych),No Intervention,500,Not Available,28/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50227,No Results,No Results,No Results,02/03/2020,08/03/2020,None
297,ChiCTR2000030866,ChiCTR,16/03/2020,01/02/2020,TRUE,The First Hospital of Changsha,Recruiting,Not Applicable,Observational,China,"Open-label, observational study of human umbilical cord derived mesenchymal stem cells in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19)",ATMP,Cells (mesenchymal),30,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50299,No Results,No Results,No Results,16/03/2020,18/03/2020,None
298,ChiCTR2000030883,ChiCTR,16/03/2020,18/02/2020,TRUE,"Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University",Recruiting,Not Applicable,Observational,China,Clinical research and preparation development of qingfei detoxification decoction (mixture) for prevention and treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50960,No Results,No Results,No Results,16/03/2020,18/03/2020,None
299,ChiCTR2000030864,ChiCTR,16/03/2020,01/02/2020,TRUE,Xiangyang First People's Hospital,Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine for novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,50,Not Available,31/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=50662,No Results,No Results,No Results,16/03/2020,18/03/2020,None
300,ChiCTR2000030324,ChiCTR,28/02/2020,28/02/2020,FALSE,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine 'Zang-Fu Point-pressing' massage for children with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,40,Not Available,28/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50231,No Results,No Results,No Results,02/03/2020,08/03/2020,None
301,ChiCTR2000030865,ChiCTR,16/03/2020,01/02/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Establishment of an early warning model for maternal and child vertical transmission of COVID-19 infection,Clinical Presentation,No Intervention,200,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49933,No Results,No Results,No Results,16/03/2020,18/03/2020,None
302,ChiCTR2000030859,ChiCTR,16/03/2020,01/03/2020,TRUE,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,A medical based analysis for influencing factors of death of novel coronavirus pneumonia (COVID-19) patients in Wuhan third hospital,Prognosis,No Intervention,1305,Not Available,01/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51025,No Results,No Results,No Results,16/03/2020,18/03/2020,None
303,ChiCTR2000030293,ChiCTR,27/02/2020,01/03/2020,FALSE,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Observational,China,Clinical observation and research plan of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,300,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50195,No Results,No Results,No Results,02/03/2020,08/03/2020,None
304,ChiCTR2000030858,ChiCTR,16/03/2020,06/02/2020,TRUE,Hubei Cancer Hospital,Recruiting,Not Applicable,Observational,China,"Clinical characteristics and outcomes of 483 mild patients with novel coronavirus pneumonia (COVID-19) in Wuhan, China during the outbreak: A single-center, retrospective study from the mobile cabin hospital",Clinical Presentation,No Intervention,483,Not Available,15/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51097,No Results,No Results,No Results,16/03/2020,18/03/2020,None
305,ChiCTR2000030857,ChiCTR,16/03/2020,01/03/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical study for bronchoscopic alveolar lavage in the treatment of critically trachea intubation patients with new coronavirus pneumonia (COVID-19),Other (physical),Bronchoscopic lavage,30,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51040,No Results,No Results,No Results,16/03/2020,18/03/2020,None
306,ChiCTR2000030290,ChiCTR,27/02/2020,11/02/2020,TRUE,Xiamen University,Not Recruiting,Not Applicable,Observational,China,Health related quality of life and its influencing factors among front line nurses caring patients with new coronavirus pneumonia (COVID-19) from two hospitals in China,Other (psych),No Intervention,2000,Not Available,27/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=50175,No Results,No Results,No Results,02/03/2020,08/03/2020,None
307,ChiCTR2000030856,ChiCTR,16/03/2020,15/02/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Diagnostic test,China,An artificial intelligence assistant system for suspected novel coronavirus pneumonia (COVID-19) based on chest CT,Diagnostics,Diagnostic Test or Assessment,600,Not Available,15/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=51091,No Results,No Results,No Results,16/03/2020,18/03/2020,None
308,ChiCTR2000030855,ChiCTR,16/03/2020,01/02/2020,TRUE,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Phase 1,Interventional,No Country Given,Study for the effect of external diaphragmatic pacing assisted invasive ventilation and weaning in patients with severe novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,200,Not Available,01/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=51090,No Results,No Results,No Results,16/03/2020,18/03/2020,None
309,ChiCTR2000030849,ChiCTR,15/03/2020,16/03/2020,FALSE,Zhengzhou People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Investigation on psychological status of novel coronavirus pneumonia (COVID-19) rehabilitation patients in Zhengzhou City and research on coping strategies,Other (psych),No Intervention,81,Not Available,01/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51086,No Results,No Results,No Results,16/03/2020,18/03/2020,None
310,ChiCTR2000030479,ChiCTR,03/03/2020,26/02/2020,TRUE,"Affiliated Hospital of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine",Not Recruiting,Not Applicable,Interventional,China,Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,25/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=50450,No Results,No Results,No Results,09/03/2020,08/03/2020,None
311,ChiCTR2000030850,ChiCTR,15/03/2020,15/03/2020,FALSE,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Study for the physical and mental health status of medical workers under the novel coronavirus pneumonia (COVID-19) epidemic,Other (psych),No Intervention,226,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51056,No Results,No Results,No Results,16/03/2020,18/03/2020,None
312,ChiCTR2000030259,ChiCTR,26/02/2020,22/02/2020,TRUE,Shanghai Changzheng Hospital,Recruiting,Not Applicable,Interventional,China,"Evaluation Danorevir sodium tablets combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19): a randomized, open and controlled trial",Drug,Combination: Danoprevir + ritonavir,60,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49918,No Results,No Results,No Results,02/03/2020,08/03/2020,None
313,ChiCTR2000030258,ChiCTR,26/02/2020,21/02/2020,TRUE,The Fourth Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for efficacy and safety of hydrogen inhalation in the treatment of novel coronavirus pneumonia (COVID-19) patients",Drug,Hydrogen,60,Not Available,20/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49887,No Results,No Results,No Results,02/03/2020,08/03/2020,None
314,ChiCTR2000030477,ChiCTR,03/03/2020,04/03/2020,FALSE,Chinese Academy of Medical Sciences Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Interventional,China,oXiris Membrane in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,19,Not Available,25/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50458,No Results,No Results,No Results,09/03/2020,08/03/2020,None
315,ChiCTR2000030841,ChiCTR,15/03/2020,17/02/2020,TRUE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Exploratory study for Immunoglobulin From Cured COVID-19 Patients in the Treatment of Acute Severe novel coronavirus pneuvirus (COVID-19),ATMP,Immunoglobulin,10,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=51072,No Results,No Results,No Results,16/03/2020,18/03/2020,None
316,ChiCTR2000030257,ChiCTR,26/02/2020,09/03/2020,FALSE,Puren Hospital of Wuhan City,Not Recruiting,Not Applicable,Observational,China,The coagulation function of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,100,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50006,No Results,No Results,No Results,02/03/2020,08/03/2020,None
317,ChiCTR2000030436,ChiCTR,01/03/2020,06/03/2020,FALSE,Shanghai Sixth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Application of flash glucose monitoring to evaluate the effect of blood glucose changes on prognosis in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,100,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50297,No Results,No Results,No Results,09/03/2020,08/03/2020,None
318,ChiCTR2000030839,ChiCTR,15/03/2020,01/03/2020,TRUE,"Tongren Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Screening,China,Preliminary screening of novel coronavirus pneumonia (COVID-19) by special laboratory examination and CT imaging before surgery,Diagnostics,Diagnostic Test or Assessment,100,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50904,No Results,No Results,No Results,16/03/2020,18/03/2020,None
319,ChiCTR2000030832,ChiCTR,15/03/2020,16/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,No Country Given,Study for the pathogenesis and effective intervention of mood disorders caused by the novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,800,Not Available,30/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=51044,No Results,No Results,No Results,16/03/2020,18/03/2020,None
320,ChiCTR2000029958,ChiCTR,17/02/2020,17/02/2020,FALSE,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,A medical records based study for the clinical characteristics of anesthesia novel coronavirus pneumonia (COVID-19) patients during perioperative period and assessment of infection and mental health of Anesthesiology Department,Clinical Presentation,No Intervention,260,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49635,No Results,No Results,No Results,09/03/2020,08/03/2020,None
321,ChiCTR2000030833,ChiCTR,15/03/2020,22/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Clinical validation and application of high-throughput novel coronavirus (2019-nCoV) screening detection kit,Diagnostics,Diagnostic Test or Assessment,400,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51035,No Results,No Results,No Results,16/03/2020,18/03/2020,None
322,ChiCTR2000030226,ChiCTR,26/02/2020,01/02/2020,TRUE,The Fourth Hospital of Hebei Medical University,Recruiting,Not Applicable,Observational,China,"The treatment status and risk factors related to prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19) in intensive care unit, Hebei, China: a descriptive study",Prognosis,No Intervention,40,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49855,No Results,No Results,No Results,02/03/2020,08/03/2020,None
323,ChiCTR2000030830,ChiCTR,15/03/2020,01/01/2020,TRUE,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Observational,China,Development and application of novel coronavirus pneumonia (COVID-19) intelligent image classification system based on deep learning,Diagnostics,Diagnostic Test or Assessment,150,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51009,No Results,No Results,No Results,16/03/2020,18/03/2020,None
324,ChiCTR2000029757,ChiCTR,12/02/2020,14/02/2020,FALSE,China-Japan Friendship Hospital,Recruiting,Not Applicable,Interventional,China,Convalescent plasma for the treatment of severe and critical novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,ATMP,Plasma,200,Not Available,05/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=49081,No Results,No Results,No Results,09/03/2020,08/03/2020,None
325,ChiCTR2000030225,ChiCTR,26/02/2020,22/02/2020,TRUE,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Interventional,China,Clinical Reseach of Acupuncture in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,186,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=49945,No Results,No Results,No Results,02/03/2020,08/03/2020,None
326,ChiCTR2000030831,ChiCTR,15/03/2020,01/01/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,The analysis of related factors on improving oxygenation status by endotracheal intubation ventilation in severe patients suffered from novel coronavirus pneumonia (COVID-19): a single center and descriptive study in Wuhan,Prognosis,No Intervention,75,Not Available,15/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51036,No Results,No Results,No Results,16/03/2020,18/03/2020,None
327,ChiCTR2000030223,ChiCTR,26/02/2020,20/02/2020,TRUE,No Sponsor Name Given,Recruiting,Not Applicable,Health services research,China,Quality of life among Chinese residents during and after novel coronavirus pneumonia (COVID19) outbreak: an online survey,Other (psych),No Intervention,5000,Not Available,19/05/2022,http://www.chictr.org.cn/showproj.aspx?proj=50026,No Results,No Results,No Results,02/03/2020,18/03/2020,None
328,ChiCTR2000030806,ChiCTR,15/03/2020,01/02/2020,TRUE,Wuhan Third Hospital,Recruiting,Not Applicable,Observational,China,Retrospective study for the efficacy of ulinastatin combined with ''clear lung detoxification soup'' in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,20,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51029,No Results,No Results,No Results,16/03/2020,18/03/2020,None
329,ChiCTR2000030816,ChiCTR,15/03/2020,24/02/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Nutritional risk assessment and outcome prediction of critically ill novel coronavirus pneumonia (COVID-19) patients,Prognosis,No Intervention,200,Not Available,23/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=51048,No Results,No Results,No Results,16/03/2020,18/03/2020,None
330,ChiCTR2000030804,ChiCTR,15/03/2020,01/02/2020,TRUE,Maoming People's Hospital,Recruiting,Phase 4,Interventional,China,Exocarpium Citri Grandis Relieves Symptoms of Novel Coronavirus Pneunomia (COVID-19): a Randomized Controlled Clinical Trial,Traditional Medicine (Drug),Traditional Medicine,128,Not Available,31/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51018,No Results,No Results,No Results,16/03/2020,18/03/2020,None
331,ChiCTR2000029899,ChiCTR,16/02/2020,17/02/2020,FALSE,Peking University Third Hospital,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Mild and Commen Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-label, Parallel, Controlled Trial",Drug,Combination: hydroxychloroquine vs. chloroquine,100,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49536,No Results,No Results,No Results,02/03/2020,08/03/2020,None
332,ChiCTR2000030799,ChiCTR,15/03/2020,20/01/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Establishment and validation of Premonitory model of deterioration of the 2019 novel corona virus pneumonia (COVID-19),Prognosis,No Intervention,1000,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50995,No Results,No Results,No Results,16/03/2020,18/03/2020,None
333,ChiCTR2000030814,ChiCTR,15/03/2020,20/02/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based analysis of clinical evidence of human-to-human transmission of 2019 novel coronavirus pneumonia (COVID-19) by conjunctival route,Clinical Presentation,No Intervention,100,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51042,No Results,No Results,No Results,16/03/2020,18/03/2020,None
334,ChiCTR2000029898,ChiCTR,16/02/2020,17/02/2020,FALSE,Peking University Third Hospital,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Severe Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-Label, Parallel, Controlled Trial",Drug,Combination: hydroxychloroquine vs. chloroquine,100,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49482,No Results,No Results,No Results,02/03/2020,08/03/2020,None
335,ChiCTR2000030797,ChiCTR,15/03/2020,07/03/2020,TRUE,"Shanghai Fifth People's Hospital, Fudan University",Recruiting,Not Applicable,Observational,China,clinical study for hemodynamics and cardiac arrhythmia of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,100,Not Available,07/07/2021,http://www.chictr.org.cn/showproj.aspx?proj=50988,No Results,No Results,No Results,16/03/2020,18/03/2020,None
336,NCT04292340,ClinicalTrials.gov,25/02/2020,01/02/2020,TRUE,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Observational,China,Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19,ATMP,Plasma,15,31/07/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04292340,No Results,No Results,No Results,16/03/2020,18/03/2020,None
337,NCT04293887,ClinicalTrials.gov,15/02/2020,01/03/2020,FALSE,Tongji Hospital,Not Recruiting,Phase 1,Interventional,No Country Given,Efficacy and Safety of IFN-a2√ü in the Treatment of Novel Coronavirus Patients,Drug,Interferon alfa,328,30/05/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04293887,No Results,No Results,No Results,16/03/2020,18/03/2020,None
338,ChiCTR2000030807,ChiCTR,15/03/2020,15/02/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical characteristics and prognosis of cancer patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,100,Not Available,30/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51019,No Results,No Results,No Results,16/03/2020,18/03/2020,None
339,ChiCTR2000030902,ChiCTR,16/03/2020,10/02/2020,TRUE,Jingzhou Mental Health Center,Recruiting,Not Applicable,Observational,China,Analysis for the mental health status of residents in Jingzhou during the outbreak of the novel coronavirus pneumonia (COVID-19) and corresponding influencing factors,Other (psych),No Intervention,1000,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51130,No Results,No Results,No Results,16/03/2020,18/03/2020,None
340,ChiCTR2000030779,ChiCTR,14/03/2020,16/03/2020,FALSE,Shanghai Changzheng Hospital,Recruiting,Phase 4,Interventional,China,A clinical trial for Ulinastatin Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50973,No Results,No Results,No Results,16/03/2020,18/03/2020,None
341,ChiCTR2000030805,ChiCTR,15/03/2020,15/02/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,No Country Given,Quantitative CT characteristic estimate the severity of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,200,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51026,No Results,No Results,No Results,16/03/2020,18/03/2020,None
342,ChiCTR2000030901,ChiCTR,16/03/2020,09/03/2020,TRUE,The Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,China,Retrospective analysis of epidemiology and transmission dynamics of patients confirmed with Coronavirus Disease (COVID-19) in Hong Kong,Clinical Presentation ,No Intervention,100,Not Available,14/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51064,No Results,No Results,No Results,16/03/2020,18/03/2020,None
343,ChiCTR2000030763,ChiCTR,13/03/2020,01/02/2020,TRUE,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,A Medical Records Based analysis for Risk Factors for Outcomes After Respiratory Support in Patients with ARDS Due to Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50921,No Results,No Results,No Results,16/03/2020,18/03/2020,None
344,ChiCTR2000030854,ChiCTR,16/03/2020,22/01/2020,TRUE,Li Lanjuan,Not Recruiting,Not Applicable,Observational,China,"A clinical multicenter study for the occurrence, development and prognosis of novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,237,Not Available,15/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51083,No Results,No Results,No Results,16/03/2020,18/03/2020,None
345,ChiCTR2000030761,ChiCTR,13/03/2020,31/05/2020,FALSE,"Renji Hospital, Shanghai Jiaotong University School of Medicine",Not Recruiting,Not Applicable,Interventional,China,Continuous renal replacement therapy (CRRT) alleviating inflammatory response in severe patients with novel coronavirus pneumonia (COVID-19) associated with renal injury: A Prospective study,Other (renal),Renal replacement therapy,20,Not Available,01/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50956,No Results,No Results,No Results,16/03/2020,18/03/2020,None
346,ChiCTR2000030798,ChiCTR,15/03/2020,10/02/2020,TRUE,Wuhan Third Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,01/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50994,No Results,No Results,No Results,16/03/2020,18/03/2020,None
347,ChiCTR2000030853,ChiCTR,16/03/2020,01/02/2020,TRUE,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of the protective effect of dexmedetomidine on patients with severe novel coronavirus pneumonia (COVID-19),Drug,Dexmedetomidine,200,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=51081,No Results,No Results,No Results,16/03/2020,18/03/2020,None
348,ChiCTR2000030796,ChiCTR,15/03/2020,29/01/2020,TRUE,The Second Hospital of Hebei Medical University,Recruiting,Not Applicable,Observational,No Country Given,Clinical characteristics and treatment of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,500,Not Available,31/01/2022,http://www.chictr.org.cn/showproj.aspx?proj=50991,No Results,No Results,No Results,16/03/2020,18/03/2020,None
349,ChiCTR2000030754,ChiCTR,13/03/2020,11/03/2020,TRUE,The Third Affiliated Hospital of Sun Yat-sen University,Not Recruiting,Not Applicable,Diagnostic test,China,Medical records based study for the accuracy of SARS-CoV-2 IgM antibody screening for diagnosis of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,30,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50824,No Results,No Results,No Results,16/03/2020,18/03/2020,None
350,ChiCTR2000030852,ChiCTR,16/03/2020,27/01/2020,TRUE,"Beijing An Zhen Hospital, Capital Medical University",Not Recruiting,Not Applicable,Observational,China,Factors associated with death in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,150,Not Available,27/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=51077,Journal Article,11/03/2020,https://doi.org/10.1016/S0140-6736(20)30566-3,16/03/2020,18/03/2020,None
351,ChiCTR2000030552,ChiCTR,07/03/2020,08/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Critical ultrasound in evaluating cardiopulmonary function in critical patients infected with 2019 novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,70,Not Available,08/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49708,No Results,No Results,No Results,09/03/2020,08/03/2020,None
352,ChiCTR2000030752,ChiCTR,13/03/2020,01/02/2020,TRUE,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,A medical records based analysis for risk factors for death in patients with Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,500,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50925,No Results,No Results,No Results,16/03/2020,18/03/2020,None
353,ChiCTR2000030838,ChiCTR,15/03/2020,20/01/2020,TRUE,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Diagnostic test,China,Development of warning system with clinical differential diagnosis and prediction for severe type of novel coronavirus pneumonia (COVID-19) patients based on artificial intelligence and CT images,Diagnostics,Diagnostic Test or Assessment,1000,Not Available,06/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=51071,No Results,No Results,No Results,16/03/2020,18/03/2020,None
354,ChiCTR2000030782,ChiCTR,14/03/2020,01/02/2020,TRUE,Cangzhou People's Hospital,Recruiting,Not Applicable,Observational,No Country Given,"The value of CD4 / CD8 cells, CRP / ALB and APCHEII in novel coronavirus pneumonia (COVID-19)",Prognosis,No Intervention,20,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50976,No Results,No Results,No Results,16/03/2020,18/03/2020,None
355,ChiCTR2000030747,ChiCTR,13/03/2020,22/02/2020,TRUE,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,A prospective cohort  study for comprehensive treatment of Chinese medicine in the treatment of convalescent patients of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,1500,Not Available,01/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50000,No Results,No Results,No Results,16/03/2020,18/03/2020,None
356,ChiCTR2000030836,ChiCTR,15/03/2020,01/02/2020,TRUE,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on ''Internal and External Relieving -Truncated Torsion'' strategy,Traditional Medicine + Western Medicine,Traditional Medicine,300,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51054,No Results,No Results,No Results,16/03/2020,18/03/2020,None
357,ChiCTR2000030773,ChiCTR,14/03/2020,12/02/2020,TRUE,Huashan Hospital; Fudan Universtiy,Recruiting,Not Applicable,Interventional,China,Application of blood purification in the treatment of novel coronavirus pneumonia (COVID-19),Other (physical),Blood purification,20,Not Available,12/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=50934,No Results,No Results,No Results,16/03/2020,18/03/2020,None
358,ChiCTR2000030835,ChiCTR,15/03/2020,14/02/2020,TRUE,The First Affiliated Hospital of Xinxiang Medical University,Recruiting,Not Applicable,Interventional,China,Clinical study for the efficacy of Mesenchymal stem cells (MSC) in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),20,Not Available,14/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=51050,No Results,No Results,No Results,16/03/2020,18/03/2020,None
359,ChiCTR2000030535,ChiCTR,06/03/2020,20/02/2020,TRUE,Wuhan Red Cross Hospital,Recruiting,Phase 4,Interventional,China,Multi-Center Clinical Study on the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19) by Ebastine,Drug,Combination: Ebastine + interferon alpha + lopinavir vs. interferon alpha + lopinavir,100,Not Available,30/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49790,No Results,No Results,No Results,09/03/2020,08/03/2020,None
360,ChiCTR2000030722,ChiCTR,12/03/2020,09/03/2020,TRUE,Shanghai First People's Hospital,Not Recruiting,Not Applicable,Observational,China,Auscultatory characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,30,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50338,No Results,No Results,No Results,16/03/2020,18/03/2020,None
361,ChiCTR2000030764,ChiCTR,13/03/2020,07/03/2020,TRUE,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Recruiting,Not Applicable,Observational,China,"Research for the influence of epidemic of novel coronavirus pneumonia (COVID-19) on sleep, psychological and chronic diseases among different populations",Clinical Presentation,No Intervention,2800,Not Available,01/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50852,No Results,No Results,No Results,16/03/2020,18/03/2020,None
362,ChiCTR2000030834,ChiCTR,15/03/2020,16/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Epidemiological Characteristics and Antibody Levels of novel coronavirus pneumonia (COVID-19) of Pediatric Medical Staff working in Quarantine Area,Clinical Presentation (Epidemiology),No Intervention,500,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51047,No Results,No Results,No Results,16/03/2020,18/03/2020,None
363,ChiCTR2000030720,ChiCTR,11/03/2020,01/03/2020,TRUE,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Prognosis Investigation and Intervention Study on Patients with novel coronavirus pneumonia (COVID-19) in recovery period Based on Community Health Management,Prognosis,No Intervention,120,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50793,No Results,No Results,No Results,16/03/2020,18/03/2020,None
364,ChiCTR2000030762,ChiCTR,13/03/2020,01/12/2019,TRUE,The Second Affiliated Hospital of Guizhou University of traditional Chinese Medicine,Not Recruiting,Not Applicable,Epidemiological research,China,Diagnosis and treatment of novel coronavirus pneumonia (COVID-19) in common and severe cases based on the theory of ''Shi-Du-Yi (damp and plague)'',Traditional Medicine (Other),Traditional Medicine,100,Not Available,31/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=50950,No Results,No Results,No Results,16/03/2020,18/03/2020,None
365,ChiCTR2000030819,ChiCTR,15/03/2020,01/03/2020,TRUE,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,"Retrospective analysis of digestive system symptoms in 600 cases of novel coronavirus pneumonia (COVID-19) in Guanggu district, Wuhan",Clinical Presentation,No Intervention,600,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51039,No Results,No Results,No Results,16/03/2020,18/03/2020,None
366,ChiCTR2000030702,ChiCTR,10/03/2020,15/02/2020,TRUE,China-Japan Friendship Hospital,Recruiting,Not Applicable,Interventional,China,Plasma of the convalescent in the treatment of novel coronavirus pneumonia (COVID-19) common patient: a prospective clinical trial,ATMP,Plasma,50,Not Available,15/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50537,No Results,No Results,No Results,16/03/2020,18/03/2020,None
367,ChiCTR2000030818,ChiCTR,15/03/2020,31/01/2020,TRUE,"The First Affiliated Hospital, Henan Traditional Chinese Medicine University",Not Recruiting,Not Applicable,Observational,China,A medical records based study for the value of Lymphocyte subsets in the diagnose and treatment of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,10,Not Available,24/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=51037,No Results,No Results,No Results,16/03/2020,18/03/2020,None
368,ChiCTR2000030760,ChiCTR,13/03/2020,13/03/2020,FALSE,Zhejiang Hospital,Not Recruiting,Not Applicable,Observational,China,"A medical records based study for clinical characteristics of 2019 novel coronavirus pneumonia (COVID-19) in Zhejiang province, China",Clinical Presentation,No Intervention,74,Not Available,02/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50955,No Results,No Results,No Results,16/03/2020,18/03/2020,None
369,ChiCTR2000030803,ChiCTR,15/03/2020,31/01/2020,TRUE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,No Country Given,Collection and analysis of clinical data in severe and critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,400,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51007,No Results,No Results,No Results,16/03/2020,18/03/2020,None
370,ChiCTR2000030697,ChiCTR,10/03/2020,10/03/2020,FALSE,Ningbo First Hospital,Not Recruiting,Not Applicable,Observational,China,"A multi-center, open-label observation study for psychological status and intervention efficacy of doctors, nurses, patients and their families in novel coronavirus pneumonia (COVID-19) designated hospitals",Other (psych),Psychological,1500,Not Available,10/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=50781,Pre-Print Article,No Results,"https://doi.org/10.1101/2020.03.13.20033290

https://doi.org/10.1101/2020.03.22.20040899",16/03/2020,18/03/2020,None
371,ChiCTR2000030802,ChiCTR,15/03/2020,27/01/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A retrospective study of clinical drug therapy in patients with novel coronavirus pneumonia (COVID-19),Drug,Unspecified Drug,2000,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51004,No Results,No Results,No Results,16/03/2020,18/03/2020,None
372,ChiCTR2000030755,ChiCTR,13/03/2020,15/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"A medical records based study for characteristics, prognosis of ederly patients with Novel Coronavirus Pneumonia (COVID-19) in Wuhan area",Prognosis,No Intervention,400,Not Available,15/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=50945,No Results,No Results,No Results,16/03/2020,18/03/2020,None
373,ChiCTR2000030801,ChiCTR,15/03/2020,23/01/2020,TRUE,The Third Hospital of Wuhan,Recruiting,Not Applicable,Observational,China,Analysis of risk factors affecting prognosis of elderly patients infected with novel coronavirus pneumonia (COVID-19): a single-center retrospective observational study,Prognosis,No Intervention,100,Not Available,29/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=50998,No Results,No Results,No Results,16/03/2020,18/03/2020,None
374,ChiCTR2000030522,ChiCTR,06/03/2020,09/03/2020,FALSE,Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of Ma-Xing-Gan-Shi decoction in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,100,Not Available,09/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=44213,No Results,No Results,No Results,09/03/2020,08/03/2020,None
375,ChiCTR2000030686,ChiCTR,09/03/2020,03/03/2020,TRUE,Peking University Third Hospital,Recruiting,Not Applicable,Observational,China,The effects of prevention and control measures on treatment and psychological status of cancer patients during the novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),Psychological,300,Not Available,03/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=50714,No Results,No Results,No Results,16/03/2020,18/03/2020,None
376,ChiCTR2000030753,ChiCTR,13/03/2020,01/02/2020,TRUE,Shandong Provincial Chest hospital,No Status Given,Not Applicable,Observational,China,A medical records based analysis of the Incidence and Risk Factors of Ventilator-associated Pneumonia in ARDS Patients with Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,100,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50901,No Results,No Results,No Results,16/03/2020,18/03/2020,None
377,ChiCTR2000030503,ChiCTR,05/03/2020,20/01/2020,TRUE,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Extracorporeal blood purification therapy using Li's Artifical Liver System for patients with severe novel coronavirus pneumonia (COVID19) patient,Traditional Medicine (Other),Traditional Medicine,60,Not Available,30/06/2022,http://www.chictr.org.cn/showproj.aspx?proj=49632,No Results,No Results,No Results,09/03/2020,08/03/2020,None
378,ChiCTR2000030679,ChiCTR,09/03/2020,28/01/2020,TRUE,"Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology",Recruiting,Not Applicable,Observational,China,Cohort study of Novel Coronavirus Infected Diseases (COVID-19) in children,Clinical Presentation,No Intervention,500,Not Available,31/12/2022,http://www.chictr.org.cn/showproj.aspx?proj=50730,No Results,No Results,No Results,16/03/2020,18/03/2020,None
379,ChiCTR2000030784,ChiCTR,14/03/2020,17/01/2020,TRUE,The People's Hospital of Guangxi Zhuang Autonomous Region,Recruiting,Not Applicable,Observational,China,A study for clinical characteristics of novel coronavirus pneumonia (COVID-19) patients follow-up in Guangxi,Clinical Presentation,No Intervention,150,Not Available,17/01/2020,http://www.chictr.org.cn/showproj.aspx?proj=50307,No Results,No Results,No Results,16/03/2020,18/03/2020,None
380,ChiCTR2000030744,ChiCTR,13/03/2020,01/02/2020,TRUE,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Interventional,China,Clinical Application of ECMO(or Ultra-Protective Lung Mechanical Ventilation) in the Treatment of Patients with ARDS due to novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,30,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50910,No Results,No Results,No Results,16/03/2020,18/03/2020,None
381,ChiCTR2000030487,ChiCTR,04/03/2020,04/03/2020,FALSE,The First Affiliated Hospital of He'nan University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,10,Not Available,04/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50507,No Results,No Results,No Results,09/03/2020,08/03/2020,None
382,ChiCTR2000030768,ChiCTR,14/03/2020,01/02/2020,TRUE,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Epidemiological research,China,Study for the Psychological Status of Medical Staff of Otolaryngology Head and Neck Surgery in Hubei Province under the Epidemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,450,Not Available,01/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=50968,No Results,No Results,No Results,16/03/2020,18/03/2020,None
383,ChiCTR2000030485,ChiCTR,03/03/2020,03/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for timing of mechanical ventilation for critically ill patients with novel coronavirus pneumonia (COVID-19): A medical records based retrospective Cohort study,Other (physical),Mechanical ventilation,90,Not Available,01/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=50459,No Results,No Results,No Results,09/03/2020,08/03/2020,None
384,ChiCTR2000030751,ChiCTR,13/03/2020,25/01/2020,TRUE,Affiliated Hospital of Inner Mongolia University for the Nationalities,Not Recruiting,Not Applicable,Interventional,China,Clinical Research for Traditional Mongolian Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,60,Not Available,25/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50941,No Results,No Results,No Results,16/03/2020,18/03/2020,None
385,ChiCTR2000030472,ChiCTR,03/03/2020,25/02/2020,TRUE,Shenyang Sixth People's Hospital,Recruiting,Not Applicable,Interventional,China,An open and controlled clinical study to evaluate the efficacy and safety of Ganovo combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,20,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49753,No Results,No Results,No Results,09/03/2020,08/03/2020,None
386,ChiCTR2000030718,ChiCTR,11/03/2020,12/02/2020,TRUE,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Randomized controlled trial for Chloroquine Phosphate in the Treatment of novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,80,Not Available,30/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50843,No Results,No Results,No Results,16/03/2020,18/03/2020,None
387,ChiCTR2000030739,ChiCTR,13/03/2020,01/02/2020,TRUE,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Exploration of the Clinical Characteristics of Patients with Novel Coronavirus Pneumonia (COVID-19) and Its Differences from Patients with Severe Influenza A and MERS,Clinical Presentation,No Intervention,100,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50896,No Results,No Results,No Results,16/03/2020,18/03/2020,None
388,ChiCTR2000030471,ChiCTR,02/03/2020,02/03/2020,FALSE,Maoming People's Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and safety of lipoic acid injection in reducing the risk of progression in common patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,394,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50421,No Results,No Results,No Results,09/03/2020,08/03/2020,None
389,ChiCTR2000030606,ChiCTR,08/03/2020,09/03/2020,FALSE,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Not Recruiting,Not Applicable,Observational,China,Medical records based study for the correlation between Chinese medicine certificate and lung image of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,120,Not Available,31/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=50713,No Results,No Results,No Results,16/03/2020,18/03/2020,None
390,ChiCTR2000030717,ChiCTR,11/03/2020,01/04/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based study for risk assessment and treatment timing of invasive fungal infection in novel coronavirus pneumonia (COVID-19) critical patients,Clinical Presentation,No Intervention,260,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50860,No Results,No Results,No Results,16/03/2020,18/03/2020,None
391,ChiCTR2000030721,ChiCTR,12/03/2020,16/03/2020,FALSE,Affiliated Hospital of Guangdong Medical University,Not Recruiting,Not Applicable,Diagnostic test,China,A comparative study for the sensitivity of induced sputum and throat swabs for the detection of SARS-CoV-2 by real-time PCR in patients with novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,50,Not Available,26/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50759,No Results,No Results,No Results,16/03/2020,18/03/2020,None
392,ChiCTR2000030597,ChiCTR,08/03/2020,09/03/2020,FALSE,China Academy of Chinese Medical Science,Not Recruiting,Not Applicable,Observational,China,Medical records based study for the correlation between Chinese medicine certificate and lung image of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,150,Not Available,31/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=50702,No Results,No Results,No Results,16/03/2020,08/03/2020,None
393,ChiCTR2000030469,ChiCTR,02/03/2020,27/02/2020,TRUE,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,A randomized parallel controlled trial for LIUSHENWAN in Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,96,Not Available,27/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50082,No Results,No Results,No Results,09/03/2020,08/03/2020,None
394,ChiCTR2000030716,ChiCTR,11/03/2020,05/03/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Shedding of SARS-CoV-2 in human semen and evaluation of reproductive health of novel coronavirus pneumonia (COVID-19) male patients,Clinical Presentation,No Intervention,150,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50850,No Results,No Results,No Results,16/03/2020,18/03/2020,None
395,ChiCTR2000030719,ChiCTR,11/03/2020,01/03/2020,TRUE,Wuhan Hospital of Integrated Traditional Chinese and Western Medicine,Recruiting,Not Applicable,Observational,China,A retrospective cohort study for integrated traditional Chinese and western medicine in the treatment of 1071 patients with novel coronavirus pneumonia (COVID-19) in Wuhan,Traditional Medicine + Western Medicine,Traditional Medicine,1071,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50867,No Results,No Results,No Results,16/03/2020,18/03/2020,None
396,ChiCTR2000030468,ChiCTR,02/03/2020,28/02/2020,TRUE,Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Study for the key technique of integrative therapy of Novel Coronavirus Pneumonia (COVID-19): the TCM symptoms and treatment regulation,Traditional Medicine (Unspecified),Traditional Medicine,950,Not Available,30/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=50390,No Results,No Results,No Results,09/03/2020,08/03/2020,None
397,ChiCTR2000030701,ChiCTR,10/03/2020,10/03/2020,FALSE,The Third People's Hospital of Shenzhen,Not Recruiting,Not Applicable,Interventional,China,"A randomized, parallel controlled open-label trial for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in the treatment of adult patients with novel coronavirus pneumonia (COVID-19)",Drug,LMWH (Enoxaparin),60,Not Available,30/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=50795,No Results,No Results,No Results,16/03/2020,18/03/2020,None
398,ChiCTR2000030703,ChiCTR,10/03/2020,10/03/2020,FALSE,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Interventional,China,"A randomized, blinded, controlled, multicenter clinical trial to evaluate the efficacy and safety of Ixekizumab combined with conventional antiviral drugs in patients with novel coronavirus pneumonia (COVID-19)",Drug,"Combination: Ixekizumab + up to three of interferon-alfa, lopinavir/ritonavir, chloroquine, ribavirin, umifenovir",40,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50251,No Results,No Results,No Results,16/03/2020,18/03/2020,None
399,ChiCTR2000030700,ChiCTR,10/03/2020,09/03/2020,TRUE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in treatment of novel coronavirus pneumonia (COVID-19) adult common patients,Drug,LMWH (Enoxaparin),60,Not Available,30/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=50786,No Results,No Results,No Results,16/03/2020,18/03/2020,None
400,ChiCTR2000030687,ChiCTR,09/03/2020,01/02/2020,TRUE,"Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology",Not Recruiting,Not Applicable,Basic Science,China,Novel coronavirus pneumonia (COVID-19) associated kidney injury in children,Clinical Presentation,No Intervention,120,Not Available,31/10/2020,http://www.chictr.org.cn/showproj.aspx?proj=50572,No Results,No Results,No Results,16/03/2020,18/03/2020,None
401,ChiCTR2000030683,ChiCTR,09/03/2020,09/03/2020,FALSE,The Sixth Affiliated Hospital of Sun Yat-sen University,Not Recruiting,Not Applicable,Diagnostic test,China,The prediction value of prognosis of novel coronavirus pneumonia (COVID-19) in elderly patients by modified early warning score (MEWS): a medical records based retrospective observational study,Prognosis,No Intervention,234,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50633,No Results,No Results,No Results,16/03/2020,18/03/2020,None
402,ChiCTR2000030681,ChiCTR,09/03/2020,16/03/2020,FALSE,Liaocheng People's Hospital,Not Recruiting,Not Applicable,Interventional,China,An anaesthesia procedure and extubation strategy for reducing patient agitation and cough after extubation that can be used to prevent the spread of Novel Coronavirus Pneumonia (COVID-19) and other infectious viruses in the operating Room,Other (physical),Extubation,240,Not Available,16/11/2021,http://www.chictr.org.cn/showproj.aspx?proj=50763,No Results,No Results,No Results,16/03/2020,18/03/2020,None
403,ChiCTR2000030453,ChiCTR,02/03/2020,02/03/2020,FALSE,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Observational,China,Clinical study for the effects of ACEIs/ARBs on the infection of novel coronavirus pneumonia (CoVID-19),Drug,ACE inhibitors or ARBs,100,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50381,No Results,No Results,No Results,09/03/2020,08/03/2020,None
404,ChiCTR2000030619,ChiCTR,08/03/2020,01/02/2020,TRUE,The First Affiliated Hospital of Bengbu Medical College,Not Recruiting,Not Applicable,Observational,China,A medical records based real world study for the characteristics and correlation mechanism of traditional Chinese medicine combined with western medicine in the treatment of patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,160,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50656,No Results,No Results,No Results,16/03/2020,08/03/2020,None
405,ChiCTR2000030528,ChiCTR,06/03/2020,06/03/2020,FALSE,The Second Clinical College of Guangzhou University of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Application of TCM Nursing Scheme in Patients with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,60,Not Available,25/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50641,No Results,No Results,No Results,16/03/2020,08/03/2020,None
406,ChiCTR2000030545,ChiCTR,06/03/2020,04/02/2020,TRUE,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",Traditional Medicine (Drug),Traditional Medicine,300,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50126,No Results,No Results,No Results,16/03/2020,08/03/2020,None
407,ChiCTR2000030304,ChiCTR,28/02/2020,10/03/2020,FALSE,The Third Affiliated Hospital of Sun Yat-sen University,Not Recruiting,Not Applicable,Observational,China,Protective factors of mental resilience in first-line nurses with novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,300,Not Available,31/12/2022,http://www.chictr.org.cn/showproj.aspx?proj=49653,No Results,No Results,No Results,09/03/2020,08/03/2020,None
408,ChiCTR2000030476,ChiCTR,03/03/2020,03/03/2020,FALSE,"Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine",Recruiting,Not Applicable,Interventional,China,Study for meditation assists for the rehabilitation of patients with novel coronaviruse pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,200,Not Available,01/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=50455,No Results,No Results,No Results,16/03/2020,08/03/2020,None
409,ChiCTR2000030388,ChiCTR,01/03/2020,18/02/2020,TRUE,Jingzhou First People's Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of Xue-Bi-Jing injection in the treatment of severe cases of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50306,No Results,No Results,No Results,16/03/2020,08/03/2020,None
410,ChiCTR2000029550,ChiCTR,04/02/2020,29/01/2020,TRUE,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations for Diagnosis and Treatment of Influenza Patients in the Hospital of Chengdu University of Traditional Chinese Medicine Under the Raging of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,300,Not Available,01/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=48775,No Results,No Results,No Results,09/03/2020,18/03/2020,None
411,ChiCTR2000030114,ChiCTR,23/02/2020,24/02/2020,FALSE,Peking University People's Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,"Lung ultrasound in the diagnosis, treatment and prognosis of pulmonary lesions of novel coronavirus pneumonia (COVID-19)",Diagnostics,Diagnostic Test or Assessment,150,Not Available,24/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49987,No Results,No Results,No Results,16/03/2020,18/03/2020,None
412,ChiCTR2000030055,ChiCTR,22/02/2020,10/02/2020,TRUE,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Prognosis,China,Multicenter study for the treatment of Dipyridamole with novel coronavirus pneumonia (COVID-19),Drug,Dipyridamole,460,Not Available,10/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49864,Pre-Print Article,29/02/2020,https://doi.org/10.1101/2020.02.27.20027557,16/03/2020,08/03/2020,None
413,ChiCTR2000030005,ChiCTR,19/02/2020,21/02/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Nucleic acid analysis of novel coronavirus pneumonia (COVID-19) in morning sputum samples and pharyngeal swabs-a prospectively diagnostic test,Diagnostics,Diagnostic Test or Assessment,200,Not Available,21/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49669,No Results,No Results,No Results,16/03/2020,08/03/2020,None
414,ChiCTR2000029592,ChiCTR,05/02/2020,07/02/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Clinical Study of Arbidol Hydrochloride Using for Post-exposure Prophylaxis of 2019-nCoV in High-risk Population Including Medical Staff,Drug (Chemoprophylaxis),Umifenovir,1000,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49069,No Results,No Results,No Results,16/03/2020,08/03/2020,None
415,NCT04307693,ClinicalTrials.gov,10/03/2020,11/03/2020,FALSE,Asan Medical Center,Recruiting,Phase 2,Interventional,South Korea,Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),Drug,Lopinavir/ritonavir vs. hydroxychloroquine,150,01/05/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04307693,No Results,No Results,No Results,23/03/2020,18/03/2020,None
416,ChiCTR2000031104,ChiCTR,22/03/2020,05/02/2020,TRUE,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Study for metagenomics of patients with novel coronavirus pneumonia (COVID-19),Genomics,No Intervention,200,Not Available,01/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51185,No Results,No Results,No Results,23/03/2020,25/03/2020,None
417,ChiCTR2000029549,ChiCTR,04/02/2020,03/02/2020,TRUE,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,400,Not Available,01/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49014,No Results,No Results,No Results,09/03/2020,08/03/2020,None
418,ChiCTR2000029770,ChiCTR,13/02/2020,13/02/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"Study for epidemiology, diagnosis and treatment of novel coronavirus pneumonia (COVID-19)",Clinical Presentation (Epidemiology),No Intervention,500,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49412,No Results,No Results,No Results,16/03/2020,08/03/2020,None
419,ChiCTR2000031088,ChiCTR,22/03/2020,09/02/2020,TRUE,Xiangyang First People's Hospital,Recruiting,Not Applicable,Observational,China,A prognosis study of novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,314,Not Available,09/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=51132,No Results,No Results,No Results,23/03/2020,25/03/2020,None
420,NCT04302519,ClinicalTrials.gov,27/02/2020,05/03/2020,FALSE,"CAR-T (Shanghai) Biotechnology Co., Ltd.",Not Recruiting,Phase 1,Interventional,No Country Given,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),24,30/06/2021,30/07/2021,https://clinicaltrials.gov/show/NCT04302519,No Results,No Results,No Results,23/03/2020,18/03/2020,None
421,ChiCTR2000031163,ChiCTR,23/03/2020,16/02/2020,TRUE,The People's Hospital of Guangxi Zhuang Autonomous Region,Not Recruiting,Not Applicable,Observational,China,The relationship between Vitamin D andnovel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,80,Not Available,16/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=51390,No Results,No Results,No Results,23/03/2020,25/03/2020,None
422,ChiCTR2000029479,ChiCTR,02/02/2020,30/01/2020,TRUE,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Research for Traditional Chinese Medicine Technology Prevention and Control of Novel Coronavirus Pneumonia (COVID-19) in the Community Population,Traditional Medicine (Unspecified),Traditional Medicine,20000,Not Available,01/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=48773,No Results,No Results,No Results,09/03/2020,08/03/2020,None
423,ChiCTR2000031023,ChiCTR,21/03/2020,16/03/2020,TRUE,Hu'nan Cancer Hospital,Recruiting,Not Applicable,Interventional,China,Perioperative immune prediction and intervention of tumor patients undergoing surgery during the novel coronavirus pneumonia (COVID-19) outbreak period,Prognosis,No Intervention,320,Not Available,16/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50984,No Results,No Results,No Results,23/03/2020,25/03/2020,None
424,NCT04285801,ClinicalTrials.gov,24/02/2020,14/02/2020,TRUE,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,Hong Kong,Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study,Clinical Presentation,No Intervention,8,25/02/2020,25/02/2020,https://clinicaltrials.gov/show/NCT04285801,No Results,No Results,No Results,23/03/2020,08/03/2020,None
425,NCT04299724,ClinicalTrials.gov,05/03/2020,15/02/2020,TRUE,Shenzhen Geno-Immune Medical Institute,Recruiting,Phase 1,Interventional,China,Safety and Immunity of Covid-19 aAPC Vaccine,ATMP,Plasma,100,31/07/2023,31/12/2024,https://clinicaltrials.gov/show/NCT04299724,No Results,No Results,No Results,23/03/2020,18/03/2020,None
426,ChiCTR2000031014,ChiCTR,21/03/2020,19/03/2020,TRUE,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Not Recruiting,Not Applicable,Observational,China,A Study for SARS-COV-2 RNA Level in Blood and Excrement of Novel Coronavirus Pneumonia (COVID-19) Convalescent Patients,Clinical Presentation,No Intervention,100,Not Available,19/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=51348,No Results,No Results,No Results,23/03/2020,25/03/2020,None
427,ChiCTR2000031140,ChiCTR,22/03/2020,01/02/2020,TRUE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Study for the impact on fetus and neonates of vertical transmission of 2019-nCoV,Clinical Presentation,No Intervention,300,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50605,No Results,No Results,No Results,23/03/2020,25/03/2020,None
428,ChiCTR2000031138,ChiCTR,22/03/2020,26/02/2020,TRUE,"The Third Xiangya Hospital, Central South University",Recruiting,Not Applicable,Interventional,China,Prospective exploratory clinical research on the efficacy and safety of pirfenidone capsules in the treatment of severe novel coronavirus pneumonia (COVID-19),Drug,Pirfenidone,40,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51416,No Results,No Results,No Results,23/03/2020,25/03/2020,None
429,ChiCTR2000030947,ChiCTR,19/03/2020,11/02/2020,TRUE,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Not Applicable,Observational,China,A medical records based study for clinical application of extracorporeal membrane oxygenation in the treatment of severe respiratory failure patients with novel coronavirus pneumonia (COVID-19),Drug,Oxygen,34,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51267,No Results,No Results,No Results,23/03/2020,25/03/2020,None
430,NCT04302688,ClinicalTrials.gov,07/03/2020,10/12/2019,TRUE,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Accurate Classification System for Patients With COVID-19 Pneumonitis,Prognosis,No Intervention,669,10/02/2020,04/03/2020,https://clinicaltrials.gov/show/NCT04302688,No Results,No Results,No Results,23/03/2020,18/03/2020,None
431,ChiCTR2000031150,ChiCTR,23/03/2020,01/04/2020,FALSE,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Health services research,China,Application of radiology in the prevention and control system of emergency respiratory infectious diseases,Other (radiology),Radiology,150,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51021,No Results,No Results,No Results,23/03/2020,25/03/2020,None
432,ChiCTR2000031090,ChiCTR,22/03/2020,23/03/2020,FALSE,Ningbo Kangning Hospital,Not Recruiting,Not Applicable,Interventional,China,Psychological Support for Diagnosed Patients with novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,60,Not Available,23/03/2022,http://www.chictr.org.cn/showproj.aspx?proj=51148,No Results,No Results,No Results,23/03/2020,25/03/2020,None
433,ChiCTR2000030896,ChiCTR,16/03/2020,06/02/2020,TRUE,Zhengzhou People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical Application and Theoretical Discussion of Fu-Zheng Qing-Fei Thought in Treating Non-Critical Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,24,Not Available,30/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51028,No Results,No Results,No Results,16/03/2020,18/03/2020,None
434,ChiCTR2000031139,ChiCTR,22/03/2020,20/03/2020,TRUE,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Human embryonic stem cell-derived M cells (CAStem) for Pulmonary Fibrosis Correlated with novel coronavirus pneumonia (COVID-19),ATMP,Cells (stem cells),20,Not Available,19/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51404,No Results,No Results,No Results,23/03/2020,25/03/2020,None
435,ChiCTR2000030946,ChiCTR,19/03/2020,10/02/2020,TRUE,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Interventional,China,Effects of different VTE prevention methods on the prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19),Drug,LMWH,120,Not Available,10/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51265,No Results,No Results,No Results,23/03/2020,25/03/2020,None
436,ChiCTR2000030895,ChiCTR,16/03/2020,14/03/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Retrospective and Prospective Study for Nosocomial infection in Stomatology Department under the Background of novel coronavirus pneumonia (COVID-19) epidemic period,Clinical Presentation,No Intervention,1000,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51034,No Results,No Results,No Results,16/03/2020,18/03/2020,None
437,ChiCTR2000030996,ChiCTR,20/03/2020,18/03/2020,TRUE,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Recruiting,Not Applicable,Interventional,China,Effect of Auricular point pressing on insomnia of novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial.,Traditional Medicine (Other),Traditional Medicine,60,Not Available,26/10/2020,http://www.chictr.org.cn/showproj.aspx?proj=51349,No Results,No Results,No Results,23/03/2020,25/03/2020,None
438,ChiCTR2000031089,ChiCTR,22/03/2020,13/03/2020,TRUE,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A medical records based study for Tou-Jie-Qu-Wen Granules in the Treatment of mild and moderate patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,300,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51136,No Results,No Results,No Results,23/03/2020,25/03/2020,None
439,ChiCTR2000030933,ChiCTR,18/03/2020,31/03/2020,FALSE,The First Affiliated Hospital of Nanchang University,Not Recruiting,Not Applicable,Interventional,China,Effectiveness of ''Liu-Zi-Jue'' combined with respiratory muscle training for respiratory function in novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,108,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51184,No Results,No Results,No Results,23/03/2020,25/03/2020,None
440,ChiCTR2000030993,ChiCTR,20/03/2020,12/03/2020,TRUE,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Diagnostic test,China,A medical records based study for the value of Upper Respiratory Tract Virus Detection in the assessment of rehabilitation of novel coronavirus pneumonia (COVID-19) patient,Prognosis,No Intervention,300,Not Available,12/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51342,No Results,No Results,No Results,23/03/2020,25/03/2020,None
441,ChiCTR2000030932,ChiCTR,18/03/2020,01/02/2020,TRUE,Anqing Municipal Hospital,Recruiting,Not Applicable,Observational,China,Correlation between virological negative conversion and clinical factors and prognosis in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,100,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51230,No Results,No Results,No Results,23/03/2020,25/03/2020,None
442,ChiCTR2000030986,ChiCTR,20/03/2020,20/03/2020,FALSE,Shenzhen Third People's Hospital,Recruiting,Not Applicable,Observational,China,Correlation of T lymphocytes level and clinical severity in novel coronavirus pneumonia (COVID-19) patients: a medical records based retrospective study,Clinical Presentation,No Intervention,200,Not Available,01/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51316,No Results,No Results,No Results,23/03/2020,25/03/2020,None
443,ChiCTR2000030931,ChiCTR,18/03/2020,23/03/2020,FALSE,HuiZhou Municipal Central Hospital,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for Clinical Characteristic and Outcomes of Hospitalized Patients With Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,60,Not Available,22/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=51212,No Results,No Results,No Results,23/03/2020,25/03/2020,None
444,ChiCTR2000030987,ChiCTR,20/03/2020,05/03/2020,TRUE,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2/Phase 3,Interventional,China,A Randomized Controlled Trial for Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Combination: Favipiravir + chloroquine vs. favipiravir,150,Not Available,25/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51329,No Results,No Results,No Results,23/03/2020,25/03/2020,None
445,ChiCTR2000030961,ChiCTR,20/03/2020,01/01/2020,TRUE,"Changzheng Hospital, Naval Military Medical University, Shanghai",Recruiting,Not Applicable,Observational,No Country Given,"A Medical Records Based Retrospective Study for Clinical Characteristics, Treatments and Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19) in WuHan",Clinical Presentation,No Intervention,2000,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51291,No Results,No Results,No Results,23/03/2020,25/03/2020,None
446,ChiCTR2000030985,ChiCTR,20/03/2020,04/03/2020,TRUE,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,"Psychological Responses of Medical Staff during the Metaphase of novel coronavirus pneumonia (COVID-19) Outbreak in Hubei, China",Other (psych),No Intervention,1300,Not Available,09/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51311,No Results,No Results,No Results,23/03/2020,25/03/2020,None
447,ChiCTR2000030771,ChiCTR,14/03/2020,01/03/2020,TRUE,The Second Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Diagnostic test,China,Screening and identification of peripheral blood biomarkers in patients with COVID-19 infection based on multiomics studies,Genomics,No Intervention,30,Not Available,01/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=50961,No Results,No Results,No Results,23/03/2020,25/03/2020,None
448,ChiCTR2000030894,ChiCTR,16/03/2020,01/03/2020,TRUE,Peking University First Hospital,Recruiting,Phase 4,Interventional,China,"Favipiravir Combined With Tocilizumab in the Treatment of novel coronavirus pneumonia (COVID-19) - A Multicenter, Randomized, Controlled Trial",Drug,Combination: Favipiravir + tocilizumab vs. favipiravir vs. tocilizumab,150,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=51126,No Results,No Results,No Results,16/03/2020,18/03/2020,None
449,ChiCTR2000030952,ChiCTR,19/03/2020,18/01/2020,TRUE,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Myocardial injury and arrythmias in the novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,93,Not Available,01/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51278,No Results,No Results,No Results,23/03/2020,25/03/2020,None
450,ChiCTR2000030951,ChiCTR,19/03/2020,20/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Developing and evaluating of artificial intelligence triage system for suspected novel coronavirus pneumonia (COVID-19): a retrospective study,Other (software),No Intervention,2500,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51283,No Results,No Results,No Results,23/03/2020,25/03/2020,None
451,ChiCTR2000030950,ChiCTR,19/03/2020,10/02/2020,TRUE,West China Hospital of Sichuan University,Recruiting,Not Applicable,Basic Science,China,Study for novel coronavirus pneumonia (COVID-19) patients etiology and immune response and guidance for vaccine design,Clinical Presentation,No Intervention,50,Not Available,10/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=51272,No Results,No Results,No Results,23/03/2020,25/03/2020,None
452,ChiCTR2000030944,ChiCTR,18/03/2020,01/09/2020,FALSE,The Second Affiliated Hospital of Nanchang University,Not Recruiting,Phase 1,Interventional,China,Clinical study of human NK cells and MSCs transplantation for severe novel coronavirus pneumonia (COVID-19),ATMP,"Cells, (mesenchymal/NK)",20,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50199,No Results,No Results,No Results,23/03/2020,25/03/2020,None
453,ChiCTR2000029658,ChiCTR,09/02/2020,10/02/2020,FALSE,Central Theater General Hospital of PLA,No Status Given,Not Applicable,Interventional,China,Nasal high-fow preoxygenation assisted fibre-optic bronchoscope intubation in patients with critical novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,60,Not Available,06/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49074,Correspondence,19/03/2020,https://doi.org/10.1016/j.bja.2020.02.020,23/03/2020,08/03/2020,None
454,ChiCTR2000030943,ChiCTR,18/03/2020,31/03/2020,FALSE,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Venous Thrombosis Risk of novel coronavirus pneumonia (COVID-19) Patients: A Prospective Study,Prognosis,No Intervention,200,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50898,No Results,No Results,No Results,23/03/2020,25/03/2020,None
455,ChiCTR2000030893,ChiCTR,16/03/2020,19/03/2020,FALSE,Zhengzhou People's Hospital,Not Recruiting,Not Applicable,Observational,China,Study for effects of crisis intervention based on positive psychology for medical staffs working in the novel coronavirus pneumonia (COVID-19) field,Other (psych),Psychological,50,Not Available,11/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51073,No Results,No Results,No Results,16/03/2020,18/03/2020,None
456,ChiCTR2000030942,ChiCTR,18/03/2020,20/01/2020,TRUE,Shanghai Kongjiang Hospital,Not Recruiting,Not Applicable,Observational,China,Combined diagnostic value of novel coronavirus (2019-CoV) infection detected by NLR and CRP,Diagnostics,Diagnostic Test or Assessment,191,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50981,No Results,No Results,No Results,23/03/2020,25/03/2020,None
457,ChiCTR2000029573,ChiCTR,05/02/2020,06/02/2020,FALSE,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection",ATMP,Gene-derived protein,480,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49065,No Results,No Results,No Results,23/03/2020,08/03/2020,None
458,ChiCTR2000030934,ChiCTR,18/03/2020,01/03/2020,TRUE,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,A Platform for Rapid Immuno-detection and Emergency Vaccine Development of Novel Coronavirus (2019-COV),Other (software),No Intervention,90,Not Available,28/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=51160,No Results,No Results,No Results,23/03/2020,25/03/2020,None
459,ChiCTR2000029496,ChiCTR,03/02/2020,29/01/2020,TRUE,The First Hospital of Changsha; The Second Xiangya Hospital of Central South University,Recruiting,Phase 4,Interventional,China,"A randomized, open label, parallel controlled trial of evaluating the efficacy of recombinant cytokine gene-derived protein injection for clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19)",ATMP,Gene-derived protein,90,Not Available,29/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=48809,Pre-Print Article,29/04/2020,https://doi.org/10.1101/2020.04.24.20077735,23/03/2020,08/03/2020,None
460,ChiCTR2000030863,ChiCTR,16/03/2020,22/01/2020,TRUE,"Jinling Hospital, Medical School of Nanjing University",Recruiting,Not Applicable,Observational,China,Clinical and CT imaging Characteristics of novel coronavirus pneumonia (COVID-19): An Multicenter Cohort Study,Clinical Presentation,No Intervention,5000,Not Available,31/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=50767,No Results,No Results,No Results,16/03/2020,18/03/2020,None
461,ChiCTR2000030919,ChiCTR,17/03/2020,20/03/2020,FALSE,Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Observational,China,An observational study for cardiac and pulmonary ultrasound and evaluation of treatment of severe patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,80,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=51149,No Results,No Results,No Results,23/03/2020,25/03/2020,None
462,ChiCTR2000030929,ChiCTR,17/03/2020,17/03/2020,FALSE,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia (COVID-19)",ATMP,Plasma,60,Not Available,16/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50696,No Results,No Results,No Results,23/03/2020,25/03/2020,None
463,ChiCTR2000030539,ChiCTR,06/03/2020,06/03/2020,FALSE,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Study for clinical oral characteristics of patients with novel coronavirus pneumonia (COVID-19) and Effect of 3% hydrogen peroxide gargle on the Intraoral novel coronavirus,Drug,Hydrogen peroxide,40,Not Available,05/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=50660,No Results,No Results,No Results,23/03/2020,08/03/2020,None
464,ChiCTR2000030920,ChiCTR,17/03/2020,20/02/2020,TRUE,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,"Evaluation of the effect of taking tricholoma matsutake, cannabis sativa capsule and dendrobium candidum to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19) during convalescence.",Traditional Medicine (Drug),Traditional Medicine,100,Not Available,01/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=50476,No Results,No Results,No Results,23/03/2020,25/03/2020,None
465,ChiCTR2000030862,ChiCTR,16/03/2020,24/01/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Correlation analysis of blood eosinophil cell levels and clinical type category of novel coronavirus pneumonia (COVID-19): a medical records based retrospective study,Clinical Presentation,No Intervention,150,Not Available,16/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51107,No Results,No Results,No Results,16/03/2020,18/03/2020,None
466,NCT04251767,ClinicalTrials.gov,30/01/2020,05/02/2020,FALSE,The Second Hospital of Nanjing Medical University,Not Recruiting,Not Applicable,Interventional,China,Washed Microbiota Transplantation for Patients With 2019-nCoV Infection,ATMP,Intestinal microbiome,Not Available,30/04/2020,30/04/2020,https://clinicaltrials.gov/show/NCT04251767,No Results,No Results,No Results,30/03/2020,08/03/2020,None
467,NCT04254874,ClinicalTrials.gov,02/02/2020,01/02/2020,TRUE,Tongji Hospital,Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia",Drug,Combination: Interferon + Umifenovir vs. Umifenovir,100,01/06/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04254874,No Results,No Results,No Results,30/03/2020,08/03/2020,None
468,ChiCTR2000030095,ChiCTR,23/02/2020,23/02/2020,FALSE,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Observational,China,A medical records based study for optimization and evaluation of the comprehensive diagnosis and treatment of novel coronavirus pneumonia (COVID-19) and the assessment of risk factors for severe pneumonia,Clinical Presentation,No Intervention,94,Not Available,31/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=49845,No Results,No Results,No Results,23/03/2020,18/03/2020,None
469,ChiCTR2000029955,ChiCTR,17/02/2020,01/03/2020,FALSE,"West China Second Hospital, Sichuan University",Not Recruiting,Not Applicable,Diagnostic test,China,Evaluation of myocardial injury of novel coronavirus pneumonia (COVID-19) assessed by multimodal MRI imaging,Clinical Presentation,No Intervention,80,Not Available,01/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=49531,No Results,No Results,No Results,23/03/2020,08/03/2020,None
470,ChiCTR2000029868,ChiCTR,15/02/2020,11/02/2020,TRUE,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Phase 4,Interventional,China,"Hydroxychloroquine treating novel coronavirus pneumonia (COVID-19): a randomized controlled, open label, multicenter trial",Drug,Hydroxychloroquine,360,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=49524,Pre-Print Article,14/04/2020,https://doi.org/10.1101/2020.04.10.20060558,23/03/2020,08/03/2020,None
471,ChiCTR2000029830,ChiCTR,15/02/2020,14/02/2020,TRUE,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Observational,China,"A study for the psychological status, social support, and care needs of tumor patients admitted to a general hospital during the novel coronavirus pneumonia (COVID-19) outbreak",Other (psych),No Intervention,400,Not Available,12/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49511,No Results,No Results,No Results,23/03/2020,18/03/2020,None
472,ChiCTR2000030861,ChiCTR,16/03/2020,27/02/2019,TRUE,The First Affiliated Hospital of the Guangzhou Medical University,Recruiting,Not Applicable,Health services research,No Country Given,Development and application of a new intelligent robot for novel coronavirus (2019-nCOV) oropharygeal sampling,Other (physical),Other,90,Not Available,01/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=51103,No Results,No Results,No Results,16/03/2020,18/03/2020,None
473,NCT04255017,ClinicalTrials.gov,02/02/2020,01/02/2020,TRUE,Tongji Hospital,Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia",Drug,Umeprevir vs. Oseltamivir vs. lopinavir/ritonavir,400,01/06/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04255017,No Results,No Results,No Results,30/03/2020,08/03/2020,None
474,NCT04261270,ClinicalTrials.gov,04/02/2020,01/02/2020,TRUE,Tongji Hospital,Recruiting,Phase 3,Interventional,China,"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia",Drug,Combination: ASCO9F + ritonavir vs ritonavir + oseltamivir vs. oseltamivir,60,01/05/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04261270,No Results,No Results,No Results,30/03/2020,08/03/2020,None
475,ChiCTR2000030860,ChiCTR,16/03/2020,16/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for investigation of dynamic profile of RT-PCR test for SARS-CoV-2 nucleic acid of novel coronavirus pneumonia (COVID-19) patients,Diagnostics,Diagnostic Test or Assessment,100,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=51102,No Results,No Results,No Results,16/03/2020,18/03/2020,None
476,JPRN-jRCTs041190120,JPRN,02/03/2020,02/03/2020,FALSE,Doi Yohei,Recruiting,Phase 2,Interventional,Japan,Favipiravir for SARS-CoV-infected patients,Drug,Favipiravir,86,Not Available,Not Available,https://jrct.niph.go.jp/latest-detail/jRCTs041190120,No Results,No Results,No Results,23/03/2020,25/03/2020,None
477,EUCTR2020-000890-25-FR,EU Clinical Trials Register,10/03/2020,05/03/2020,TRUE,Fondation Méditerranée Infection (FMI) - IHU Méditerranée Infection,Authorised,Phase 3,Interventional,France,Hydroxychloroquine as a treatment for coronavirus disease COVID-19,Drug,Hydroxychloroquine,25,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000890-25,Journal Article,20/03/2020,https://doi.org/10.1016/j.ijantimicag.2020.105949,23/03/2020,25/03/2020,None
478,JPRN-UMIN000039873,JPRN,19/03/2020,19/03/2020,FALSE,National Center for Global Health and Medicine,Recruiting,Not Applicable,Observational,Japan,COVID-19 Registry,Clinical Presentation,No Intervention,9999,Not Available,31/01/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045453,No Results,No Results,No Results,23/03/2020,25/03/2020,None
479,ChiCTR2000030812,ChiCTR,15/03/2020,31/01/2020,TRUE,Shanghai Ninth People's Hospital,Recruiting,Not Applicable,Observational,China,Study for the virus molecular evolution which driven the immune-pathological responses and the protection mechanisms of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,50,Not Available,31/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=50947,No Results,No Results,No Results,16/03/2020,18/03/2020,None
480,ChiCTR2000030810,ChiCTR,15/03/2020,23/02/2020,TRUE,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Recruiting,Phase 1,Interventional,China,Clinical observation and evaluation of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine,Traditional Medicine (Unspecified),Traditional Medicine,100,Not Available,30/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50986,No Results,No Results,No Results,16/03/2020,18/03/2020,None
481,NCT04264858,ClinicalTrials.gov,08/02/2020,17/03/2020,FALSE,"Wuhan Union Hospital, China",Not Recruiting,Not Applicable,Interventional,China,Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients,ATMP,Immunoglobulin,10,30/04/2020,31/05/2020,https://clinicaltrials.gov/show/NCT04264858,No Results,No Results,No Results,30/03/2020,08/03/2020,None
482,NCT04278963,ClinicalTrials.gov,19/02/2020,27/02/2020,FALSE,China Academy of Chinese Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,Traditional Medicine (Drug),Traditional Medicine,300,01/01/2021,01/01/2021,https://clinicaltrials.gov/show/NCT04278963,No Results,No Results,No Results,30/03/2020,08/03/2020,None
483,JPRN-UMIN000039686,JPRN,06/03/2020,01/02/2020,TRUE,The Prince Charles Hospital,Recruiting,Not Applicable,Observational,"Japan, Australia, Asia, Europe",ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease,Drug,Oxygen,500,Not Available,31/08/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045268,No Results,No Results,No Results,23/03/2020,25/03/2020,None
484,ChiCTR2000030809,ChiCTR,15/03/2020,22/02/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for clinical outcomes and follow-up of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,1000,Not Available,30/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51015,No Results,No Results,No Results,16/03/2020,18/03/2020,None
485,ChiCTR2000030795,ChiCTR,15/03/2020,20/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A multicenter retrospective study of rheumatic  patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,90,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=50982,No Results,No Results,No Results,16/03/2020,18/03/2020,None
486,NCT04272710,ClinicalTrials.gov,12/02/2020,25/01/2020,TRUE,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Prognositc Factors in COVID-19 Patients Complicated With Hypertension,Drug,ACE inhibitors,Not Available,31/03/2020,30/04/2020,https://clinicaltrials.gov/show/NCT04272710,No Results,No Results,No Results,30/03/2020,08/03/2020,None
487,NCT04304313,ClinicalTrials.gov,14/02/2020,09/02/2020,TRUE,Tongji Hospital,Recruiting,Phase 3,Interventional,China,A Pilot Study of Sildenafil in COVID-19,Drug,Sildenafil,10,01/03/2020,09/11/2020,https://clinicaltrials.gov/show/NCT04304313,No Results,No Results,No Results,30/03/2020,18/03/2020,None
488,NCT04306705,ClinicalTrials.gov,08/03/2020,20/02/2020,TRUE,Tongji Hospital,Recruiting,Not Applicable,Observational,China,Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19,Drug,Tocilizumab,120,30/05/2020,20/06/2020,https://clinicaltrials.gov/show/NCT04306705,No Results,No Results,No Results,30/03/2020,18/03/2020,None
489,ChiCTR2000030778,ChiCTR,14/03/2020,20/01/2020,TRUE,Ningbo First Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based study for epidemic and clinical features of novel coronavirus pneumonia (COVID-19) in Ningbo First Hospital,Clinical Presentation,No Intervention,40,Not Available,29/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=50987,No Results,No Results,No Results,16/03/2020,18/03/2020,None
490,NCT04292964,ClinicalTrials.gov,01/03/2020,01/03/2020,FALSE,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Prognostic Factors of Patients With COVID-19,Prognosis,No Intervention,201,13/03/2020,13/03/2020,https://clinicaltrials.gov/show/NCT04292964,Pre-Print Article,10/03/2020,https://doi.org/10.1101/2020.03.07.20031575,30/03/2020,18/03/2020,None
491,NCT04306497,ClinicalTrials.gov,01/03/2020,02/03/2020,FALSE,"Jiangsu Famous Medical Technology Co., Ltd.",Recruiting,Not Applicable,Observational,China,Clinical Trial on Regularity of TCM Syndrome and Differentiation Treatment of COVID-19.,Traditional Medicine (Unspecified),Traditional Medicine,340,01/05/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04306497,No Results,No Results,No Results,30/03/2020,18/03/2020,None
492,NCT04312100,ClinicalTrials.gov,13/03/2020,01/02/2020,TRUE,Henan Provincial People's Hospital,Recruiting,Not Applicable,Observational,China,Sequential Oxygen Therapy Strategy for Patients With COVID-19,Drug,Oxygen,30,01/10/2020,01/02/2021,https://clinicaltrials.gov/show/NCT04312100,No Results,No Results,No Results,30/03/2020,25/03/2020,None
493,NCT04276896,ClinicalTrials.gov,17/02/2020,24/03/2020,FALSE,Shenzhen Geno-Immune Medical Institute,Recruiting,Phase 1/Phase 2,Interventional,China,Immunity and Safety of Covid-19 Synthetic Minigene Vaccine,ATMP,Vaccine,100,31/07/2023,31/12/2024,https://clinicaltrials.gov/show/NCT04276896,No Results,No Results,No Results,30/03/2020,18/03/2020,None
494,NCT04291053,ClinicalTrials.gov,27/02/2020,01/04/2020,FALSE,Tongji Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,550,01/08/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04291053,No Results,No Results,No Results,30/03/2020,18/03/2020,None
495,ChiCTR2000030759,ChiCTR,13/03/2020,15/02/2020,TRUE,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for the therapeutic effect and mechanism of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,70,Not Available,17/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=49284,No Results,No Results,No Results,16/03/2020,18/03/2020,None
496,ChiCTR2000030758,ChiCTR,13/03/2020,10/03/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based study for sedation and Analgesia Usage in critically ill patients with novel coronavirus pneumonia (COVID-19),Drug,Unspecified sedation and analgesia,200,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50590,No Results,No Results,No Results,16/03/2020,18/03/2020,None
497,NCT04293692,ClinicalTrials.gov,24/02/2020,24/02/2020,FALSE,Puren Hospital Affiliated to Wuhan University of Science and Technology,Not Recruiting,Not Applicable,Interventional,China,Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus,ATMP,Cells (mesenchymal),Not Available,25/02/2020,25/02/2020,https://clinicaltrials.gov/show/NCT04293692,No Results,No Results,No Results,30/03/2020,18/03/2020,None
498,NCT04305574,ClinicalTrials.gov,08/03/2020,08/03/2020,FALSE,Jean Liu,Recruiting,Not Applicable,Observational,Singapore,Social Media Use During COVID-19,Other,No Intervention,5000,31/05/2020,31/05/2020,https://clinicaltrials.gov/show/NCT04305574,No Results,No Results,No Results,30/03/2020,18/03/2020,None
499,NCT04314232,ClinicalTrials.gov,17/03/2020,23/03/2020,FALSE,"University Hospital, Akershus",Not Recruiting,Not Applicable,Observational,No Country Given,Mechanisms to Morbidity and Mortality for Covid-19,Prognosis,No Intervention,200,31/12/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04314232,No Results,No Results,No Results,30/03/2020,25/03/2020,None
500,NCT04314817,ClinicalTrials.gov,17/03/2020,17/03/2020,FALSE,Groupe Hospitalier Pitié Salpêtrière,Recruiting,Not Applicable,Observational,France,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,Traditional Medicine (Unspecified),Traditional Medicine,1000,01/01/2021,01/01/2023,https://clinicaltrials.gov/show/NCT04314817,No Results,No Results,No Results,30/03/2020,25/03/2020,None
501,NCT04316884,ClinicalTrials.gov,13/03/2020,12/03/2020,TRUE,Uppsala University,Recruiting,Not Applicable,Observational,Sweden,Mechanisms for Organ Dysfunction in Covid-19,Clinical Presentation,No Intervention,100,31/12/2020,31/12/2021,https://clinicaltrials.gov/show/NCT04316884,No Results,No Results,No Results,30/03/2020,25/03/2020,None
502,ChiCTR2000030757,ChiCTR,13/03/2020,13/03/2020,FALSE,Shenzhen-Peking University; The Hong Kong University of Science & Technology Medical Center,Not Recruiting,Not Applicable,Observational,China,Impact of Novel Coronavirus Pneumonia (COVID-19) Epidemic Period on the Management of investigator-initiated clinical trial and the resilience of medical service providers,Other (psych),No Intervention,100,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50648,No Results,No Results,No Results,16/03/2020,18/03/2020,None
503,NCT04318418,ClinicalTrials.gov,19/03/2020,23/03/2020,FALSE,Neuromed IRCCS,Not Recruiting,Not Applicable,Observational,Italy,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",Drug,ACE inhibitors or ARBs,5000,10/04/2020,30/04/2020,https://clinicaltrials.gov/show/NCT04318418,No Results,No Results,No Results,30/03/2020,04/01/2020,None
504,ChiCTR2000031356,ChiCTR,28/03/2020,12/04/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the changes of the brain structure and function in healed patients of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,600,Not Available,04/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=51499,No Results,No Results,No Results,30/03/2020,04/01/2020,None
505,ChiCTR2000030756,ChiCTR,13/03/2020,20/02/2020,TRUE,Shenzhen Hospital of Southern Medical University,Recruiting,Not Applicable,Observational,China,Detection of SARS-CoV-2 in EPS / semen of patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation ,No Intervention,60,Not Available,20/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50705,Pre-Print Article,30/03/2020,https://doi.org/10.1101/2020.03.26.20044198,16/03/2020,18/03/2020,None
506,ChiCTR2000031361,ChiCTR,28/03/2020,31/03/2020,FALSE,Hubei Maternal and Child Health Care Hospital,Not Recruiting,Not Applicable,Observational,China,Retrospective analysis of anesthesia management of emergency cesarean section in non-pneumonia hospital of Wuhan during pandemic of novel coronavirus pneumonia (COVID-19),Drug,Other,2000,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=51385,No Results,No Results,No Results,30/03/2020,04/01/2020,None
507,ChiCTR2000031330,ChiCTR,27/03/2020,18/03/2020,TRUE,Shandong Eye Institute,Recruiting,Not Applicable,Observational,China,Analysis for prevention and control effects of orthokeratology lens on myopia adolescents during the novel coronavirus pneumonia (COVID-19) pandemic situation,Other (device),Orthokeratology lens,160,Not Available,18/06/2021,http://www.chictr.org.cn/showproj.aspx?proj=51504,No Results,No Results,No Results,30/03/2020,04/01/2020,None
508,ChiCTR2000031336,ChiCTR,28/03/2020,12/04/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,AI based prognostic evaluation of novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,1000,Not Available,31/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51517,No Results,No Results,No Results,30/03/2020,04/01/2020,None
509,ChiCTR2000031329,ChiCTR,27/03/2020,11/03/2020,TRUE,Guangdong Second Provincial General Hospital,Recruiting,Not Applicable,Observational,No Country Given,"Influence of novel coronavirus pneumonia (COVID-19) on disease activity, medical and mental condition of patients with rheumatic diseases",Clinical Presentation,No Intervention,120,Not Available,31/12/2023,http://www.chictr.org.cn/showproj.aspx?proj=51667,No Results,No Results,No Results,30/03/2020,04/01/2020,None
510,NCT04310865,ClinicalTrials.gov,15/03/2020,20/03/2020,FALSE,Zhong Wang,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,Traditional Medicine (Drug),Traditional Medicine,116,30/03/2021,30/06/2021,https://clinicaltrials.gov/show/NCT04310865,No Results,No Results,No Results,30/03/2020,25/03/2020,None
511,NCT04311398,ClinicalTrials.gov,14/03/2020,14/03/2020,FALSE,Huashan Hospital,Not Recruiting,Not Applicable,Observational,China,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,Diagnostics,Diagnostic Test or Assessment,100,01/06/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04311398,No Results,No Results,No Results,30/03/2020,25/03/2020,None
512,ChiCTR2000030742,ChiCTR,13/03/2020,15/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"Characteristics, prognosis, and treatments effectiveness of critically ill patients with Novel Coronavirus Pneumonia (COVID-19)",Clinical Presentation,No Intervention,200,Not Available,15/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50857,No Results,No Results,No Results,16/03/2020,18/03/2020,None
513,ChiCTR2000031324,ChiCTR,27/03/2020,10/04/2020,FALSE,Nanjing University Medical College Affiliated Drum Tower Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,The investigation on medical adhesive-related skin injury caused by protective dressings of medical staffs during the period of novel coronavirus pneumonia (COVID-19),Other (device),No Intervention,300,Not Available,01/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=51668,No Results,No Results,No Results,30/03/2020,04/01/2020,None
514,ChiCTR2000031328,ChiCTR,27/03/2020,13/03/2020,TRUE,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The protective effect of sleep psychology and music therapy of novel coronavirus pneumonia (COVID-19) mild and moderate type patients,Other,Sleep aids,60,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51425,No Results,No Results,No Results,30/03/2020,04/01/2020,None
515,ChiCTR2000030741,ChiCTR,13/03/2020,01/02/2020,TRUE,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Observational Study for Prone Position Ventilation and Conventional Respiratory Support in ARDS Patients with  Novel Coronavirus Pneumonia (COVID-19),Other (physical),Mechanical ventilation,100,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50907,No Results,No Results,No Results,16/03/2020,18/03/2020,None
516,ChiCTR2000031272,ChiCTR,26/03/2020,18/02/2020,TRUE,China European International Business School (CEIBS),Not Recruiting,Not Applicable,Interventional,China,The effectiveness of mindfulness intervention in improving people's psychological and physical well-being during novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),Psychological,110,Not Available,02/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51455,No Results,No Results,No Results,30/03/2020,04/01/2020,None
517,ChiCTR2000030740,ChiCTR,13/03/2020,01/02/2020,TRUE,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Analysis of the incidence and risk factors of ARDS in patients with Novel Coronavirus Pneumonia (COVID-19).,Clinical Presentation,No Intervention,100,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50900,No Results,No Results,No Results,16/03/2020,18/03/2020,None
518,NCT04314271,ClinicalTrials.gov,16/03/2020,20/03/2020,FALSE,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia,Clinical Presentation,No Intervention,80,01/05/2020,31/05/2020,https://clinicaltrials.gov/show/NCT04314271,No Results,No Results,No Results,30/03/2020,25/03/2020,None
519,NCT04315870,ClinicalTrials.gov,18/03/2020,01/01/2020,TRUE,Federico II University,Recruiting,Not Applicable,Observational,Italy,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.,Clinical Presentation,No Intervention,20,20/04/2020,30/04/2020,https://clinicaltrials.gov/show/NCT04315870,No Results,No Results,No Results,30/03/2020,25/03/2020,None
520,ChiCTR2000031301,ChiCTR,27/03/2020,01/02/2020,TRUE,China-Japan Union Hospital of Jilin Unversity,Not Recruiting,Not Applicable,Observational,China,A retrospective study of clinical characteristics and prognosis of novel coronavirus pneumonia (COVID-19) patients with myocardial injury,Prognosis,No Intervention,100,Not Available,27/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51603,No Results,No Results,No Results,30/03/2020,04/01/2020,None
521,ChiCTR2000030708,ChiCTR,11/03/2020,10/03/2020,TRUE,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Cross sectional study of dialysis treatment and mental status under the outbreak of novel coronavirus pneumonia (COVID-2019) in China,Other (renal),Dialysis,1000,Not Available,02/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50083,No Results,No Results,No Results,16/03/2020,18/03/2020,None
522,ChiCTR2000031252,ChiCTR,25/03/2020,10/02/2020,TRUE,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Outcomes and infectivity of patients with asymptomatic novel coronavirus (COVID-19) infection,Clinical Presentation,No Intervention,60,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51559,No Results,No Results,No Results,30/03/2020,04/01/2020,None
523,ChiCTR2000031247,ChiCTR,25/03/2020,01/03/2020,TRUE,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,No Country Given,Study on the mental state of medical staff  during the epidemic period of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,500,Not Available,01/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51540,No Results,No Results,No Results,30/03/2020,04/01/2020,None
524,ChiCTR2000031246,ChiCTR,25/03/2020,01/02/2020,TRUE,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Epidemiological survey of close contacts of novel coronavirus pneumonia (COVID-19),Clinical Presentation (Epidemiology),No Intervention,68,Not Available,30/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=51535,No Results,No Results,No Results,30/03/2020,04/01/2020,None
525,NCT04316728,ClinicalTrials.gov,14/03/2020,01/03/2020,TRUE,"Centro Studi Internazionali, Italy",Not Recruiting,Not Applicable,Interventional,Italy,Clinical Performance of the VivaDiag ‚Ñ¢ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19,Diagnostics,Diagnostic Test or Assessment,200,01/09/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04316728,No Results,No Results,No Results,30/03/2020,25/03/2020,None
526,ChiCTR2000031337,ChiCTR,28/03/2020,18/03/2020,TRUE,Shandong Eye Institute,Recruiting,Not Applicable,Observational,China,"The relationship between habits of using eyes, degree of visual fatigue and myopia progression in students during the novel coronavirus pneumonia (COVID-19) pandemic",Clinical Presentation,No Intervention,400,Not Available,18/06/2021,http://www.chictr.org.cn/showproj.aspx?proj=51170,No Results,No Results,No Results,30/03/2020,04/01/2020,None
527,ChiCTR2000031214,ChiCTR,24/03/2020,31/03/2020,FALSE,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical study on the correlation between novel coronavirus pneumonia (COVID-19) clinical rehabilitation assessment and prognosis,Prognosis,No Intervention,60,Not Available,31/03/2022,http://www.chictr.org.cn/showproj.aspx?proj=51509,No Results,No Results,No Results,30/03/2020,04/01/2020,None
528,ChiCTR2000031244,ChiCTR,25/03/2020,25/03/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Shedding virus and functional prognosis in patients with novel coronavirus pneumonia (COVID-19): a medical records based study,Prognosis,No Intervention,200,Not Available,25/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=51486,No Results,No Results,No Results,30/03/2020,04/01/2020,None
529,ChiCTR2000030707,ChiCTR,11/03/2020,20/03/2020,FALSE,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Observational,China,Retrospective study on novel coronavirus pneumonia (COVID-19) in Tibetan Plateau,Clinical Presentation,No Intervention,78,Not Available,19/03/2022,http://www.chictr.org.cn/showproj.aspx?proj=50160,No Results,No Results,No Results,16/03/2020,18/03/2020,None
530,ChiCTR2000031271,ChiCTR,26/03/2020,01/04/2020,FALSE,The Third Affiliated Hospital of Sun Yat-sen University,Not Recruiting,Not Applicable,Interventional,China,Metabolic abnormalities and rearrangement reversal treatment of patient with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,80,Not Available,31/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51194,No Results,No Results,No Results,30/03/2020,04/01/2020,None
531,ChiCTR2000031245,ChiCTR,25/03/2020,25/01/2020,TRUE,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,Epidemiologic and Clinical Characteristics of novel coronavirus pneumonia (COVID-19) in surgical patients: a medical records based retrospective study,Clinical Presentation (Epidemiology),No Intervention,2000,Not Available,12/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51518,No Results,No Results,No Results,30/03/2020,04/01/2020,None
532,ChiCTR2000031203,ChiCTR,24/03/2020,16/03/2020,TRUE,Zhengzhou People's Hospital,Recruiting,Not Applicable,Interventional,China,Study for the effect of Moxibustion Guidance and Intervention based on internet for the discharged patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,28,Not Available,28/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=51030,No Results,No Results,No Results,30/03/2020,04/01/2020,None
533,ChiCTR2000031198,ChiCTR,23/03/2020,01/04/2020,FALSE,Nothern Jiangsu People's Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for clinical characteristics and risk factors of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,150,Not Available,30/06/2022,http://www.chictr.org.cn/showproj.aspx?proj=51488,No Results,No Results,No Results,30/03/2020,04/01/2020,None
534,ChiCTR2000030690,ChiCTR,10/03/2020,10/02/2020,TRUE,The Third Affiliated Hospital of the Second Military Medical University,Recruiting,Not Applicable,Basic Science,China,Study for immune cell subsets in convalescent patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,30,Not Available,10/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=50261,Pre-Print Article,31/03/2020,https://doi.org/10.1101/2020.03.23.20039362,16/03/2020,18/03/2020,None
535,ChiCTR2000031176,ChiCTR,23/03/2020,20/02/2020,TRUE,Zhengzhou People's Hospital,Recruiting,Not Applicable,Observational,China,Study on home pharmaceutical care for chronic patients over the novel coronavirus pneumonia (COVID-19) epidemic,Other,No Intervention,100,Not Available,11/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51443,No Results,No Results,No Results,30/03/2020,04/01/2020,None
536,ChiCTR2000031227,ChiCTR,25/03/2020,26/03/2020,FALSE,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,No Country Given,"Clinical features and prognosis of invasive echanicalventilation patients with novel coronavirus pneumonia (COVID-19) in Wuhan, China: a single-centered, retrospective, observational study",Other (physical),Mechanical ventilation,40,Not Available,06/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51473,No Results,No Results,No Results,30/03/2020,04/01/2020,None
537,ChiCTR2000031196,ChiCTR,23/03/2020,10/01/2020,TRUE,The Fifth Medical Center of PLA General Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and optimization of antiviral therapy for novel coronavirus pneumonia (COVID-19) patients,Drug,Combination: Lopinavir/ritonavir + Interferon,90,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51112,No Results,No Results,No Results,30/03/2020,04/01/2020,None
538,ChiCTR2000030580,ChiCTR,08/03/2020,01/02/2020,TRUE,Shanghai General Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and safety of tozumab combined with adamumab(Qletli) in severe and critical patients with novel coronavirus pneumonia (COVID-19),Drug,Adamumab,60,Not Available,30/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50693,No Results,No Results,No Results,16/03/2020,08/03/2020,None
539,ChiCTR2000030962,ChiCTR,20/03/2020,01/03/2020,TRUE,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,"Clinical efficacy of TCM syndrome differentiation in the treatment of severe/critical type of novel coronavirus pneumonia (COVID-19): a prospective, observational, one-arm clinical study",Traditional Medicine (Other),Traditional Medicine,60,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51254,No Results,No Results,No Results,30/03/2020,25/03/2020,None
540,ChiCTR2000030940,ChiCTR,18/03/2020,01/02/2020,TRUE,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for ''Bai-Du Duan Fang'' application on the acupoint in the treatment of general type novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,76,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51061,No Results,No Results,No Results,30/03/2020,25/03/2020,None
541,ChiCTR2000030937,ChiCTR,18/03/2020,19/03/2020,FALSE,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for Gu-Shen Ding-Chuan-Wan in the treatment of patients with novel coronavirus pneumonia (COVID-19) at recovery phase with Fei-Pi-Qi-Xu Zhen",Traditional Medicine (Drug),Traditional Medicine,144,Not Available,30/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=51240,No Results,No Results,No Results,30/03/2020,25/03/2020,None
542,ChiCTR2000030988,ChiCTR,20/03/2020,23/03/2020,FALSE,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A RCT for Hua-Shi Bai-Du granules in patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,204,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=51317,No Results,No Results,No Results,30/03/2020,25/03/2020,None
543,ChiCTR2000030938,ChiCTR,18/03/2020,28/02/2020,TRUE,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical investigation and reseach on TCM syndrome of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,160,Not Available,30/06/2021,http://www.chictr.org.cn/showproj.aspx?proj=51239,No Results,No Results,No Results,30/03/2020,25/03/2020,None
544,ChiCTR2000030704,ChiCTR,10/03/2020,10/02/2020,TRUE,The First People's Hospital of Jiangxia District,No Status Given,Phase 4,Interventional,China,Observation Of Clinical Efficacy And Safety Of Bufonis Venenum Injection In The Treatment Of Severe Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,50,Not Available,10/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50778,No Results,No Results,No Results,30/03/2020,04/01/2020,None
545,ChiCTR2000030817,ChiCTR,15/03/2020,28/02/2020,TRUE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Multicenter clinical study of evaluation of multi-organ function in patients with novel coronavirus pneumonia (COVID-19) by ultrasound,Clinical Presentation,No Intervention,800,Not Available,28/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=50631,No Results,No Results,No Results,30/03/2020,18/03/2020,None
546,ChiCTR2000030288,ChiCTR,27/02/2020,27/02/2020,FALSE,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Efficacy of Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Unspecified),Traditional Medicine,204,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=50202,No Results,No Results,No Results,30/03/2020,08/03/2020,None
547,ChiCTR2000030256,ChiCTR,26/02/2020,01/02/2020,TRUE,"Daping Hospital,Army Medical University",Not Recruiting,Not Applicable,Epidemiological research,China,"Epidemiological and clinical characteristics of COVID-19: a large-scale investigation in epicenter Wuhan, China",Clinical Presentation (Epidemiology),No Intervention,1000,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50078,No Results,No Results,No Results,30/03/2020,08/03/2020,None
548,ChiCTR2000029982,ChiCTR,18/02/2020,26/03/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Prediction of prognosis and antiviral effect of patients with neocoronavirus infected pneumonia based on Peripheral blood exosomal metabolomics analysis and radiomics in CT of lung and its mechanism,Genomics,No Intervention,150,Not Available,31/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=49724,No Results,No Results,No Results,30/03/2020,08/03/2020,None
549,ChiCTR2000030028,ChiCTR,20/02/2020,24/02/2020,FALSE,West China Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical comparative study of PD-1 mAb in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19),Drug,PD1,40,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=49840,No Results,No Results,No Results,30/03/2020,08/03/2020,None
550,ChiCTR2000030198,ChiCTR,25/02/2020,24/02/2020,TRUE,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical research of pulmonary rehabilitation in survivors due to severe or critial novel coronavirus pneumonia (COVID-19),Other (physio),Physio,60,Not Available,24/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=50066,No Results,No Results,No Results,30/03/2020,08/03/2020,None
551,EUCTR2020-000919-69-NL,EU Clinical Trials Register,17/03/2020,17/03/2020,FALSE,UMC Utrecht,Authorised,Phase 4,Interventional,Netherlands,Reducing health care workers absenteeism in Coronavirus 2019 pandemic nu enhancement of the immune system through vaccination with Bacillus Calmette-Gu√©rin,ATMP,Vaccine,1000,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000919-69,No Results,No Results,No Results,30/03/2020,04/01/2020,None
552,EUCTR2020-001243-15-BE,EU Clinical Trials Register,27/03/2020,26/03/2020,TRUE,UZLeuven,Authorised,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",Drug,Itraconazole,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001243-15,No Results,No Results,No Results,30/03/2020,04/01/2020,None
553,NCT04288713,ClinicalTrials.gov,27/02/2020,25/02/2020,TRUE,Hudson Medical,Not Recruiting,Phase 2,Expanded Access,No Country Given,Eculizumab (Soliris) in Covid-19 Infected Patients,Drug,Eculizumab,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04288713,No Results,No Results,No Results,06/04/2020,08/03/2020,None
554,NCT04290871,ClinicalTrials.gov,27/02/2020,23/03/2020,FALSE,Xijing Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.,Drug,Nitric oxide,Not Available,01/03/2021,01/03/2022,https://clinicaltrials.gov/show/NCT04290871,No Results,No Results,No Results,06/04/2020,18/03/2020,None
555,EUCTR2020-001023-14-GB,EU Clinical Trials Register,17/03/2020,17/03/2020,FALSE,Synairgen Research Limited,Authorised,Phase 2,Interventional,United Kingdom,a trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients with COVID-19,Drug,Interferon beta,400,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001023-14,No Results,No Results,No Results,30/03/2020,25/03/2020,None
556,ChiCTR2000030187,ChiCTR,24/02/2020,25/02/2020,FALSE,Jingzhou First People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for Lopinavir and Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Lopinavir/ritonavir,60,Not Available,25/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50057,No Results,No Results,No Results,16/03/2020,08/03/2020,None
557,NCT04319900,ClinicalTrials.gov,20/03/2020,05/03/2020,TRUE,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2/Phase 3,Interventional,China,Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia,Drug,Combination: Chloroquine + favipiravir vs. favipiravir,150,30/04/2020,25/06/2020,https://clinicaltrials.gov/show/NCT04319900,No Results,No Results,No Results,06/04/2020,04/01/2020,None
558,NCT04323514,ClinicalTrials.gov,18/03/2020,13/03/2020,TRUE,University of Palermo,Recruiting,Not Applicable,Interventional,Italy,Use of Ascorbic Acid in Patients With COVID 19,Drug,Vitamin C,500,13/03/2021,13/03/2021,https://clinicaltrials.gov/show/NCT04323514,No Results,No Results,No Results,06/04/2020,04/01/2020,None
559,NCT04316299,ClinicalTrials.gov,17/03/2020,26/02/2020,TRUE,Zhenhua Zen,Not Recruiting,Not Applicable,Observational,China,Acute Kidney Injury in Patients Hospitalized With COVID-19,Clinical Presentation,No Intervention,287,28/02/2020,08/03/2020,https://clinicaltrials.gov/show/NCT04316299,No Results,No Results,No Results,06/04/2020,25/03/2020,None
560,NCT04318314,ClinicalTrials.gov,17/03/2020,18/03/2020,FALSE,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,Clinical Presentation,No Intervention,400,31/12/2020,31/12/2021,https://clinicaltrials.gov/show/NCT04318314,No Results,No Results,No Results,06/04/2020,04/01/2020,None
561,NCT04305106,ClinicalTrials.gov,09/03/2020,17/03/2020,FALSE,Qilu Hospital of Shandong University,Recruiting,Not Applicable,Interventional,China,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,Drug,Bevacizumab,140,30/06/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04305106,No Results,No Results,No Results,06/04/2020,18/03/2020,None
562,NCT04321928,ClinicalTrials.gov,20/03/2020,01/04/2020,FALSE,University of Pecs,Not Recruiting,Not Applicable,Interventional,No Country Given,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,Other,Health Education,7576,21/04/2021,21/08/2021,https://clinicaltrials.gov/show/NCT04321928,No Results,No Results,No Results,06/04/2020,04/01/2020,None
563,NCT04323631,ClinicalTrials.gov,25/03/2020,01/03/2020,TRUE,Rambam Health Care Campus,Not Recruiting,Phase 1,Interventional,No Country Given,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death,Drug,Hydroxychloroquine,1116,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04323631,No Results,No Results,No Results,06/04/2020,04/01/2020,None
564,NCT04325919,ClinicalTrials.gov,24/03/2020,24/02/2020,TRUE,Chinese University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong,Clinical Presentation,No Intervention,170,28/02/2021,17/06/2021,https://clinicaltrials.gov/show/NCT04325919,No Results,No Results,No Results,06/04/2020,04/07/2020,None
565,NCT04322344,ClinicalTrials.gov,23/03/2020,23/03/2020,FALSE,University of Catanzaro,Recruiting,Phase 2/Phase 3,Interventional,Italy,Escin in Patients With Covid-19 Infection,Traditional Medicine (Drug),Traditional Medicine,120,30/06/2020,30/08/2020,https://clinicaltrials.gov/show/NCT04322344,No Results,No Results,No Results,06/04/2020,04/01/2020,None
566,NCT04323644,ClinicalTrials.gov,25/03/2020,31/03/2020,FALSE,University of Birmingham,Not Recruiting,Not Applicable,Observational,No Country Given,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),Other (surgery),No Intervention,1000,30/09/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04323644,No Results,No Results,No Results,06/04/2020,04/01/2020,None
567,NCT04322786,ClinicalTrials.gov,23/03/2020,01/01/1998,TRUE,"University College, London",Not Recruiting,Not Applicable,Observational,No Country Given,"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?",Drug,ACE inhibitors,1302508,31/05/2016,31/03/2020,https://clinicaltrials.gov/show/NCT04322786,No Results,No Results,No Results,06/04/2020,04/01/2020,None
568,NCT04324996,ClinicalTrials.gov,25/03/2020,21/03/2020,TRUE,Chongqing Public Health Medical Center,Recruiting,Phase 1/Phase 2,Interventional,China,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19,ATMP,Cells (NK),90,31/05/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04324996,No Results,No Results,No Results,06/04/2020,04/01/2020,None
569,ChiCTR2000031630,ChiCTR,05/04/2020,17/02/2020,TRUE,Guangzhou Eighth People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for Celebrex in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Celecoxib,60,Not Available,17/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=50474,No Results,No Results,No Results,06/04/2020,04/07/2020,None
570,NCT04327570,ClinicalTrials.gov,26/03/2020,27/03/2020,FALSE,UZLeuven,Not Recruiting,Not Applicable,Observational,No Country Given,In-depth Immunological Investigation of COVID-19.,Clinical Presentation,No Intervention,100,30/09/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04327570,No Results,No Results,No Results,06/04/2020,04/07/2020,None
571,ChiCTR2000031539,ChiCTR,03/04/2020,15/03/2020,TRUE,Wuhan Women and Children's Health Care Center,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for the Correlation between Angiotensin II Type 1 Receptor Blockers (ARBs) and  the Progression and Outcome of Novel Coronavirus Pneumonia (COVID-19),Drug,ARBs,180,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51893,No Results,No Results,No Results,06/04/2020,04/07/2020,None
572,ChiCTR2000031589,ChiCTR,05/04/2020,06/03/2020,TRUE,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Investigation for the sleep quality in non-health care workers during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,462,Not Available,10/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51969,No Results,No Results,No Results,06/04/2020,04/07/2020,None
573,NCT04325412,ClinicalTrials.gov,25/03/2020,23/03/2020,TRUE,UMC Utrecht,Recruiting,Not Applicable,Observational,Netherlands,Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY,Clinical Presentation,No Intervention,1000,23/03/2021,23/06/2021,https://clinicaltrials.gov/show/NCT04325412,No Results,No Results,No Results,06/04/2020,04/01/2020,None
574,NCT04326309,ClinicalTrials.gov,26/03/2020,25/03/2020,TRUE,HealthMode Inc.,Recruiting,Not Applicable,Observational,United States,Audio Data Collection for Identification and Classification of Coughing,Diagnostics,Diagnostic Test or Assessment,1000,25/09/2022,25/09/2022,https://clinicaltrials.gov/show/NCT04326309,No Results,No Results,No Results,06/04/2020,04/07/2020,None
575,NCT04264533,ClinicalTrials.gov,04/02/2020,14/02/2020,FALSE,ZhiYong Peng,Recruiting,Phase 2,Interventional,China,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia,Drug,Vitamin C,140,30/09/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04264533,No Results,No Results,No Results,23/03/2020,08/03/2020,None
576,NCT04308187,ClinicalTrials.gov,12/03/2020,11/03/2020,TRUE,"University Hospital, Clermont-Ferrand",Not Recruiting,Not Applicable,Observational,France,Influence of the COvid-19 Epidemic on STRESS,Other (psych),No Intervention,50000,01/03/2022,01/03/2022,https://clinicaltrials.gov/show/NCT04308187,No Results,No Results,No Results,23/03/2020,18/03/2020,None
577,ChiCTR2000031494,ChiCTR,02/04/2020,01/02/2020,TRUE,Huangshi Hospital of Traditional Chinese Medicine,Recruiting,Phase 1,Interventional,China,Clinical study for stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),36,Not Available,02/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51904,No Results,No Results,No Results,06/04/2020,04/07/2020,None
578,ChiCTR2000031587,ChiCTR,04/04/2020,27/01/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"A paired clinical study for novel coronavirus pneumonia (COVID-19) patients with ordinary, severe, critical, and deceased patients in Tongji Hospital",Clinical Presentation,No Intervention,2000,Not Available,31/12/2022,http://www.chictr.org.cn/showproj.aspx?proj=51952,No Results,No Results,No Results,06/04/2020,04/07/2020,None
579,ChiCTR2000031627,ChiCTR,05/04/2020,20/04/2020,FALSE,Second People's Hospital of Fuyang City,Not Recruiting,Not Applicable,Basic Science,China,Study for the Mechanism of the Relationship between Infection of novel coronavirus pneumonia (COVID-19) and Host Innate Immune,Clinical Presentation,No Intervention,60,Not Available,20/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=51865,No Results,No Results,No Results,06/04/2020,04/07/2020,None
580,ChiCTR2000031540,ChiCTR,03/04/2020,05/02/2020,TRUE,Affiliated Hospital of Zunyi Medical University,Recruiting,Phase 1,Interventional,China,Study for clinical effect of rehabilitation nursing program for patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio,100,Not Available,05/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51684,No Results,No Results,No Results,06/04/2020,04/07/2020,None
581,ChiCTR2000031533,ChiCTR,03/04/2020,10/04/2020,FALSE,Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Health services research,China,Survey of psychological status and related factors of emergency medical staff in the country during the novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,7000,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51835,No Results,No Results,No Results,06/04/2020,04/07/2020,None
582,ChiCTR2000031538,ChiCTR,03/04/2020,03/04/2020,FALSE,"Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Health services research,China,Assessment of mental health status of first-line dental emergency medical personnel during novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,123,Not Available,30/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=51938,No Results,No Results,No Results,06/04/2020,04/07/2020,None
583,ChiCTR2000031465,ChiCTR,02/04/2020,25/03/2020,TRUE,The First People's Hospital of Jiangxia District,Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus (2019-nCOV) IgG detection kit (magnetic particle chemiluminescence) clinical trial,Diagnostics,Diagnostic Test or Assessment,200,Not Available,31/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51538,No Results,No Results,No Results,06/04/2020,04/07/2020,None
584,ChiCTR2000031504,ChiCTR,03/04/2020,01/12/2019,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A multi-center telephone follow-up study of disease management and infection in rheumatic patients during novel coronavirus pneumonia (COVID-19) pandemic in Hubei province,Clinical Presentation,No Intervention,2000,Not Available,31/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51781,No Results,No Results,No Results,06/04/2020,04/07/2020,None
585,ChiCTR2000031115,ChiCTR,22/03/2020,01/05/2020,FALSE,Zhengzhou People's Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study of peripheral blood T lymphocyte subsets in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,30,Not Available,31/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51032,No Results,No Results,No Results,23/03/2020,25/03/2020,None
586,ChiCTR2000031199,ChiCTR,23/03/2020,04/02/2020,TRUE,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,A Medical Records Based Retrospective Study for Clinical Characteristics of severe Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,120,Not Available,09/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51478,No Results,No Results,No Results,06/04/2020,04/01/2020,None
587,ChiCTR2000031499,ChiCTR,02/04/2020,10/02/2020,TRUE,Shanghai Oriental Hospital,Not Recruiting,Not Applicable,Observational,China,Sleep quality of patients with novel coronavirus pneumonia (COVID-19) treated in mobile cabin hospital: a retrospective study,Other,Sleep aids,55,Not Available,25/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=51915,No Results,No Results,No Results,06/04/2020,04/07/2020,None
588,ChiCTR2000031454,ChiCTR,01/04/2020,25/01/2020,TRUE,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Interventional,China,Clinical study for prevention and treatment of digestive tract lesions caused by novel coronavirus pneumonia (COVID-19),Drug,Combination: Rabeprazole + chloroquine vs. lopinavir + rabeprazole,56,Not Available,31/07/2021,http://www.chictr.org.cn/showproj.aspx?proj=51693,No Results,No Results,No Results,06/04/2020,04/07/2020,None
589,ChiCTR2000031453,ChiCTR,01/04/2020,01/04/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 4,Interventional,China,"Efficacy and safety of Nintedanib esilate soft capsules in the treatment of pulmonary fibrosis in healed moderate to severe patients of novel coronavirus pneumonia (COVID-19): a single-center, randomized, placebo-controlled trial",Drug,Nintedanib,80,Not Available,01/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=51859,No Results,No Results,No Results,06/04/2020,04/07/2020,None
590,ChiCTR2000030992,ChiCTR,20/03/2020,10/03/2020,TRUE,"Changzheng Hospital, Naval Military Medical University, Shanghai",Recruiting,Not Applicable,Diagnostic test,No Country Given,A medical records based study for the diagnosis and prognosis prediction AI model of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,1000,Not Available,28/02/2023,http://www.chictr.org.cn/showproj.aspx?proj=51338,No Results,No Results,No Results,23/03/2020,25/03/2020,None
591,ChiCTR2000031439,ChiCTR,01/04/2020,20/03/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,No Country Given,A medical records based study for novel coronavirus pneumonia (COVID-19) patients undergoing endotracheal intubation,Other (physical),Mechanical ventilation,Not Available,Not Available,12/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51837,No Results,No Results,No Results,06/04/2020,04/07/2020,None
592,ChiCTR2000031438,ChiCTR,01/04/2020,01/04/2020,FALSE,Affiliated Hospital of Southwest Medical University,Not Recruiting,Not Applicable,Observational,China,Analysis of changes in high risk factors of cervical spondylosis during novel coronavirus pneumonia (COVID-19) pandemic,Clinical Presentation,No Intervention,820,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51815,No Results,No Results,No Results,06/04/2020,04/07/2020,None
593,ChiCTR2000030989,ChiCTR,20/03/2020,20/03/2020,FALSE,Beijing Normal University,Not Recruiting,Not Applicable,Interventional,China,Internet based Solution Focused Brief Therapy treating adolescent anxiety under the novel coronavirus pneumonia (COVID-19) outbreak: A randomized controlled trial,Other (psych),Psychological,76,Not Available,08/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=51331,No Results,No Results,No Results,23/03/2020,25/03/2020,None
594,ChiCTR2000031429,ChiCTR,31/03/2020,01/04/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"The Effects of novel coronavirus pneumonia (COVID-19) Risk Factors on Dynamic Changes of  Immunological, biochemical, and Metabolic Parameters: a Retrospective Observational Study",Clinical Presentation,No Intervention,2000,Not Available,31/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51816,No Results,No Results,No Results,06/04/2020,04/07/2020,None
595,ChiCTR2000031428,ChiCTR,31/03/2020,05/02/2020,TRUE,Wuhan Asia Heart Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical application value of multiple tests for novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,500,Not Available,04/10/2020,http://www.chictr.org.cn/showproj.aspx?proj=51813,No Results,No Results,No Results,06/04/2020,04/07/2020,None
596,ChiCTR2000031427,ChiCTR,31/03/2020,25/03/2020,TRUE,The First People's Hospital of Jiangxia District,Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus infection (COVID-19) IgM detection kit (magnetic particle chemiluminescence) clinical trial,Diagnostics,Diagnostic Test or Assessment,200,Not Available,31/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51809,No Results,No Results,No Results,06/04/2020,04/07/2020,None
597,NCT04275414,ClinicalTrials.gov,14/02/2020,15/02/2020,FALSE,Qilu Hospital of Shandong University,Recruiting,Phase 2/Phase 3,Interventional,"China, Italy",Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,Drug,Bevacizumab,20,01/04/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04275414,No Results,No Results,No Results,14/04/2020,18/03/2020,None
598,NCT04315298,ClinicalTrials.gov,15/03/2020,18/03/2020,FALSE,Regeneron Pharmaceuticals,Recruiting,Phase 2/Phase 3,Interventional,United States,Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19,Drug,Sarilumab,400,09/03/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04315298,No Results,No Results,No Results,14/04/2020,25/03/2020,None
599,ChiCTR2000030941,ChiCTR,18/03/2020,28/01/2020,TRUE,"Hu'nan Provincial People's Hospital, Hu'nan Normal University",Recruiting,Not Applicable,Observational,China,"A medical records based study for clinical features and prognosis of severe patients with novel coronavirus pneumonia (COVID-19) in Huanggan, Hubei in Huanggang.",Clinical Presentation,No Intervention,200,Not Available,15/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51000,No Results,No Results,No Results,23/03/2020,25/03/2020,None
600,ChiCTR2000031376,ChiCTR,29/03/2020,28/03/2020,TRUE,Peking University Third Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for safety and effectiveness analysis of data from novel coronavirus pneumonia (COVID-19) patients with conventional therapy,Drug,Unspecified Drug,600,Not Available,29/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=51724,No Results,No Results,No Results,06/04/2020,04/01/2020,None
601,EUCTR2020-001236-10-NL,EU Clinical Trials Register,31/03/2020,31/03/2020,FALSE,UMC Amsterdam,Authorised,Phase 2,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection: the CounterCovid Study,Drug,Imatinib,304,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001236-10,No Results,No Results,No Results,06/04/2020,04/07/2020,None
602,ChiCTR2000030939,ChiCTR,18/03/2020,16/03/2020,TRUE,PLA General Hospital,Recruiting,Not Applicable,Interventional,China,Preliminary evaluation of the safety and efficacy of oral LL-37 antiviral peptide (CAS001) in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Gene-derived protein,10,Not Available,01/10/2020,http://www.chictr.org.cn/showproj.aspx?proj=51059,No Results,No Results,No Results,23/03/2020,25/03/2020,None
603,NCT04318366,ClinicalTrials.gov,19/03/2020,19/03/2020,FALSE,Universita Vita-Salute San Raffaele,Recruiting,Not Applicable,Observational,Italy,"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor",Prognosis,No Intervention,1000,19/03/2022,19/03/2022,https://clinicaltrials.gov/show/NCT04318366,Journal Article,07/05/2020,https://doi.org/10.1016/S2665-9913(20)30127-2,14/04/2020,04/01/2020,None
604,NCT04321811,ClinicalTrials.gov,23/03/2020,21/03/2020,TRUE,xCures,Recruiting,Not Applicable,Observational,United States,"Behavior, Environment And Treatments for Covid-19",Clinical Presentation,No Intervention,100000,20/03/2021,20/03/2022,https://clinicaltrials.gov/show/NCT04321811,No Results,No Results,No Results,14/04/2020,04/01/2020,None
605,EUCTR2020-001271-33-FR,EU Clinical Trials Register,24/03/2020,31/03/2020,FALSE,CHU Angers,Authorised,Phase 3,Interventional,France,HYCOVID - Hydroxychloroquine versus placebo chez les patients ayant une infection COVID-19 √† risque d‚Äôaggravation secondaire : √©tude prospective multicentrique randomis√©e en double aveugle,Drug,Hydroxychloroquine,1300,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001271-33,No Results,No Results,No Results,06/04/2020,04/07/2020,None
606,ChiCTR2000030922,ChiCTR,17/03/2020,26/02/2020,TRUE,Foshan First People's Hospital,Recruiting,Not Applicable,Interventional,China,"Prospective, open-label, controlled, multicenter cohort study of long-acting interferon plus ribavirin in patients with novel coronavirus pneumonia (COVID-19)",Drug,Combination: Interferon + ribavirin vs. umifenovir + ribavirin,30,Not Available,26/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=51141,No Results,No Results,No Results,23/03/2020,25/03/2020,None
607,EUCTR2020-001010-38-NO,EU Clinical Trials Register,16/03/2020,23/03/2020,FALSE,Akershus University Hospital,Authorised,Phase 4,Interventional,Norway,NORWEGIAN CORONAVIRUS DISEASE 2019 [NO-COVID-19] STUDY: A TRIAL TO EVALUATE THE ANTIVIRAL EFFECT OF CHLOROQUINE IN ADULT PATIENTS WITH SARS-COV-2 INFECTION,Drug,Hydroxychloroquine,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001010-38,No Results,No Results,No Results,06/04/2020,04/01/2020,None
608,EUCTR2020-001281-11-FR,EU Clinical Trials Register,26/03/2020,30/03/2020,FALSE,CHU de Saint Etienne,Authorised,Phase 4,Interventional,France,Evaluation of the concentration/viral effect relationship of hydroxychloroquine in COVID-19 patients in the intensive care unit..,Drug,Hydroxychloroquine,50,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001281-11,No Results,No Results,No Results,06/04/2020,04/07/2020,None
609,NCT04324047,ClinicalTrials.gov,25/03/2020,27/03/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Drug,Unspecified Drug,1000,27/03/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04324047,No Results,No Results,No Results,14/04/2020,04/01/2020,EUCTR2020-001246-18
611,NCT04325867,ClinicalTrials.gov,21/03/2020,31/03/2020,FALSE,Professor Adrian Covic,Recruiting,Not Applicable,Interventional,Romania,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,Other,Other,200,01/10/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04325867,No Results,No Results,No Results,14/04/2020,04/07/2020,None
612,ChiCTR2000030906,ChiCTR,17/03/2020,10/03/2020,TRUE,Jiangsu Provincial Center for Disease Control and Prevention,Recruiting,Phase 1,Prevention,China,A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector),ATMP,Adenovirus vector,108,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51154,No Results,No Results,No Results,23/03/2020,25/03/2020,None
613,EUCTR2020-001275-32-DK,EU Clinical Trials Register,24/03/2020,03/04/2020,FALSE,The Parker Institute (Bispebjerg and Frederiksberg Hospital),Authorised,Phase 2,Interventional,Denmark,Anti-il6 treatment of serious COVID-19 disease with threatening respiratory failure,Drug,Tocilizumab vs. sarilumab,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001275-32,No Results,No Results,No Results,06/04/2020,04/07/2020,None
614,NCT04326075,ClinicalTrials.gov,26/03/2020,06/04/2020,FALSE,Mario Negri Institute for Pharmacological Research,Not Recruiting,Not Applicable,Interventional,No Country Given,Early CPAP in COVID Patients With Respiratory Failure.,Other (physical),Mechanical ventilation,900,05/10/2020,09/11/2020,https://clinicaltrials.gov/show/NCT04326075,No Results,No Results,No Results,14/04/2020,04/07/2020,None
615,NCT04326114,ClinicalTrials.gov,26/03/2020,26/04/2020,FALSE,Complutense University of Madrid,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19,Other (training),Other,240,26/09/2020,12/10/2020,https://clinicaltrials.gov/show/NCT04326114,No Results,No Results,No Results,14/04/2020,04/07/2020,None
616,ACTRN12620000421932,ANZCTR,30/03/2020,05/03/2020,TRUE,The Prince Charles Hospital,Recruiting,Not Applicable,Observational,"Italy, Indonesia, South Korea, China, United States, Japan, Hong Kong, Vietnam, Singapore, Thailand, United Kingdom, Australia",ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease (COVID-19),Drug,Oxygen,400,Not Available,31/07/2020,https://anzctr.org.au/ACTRN12620000421932.aspx,No Results,No Results,No Results,06/04/2020,04/01/2020,None
617,NCT04320238,ClinicalTrials.gov,21/03/2020,21/01/2020,TRUE,Shanghai Jiaotong University,Recruiting,Phase 3,Interventional,China,Experimental Trial of rhIFNa Nasal Drops to Prevent 2019-nCOV in Medical Staff,Drug,Combination: Interferon Alpha vs. Interferon Alpha + Thymosin Alpha,2944,01/05/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04320238,Pre-Print Article,17/04/2020,https://doi.org/10.1101/2020.04.11.20061473,14/04/2020,04/01/2020,None
618,NCT04322188,ClinicalTrials.gov,24/03/2020,19/03/2020,TRUE,A.O. Ospedale Papa Giovanni XXIII,Recruiting,Not Applicable,Observational,Italy,An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection,Drug,Siltuximab,50,19/05/2020,19/05/2020,https://clinicaltrials.gov/show/NCT04322188,Pre-Print Article,03/04/2020,https://doi.org/10.1101/2020.04.01.20048561,14/04/2020,04/01/2020,None
619,NCT04329507,ClinicalTrials.gov,26/03/2020,25/03/2020,TRUE,NHS Lothian,Not Recruiting,Not Applicable,Observational,No Country Given,Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS),Diagnostics,Diagnostic Test or Assessment,200,25/03/2020,25/03/2020,https://clinicaltrials.gov/show/NCT04329507,No Results,No Results,No Results,14/04/2020,04/07/2020,None
620,NCT04330144,ClinicalTrials.gov,30/03/2020,01/04/2020,TRUE,Gangnam Severance Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),Drug (Chemoprophylaxis),Hydroxychloroquine,2486,30/03/2021,30/03/2022,https://clinicaltrials.gov/show/NCT04330144,No Results,No Results,No Results,14/04/2020,04/07/2020,KCT0004907
621,ChiCTR2000030519,ChiCTR,05/03/2020,06/03/2020,FALSE,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Study for the clinical characteristics and digestive system damage of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,40,Not Available,05/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=50604,No Results,No Results,No Results,23/03/2020,08/03/2020,None
622,NCT04320511,ClinicalTrials.gov,23/03/2020,01/04/2020,FALSE,William Beaumont Hospitals,Not Recruiting,Not Applicable,Observational,United States,Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2,Clinical Presentation,No Intervention,25,01/03/2021,01/03/2022,https://clinicaltrials.gov/show/NCT04320511,No Results,No Results,No Results,14/04/2020,04/01/2020,None
623,NCT04320732,ClinicalTrials.gov,23/03/2020,27/03/2020,FALSE,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,Risk Factors for Community- and Workplace Transmission of COVID-19,Clinical Presentation,No Intervention,50000,27/03/2022,20/03/2030,https://clinicaltrials.gov/show/NCT04320732,No Results,No Results,No Results,14/04/2020,04/01/2020,None
624,NCT04326452,ClinicalTrials.gov,25/03/2020,27/03/2020,FALSE,TMC HealthCare,Recruiting,Not Applicable,Interventional,United States,Treating COVID-19 With a Bidirectional Oxygenation Valve,Other (device),Bidirectional Oxygenation Valve,15,01/05/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04326452,No Results,No Results,No Results,14/04/2020,04/07/2020,None
625,NCT04326790,ClinicalTrials.gov,26/03/2020,06/04/2020,TRUE,National and Kapodistrian University of Athens,Not Recruiting,Phase 2,Interventional,No Country Given,The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention,Drug,Colchicine,180,31/08/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04326790,No Results,No Results,No Results,14/04/2020,04/07/2020,EUCTR2020-001455-40
626,NCT04330586,ClinicalTrials.gov,31/03/2020,01/04/2020,FALSE,Korea University Guro Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,A Trial of Ciclesonide in Adults With Mild COVID-19,Drug,Ciclesonide + hydroxychloroquine vs. hydroxychloroquine,141,30/06/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04330586,No Results,No Results,No Results,14/04/2020,04/07/2020,None
627,NCT04333862,ClinicalTrials.gov,01/04/2020,19/03/2020,TRUE,"University Hospital, Bern",Recruiting,Not Applicable,Observational,Switzerland,Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy,Health System,No Intervention,500,30/06/2020,31/12/2021,https://clinicaltrials.gov/show/NCT04333862,No Results,No Results,No Results,14/04/2020,04/07/2020,None
628,ChiCTR2000030254,ChiCTR,26/02/2020,20/02/2020,TRUE,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"the Efficacy and Safety of Favipiravir for novel coronavirus‚Äìinfected pneumonia: A multicenter, randomized, open, positive, parallel-controlled clinical study",Drug,Favipiravir vs. Umifenovir,240,Not Available,20/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=50137,Pre-Print Article,27/03/2020,https://doi.org/10.1101/2020.03.17.20037432,23/03/2020,08/03/2020,None
629,NCT04323878,ClinicalTrials.gov,25/03/2020,06/04/2020,FALSE,Mario Negri Institute for Pharmacological Research,Not Recruiting,Not Applicable,Observational,No Country Given,Early CPAP in COVID Patients With Respiratory Failure. A Prospective Cohort Study.,Other (physical),Mechanical ventilation,3000,05/10/2020,09/11/2020,https://clinicaltrials.gov/show/NCT04323878,No Results,No Results,No Results,14/04/2020,04/01/2020,None
630,NCT04326036,ClinicalTrials.gov,26/03/2020,25/03/2020,TRUE,Healeon Medical Inc,Recruiting,Phase 1,Interventional,United States,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,ATMP,Stromal Vascular Fraction,10,01/11/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04326036,No Results,No Results,No Results,14/04/2020,04/07/2020,None
631,ACTRN12620000438954,ANZCTR,06/04/2020,20/04/2020,FALSE,Griffith University,Not Recruiting,Not Applicable,Observational,Australia,Utilizing lung ultrasound in COVID-19 patients in ICU ‚Äì comparison of management strategies on survival and time on ventilation.,Diagnostics,Diagnostic Test or Assessment,60,Not Available,31/10/2020,https://anzctr.org.au/ACTRN12620000438954.aspx,No Results,No Results,No Results,14/04/2020,04/07/2020,None
632,ACTRN12620000449932,ANZCTR,06/04/2020,10/04/2020,FALSE,University of Melbourne,Not Recruiting,Not Applicable,Observational,Australia,Maternal and neonatal outcomes from women infected with SARS-COV2 (COVID-19) during pregnancy,Clinical Presentation,No Intervention,200,Not Available,31/12/2021,https://anzctr.org.au/ACTRN12620000449932.aspx,No Results,No Results,No Results,14/04/2020,04/07/2020,None
633,NCT04327531,ClinicalTrials.gov,27/03/2020,26/03/2020,TRUE,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study",Other (psych),No Intervention,200,26/04/2020,28/04/2020,https://clinicaltrials.gov/show/NCT04327531,No Results,No Results,No Results,14/04/2020,04/07/2020,None
634,NCT04330521,ClinicalTrials.gov,30/03/2020,01/04/2020,FALSE,Stanford University,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of the Coronavirus (COVID-19) on Patients With Cancer,Clinical Presentation,No Intervention,50,01/05/2022,01/05/2022,https://clinicaltrials.gov/show/NCT04330521,No Results,No Results,No Results,14/04/2020,04/07/2020,None
635,NCT04331613,ClinicalTrials.gov,06/02/2020,27/01/2020,TRUE,Chinese Academy of Sciences,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS,ATMP,Cells (IMRC),9,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04331613,No Results,No Results,No Results,14/04/2020,04/07/2020,None
636,NCT04327180,ClinicalTrials.gov,25/03/2020,30/03/2020,FALSE,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,PREdiction of DIagnosed Covid-19 infecTion in IUC Patients,Diagnostics,Diagnostic Test or Assessment,500,01/09/2021,01/09/2021,https://clinicaltrials.gov/show/NCT04327180,No Results,No Results,No Results,14/04/2020,04/07/2020,None
637,NCT04327349,ClinicalTrials.gov,24/03/2020,28/03/2020,FALSE,Mazandaran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,ATMP,Plasma,30,20/05/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04327349,No Results,No Results,No Results,14/04/2020,04/07/2020,None
638,ACTRN12620000454976,ANZCTR,08/04/2020,09/04/2020,FALSE,Austin Health,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Can intravenous high dose zinc improve clinical outcomes in patients with COVID-19 infection?,Drug,Zinc,160,Not Available,09/04/2021,https://anzctr.org.au/ACTRN12620000454976.aspx,No Results,No Results,No Results,14/04/2020,15/04/2020,None
639,NCT04333251,ClinicalTrials.gov,27/03/2020,01/04/2020,FALSE,Baylor Research Institute,Not Recruiting,Phase 1,Interventional,No Country Given,Study Testing Convalescent Plasma vs Best Supportive Care,ATMP,Plasma,115,31/12/2022,31/12/2022,https://clinicaltrials.gov/show/NCT04333251,No Results,No Results,No Results,14/04/2020,04/07/2020,None
640,NCT04333693,ClinicalTrials.gov,31/03/2020,01/04/2020,FALSE,Spanish Society for Angiology and Vascular Surgery,Not Recruiting,Not Applicable,Observational,Spain,Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study,Clinical Presentation,No Intervention,50,01/10/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04333693,No Results,No Results,No Results,14/04/2020,04/07/2020,None
641,ChiCTR2000031836,ChiCTR,11/04/2020,23/01/2020,TRUE,The First Affiliated Hospital of Yangtze University,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based study for the Clinical Characteristics Of Hospitalized Novel Coronavirus Pneumonia (COVID-19) Patients With Acute Respiratory Distress Syndrome,Clinical Presentation,No Intervention,45,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=52213,No Results,No Results,No Results,13/04/2020,15/04/2020,None
642,NCT04327674,ClinicalTrials.gov,27/03/2020,14/03/2020,TRUE,Aarhus University,Recruiting,Not Applicable,Observational,Denmark,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,Diagnostics,Diagnostic Test or Assessment,375,15/05/2020,15/05/2020,https://clinicaltrials.gov/show/NCT04327674,No Results,No Results,No Results,14/04/2020,04/07/2020,None
643,NCT04328454,ClinicalTrials.gov,27/03/2020,30/01/2020,TRUE,Shanghai 10th People's Hospital,Recruiting,Not Applicable,Observational,China,Clinical Characteristics and Prognostic Factors of Patients With COVID-19,Prognosis,No Intervention,120,02/04/2020,15/04/2020,https://clinicaltrials.gov/show/NCT04328454,No Results,No Results,No Results,14/04/2020,04/07/2020,None
644,ChiCTR2000031782,ChiCTR,10/04/2020,13/04/2020,FALSE,The Second Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Observational,China,A questionnaire investigation of hydroxychloroquine for its potential protective effect against novel coronavirus infection (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,550,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=51934,No Results,No Results,No Results,13/04/2020,15/04/2020,None
645,NCT04334967,ClinicalTrials.gov,02/04/2020,30/03/2020,TRUE,Providence Health & Services,Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,Drug,Hydroxychloroquine vs. Vitamin C,1250,30/09/2021,30/09/2023,https://clinicaltrials.gov/show/NCT04334967,No Results,No Results,No Results,14/04/2020,15/04/2020,None
646,NCT04335019,ClinicalTrials.gov,02/04/2020,01/04/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +,Diagnostics,Diagnostic Test or Assessment,300,01/04/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04335019,No Results,No Results,No Results,14/04/2020,15/04/2020,None
647,NCT04329559,ClinicalTrials.gov,29/03/2020,30/03/2020,FALSE,Hepatopancreatobiliary Surgery Institute of Gansu Province,Recruiting,Not Applicable,Observational,China,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Clinical Presentation,No Intervention,50,29/06/2020,29/06/2021,https://clinicaltrials.gov/show/NCT04329559,No Results,No Results,No Results,14/04/2020,04/07/2020,None
648,NCT04331600,ClinicalTrials.gov,30/03/2020,06/04/2020,TRUE,Wroclaw Medical University,Not Recruiting,Phase 4,Interventional,No Country Given,ChloroQUine As antiviRal treAtmeNT In coroNavirus infEction 2020,Drug,Chloroquine,400,30/09/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04331600,No Results,No Results,No Results,14/04/2020,04/07/2020,EUCTR2020-001469-35
649,ChiCTR2000031781,ChiCTR,10/04/2020,09/04/2020,TRUE,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 2,Interventional,China,"A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector)",ATMP,Vaccine,500,Not Available,31/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=52006,No Results,No Results,No Results,13/04/2020,15/04/2020,None
650,NCT04335201,ClinicalTrials.gov,31/03/2020,06/04/2020,FALSE,IRCCS San Raffaele,Not Recruiting,Phase 2,Interventional,No Country Given,Defibrotide in COVID-19 Pneumonia,Drug,Defibrotide,50,30/09/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04335201,No Results,No Results,No Results,14/04/2020,15/04/2020,None
651,ACTRN12620000448943,ANZCTR,06/04/2020,01/06/2020,FALSE,Deakin University,Not Recruiting,Not Applicable,Interventional,Australia,Expressive Writing To Combat Distress Associated With The COVID-19 Pandemic In People With Inflammatory Bowel Disease,Other (psych),Psychological,154,Not Available,01/03/2021,https://anzctr.org.au/ACTRN12620000448943.aspx,No Results,No Results,No Results,14/04/2020,04/07/2020,None
652,ChiCTR2000031779,ChiCTR,10/04/2020,01/01/2020,TRUE,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Effect of novel coronavirus pneumonia (COVID-19) upon male reproductive system,Clinical Presentation,No Intervention,50,Not Available,01/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=52051,No Results,No Results,No Results,13/04/2020,15/04/2020,None
653,NCT04333355,ClinicalTrials.gov,31/03/2020,15/04/2020,FALSE,Hospital San Jose Tec de Monterrey,Not Recruiting,Phase 1,Interventional,Mexico,Safety in Convalescent Plasma Transfusion to COVID-19,ATMP,Plasma,20,20/12/2020,30/04/2021,https://clinicaltrials.gov/show/NCT04333355,No Results,No Results,No Results,14/04/2020,04/07/2020,None
654,NCT04333472,ClinicalTrials.gov,01/04/2020,06/04/2020,FALSE,Can-Fite BioPharma,Not Recruiting,Phase 2,Interventional,Israel,Piclidenoson for Treatment of COVID-19,Drug,Piclidenoson,40,06/06/2020,06/07/2020,https://clinicaltrials.gov/show/NCT04333472,No Results,No Results,No Results,14/04/2020,04/07/2020,None
655,ChiCTR2000031794,ChiCTR,10/04/2020,08/04/2020,TRUE,Huanggang Central Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for analysis clinical characteristics and risk factors of death in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,130,Not Available,08/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=52193,No Results,No Results,No Results,13/04/2020,15/04/2020,None
656,NCT04263402,ClinicalTrials.gov,02/02/2020,01/02/2020,TRUE,Tongji Hospital,Recruiting,Phase 4,Interventional,China,The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia,Drug,Corticosteroids,100,01/06/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04263402,No Results,No Results,No Results,30/03/2020,08/03/2020,None
657,NCT04283396,ClinicalTrials.gov,13/02/2020,21/02/2020,FALSE,"Wuhan Union Hospital, China",Recruiting,Not Applicable,Observational,China,Study for Novel Coronavirus Pneumonia (NCP),Clinical Presentation,No Intervention,2000,30/05/2020,30/07/2020,https://clinicaltrials.gov/show/NCT04283396,No Results,No Results,No Results,30/03/2020,18/03/2020,None
658,ACTRN12620000444987,ANZCTR,06/04/2020,07/04/2020,FALSE,South Metropolitan Health Service,Not Recruiting,Not Applicable,Observational,Australia,COVID-19 Research Response (ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections COVID-19 Research Response Trial),Clinical Presentation,No Intervention,100000,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000444987.aspx,No Results,No Results,No Results,14/04/2020,04/07/2020,None
659,ChiCTR2000031700,ChiCTR,07/04/2020,21/04/2020,FALSE,Chinese PLA General Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Development and clinical application of novel coronavirus pneumonia (COVID-19) antigen reagent,Diagnostics,Diagnostic Test or Assessment,600,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=52052,No Results,No Results,No Results,13/04/2020,15/04/2020,None
660,ACTRN12620000447954,ANZCTR,06/04/2020,31/03/2020,TRUE,Royal Brisbane & Women's Hospital,Recruiting,Not Applicable,Interventional,Australia,Use of therapeutic drug monitoring (TDM) to optimise oral/enteral hydroxychloroquine dosing in critically ill patients with COVID-19,Drug,Hydroxychloroquine,150,Not Available,31/08/2020,https://anzctr.org.au/ACTRN12620000447954.aspx,No Results,No Results,No Results,14/04/2020,04/07/2020,None
661,ChiCTR2000031699,ChiCTR,07/04/2020,01/02/2020,TRUE,Wenzhou Central Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Study for immune antibody and multi-group function of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,33,Not Available,31/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=51924,No Results,No Results,No Results,13/04/2020,15/04/2020,None
662,ChiCTR2000031783,ChiCTR,10/04/2020,24/03/2020,TRUE,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,Bolivia,Investigation for Prevention Awareness against COVID-19,Other,No Intervention,883,Not Available,13/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51832,No Results,No Results,No Results,13/04/2020,15/04/2020,None
663,ChiCTR2000031860,ChiCTR,12/04/2020,27/04/2020,FALSE,Beijing Sports University,Not Recruiting,Not Applicable,Observational,China,Study for the exercise rehabilitation therapy for the dysfunction of cured discharged novel coronavirus pneumonia (COVID-19) patients,Other (exercise),Exercise,150,Not Available,16/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=52198,No Results,No Results,No Results,13/04/2020,15/04/2020,None
664,EUCTR2020-001301-23-FR,EU Clinical Trials Register,26/03/2020,10/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 3,Interventional,France,Efficacy of Addition of Naproxen for COVID-19 Infection / Enacovid Study,Drug,Naproxen,584,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001301-23,No Results,No Results,No Results,14/04/2020,15/04/2020,None
665,ChiCTR2000031734,ChiCTR,08/04/2020,19/03/2020,TRUE,Huo-Shen-Shan Hospital,Recruiting,Not Applicable,Interventional,China,"Evaluation Danorevir sodium tablets combined with ritonavir in the treatment of novel Coronavirus Pneumonia (COVID-19): a randomized, open-label, controlled trial",Drug,Combination: Danorevir + ritonavir,40,Not Available,29/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=52103,No Results,No Results,No Results,13/04/2020,15/04/2020,None
666,ChiCTR2000031834,ChiCTR,11/04/2020,20/04/2020,FALSE,Jiangsu Province Hospital,Not Recruiting,Not Applicable,Interventional,China,A clinical study for the effect of remote monitoring exercise rehabilitation on the discharged patients with novel coronavirus pneumonia (COVID-19),Telehealth,Telehealth,120,Not Available,20/10/2020,http://www.chictr.org.cn/showproj.aspx?proj=52216,No Results,No Results,No Results,13/04/2020,15/04/2020,None
667,ChiCTR2000031735,ChiCTR,08/04/2020,01/03/2020,TRUE,Huzhou Central Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical study for natural killer (NK) cells from umbilical cord blood in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Cells (NK),20,Not Available,28/02/2021,http://www.chictr.org.cn/showproj.aspx?proj=50613,No Results,No Results,No Results,13/04/2020,15/04/2020,None
668,EUCTR2020-001335-28-NL,EU Clinical Trials Register,27/03/2020,29/03/2020,FALSE,InflaRx GmbH,Authorised,Phase 2/Phase 3,Interventional,Netherlands,An open label phase II/III study of IFX-1 in patients with severe COVID-19 Pneumonia,Drug,IFX-1,130,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001335-28,No Results,No Results,No Results,14/04/2020,15/04/2020,None
669,ChiCTR2000031705,ChiCTR,07/04/2020,10/03/2020,TRUE,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Recruiting,Not Applicable,Observational,China,Study for early biological warning signals in patients with acute renal injury caused by novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,200,Not Available,31/12/2022,http://www.chictr.org.cn/showproj.aspx?proj=51793,No Results,No Results,No Results,13/04/2020,15/04/2020,None
670,ChiCTR2000031675,ChiCTR,06/04/2020,06/04/2020,FALSE,Women's Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Observational,China,A medical records based retrospective analysis of maternal and infant outcomes in Cesarean delivery in Hangzhou non pneumonia Hospital during pandemic of Novel coronovirus pneumonia(COVID-19),Clinical Presentation,No Intervention,2000,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=52037,No Results,No Results,No Results,13/04/2020,15/04/2020,None
671,ChiCTR2000030494,ChiCTR,05/03/2020,01/03/2020,TRUE,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Early risk stratification of the novel coronavirus infected diseases (COVID-19): a multicenter retrospective study  (ERS-COVID-19 study),Prognosis,No Intervention,600,Not Available,01/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=50077,No Results,No Results,No Results,13/04/2020,08/03/2020,None
672,EUCTR2020-001381-11-FR,EU Clinical Trials Register,29/03/2020,08/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 3,Interventional,France,COVID-19 - ACORES-2 study: ACE inhibitors or ARBs discontinuation for Clinical Outcome Risk reduction in patients hospitalized for the Endemic Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection,Drug,ACE inhibitors or ARBs,554,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001381-11,No Results,No Results,No Results,14/04/2020,15/04/2020,None
673,ChiCTR2000030331,ChiCTR,28/02/2020,01/02/2020,TRUE,The First Affiliated Hospital Division of Life Sciences and Medicine University of Science and Technology of China,Recruiting,Not Applicable,Epidemiological research,China,Construction of a Bio information platform for novel coronavirus pneumonia (COVID-19) patients follow-up in Anhui,Clinical Presentation,No Intervention,498,Not Available,01/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=50271,No Results,No Results,No Results,13/04/2020,08/03/2020,None
674,EUCTR2020-001457-43-FR,EU Clinical Trials Register,02/04/2020,10/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 3,Interventional,France,Dexamethasone and oxygen support strategies in ICU patients with Covid-19 pneumonia,Drug,Combination: Dexamethasone + Oxygen,550,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001457-43,No Results,No Results,No Results,14/04/2020,15/04/2020,None
675,EUCTR2020-001435-27-FR,EU Clinical Trials Register,01/04/2020,10/04/2020,FALSE,CHU de Bordeaux,Authorised,Phase 3,Interventional,France,"Home treatment of elderly patients with symptomatic SARS-CoV-2 infection (COVID-19) : a multiarm, multi-stage (MAMS) randomized trial to assess the efficacy and safety
of several experimental treatments to reduce the risk of hospitalization or death
(COVERAGE trial)",Drug,Hydroxychloroquine vs. imatinib vs. favipiravir vs. telmisartan,1057,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001435-27,No Results,No Results,No Results,14/04/2020,15/04/2020,None
676,EUCTR2020-001333-13-FR,EU Clinical Trials Register,02/04/2020,09/04/2020,FALSE,Groupe Hospitalier Paris Saint-Joseph,Authorised,Phase 3,Interventional,France,Dexamethasone associated with hydroxychloroquine vs. hydroxychloroquine alone for the early treatment of severe ARDS caused by COVID-19 : a randomized controlled trial,Drug,Combination: Dexamethasone + hydroxychloroquine vs. hydroxychloroquine,122,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001333-13,No Results,No Results,No Results,14/04/2020,15/04/2020,None
677,EUCTR2020-001421-31-ES,EU Clinical Trials Register,07/04/2020,06/04/2020,TRUE,Sociedad Espaola de Farmacia Hospitalaria,Authorised,Phase 4,Interventional,Spain,Clinical trial for evaluation of efficacy and safety of hydroxychloroquine chemoprophylaxis against SARS-CoV-2 (COVID-19) infection in healthcare professionals.,Drug (Chemoprophylaxis),Hydroxychloroquine,1530,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001421-31,No Results,No Results,No Results,14/04/2020,15/04/2020,None
678,EUCTR2020-001442-19-ES,EU Clinical Trials Register,03/04/2020,02/04/2020,TRUE,Institut de Recerca Hospital de la Santa Creu i Sant Pau,Authorised,Phase 2,Interventional,Spain,"Clinical trial of combined use of hydroxychloroquine, azithromycin, and tocilizumab for the treatment of COVID-19",Drug,Combination: Tocilizumab + hydroxychloroquine + azithromycin,276,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001442-19,No Results,No Results,No Results,14/04/2020,15/04/2020,None
679,EUCTR2020-001409-21-ES,EU Clinical Trials Register,03/04/2020,01/04/2020,TRUE,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Authorised,Phase 2,Interventional,Spain,DEFIBROTIDE AS PREVENTION AND TREATMENT OF RESPIRATORY DISTRESS AND CYTOKINE RELEASE SYNDROME OF COVID-19,Drug,Defibrotide,120,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001409-21,No Results,No Results,No Results,14/04/2020,15/04/2020,None
680,NCT04287686,ClinicalTrials.gov,21/02/2020,01/02/2020,TRUE,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug,ACE enzyme,Not Available,01/04/2020,01/04/2020,https://clinicaltrials.gov/show/NCT04287686,No Results,No Results,No Results,30/03/2020,18/03/2020,None
681,NCT04308317,ClinicalTrials.gov,04/03/2020,05/03/2020,FALSE,Henan Provincial People's Hospital,Recruiting,Phase 4,Interventional,China,Tetrandrine Tablets Used in the Treatment of COVID-19,Drug,Tetrandrine,60,01/03/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04308317,No Results,No Results,No Results,30/03/2020,25/03/2020,None
682,EUCTR2020-001606-33-ES,EU Clinical Trials Register,07/04/2020,07/04/2020,FALSE,Instituto Investigacin Sanitario Biocruces Bizkaia,Authorised,Phase 3,Interventional,Spain,Randomized clinical trial to evaluate the efficacy of hydroxychloroquine associated or not with azithromycin as a treatment for COVID-19 infection,Drug,Combination: Hydroxychloroquine + azithromycin vs. hydroxychloroquine,132,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001606-33,No Results,No Results,No Results,14/04/2020,15/04/2020,None
683,EUCTR2020-001385-11-ES,EU Clinical Trials Register,03/04/2020,28/03/2020,TRUE,Plan Nacional sobre el Sida (PNS),Authorised,Phase 3,Interventional,Spain,EPICOS - Experimental clinical trial for PreventIon or COronavirus in health Care professionalS,Drug (Chemoprophylaxis),Combination: Emtricitabine/tenofovir + hydroxychloroquine,4000,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001385-11,No Results,No Results,No Results,14/04/2020,15/04/2020,None
684,EUCTR2020-001492-33-FR,EU Clinical Trials Register,01/04/2020,10/04/2020,FALSE,L'Hôpital Fondation Adolphe de Rothschild,Authorised,Phase 3,Interventional,France,Interest in the administration of Dornase alpha aerosol in Acute Respiratory Distress Syndrome secondary to respiratory infection by the coronavirus SRASCoV-2 / COVID-19,Drug,Dornase alfa,100,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001492-33,No Results,No Results,No Results,14/04/2020,15/04/2020,None
685,NCT04252274,ClinicalTrials.gov,29/01/2020,30/01/2020,FALSE,Shanghai Public Health Clinical Center,Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,Drug,Combination: Darunavir + cobicistat,30,31/08/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04252274,No Results,No Results,No Results,20/04/2020,08/03/2020,None
686,NCT04261517,ClinicalTrials.gov,06/02/2020,06/02/2020,FALSE,Shanghai Public Health Clinical Center,Not Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,Drug,Hydroxychloroquine,30,25/02/2020,25/02/2020,https://clinicaltrials.gov/show/NCT04261517,Journal Article,06/03/2020,https://doi.org/10.3785/j.issn.1008-9292.2020.03.03,20/04/2020,08/03/2020,None
687,EUCTR2020-001194-69-ES,EU Clinical Trials Register,07/04/2020,30/03/2020,TRUE,Félix Gutiérrez Rodero,Authorised,Phase 3,Interventional,Spain,Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19),Drug (Chemoprophylaxis),Mefloquine,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001194-69,No Results,No Results,No Results,14/04/2020,15/04/2020,None
688,EUCTR2020-001307-16-ES,EU Clinical Trials Register,08/04/2020,01/04/2020,TRUE,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,Authorised,Phase 3,Interventional,Spain,Efficacy and Safety of corticoids in patients with adult respiratory distress syndrome (ARDS) secondary to coronavirus infection.,Drug,Corticosteroids,104,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001307-16,No Results,No Results,No Results,14/04/2020,15/04/2020,None
689,EUCTR2020-001565-37-ES,EU Clinical Trials Register,07/04/2020,03/04/2020,TRUE,ISGlobal,Authorised,Phase 3,Interventional,Spain,Prevention of novel Coronavirus infection with hydroxychloroquine,Drug,Hydroxychloroquine,440,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001565-37,No Results,No Results,No Results,14/04/2020,15/04/2020,None
690,NCT04317092,ClinicalTrials.gov,19/03/2020,19/03/2020,TRUE,National Cancer Institute,Recruiting,Phase 2,Interventional,Italy,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),Drug,Tocilizumab,400,19/12/2020,19/12/2022,https://clinicaltrials.gov/show/NCT04317092,No Results,No Results,No Results,20/04/2020,25/03/2020,EUCTR2020-001110-38
691,NCT04325672,ClinicalTrials.gov,26/03/2020,01/04/2020,FALSE,Mayo Clinic,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit Coronavirus Associated Complications,ATMP,Plasma,Not Available,31/12/2022,31/12/2022,https://clinicaltrials.gov/show/NCT04325672,No Results,No Results,No Results,20/04/2020,04/01/2020,None
692,NCT04312464,ClinicalTrials.gov,04/03/2020,01/01/2020,TRUE,"Wuhan Union Hospital, China",Recruiting,Not Applicable,Observational,China,Myocardial Damage in COVID-19,Clinical Presentation,No Intervention,500,15/03/2020,18/03/2020,https://clinicaltrials.gov/show/NCT04312464,No Results,No Results,No Results,30/03/2020,25/03/2020,None
693,NCT04313322,ClinicalTrials.gov,15/03/2020,16/03/2020,FALSE,Stem Cells Arabia,Recruiting,Phase 1,Interventional,Jordan,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),5,30/06/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04313322,No Results,No Results,No Results,30/03/2020,25/03/2020,None
694,NCT04245631,ClinicalTrials.gov,26/01/2020,01/01/2020,TRUE,Beijing Ditan Hospital,Recruiting,Not Applicable,Observational,China,"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV",Diagnostics,Diagnostic Test or Assessment,50,31/12/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04245631,No Results,No Results,No Results,20/04/2020,08/03/2020,None
695,NCT04306055,ClinicalTrials.gov,08/03/2020,13/03/2020,FALSE,Guangzhou Blood Center,Not Recruiting,Not Applicable,Interventional,China,Blood Donor Recruitment During Epidemic of COVID-19,Other,No Intervention,19491,13/03/2020,03/04/2020,https://clinicaltrials.gov/show/NCT04306055,No Results,No Results,No Results,20/04/2020,18/03/2020,None
696,ChiCTR2000031366,ChiCTR,29/03/2020,01/04/2020,FALSE,Chinese PLA General Hospital,Not Recruiting,Not Applicable,Observational,China,Causes of fever in outpatient outside Wuhan during novel coronavirus pneumonia pandemic: a medical records based retrospective analysis,Clinical Presentation,No Intervention,5000,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=51692,No Results,No Results,No Results,30/03/2020,04/01/2020,None
697,NCT04274322,ClinicalTrials.gov,16/02/2020,19/02/2020,FALSE,Peking University Third Hospital,Not Recruiting,Not Applicable,Observational,China,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool,Other (nutrition),Nutrition,117,04/04/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04274322,No Results,No Results,No Results,20/04/2020,18/03/2020,None
698,NCT04291729,ClinicalTrials.gov,27/02/2020,17/02/2020,TRUE,The Ninth Hospital of Nanchang,Not Recruiting,Phase 4,Interventional,China,Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug,Combination: Danoprevir + ritonavir (w/ or w/o Interferon),11,19/03/2020,19/03/2020,https://clinicaltrials.gov/show/NCT04291729,Pre-Print Article,24/03/2020,https://doi.org/10.1101/2020.03.22.20034041,20/04/2020,18/03/2020,None
699,ChiCTR2000031365,ChiCTR,29/03/2020,17/01/2020,TRUE,Westlake University,Recruiting,Not Applicable,Diagnostic test,China,To explore the pathogenesis and course prediction of novel coronavirus pneumonia (COVID-19) severe patients,Prognosis,No Intervention,0,Not Available,31/01/2022,http://www.chictr.org.cn/showproj.aspx?proj=51694,Pre-Print Article,07/04/2020,https://doi.org/10.1101/2020.04.07.20054585,30/03/2020,04/01/2020,None
700,NCT04326725,ClinicalTrials.gov,26/03/2020,20/03/2020,TRUE,Istinye University,Recruiting,Not Applicable,Observational,Turkey,Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia,Drug (Chemoprophylaxis),Combination: Hydroxychloroquine + Zinc + Vitamin C,80,01/07/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04326725,No Results,No Results,No Results,20/04/2020,04/07/2020,None
701,NCT04327206,ClinicalTrials.gov,25/03/2020,30/03/2020,FALSE,Murdoch Childrens Research Institute,Recruiting,Phase 3,Interventional,Australia,BCG Vaccination to Protect Healthcare Workers Against COVID-19,ATMP,Vaccine,4170,30/10/2020,30/03/2022,https://clinicaltrials.gov/show/NCT04327206,No Results,No Results,No Results,20/04/2020,04/07/2020,None
702,ChiCTR2000031319,ChiCTR,27/03/2020,01/04/2020,FALSE,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe novel coronavirus pneumonia (COVID-19) patients,ATMP,Cells (mesenchymal),20,Not Available,31/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=51647,No Results,No Results,No Results,30/03/2020,04/01/2020,None
703,NCT04323800,ClinicalTrials.gov,24/03/2020,01/05/2020,FALSE,Johns Hopkins University,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19,ATMP,Plasma,150,31/12/2022,01/01/2023,https://clinicaltrials.gov/show/NCT04323800,No Results,No Results,No Results,20/04/2020,04/01/2020,None
704,NCT04328467,ClinicalTrials.gov,27/03/2020,06/04/2020,FALSE,University of Minnesota,Recruiting,Phase 3,Interventional,United States,Pre-exposure Prophylaxis for SARS-Coronavirus-2,Drug (Chemoprophylaxis),Hydroxychloroquine,3500,01/08/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04328467,No Results,No Results,No Results,20/04/2020,04/07/2020,None
705,ChiCTR2000031296,ChiCTR,27/03/2020,14/01/2020,TRUE,Yichang Central People's Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based study for clinical features of novel coronavirus pneumonia (COVID-19) patients and risk factors of death,Clinical Presentation,No Intervention,200,Not Available,19/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51584,Pre-Print Article,30/03/2020,https://doi.org/10.1101/2020.03.26.20041426,30/03/2020,04/01/2020,None
706,NCT04303299,ClinicalTrials.gov,24/02/2020,15/04/2020,FALSE,Rajavithi Hospital,Not Recruiting,Phase 3,Interventional,Thailand,"Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID-19 : A Randomized Control Trial",Drug,"Various Combinations of: Oseltamivir, Chloroquine, Lopipinavir/Ritonavir, Darunavir/ritonavir, Favipiravir",320,31/10/2020,30/11/2020,https://clinicaltrials.gov/show/NCT04303299,No Results,No Results,No Results,20/04/2020,18/03/2020,None
707,NCT04305457,ClinicalTrials.gov,09/03/2020,21/03/2020,FALSE,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19,Drug,Nitric oxide,240,01/04/2021,01/04/2022,https://clinicaltrials.gov/show/NCT04305457,No Results,No Results,No Results,20/04/2020,18/03/2020,None
708,NCT04328012,ClinicalTrials.gov,27/03/2020,06/04/2020,FALSE,Bassett Healthcare,Recruiting,Phase 2/Phase 3,Interventional,United States,COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2,Drug,Lopinavir/ritonavir vs. hydroxychloroquine vs. ARB (Losartan),4000,01/01/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04328012,No Results,No Results,No Results,20/04/2020,04/07/2020,None
709,NCT04329546,ClinicalTrials.gov,29/03/2020,27/03/2020,TRUE,"University Hospital, Geneva",Recruiting,Not Applicable,Observational,Switzerland,Understanding COVID-19,Clinical Presentation,No Intervention,250,31/01/2022,31/03/2022,https://clinicaltrials.gov/show/NCT04329546,No Results,No Results,No Results,20/04/2020,04/07/2020,None
710,ChiCTR2000031293,ChiCTR,27/03/2020,16/03/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Epidemiological study of novel coronavirus infection (COVID-19) in children at medium/low risk,Clinical Presentation (Epidemiology),No Intervention,240,Not Available,16/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=51629,No Results,No Results,No Results,30/03/2020,04/01/2020,None
711,ChiCTR2000031204,ChiCTR,24/03/2020,30/01/2020,TRUE,"Beijing You'an Hospital, Capital Medical University",Recruiting,Phase 2,Interventional,China,"A multicenter, single-blind, randomized controlled clinical trial for chloroquine phosphate in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine,300,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=49420,No Results,No Results,No Results,30/03/2020,04/01/2020,None
712,NCT04329832,ClinicalTrials.gov,30/03/2020,30/03/2020,FALSE,"Intermountain Health Care, Inc.",Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,Drug,Hydroxychloroquine vs. Azithromycin,300,31/12/2020,31/12/2021,https://clinicaltrials.gov/show/NCT04329832,No Results,No Results,No Results,20/04/2020,04/07/2020,None
713,NCT04331106,ClinicalTrials.gov,27/03/2020,27/03/2020,FALSE,Charité University,Recruiting,Not Applicable,Observational,Germany,Survey of the Anxiety Associated With the COVID-19 Pandemic,Other (psych),No Intervention,6000,01/09/2020,01/09/2021,https://clinicaltrials.gov/show/NCT04331106,No Results,No Results,No Results,20/04/2020,15/04/2020,None
714,NCT04306393,ClinicalTrials.gov,10/03/2020,21/03/2020,TRUE,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,Drug,Nitric oxide,200,21/03/2021,21/03/2022,https://clinicaltrials.gov/show/NCT04306393,No Results,No Results,No Results,20/04/2020,18/03/2020,EUCTR2020-001490-68
715,NCT04310228,ClinicalTrials.gov,09/03/2020,08/03/2020,TRUE,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019,Drug,Combination: Favipiravir + tocilizumab vs. favipiravir vs. tocilizumab,150,01/05/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04310228,No Results,No Results,No Results,20/04/2020,25/03/2020,None
716,NCT04332081,ClinicalTrials.gov,30/03/2020,06/04/2020,FALSE,NYU Langone Health,Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen for COVID-19 Patients,Drug,Oxygen,40,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04332081,No Results,No Results,No Results,20/04/2020,04/07/2020,None
717,NCT04333225,ClinicalTrials.gov,01/04/2020,03/04/2020,FALSE,Baylor Research Institute,Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,360,30/07/2020,30/07/2020,https://clinicaltrials.gov/show/NCT04333225,No Results,No Results,No Results,20/04/2020,04/07/2020,None
718,ChiCTR2000031187,ChiCTR,23/03/2020,23/03/2020,FALSE,Wuhan Third Hospital; Tongren Hospital of Wuhan University,Not Recruiting,Not Applicable,Epidemiological research,China,A medical records based retrospective study for novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,1292,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51442,No Results,No Results,No Results,30/03/2020,04/01/2020,None
719,NCT04334460,ClinicalTrials.gov,02/04/2020,01/05/2020,FALSE,Blade Therapeutics,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects,Drug,BLD-2660,120,01/08/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04334460,No Results,No Results,No Results,20/04/2020,15/04/2020,None
720,NCT04334512,ClinicalTrials.gov,02/04/2020,01/04/2020,TRUE,ProgenaBiome,Not Recruiting,Phase 2,Interventional,United States,A Study of Quintuple Therapy to Treat COVID-19 Infection,Drug,Combination: Hydroxychloroquine + azithromycin + vitamin C + vitamin D + zinc,600,01/04/2021,01/07/2021,https://clinicaltrials.gov/show/NCT04334512,No Results,No Results,No Results,20/04/2020,15/04/2020,None
721,ChiCTR2000030936,ChiCTR,18/03/2020,10/03/2020,TRUE,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,A real-world study for the Chinese medicines ''Xinguan 2'' and ''Xinguan 3'' in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,2840,Not Available,10/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=51100,No Results,No Results,No Results,30/03/2020,25/03/2020,None
722,NCT04315480,ClinicalTrials.gov,14/03/2020,12/03/2020,TRUE,Universit Politecnica delle Marche,Not Recruiting,Phase 2,Interventional,Italy,Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis,Drug,Tocilizumab,38,09/04/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04315480,No Results,No Results,No Results,20/04/2020,15/04/2020,None
723,NCT04321369,ClinicalTrials.gov,23/03/2020,09/03/2020,TRUE,Dr. Deneen Vojta,Not Recruiting,Not Applicable,Observational,United States,Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals,Diagnostics,Diagnostic Test or Assessment,533,23/03/2020,23/03/2020,https://clinicaltrials.gov/show/NCT04321369,Pre-Print Article,06/04/2020,https://doi.org/10.1101/2020.04.01.20050005,20/04/2020,04/07/2020,None
724,ChiCTR2000030923,ChiCTR,17/03/2020,15/02/2020,TRUE,Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The treatment and diagnosis plan of integrated traditional Chinese and Western medicine for novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,400,Not Available,16/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51139,No Results,No Results,No Results,30/03/2020,25/03/2020,None
725,NCT04333953,ClinicalTrials.gov,31/03/2020,01/04/2020,FALSE,University of Missouri-Columbia,Recruiting,Not Applicable,Observational,United States,COVID-19 in Patients With HIV,Clinical Presentation,No Intervention,500,01/10/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04333953,No Results,No Results,No Results,20/04/2020,04/07/2020,None
726,NCT04334382,ClinicalTrials.gov,02/04/2020,02/04/2020,FALSE,"Intermountain Health Care, Inc.",Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19,Drug,Hydroxychloroquine vs. azithromycin,1550,31/12/2020,31/12/2021,https://clinicaltrials.gov/show/NCT04334382,No Results,No Results,No Results,20/04/2020,15/04/2020,None
727,NCT04322513,ClinicalTrials.gov,23/03/2020,24/03/2020,FALSE,University of Catanzaro,Recruiting,Not Applicable,Observational,Italy,Biomarkers for Identification of COVID-19 Infection,Diagnostics,Diagnostic Test or Assessment,110,30/06/2020,30/08/2020,https://clinicaltrials.gov/show/NCT04322513,No Results,No Results,No Results,20/04/2020,04/01/2020,None
728,NCT04324021,ClinicalTrials.gov,25/03/2020,02/04/2020,FALSE,Swedish Orphan Biovitrum,Recruiting,Phase 2/Phase 3,Interventional,Italy,Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.,Drug,Combination: Emapalumab + Anakinra,54,01/07/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04324021,No Results,No Results,No Results,20/04/2020,04/01/2020,None
729,NCT04335747,ClinicalTrials.gov,03/04/2020,08/04/2020,FALSE,Salome Kristensen,Not Recruiting,Not Applicable,Observational,Denmark,COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases,Clinical Presentation,No Intervention,333,01/08/2021,01/09/2021,https://clinicaltrials.gov/show/NCT04335747,No Results,No Results,No Results,20/04/2020,15/04/2020,None
730,NCT04336254,ClinicalTrials.gov,28/03/2020,06/04/2020,FALSE,Renmin Hospital of Wuhan University,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,ATMP,Cells (mesenchymal),20,31/12/2020,31/03/2021,https://clinicaltrials.gov/show/NCT04336254,No Results,No Results,No Results,20/04/2020,15/04/2020,None
731,NCT04326387,ClinicalTrials.gov,26/03/2020,06/04/2020,FALSE,Cambridge Clinical Trials Unit (CCTU),Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of Novel Diagnostic Tests for COVID-19,Diagnostics,Diagnostic Test or Assessment,200,07/04/2021,07/10/2021,https://clinicaltrials.gov/show/NCT04326387,No Results,No Results,No Results,20/04/2020,04/07/2020,None
732,NCT04331470,ClinicalTrials.gov,30/03/2020,04/04/2020,FALSE,Fasa University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,Drug,Combination: Levamisole + budesonide/formoterol + lopinavir/ritonavir + hydroxychloroquine,30,20/04/2020,20/05/2020,https://clinicaltrials.gov/show/NCT04331470,No Results,No Results,No Results,20/04/2020,04/07/2020,None
733,NCT04337047,ClinicalTrials.gov,03/04/2020,31/03/2020,TRUE,Wefight,Recruiting,Not Applicable,Observational,France,Assessment of Distress in Crisis Situations During COVID-19,Other (psych),No Intervention,2000,30/04/2020,03/05/2020,https://clinicaltrials.gov/show/NCT04337047,No Results,No Results,No Results,20/04/2020,15/04/2020,None
734,NCT04337502,ClinicalTrials.gov,06/04/2020,23/12/2019,TRUE,Maastricht University,Not Recruiting,Not Applicable,Observational,China,Clinical and Radiomic Model of COVID-19,Other (software),Other,300,20/01/2020,03/03/2020,https://clinicaltrials.gov/show/NCT04337502,No Results,No Results,No Results,20/04/2020,15/04/2020,None
735,NCT04319211,ClinicalTrials.gov,20/03/2020,25/03/2020,FALSE,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,Turkey,"Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress",Other,Social Isolation,200,15/05/2020,20/07/2020,https://clinicaltrials.gov/show/NCT04319211,No Results,No Results,No Results,06/04/2020,04/01/2020,None
736,NCT04323332,ClinicalTrials.gov,08/03/2020,01/03/2020,TRUE,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Not Recruiting,Phase 3,Interventional,China,Traditional Chinese Medicine for Severe COVID-19,Traditional Medicine (Unspecified),Traditional Medicine,50,01/03/2020,01/04/2020,https://clinicaltrials.gov/show/NCT04323332,No Results,No Results,No Results,06/04/2020,04/01/2020,None
737,NCT04331509,ClinicalTrials.gov,31/03/2020,23/03/2020,TRUE,King's College London,Recruiting,Not Applicable,Observational,"United Kingdom, United States",COVID-19 Symptom Tracker,Clinical Presentation,No Intervention,10000000,23/03/2022,23/03/2022,https://clinicaltrials.gov/show/NCT04331509,No Results,No Results,No Results,20/04/2020,04/07/2020,None
738,NCT04331834,ClinicalTrials.gov,01/04/2020,03/04/2020,FALSE,Barcelona Institute for Global Health,Recruiting,Phase 3,Interventional,Spain,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,Drug (Chemoprophylaxis),Hydroxychloroquine,440,03/10/2020,30/10/2020,https://clinicaltrials.gov/show/NCT04331834,No Results,No Results,No Results,20/04/2020,04/07/2020,None
739,NCT04335136,ClinicalTrials.gov,01/04/2020,01/04/2020,TRUE,Apeiron Biologics,Not Recruiting,Phase 2,Interventional,"Germany, Austria, Denmark",Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug,ACE enzyme,200,01/09/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04335136,No Results,No Results,No Results,20/04/2020,15/04/2020,EUCTR2020-001172-15
740,NCT04336761,ClinicalTrials.gov,03/04/2020,01/04/2020,TRUE,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,France,Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France,Clinical Presentation (Epidemiology),No Intervention,914,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04336761,No Results,No Results,No Results,20/04/2020,15/04/2020,None
741,NCT04337541,ClinicalTrials.gov,02/04/2020,02/04/2020,FALSE,"Rigshospitalet, Denmark",Recruiting,Not Applicable,Interventional,Denmark,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,Other (device),Masks,6000,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04337541,No Results,No Results,No Results,20/04/2020,15/04/2020,None
742,NCT04337762,ClinicalTrials.gov,06/04/2020,06/04/2020,FALSE,Beat COVID LLC,Recruiting,Not Applicable,Observational,United States,Beat COVID-19 - Observational Trial,Clinical Presentation,No Intervention,100000,01/12/2020,01/07/2021,https://clinicaltrials.gov/show/NCT04337762,No Results,No Results,No Results,20/04/2020,15/04/2020,None
743,NCT04332094,ClinicalTrials.gov,31/03/2020,02/04/2020,FALSE,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,Recruiting,Phase 2,Interventional,Spain,"Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19",Drug,Combination: Hydroxychloroquine + Azithromycin + Tocilizumab,276,01/09/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04332094,No Results,No Results,No Results,20/04/2020,04/07/2020,None
744,NCT04333407,ClinicalTrials.gov,01/04/2020,03/04/2020,FALSE,Imperial College London,Recruiting,Not Applicable,Interventional,United Kingdom,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,Drug,Combination: Aspirin + clopidogrel + rivaroxaban + atorvastatin + omeprazole,3170,30/03/2021,30/03/2021,https://clinicaltrials.gov/show/NCT04333407,No Results,No Results,No Results,20/04/2020,04/07/2020,None
745,NCT04323592,ClinicalTrials.gov,19/03/2020,23/03/2020,FALSE,University of Trieste,Recruiting,Phase 2/Phase 3,Interventional,Italy,Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,Drug,Corticosteroids,104,20/05/2020,30/05/2020,https://clinicaltrials.gov/show/NCT04323592,No Results,No Results,No Results,06/04/2020,04/01/2020,None
746,NCT04324866,ClinicalTrials.gov,24/03/2020,01/04/2020,FALSE,Universita di Verona,Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,Clinical Presentation (Epidemiology),No Intervention,300,01/11/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04324866,No Results,No Results,No Results,06/04/2020,04/01/2020,None
747,NCT04336787,ClinicalTrials.gov,03/04/2020,12/04/2020,FALSE,Istanbul Koltor University,Not Recruiting,Not Applicable,Observational,Turkey,"Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine",Other (psych),No Intervention,100,10/05/2020,10/06/2020,https://clinicaltrials.gov/show/NCT04336787,No Results,No Results,No Results,20/04/2020,15/04/2020,None
748,NCT04337346,ClinicalTrials.gov,05/04/2020,05/04/2020,FALSE,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Covid 19 Anxiety in Endometriosis Patients,Other (psych),No Intervention,80,20/04/2020,25/04/2020,https://clinicaltrials.gov/show/NCT04337346,No Results,No Results,No Results,20/04/2020,15/04/2020,None
749,NCT04337489,ClinicalTrials.gov,01/04/2020,01/04/2020,FALSE,Imperial College London,Not Recruiting,Not Applicable,Observational,No Country Given,Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus),Other (device),Wearable,200,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04337489,No Results,No Results,No Results,20/04/2020,15/04/2020,None
750,NCT04334005,ClinicalTrials.gov,29/03/2020,10/04/2020,FALSE,University of Granada,Not Recruiting,Not Applicable,Interventional,Spain,Vitamin D on Prevention and Treatment of COVID-19,Drug,Vitamin D,200,30/06/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04334005,No Results,No Results,No Results,20/04/2020,04/07/2020,None
751,NCT04335630,ClinicalTrials.gov,02/04/2020,30/03/2020,TRUE,Memorial Hermann Health System,Recruiting,Not Applicable,Observational,United States,Cardiovascular Manifestations of COVID-19,Clinical Presentation,No Intervention,500,01/03/2021,01/03/2022,https://clinicaltrials.gov/show/NCT04335630,No Results,No Results,No Results,20/04/2020,15/04/2020,None
752,NCT04337983,ClinicalTrials.gov,30/03/2020,15/04/2020,FALSE,Bicetre Hospital,Not Recruiting,Not Applicable,Observational,France,Hemodynamic Characteristics of Patients With SARS-CoV-2,Clinical Presentation,No Intervention,200,01/10/2020,01/04/2021,https://clinicaltrials.gov/show/NCT04337983,No Results,No Results,No Results,20/04/2020,15/04/2020,None
753,NCT04338828,ClinicalTrials.gov,05/04/2020,01/04/2020,TRUE,Massachusetts General Hospital,Not Recruiting,Phase 2,Interventional,United States,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED,Drug,Nitric oxide,260,01/04/2021,01/04/2022,https://clinicaltrials.gov/show/NCT04338828,No Results,No Results,No Results,20/04/2020,15/04/2020,None
754,NCT04337788,ClinicalTrials.gov,03/04/2020,01/04/2020,TRUE,"University Hospital, Limoges",Not Recruiting,Not Applicable,Interventional,No Country Given,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease,Telehealth,Telehealth,200,01/07/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04337788,No Results,No Results,No Results,20/04/2020,15/04/2020,None
755,NCT04338360,ClinicalTrials.gov,03/04/2020,10/01/2019,TRUE,Mayo Clinic,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19,ATMP,Plasma,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04338360,No Results,No Results,No Results,20/04/2020,15/04/2020,None
756,NCT04340349,ClinicalTrials.gov,02/04/2020,10/04/2020,FALSE,Instituto Nacional de Rehabilitacion,Not Recruiting,Phase 1,Interventional,Mexico,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals,Drug (Chemoprophylaxis),Combination: Hydroxychloroquine + bromhexine vs. bromhexine,100,09/06/2020,10/07/2020,https://clinicaltrials.gov/show/NCT04340349,No Results,No Results,No Results,20/04/2020,15/04/2020,None
757,NCT04341012,ClinicalTrials.gov,07/04/2020,10/09/2019,TRUE,Mayo Clinic,Recruiting,Not Applicable,Observational,United States,Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases,Diagnostics,Diagnostic Test or Assessment,120,31/12/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04341012,No Results,No Results,No Results,20/04/2020,15/04/2020,None
758,ISRCTN14966673,ISRCTN,18/03/2020,20/03/2020,FALSE,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,Does point-of-care testing for coronavirus in hospital improve patient care compared to laboratory testing?,Diagnostics,Diagnostic Test or Assessment,500,Not Available,01/04/2021,http://isrctn.com/ISRCTN14966673,No Results,No Results,No Results,06/04/2020,25/03/2020,None
759,NCT04336774,ClinicalTrials.gov,03/04/2020,01/04/2020,TRUE,Duke University,Not Recruiting,Not Applicable,Interventional,United States,CAPTION AI to Minimize Risk of COVID Exposure,Other (software),Other,500,01/11/2020,09/11/2020,https://clinicaltrials.gov/show/NCT04336774,No Results,No Results,No Results,20/04/2020,15/04/2020,None
760,ChiCTR2000031639,ChiCTR,05/04/2020,27/03/2020,TRUE,Peking University Sixth Hospital,Not Recruiting,Not Applicable,Interventional,China,Effects of a single session internet-delivered cognitive behavioral therapy for Acute Insomnia during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,192,Not Available,27/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51119,No Results,No Results,No Results,06/04/2020,04/07/2020,None
761,NCT04341038,ClinicalTrials.gov,07/04/2020,01/04/2020,FALSE,Hospital Universitari de Bellvitge,Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury,Drug,Combination: Tacrolimus + Corticosteroids,84,01/06/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04341038,No Results,No Results,No Results,20/04/2020,15/04/2020,EUCTR2020-001445-39
762,NCT04341480,ClinicalTrials.gov,07/04/2020,10/04/2020,FALSE,Tongji Hospital,Not Recruiting,Not Applicable,Observational,China,The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19,Clinical Presentation,No Intervention,207,10/07/2020,10/07/2020,https://clinicaltrials.gov/show/NCT04341480,No Results,No Results,No Results,20/04/2020,22/04/2020,None
763,ChiCTR2000031503,ChiCTR,03/04/2020,01/04/2020,TRUE,Shanghai Sixth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Application of non-invasive multichannel cardiopulmonary monitoring cloud management platform in patients with Novel Coronavirus Pneumonia (COVID-19),Other (device),Cardiopulmonary monitoring,100,Not Available,31/10/2022,http://www.chictr.org.cn/showproj.aspx?proj=51911,No Results,No Results,No Results,06/04/2020,04/07/2020,None
764,NCT04337359,ClinicalTrials.gov,03/04/2020,05/04/2020,FALSE,Novartis Pharmaceuticals,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness,Drug,Ruxolitinib,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04337359,No Results,No Results,No Results,20/04/2020,15/04/2020,None
765,NCT04337996,ClinicalTrials.gov,01/04/2020,01/04/2020,FALSE,Tourcoing Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Dynamic Evaluation of COVID-19 Diagnostic Tests,Diagnostics,Diagnostic Test or Assessment,176,01/07/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04337996,No Results,No Results,No Results,20/04/2020,15/04/2020,None
766,NCT04338802,ClinicalTrials.gov,01/04/2020,02/04/2020,FALSE,Huilan Zhang,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19,Drug,Nintedanib,96,04/05/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04338802,No Results,No Results,No Results,20/04/2020,15/04/2020,None
767,NCT04339998,ClinicalTrials.gov,06/04/2020,15/04/2020,FALSE,University of Minnesota,Not Recruiting,Not Applicable,Observational,United States,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),Diagnostics,Diagnostic Test or Assessment,500,01/10/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04339998,No Results,No Results,No Results,20/04/2020,15/04/2020,None
768,ChiCTR2000031501,ChiCTR,02/04/2020,17/03/2020,TRUE,Eastern Theater General Hospital,Not Recruiting,Not Applicable,Interventional,China,"The efficacy  of convalescent plasma in patients with critical novel coronavirus pneumonia (COVID-19): a pragmatic, prospective cohort study",ATMP,Plasma,20,Not Available,17/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=50254,No Results,No Results,No Results,06/04/2020,04/07/2020,None
769,NCT04338347,ClinicalTrials.gov,31/03/2020,10/01/2019,TRUE,Capricor Inc.,Not Recruiting,Not Applicable,Expanded Access,United States,CAP-1002 in Severe COVID-19 Disease,ATMP,Cells (allogeneic cardiosphere-derived),Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04338347,No Results,No Results,No Results,20/04/2020,15/04/2020,None
770,NCT04338698,ClinicalTrials.gov,04/04/2020,07/04/2020,FALSE,Shehnoor Azhar,Not Recruiting,Phase 3,Interventional,No Country Given,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT",Drug,"Monotherapy and all Combinations of: Hydroxychloroquine, oseltamivir, and azithromycin",500,01/09/2020,30/11/2020,https://clinicaltrials.gov/show/NCT04338698,No Results,No Results,No Results,20/04/2020,15/04/2020,None
771,NCT04342104,ClinicalTrials.gov,08/04/2020,01/04/2020,TRUE,Hospital General Universitario Morales Meseguer,Recruiting,Not Applicable,Observational,Spain,NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure,Clinical Presentation,No Intervention,100,01/06/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04342104,No Results,No Results,No Results,20/04/2020,15/04/2020,None
772,NCT04343404,ClinicalTrials.gov,08/04/2020,01/04/2020,TRUE,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,PLACE OF VENOVENOUS ECMO IN THE MANAGEMENT OF SEVERE REFRACTORY ARDS ASSOCIATED WITH SARS-COV-2,Drug,Oxygen,100,15/04/2020,15/04/2020,https://clinicaltrials.gov/show/NCT04343404,No Results,No Results,No Results,20/04/2020,15/04/2020,None
773,NCT04340232,ClinicalTrials.gov,03/04/2020,01/04/2020,TRUE,"University of Colorado, Denver",Not Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy of Baricitinib for COVID-19,Drug,Baricitinib,80,01/08/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04340232,No Results,No Results,No Results,20/04/2020,15/04/2020,None
774,NCT04340414,ClinicalTrials.gov,03/03/2020,03/03/2020,FALSE,Peking Union Medical College Hospital,Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP,Drug,Oxygen,10,15/08/2020,15/10/2020,https://clinicaltrials.gov/show/NCT04340414,No Results,No Results,No Results,20/04/2020,15/04/2020,None
775,ChiCTR2000031500,ChiCTR,02/04/2020,05/03/2020,TRUE,Peking University First Hospital,Not Recruiting,Not Applicable,Health services research,China,Impact of measuring distance and cold outdoor environment on the screening of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,58,Not Available,12/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51897,No Results,No Results,No Results,06/04/2020,04/07/2020,None
776,NCT04338906,ClinicalTrials.gov,03/04/2020,01/06/2020,FALSE,Heinrich-Heine University,Not Recruiting,Phase 4,Interventional,No Country Given,Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19,Drug,Combination: Camostat Mesilate + hydroxychloroquine vs. hydroxychloroquine,334,01/06/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04338906,No Results,No Results,No Results,20/04/2020,15/04/2020,None
777,NCT04339322,ClinicalTrials.gov,07/04/2020,01/05/2020,FALSE,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt,Clinical Presentation,No Intervention,200,30/07/2020,30/07/2020,https://clinicaltrials.gov/show/NCT04339322,No Results,No Results,No Results,20/04/2020,15/04/2020,None
778,NCT04339660,ClinicalTrials.gov,02/04/2020,01/02/2020,TRUE,Puren Hospital Affiliated to Wuhan University of Science and Technology,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,ATMP,Cells (mesenchymal),30,30/06/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04339660,No Results,No Results,No Results,20/04/2020,15/04/2020,None
779,NCT04344080,ClinicalTrials.gov,09/04/2020,01/04/2020,TRUE,"University Hospital, Hamburg-Eppendorf",Recruiting,Not Applicable,Interventional,Germany,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,Other (device),Cytokine Adsorber,24,01/12/2020,01/02/2021,https://clinicaltrials.gov/show/NCT04344080,No Results,No Results,No Results,20/04/2020,22/04/2020,None
780,NCT04344925,ClinicalTrials.gov,03/04/2020,01/04/2020,TRUE,Lawson Health Research Institute,Not Recruiting,Not Applicable,Observational,No Country Given,Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19,Other (device),Mask,50,01/06/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04344925,No Results,No Results,No Results,20/04/2020,22/04/2020,None
781,ChiCTR2000031432,ChiCTR,31/03/2020,01/05/2020,FALSE,Nanjing University,Not Recruiting,Phase 1,Basic Science,China,A single center clinical study of evaluating the injection of microRNA2911 plasmid in healthy adults,ATMP,RNA Plasmid,15,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=51646,No Results,No Results,No Results,06/04/2020,04/07/2020,None
782,NCT04341207,ClinicalTrials.gov,08/04/2020,03/04/2020,TRUE,Institut Gustave Roussy,Recruiting,Phase 2,Interventional,France,Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients,Drug,Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,1000,01/04/2022,01/04/2022,https://clinicaltrials.gov/show/NCT04341207,No Results,No Results,No Results,20/04/2020,15/04/2020,EUCTR2020-001250-21
783,NCT04341415,ClinicalTrials.gov,07/04/2020,01/04/2020,TRUE,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Not Applicable,Interventional,France,Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome,Procedure,Auricular neuromodulation,60,01/06/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04341415,No Results,No Results,No Results,20/04/2020,15/04/2020,None
784,NCT04340219,ClinicalTrials.gov,31/03/2020,30/03/2020,TRUE,"University Hospital, Ghent",Recruiting,Not Applicable,Observational,Belgium,"Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic",Other (psych),No Intervention,180,10/04/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04340219,No Results,No Results,No Results,20/04/2020,15/04/2020,None
785,NCT04340544,ClinicalTrials.gov,03/04/2020,10/04/2020,FALSE,"University Hospital, Tübingen",Not Recruiting,Phase 3,Interventional,Germany,Hydroxychloroquine for the Treatment of Mild COVID-19 Disease,Drug,Hydroxychloroquine,2700,30/11/2021,30/09/2022,https://clinicaltrials.gov/show/NCT04340544,No Results,No Results,No Results,20/04/2020,15/04/2020,None
786,NCT04341506,ClinicalTrials.gov,07/04/2020,15/04/2020,FALSE,Northwestern Medicine,Not Recruiting,Not Applicable,Observational,No Country Given,Non-contact ECG Sensor System for COVID19,Clinical Presentation,No Intervention,100,15/07/2020,15/09/2020,https://clinicaltrials.gov/show/NCT04341506,No Results,No Results,No Results,20/04/2020,15/04/2020,None
787,NCT04341714,ClinicalTrials.gov,08/04/2020,16/03/2020,TRUE,Pierre and Marie Curie University,Recruiting,Not Applicable,Observational,France,Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic,Telehealth,Telehealth,400,30/05/2020,15/06/2020,https://clinicaltrials.gov/show/NCT04341714,No Results,No Results,No Results,20/04/2020,15/04/2020,None
788,ChiCTR2000031430,ChiCTR,31/03/2020,20/03/2020,TRUE,The Fifth Medical Center of PLA General Hospital,Recruiting,Phase 2,Interventional,China,Clinical study of human umbilical cord mesenchymal stem cells in the treatment of novel coronavirus pneumonia (COVID-19) induced pulmonary fibrosis,ATMP,Cells (mesenchymal),200,Not Available,31/12/2021,http://www.chictr.org.cn/showproj.aspx?proj=49254,No Results,No Results,No Results,06/04/2020,04/07/2020,None
789,NCT04344951,ClinicalTrials.gov,06/04/2020,06/04/2020,FALSE,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Recruiting,Phase 2,Interventional,Greece,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Drug,Chloroquine,60,01/04/2021,30/04/2021,https://clinicaltrials.gov/show/NCT04344951,No Results,No Results,No Results,20/04/2020,22/04/2020,None
790,ACTRN12620000468921,ANZCTR,14/04/2020,20/04/2020,FALSE,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Problem Management Intervention on Covid 19-Related Anxiety and Depression,Other (psych),Psychological,140,Not Available,09/11/2020,https://anzctr.org.au/ACTRN12620000468921.aspx,No Results,No Results,No Results,20/04/2020,15/04/2020,None
791,NCT04341103,ClinicalTrials.gov,16/03/2020,01/04/2020,FALSE,CareDx,Not Recruiting,Not Applicable,Observational,No Country Given,AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience,Clinical Presentation,No Intervention,500,01/12/2020,01/03/2021,https://clinicaltrials.gov/show/NCT04341103,No Results,No Results,No Results,20/04/2020,15/04/2020,None
792,NCT04341519,ClinicalTrials.gov,07/04/2020,09/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,"Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers",Other (psych),No Intervention,1464,30/11/2020,31/12/2021,https://clinicaltrials.gov/show/NCT04341519,No Results,No Results,No Results,20/04/2020,15/04/2020,None
793,ACTRN12620000480987,ANZCTR,16/04/2020,01/06/2020,FALSE,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Stress-reduction Using Probiotics to Promote Ongoing Resilience Throughout COVID-19 for Healthcare Workers (SUPPORT COVID-19 Healthcare Workers),Supplement,Probiotics,507,Not Available,18/10/2020,https://anzctr.org.au/ACTRN12620000480987.aspx,No Results,No Results,No Results,20/04/2020,22/04/2020,None
794,NCT04341922,ClinicalTrials.gov,07/04/2020,10/04/2020,FALSE,Karolinska Institutet,Not Recruiting,Not Applicable,Interventional,Sweden,A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic,Other (psych),Psychological,670,10/09/2020,10/09/2021,https://clinicaltrials.gov/show/NCT04341922,No Results,No Results,No Results,20/04/2020,15/04/2020,None
795,ACTRN12620000478910,ANZCTR,16/04/2020,01/06/2020,FALSE,Monash Health,Not Recruiting,Not Applicable,Interventional,Australia,Cord Blood Therapy to prevent progression of COVID-19 related pneumonia,ATMP,Cells (stem cells),24,Not Available,30/04/2021,https://anzctr.org.au/ACTRN12620000478910.aspx,No Results,No Results,No Results,20/04/2020,22/04/2020,None
796,ChiCTR2000032098,ChiCTR,19/04/2020,20/01/2020,TRUE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Danggui Shaoyao Powder in the synergistic treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,300,Not Available,31/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=52477,No Results,No Results,No Results,20/04/2020,22/04/2020,None
797,NCT04341610,ClinicalTrials.gov,07/04/2020,20/04/2020,FALSE,"Rigshospitalet, Denmark",Not Recruiting,Phase 1/Phase 2,Interventional,Denmark,ASC Therapy for Patients With Severe Respiratory COVID-19,ATMP,Cells (mesenchymal),40,30/01/2021,30/04/2021,https://clinicaltrials.gov/show/NCT04341610,No Results,No Results,No Results,20/04/2020,15/04/2020,None
798,NCT04341935,ClinicalTrials.gov,06/04/2020,30/04/2020,FALSE,University of Miami,Not Recruiting,Phase 4,Interventional,United States,Effects of DPP4 Inhibition on COVID-19,Drug,Linagliptin,20,30/06/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04341935,No Results,No Results,No Results,20/04/2020,15/04/2020,None
799,ChiCTR2000032095,ChiCTR,19/04/2020,18/03/2020,TRUE,The Third Affiliated Hospital of Sun Yat-sen University,Recruiting,Not Applicable,Observational,China,"Study for Healthy Behavior, Psychological Analysis and Psychological Reconstruction Strategies of Students Population Keeping in Home Under the Pandemic of Novel Coronavirus Pneumonia (COVID-19)",Other (psych),No Intervention,130,Not Available,18/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=52565,No Results,No Results,No Results,20/04/2020,22/04/2020,None
800,EUCTR2020-001257-51-DK,EU Clinical Trials Register,26/03/2020,15/04/2020,FALSE,"Rigshospitalet, Denmark",Authorised,Phase 3,Interventional,Denmark,Hydroxychloroquine for prevention of COVID-19 in patients on chronic dialysis,Drug (chemoprophylaxis),Hydroxychloroquine,568,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001257-51,No Results,No Results,No Results,20/04/2020,22/04/2020,None
801,ChiCTR2000031954,ChiCTR,16/04/2020,15/04/2020,TRUE,"International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University",Recruiting,Not Applicable,Observational,China,Medical Records Based Study for Maternal and Perinatal Outcomes of Women with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,30,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52365,No Results,No Results,No Results,20/04/2020,22/04/2020,None
802,NCT04342702,ClinicalTrials.gov,04/04/2020,16/03/2020,TRUE,The Second Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Observational,China,A Study on the Prospective Cohort Library of COVID-19 in Southeran,Clinical Presentation,No Intervention,504,01/03/2021,01/03/2021,https://clinicaltrials.gov/show/NCT04342702,No Results,No Results,No Results,20/04/2020,15/04/2020,None
803,EUCTR2020-001386-37-IT,EU Clinical Trials Register,02/04/2020,27/03/2020,TRUE,Azienda Unit Sanitaria Locale Reggio Emilia,Authorised,Phase 2,Interventional,Italy,Efficacy of Tocilizumab - COVID-19,Drug,Tocilizumab,Not Available,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001386-37,No Results,No Results,No Results,06/04/2020,04/07/2020,None
804,ACTRN12620000473965,ANZCTR,15/04/2020,01/06/2020,FALSE,The University of Queensland,Not Recruiting,Phase 3,Interventional,Australia,Reducing acute severe respiratory events in health care workers during the Covid-19 pandemic with OM85,Drug (chemoprophylaxis),OM85,1000,Not Available,30/04/2021,https://anzctr.org.au/ACTRN12620000473965.aspx,No Results,No Results,No Results,20/04/2020,22/04/2020,None
805,EUCTR2020-001290-74-ES,EU Clinical Trials Register,13/04/2020,11/04/2020,TRUE,Consorci Parc de Salut Mar (PSMAR),Authorised,Phase 3,Interventional,Spain,Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care,Drug,Sarilumab vs. Hydroxychloroquine + Azithromycin,216,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001290-74,No Results,No Results,No Results,20/04/2020,22/04/2020,None
806,EUCTR2020-001420-34-DK,EU Clinical Trials Register,01/04/2020,14/04/2020,FALSE,Aarhus University,Authorised,Phase 2,Interventional,Denmark,Senicapoc treatment of COVID-19 positive patients in intensive care,Drug,Senicapoc,46,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001420-34,No Results,No Results,No Results,20/04/2020,22/04/2020,None
807,ACTRN12620000474954,ANZCTR,15/04/2020,27/04/2020,FALSE,Sir Charles Gairdner Hospital,Not Recruiting,Not Applicable,Observational,Australia,Airway Pressure Release Ventilation for mechanically ventilated patients with COVID-19 in Western Australian Intensive Care Units: an observational study,Other (physical),Mechanical ventilation,100,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000474954.aspx,No Results,No Results,No Results,20/04/2020,22/04/2020,None
808,EUCTR2020-001406-27-FR,EU Clinical Trials Register,03/04/2020,07/04/2020,FALSE,"University Hospital, Montpellier",Authorised,Phase 3,Interventional,France,efficacy and safety of a bitherapy by hydroxychloroquine + azythromycin vs monotherapy by hydroxychoroquine in adult patients with documentated infection by covid19,Drug,Combination: Hydroxychloroquine vs. Azithromycin vs. Hydroxychloroquine,120,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001406-27,No Results,No Results,No Results,20/04/2020,22/04/2020,None
809,EUCTR2020-001262-11-ES,EU Clinical Trials Register,13/04/2020,09/04/2020,TRUE,Instituto de Investigación Sanitaria Fundación Jiménez Díaz,Authorised,Phase 4,Interventional,Spain,Clinical trial to assess the efficacy and safety of cyclosporin A treatment associated with standard treatment versus standard treatment only in hospitalized patients with confirmed coronavirus infection,Drug,cyclosporine A vs. lopinavir/ritonavir + interferon beta + darunavir + spironolactone + tocilizumab + chloroquine,120,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001262-11,No Results,No Results,No Results,20/04/2020,22/04/2020,None
810,ChiCTR2000032009,ChiCTR,17/04/2020,08/02/2020,TRUE,"Renji Hospital, Shanghai Jiaotong University School of Medicine",Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and risk factors of novel coronavirus pneumonia (COVID-19) patients with chronic liver disease,Clinical Presentation,No Intervention,30,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52490,No Results,No Results,No Results,20/04/2020,22/04/2020,None
811,EUCTR2020-001530-35-ES,EU Clinical Trials Register,13/04/2020,09/04/2020,TRUE,Fundación para la Investigación Biomédica Hospital Universitario La Paz (FIBHULP),Authorised,Phase 4,Interventional,Spain,Clinical trial to avoid infection by SARS-CoV-2 in high-risk population. COVID-19,Drug,Melatonin,450,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001530-35,No Results,No Results,No Results,20/04/2020,22/04/2020,None
812,ChiCTR2000031982,ChiCTR,16/04/2020,01/04/2020,TRUE,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Observational,China,Clinical observation for the effect of Ke-Gan-Li-Yan oral liquid on the relief of laryngeal symptoms of novel coronavirus pneumonia (COVID-19) convalescence and suspected patients and other susceptible people,Traditional Medicine (Drug),Traditional Medicine,240,Not Available,31/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=52341,No Results,No Results,No Results,20/04/2020,22/04/2020,None
813,EUCTR2020-001437-12-ES,EU Clinical Trials Register,13/04/2020,09/04/2020,TRUE,Vall d'Hebron Research Institute (VHIR),Authorised,Phase 4,Interventional,Spain,"Random, controlled, open, one-site clinical trial in adult patients with COVID-19 severe pneumonia treated with immunomodulatory drugs",Drug,"Cyclosporine, Tocilizumab",290,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001437-12,No Results,No Results,No Results,20/04/2020,22/04/2020,None
814,EUCTR2020-001587-29-ES,EU Clinical Trials Register,13/04/2020,08/04/2020,TRUE,Barcelona Institute for Global Health,Authorised,Phase 4,Interventional,Spain,Preventing SARS-CoV-2 virus infection and severity of COVID-19 diseases during pregnancy with hydroxychloroquine,Drug (chemoprophylaxis),Hydroxychloroquine,714,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001587-29,No Results,No Results,No Results,20/04/2020,22/04/2020,None
815,ChiCTR2000031955,ChiCTR,16/04/2020,01/04/2020,TRUE,Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for prevention of novel coronavirus pneumonia (COVID-19) in high risk population by Chinese medicine,Clinical Presentation (Epidemiology),No Intervention,3808,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=52364,No Results,No Results,No Results,20/04/2020,22/04/2020,None
816,EUCTR2020-001634-36-ES,EU Clinical Trials Register,13/04/2020,09/04/2020,TRUE,Rosario García de Vicuña,Authorised,Phase 2,Interventional,Spain,Randomized open pilot study to evaluate the efficacy of subcutaneous sarilumab in patients with moderate-severe COVID-19 infection.,Drug,Sarilumab,30,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001634-36,No Results,No Results,No Results,20/04/2020,22/04/2020,None
817,ChiCTR2000031944,ChiCTR,15/04/2020,16/04/2020,FALSE,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Efficacy of Chinese Herbal Tea in the Prevention of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Other),Traditional Medicine,2000,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=52414,No Results,No Results,No Results,20/04/2020,22/04/2020,None
818,EUCTR2020-001689-12-ES,EU Clinical Trials Register,13/04/2020,11/04/2020,TRUE,Montreal Heart Institute,Authorised,Phase 3,Interventional,Spain,COLCHICINA TEST IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19),Drug,Colchicine,1000,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12,No Results,No Results,No Results,20/04/2020,22/04/2020,None
819,EUCTR2020-001682-36-ES,EU Clinical Trials Register,14/04/2020,13/04/2020,TRUE,CITOSPIN S.L.,Authorised,Phase 2,Interventional,Spain,Treatment of COVID-19 with allogeneic mesenchymal cells (MSV¬Æ).,ATMP,Cells (mesenchymal),24,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001682-36,No Results,No Results,No Results,20/04/2020,22/04/2020,None
820,NCT04298060,ClinicalTrials.gov,28/02/2020,01/04/2020,FALSE,"Ansun Biopharma, Inc.",Not Recruiting,Phase 2,Interventional,China,DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19),Drug,DAS181,280,01/03/2021,01/09/2022,https://clinicaltrials.gov/show/NCT04298060,No Results,No Results,No Results,14/04/2020,04/07/2020,None
821,ChiCTR2000031928,ChiCTR,14/04/2020,01/06/2020,FALSE,The Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,China,"Delineate the prevalence, risk factors, temporal distribution and epidemiological characteristics of hidden novel coronavirus (2019-nCoV) infection in the community",Clinical Presentation (Epidemiology),No Intervention,3000,Not Available,14/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=52353,No Results,No Results,No Results,20/04/2020,22/04/2020,None
822,ChiCTR2000029976,ChiCTR,18/02/2020,18/02/2020,FALSE,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The effect of Gymnastic Qigong Yangfeifang on functional recovery and quality of life in patients with mild novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,160,Not Available,19/02/2022,http://www.chictr.org.cn/showproj.aspx?proj=49631,No Results,No Results,No Results,20/04/2020,18/03/2020,None
823,EUCTR2020-001266-11-ES,EU Clinical Trials Register,16/04/2020,16/04/2020,FALSE,Fundación Instituto de Investigación Sanitaria Fundación Jimenez Diaz,Authorised,Phase 2,Interventional,Spain,Clinical trial of administration of MSC to patients with respiratory distress type COVID-19,ATMP,Cells (mesenchymal),100,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001266-11,No Results,No Results,No Results,20/04/2020,22/04/2020,None
824,NCT04312243,ClinicalTrials.gov,15/03/2020,02/04/2020,FALSE,Massachusetts General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,NO Prevention of COVID-19 for Healthcare Providers,Drug,Nitric oxide,470,20/03/2021,20/03/2022,https://clinicaltrials.gov/show/NCT04312243,No Results,No Results,No Results,14/04/2020,25/03/2020,None
825,NCT04316377,ClinicalTrials.gov,13/03/2020,25/03/2020,FALSE,"University Hospital, Akershus",Recruiting,Phase 4,Interventional,Norway,Norwegian Coronavirus Disease 2019 Study,Drug,Hydroxychloroquine,202,01/04/2021,03/03/2025,https://clinicaltrials.gov/show/NCT04316377,No Results,No Results,No Results,14/04/2020,25/03/2020,None
826,EUCTR2020-001511-25-ES,EU Clinical Trials Register,15/04/2020,14/04/2020,TRUE,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Authorised,Phase 3,Interventional,Spain,Randomized open-blind controlled trial to study the benefit of Colchicine in Patients with COVID-19,Drug,Colchicine,102,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001511-25,No Results,No Results,No Results,20/04/2020,22/04/2020,None
827,EUCTR2020-001448-24-GB,EU Clinical Trials Register,17/04/2020,15/04/2020,TRUE,University of Birmingham,Authorised,Phase 3,Interventional,"South Africa, Ghana, Nigeria, United Kingdom, India",Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Drug (chemoprophylaxis),"Hydroxychloroquine, Lopinavir/Ritonavir",6400,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001448-24,No Results,No Results,No Results,20/04/2020,22/04/2020,None
828,EUCTR2020-001160-28-ES,EU Clinical Trials Register,13/04/2020,09/04/2020,TRUE,Medica Scientia Innovation Research S.L. (MEDSIR),Authorised,Phase 2,Interventional,Spain,Tocilizumab plus Pembrolizumab in COVID-19,Drug,Combinatino: Tocilizumab + Pembrolizumab,24,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001160-28,No Results,No Results,No Results,20/04/2020,22/04/2020,None
829,CTRI/2020/04/024413,CTRI,01/04/2020,09/04/2020,FALSE,K M Amran Hossain,No Status Given,Not Applicable,Observational,Bangladesh,"Knowledge, attitude and fear of COVID-19 in Bangladesh",Other (psych),No Intervention,1000,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42718,No Results,No Results,No Results,20/04/2020,22/04/2020,None
830,CTRI/2020/03/024402,CTRI,31/03/2020,08/04/2020,FALSE,Dr. Remesh Bhasi,Not Recruiting,Phase 3,Interventional,India,"Hydroxy Chloroquine, in open labelled, Randomised intervention for prevention of new infection and adverse outcomes following COVID-19 infection -A Tertiary Hospital based study",Drug,Hydroxychloroquine,500,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42638,No Results,No Results,No Results,20/04/2020,22/04/2020,None
831,CTRI/2020/04/024479,CTRI,07/04/2020,13/04/2020,FALSE,Command Hospital Airforce,Not Recruiting,Not Applicable,Interventional,India,Study of the effect of Chloroquine in addition to standard therapy in COVID-19 patients,Drug,Chloroquine,32,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42713,No Results,No Results,No Results,20/04/2020,22/04/2020,None
832,CTRI/2020/04/024473,CTRI,03/04/2020,15/04/2020,FALSE,Discovery the Critical Care Research Network,Not Recruiting,Not Applicable,Observational,"United Kingdom, United States, Italy, India",Viral Infection and Respiratory illness Universal Study,Clinical Presentation,No Intervention,50000,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42684,No Results,No Results,No Results,20/04/2020,22/04/2020,None
833,CTRI/2020/04/024636,CTRI,15/04/2020,01/05/2020,FALSE,DACH Jaipur,Not Recruiting,Not Applicable,Observational,India,Assessment of Objective clinical scoring system to rule out COVID-19 with high sensitivity,Diagnostics,Diagnostic Test or Assessment,1000,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42961,No Results,No Results,No Results,20/04/2020,22/04/2020,None
834,EUCTR2020-001321-31-ES,EU Clinical Trials Register,13/04/2020,11/04/2020,TRUE,Hospital Universitario de Fuenlabrada,Authorised,Phase 2,Interventional,Spain,Clinical trial phase II to evaluate the efficacy of  3 types of treatment in patients with pneumonia by COVID-19,Drug,Combination: Hydroxychloroquine + baricitinib or imatinib or lopinavir/ritonavir,165,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001321-31,No Results,No Results,No Results,20/04/2020,22/04/2020,None
835,IRCT20200128046294N2,IRCT,14/03/2020,26/03/2020,FALSE,Digestive Disease Research Institute,Recruiting,Phase 3,Interventional,Iran,Study to Evaluate the Safety and Efficacy of Sofosbuvir/Daclatasvir in Participants with Moderate to Severe Coronavirus Disease (COVID-19),Drug,Combination: sofosbuvir + daclatasvir,70,Not Available,Not Available,http://en.irct.ir/trial/46463,No Results,No Results,No Results,21/04/2020,25/03/2020,None
836,CTRI/2020/04/024659,CTRI,15/04/2020,27/04/2020,FALSE,SSV Phytopharmaceuticals,Not Recruiting,Phase 3,Interventional,India,Study of Shreepad Shree Vallabh SSV Formulation to improve immunity in quarantine patients of COVID-19,Traditional Medicine (Drug),Traditional Medicine,30,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42967,No Results,No Results,No Results,20/04/2020,22/04/2020,None
837,EUCTR2020-001413-20-ES,EU Clinical Trials Register,13/04/2020,07/04/2020,TRUE,Fundació Clínic per a la Recerca Biomèdica,Authorised,Phase 2,Interventional,Spain,Efficacy and safety of siltuximab vs. corticosteroids in hospitalized patients with COVID-19 pneumonia,Drug,Siltuximab vs. Corticosteroids,100,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001413-20,No Results,No Results,No Results,20/04/2020,22/04/2020,None
838,IRCT20200314046764N1,IRCT,20/04/2020,26/04/2020,FALSE,Kermanshah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Pirfenidine in SARS-COV2,Drug,"Interventional: Pirfenidine


Both Arms: Lopinavir/ritonavir + chloroquine + osiltamivir",40,Not Available,Not Available,http://en.irct.ir/trial/46533,No Results,No Results,No Results,21/04/2020,22/04/2020,None
839,EUCTR2020-001765-37-ES,EU Clinical Trials Register,13/04/2020,11/04/2020,TRUE,Institut Català d'Oncologia,Authorised,Phase 2,Interventional,Spain,Pragmatic clinical trial of hydroxychloroquine in the treatment of oncohematological patients and health professionals with COVID-19 infection without radiological alteration.,Drug,Hydroxychloroquine,103,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001765-37,No Results,No Results,No Results,20/04/2020,22/04/2020,None
840,IRCT20100228003449N28,IRCT,19/03/2020,15/03/2020,TRUE,Tehran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon in treatment of COVID-19,Drug,Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir,30,Not Available,Not Available,http://en.irct.ir/trial/46538,No Results,No Results,No Results,21/04/2020,25/03/2020,None
841,IRCT20151227025726N12,IRCT,23/03/2020,03/03/2020,TRUE,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluting the therapeutic and adverse effects of Interferon beta 1-a in patients with novel Coronavirus(COVID-19),Drug,Combination: Interferon beta + hydroxychloroquine + osletamivir + lopinavir/ritonavir,20,Not Available,Not Available,http://en.irct.ir/trial/46561,No Results,No Results,No Results,21/04/2020,25/03/2020,None
842,IRCT20100228003449N27,IRCT,16/03/2020,15/03/2020,TRUE,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon √ü in treatment  of COVID-19,Drug,Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir,30,Not Available,Not Available,http://en.irct.ir/trial/46545,No Results,No Results,No Results,21/04/2020,25/03/2020,None
843,EUCTR2020-001466-11-GR,EU Clinical Trials Register,14/04/2020,15/04/2020,FALSE,Hellenic Institute for the Study of Sepsis,Authorised,Phase 2,Interventional,Greece,Prevention of severe respiratory failure in Covid-19,Drug,Anakinra,100,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001466-11,No Results,No Results,No Results,20/04/2020,22/04/2020,None
844,IRCT20150303021315N17,IRCT,12/04/2020,15/03/2020,TRUE,Aryogen Pharmed,Recruiting,Phase 3,Interventional,Iran,Tocilizumab in COVID-19,Drug,Tocilizumab,500,Not Available,Not Available,http://en.irct.ir/trial/46550,No Results,No Results,No Results,21/04/2020,22/04/2020,None
845,IRCT20160625028622N1,IRCT,22/03/2020,19/03/2020,TRUE,Qazvin University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The effect of Noscapine  on clinical and pulmonary manifestations of COVID-19 patients,Drug,Noscapine,125,Not Available,Not Available,http://en.irct.ir/trial/46576,No Results,No Results,No Results,21/04/2020,25/03/2020,None
846,IRCT20190727044343N1,IRCT,05/04/2020,16/03/2020,TRUE,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,?Effect of febuxostat against coronavirus,Drug,Combination: Acetaminophen + Febuxostat vs.  Acetaminophen + Hydroxychloroquine,60,Not Available,09/04/2020,http://en.irct.ir/trial/46629,No Results,No Results,No Results,21/04/2020,22/04/2020,None
847,EUCTR2020-001379-34-ES,EU Clinical Trials Register,14/04/2020,14/04/2020,FALSE,Instituto de Investigación Sanitaria INCLIVA,Authorised,Phase 4,Interventional,Spain,Sedation with sevoflurane versus propofol in patients with Acute Respiratory Distress Syndrome caused by COVID-19 infection,Drug,Sevoflurane vs. Propofol,50,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001379-34,No Results,No Results,No Results,20/04/2020,22/04/2020,None
848,IRCT20200321046828N1,IRCT,26/03/2020,22/03/2020,TRUE,RNA Biotechnology,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Remedy of human coroviruse infection with genetic nanocomposit drug,Drug,Unspecified,30,Not Available,Not Available,http://en.irct.ir/trial/46624,No Results,No Results,No Results,21/04/2020,22/04/2020,None
849,IRCT20140617018126N2,IRCT,29/03/2020,03/04/2020,FALSE,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Persian Medicine Products in Covid-19,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46637,No Results,No Results,No Results,21/04/2020,22/04/2020,None
850,CTRI/2020/04/024442,CTRI,01/04/2020,08/04/2020,FALSE,Max Super Speciality Hospital,Not Recruiting,Not Applicable,Observational,India,Screening for symptoms of COVID-19,Clinical Presentation,No Intervention,5000,Not Available,Not Available,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42687,No Results,No Results,No Results,20/04/2020,22/04/2020,None
851,IRCT20171122037571N2,IRCT,12/04/2020,20/03/2020,TRUE,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Remdesivir in treatment of COVID-19,Drug,Remdesivir + hydroxychloroquine or chloroquine + lopinavir/ritonavir or atazanavir,120,Not Available,Not Available,http://en.irct.ir/trial/46660,No Results,No Results,No Results,21/04/2020,22/04/2020,None
852,IRCT20190727044343N2,IRCT,19/04/2020,05/04/2020,TRUE,Mazandaran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Atorvastatin effect on COVID-19,Drug,Atorvastatin,100,Not Available,Not Available,http://en.irct.ir/trial/46639,No Results,No Results,No Results,21/04/2020,22/04/2020,None
853,IRCT20200310046736N1,IRCT,01/04/2020,No Date Available,FALSE,Ahvaz University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of The Therapeutic Effect of Convalescent Plasma and Plasma-derived Immunoglobulin-enriched solution on COVID-19 Patients,ATMP,Plasma,45,Not Available,Not Available,http://en.irct.ir/trial/46424,No Results,No Results,No Results,21/04/2020,22/04/2020,None
854,IRCT20151227025726N13,IRCT,26/03/2020,11/03/2020,TRUE,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the Efficacy and Safety of Tocilizumab in COVID-19,Drug,Tocilizumab + hydroxychloroquine + oseltamivir + lopinavir/ritonavir,40,Not Available,Not Available,http://en.irct.ir/trial/46681,No Results,No Results,No Results,21/04/2020,22/04/2020,None
855,NCT04324489,ClinicalTrials.gov,25/03/2020,06/03/2020,TRUE,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,DAS181 for Severe COVID-19: Compassionate Use,Drug,DAS181,4,16/04/2020,30/04/2020,https://clinicaltrials.gov/show/NCT04324489,No Results,No Results,No Results,14/04/2020,04/01/2020,None
856,NCT04324528,ClinicalTrials.gov,25/03/2020,27/03/2020,FALSE,Dr. Alexander Supady,Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Drug,Oxygen,30,26/09/2020,26/11/2020,https://clinicaltrials.gov/show/NCT04324528,No Results,No Results,No Results,14/04/2020,04/01/2020,None
857,IRCT20180610040049N3,IRCT,29/03/2020,08/04/2020,FALSE,Arak University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of Trachyspermum copticum syrup on clinical manifestations of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46697,No Results,No Results,No Results,21/04/2020,22/04/2020,None
858,IRCT20151113025025N3,IRCT,29/03/2020,05/04/2020,FALSE,Tehran University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Clinical Trial of renin-angiotensin-aldosterone system inhibitors with halting their administration and the effect on clinical outcomes of patients with corona virus disease-2019 (COVID-19) referring to Sina Hospital in 2020,Drug,RAAS inhibitors,60,Not Available,Not Available,http://en.irct.ir/trial/46531,No Results,No Results,No Results,21/04/2020,22/04/2020,None
859,IRCT20160310026998N11,IRCT,27/03/2020,20/03/2020,TRUE,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of metformin in COVID-19  symptom improvement and death,Drug,Metformin,200,Not Available,Not Available,http://en.irct.ir/trial/46690,No Results,No Results,No Results,21/04/2020,22/04/2020,None
860,IRCT20200324046852N1,IRCT,05/04/2020,01/04/2020,TRUE,Fasa University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of efficacy of oral Levamisole and  Formoterol+Budesonide inhaler with standard treatment of Corona infection.,Drug,Combination: Levamisole + Formoterol + Budesonide + hydroxychloroquine + Lopinavir/ritonavir vs. hydroxychloroquine + Lopinavir/ritonavir,30,Not Available,Not Available,http://en.irct.ir/trial/46706,No Results,No Results,No Results,21/04/2020,22/04/2020,None
861,IRCT20100228003449N30,IRCT,22/03/2020,15/03/2020,TRUE,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Combination therapy in COVID 19,Drug,Combination: Hydroxychloroquine +  Oseltamivir + lopinavir/ritonavir or atazanavir/ritonavir ,50,Not Available,Not Available,http://en.irct.ir/trial/46536,No Results,No Results,No Results,21/04/2020,25/03/2020,None
862,IRCT20200323046841N1,IRCT,28/03/2020,28/03/2020,FALSE,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy evaluation of an herbal compound in COVID-19,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46715,No Results,No Results,No Results,21/04/2020,22/04/2020,None
863,IRCT20200312046749N1,IRCT,28/03/2020,27/03/2020,TRUE,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Tumor Necrosis Factor alpha inhibitor in COVID-19,Drug,TNF-alpha inhibitor,80,Not Available,Not Available,http://en.irct.ir/trial/46551,No Results,No Results,No Results,21/04/2020,22/04/2020,None
864,IRCT20140907019073N4,IRCT,29/03/2020,03/04/2020,FALSE,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of Ipecac homeopathic remedy  in control of Clinical manifestations of COVID-19,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46736,No Results,No Results,No Results,21/04/2020,22/04/2020,None
865,IRCT20180923041093N4,IRCT,28/03/2020,02/04/2020,FALSE,Kerman University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Efficacy of the barley-based remedy in the treatment of novel corona,Traditional Medicine (Drug),Traditional Medicine,100,Not Available,Not Available,http://en.irct.ir/trial/46728,No Results,No Results,No Results,21/04/2020,22/04/2020,None
866,NCT04328272,ClinicalTrials.gov,25/03/2020,28/03/2020,FALSE,Dr. Umar Farooq,Not Recruiting,Phase 3,Interventional,Pakistan,Effectiveness of Hydroxychloroquine in Covid-19 Patients,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,75,28/05/2020,28/06/2020,https://clinicaltrials.gov/show/NCT04328272,No Results,No Results,No Results,14/04/2020,04/07/2020,None
867,NCT04330261,ClinicalTrials.gov,30/03/2020,18/03/2020,TRUE,University of Calgary,Recruiting,Not Applicable,Observational,Canada,Clinical Characteristics and Outcomes of Pediatric COVID-19,Clinical Presentation,No Intervention,12500,17/03/2021,17/03/2022,https://clinicaltrials.gov/show/NCT04330261,No Results,No Results,No Results,14/04/2020,04/07/2020,None
868,IRCT20200316046792N1,IRCT,17/03/2020,16/03/2020,TRUE,Iran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of herbal syrup and solution in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,150,Not Available,Not Available,http://en.irct.ir/trial/46554,No Results,No Results,No Results,21/04/2020,25/03/2020,None
869,IRCT20200322046833N1,IRCT,03/04/2020,28/03/2020,TRUE,Center for Progress and Development of Iran,Not Recruiting,Phase 3,Interventional,Iran,Umifenovir effectiveness in the treatment of COVID-19,Drug,"Investigational: Umifenovir

All Arms: Hydroxychloroquine + Atazanavir/Ritonavir",100,Not Available,Not Available,http://en.irct.ir/trial/46731,No Results,No Results,No Results,21/04/2020,22/04/2020,None
870,IRCT20190804044429N1,IRCT,11/04/2020,25/03/2020,TRUE,Mazandaran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon beta 1b in COVID-19,Drug,"Interventional: Interferon beta

Both Arms: Hydroxychloroquine + lopinavir/ritonavir",70,Not Available,Not Available,http://en.irct.ir/trial/46741,No Results,No Results,No Results,21/04/2020,22/04/2020,None
871,IRCT20160131026298N2,IRCT,20/04/2020,10/03/2020,TRUE,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of PHR spray on patients with coronavirus-19,Traditional Medicine (Drug),Traditional Medicine,64,Not Available,24/03/2020,http://en.irct.ir/trial/46733,No Results,No Results,No Results,21/04/2020,22/04/2020,None
872,IRCT20200317046797N1,IRCT,03/04/2020,08/04/2020,FALSE,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Camostate mesylate on the outcome of Coronavirus (COVID-19)-induced pneumonia,Drug,Camostat Mesilate,40,Not Available,Not Available,http://en.irct.ir/trial/46573,No Results,No Results,No Results,21/04/2020,22/04/2020,None
873,NCT04331574,ClinicalTrials.gov,30/03/2020,10/03/2020,TRUE,Società Italiana dell'Ipertensione Arteriosa-Lega Italiana,Recruiting,Not Applicable,Observational,Italy,Renin-Angiotensin System Inhibitors and COVID-19,Drug,ACE Inhibitors or ARBs,2000,10/04/2020,30/04/2020,https://clinicaltrials.gov/show/NCT04331574,No Results,No Results,No Results,14/04/2020,04/07/2020,None
874,NCT04332016,ClinicalTrials.gov,30/03/2020,02/04/2020,FALSE,"University Hospital, Bordeaux",Recruiting,Not Applicable,Observational,France,COVID-19 Biological Samples Collection,Clinical Presentation,No Intervention,2000,01/03/2023,01/03/2023,https://clinicaltrials.gov/show/NCT04332016,No Results,No Results,No Results,14/04/2020,04/07/2020,None
875,IRCT20120826010664N6,IRCT,05/04/2020,29/03/2020,TRUE,Tehran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of hydroxychloroquine on prevention of covid-19 virus,Drug (chemoprophylaxis),Hydroxychloroquine,310,Not Available,Not Available,http://en.irct.ir/trial/46603,No Results,No Results,No Results,21/04/2020,22/04/2020,None
876,NCT04332666,ClinicalTrials.gov,27/03/2020,31/03/2020,FALSE,Erasme University Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",Drug,Angiotensin (1-7),60,30/05/2020,15/06/2020,https://clinicaltrials.gov/show/NCT04332666,No Results,No Results,No Results,14/04/2020,04/07/2020,None
877,NCT04333550,ClinicalTrials.gov,01/04/2020,01/04/2020,FALSE,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Application of Desferal to Treat COVID-19,Drug,Deferoxamine,50,01/09/2020,01/03/2021,https://clinicaltrials.gov/show/NCT04333550,No Results,No Results,No Results,14/04/2020,04/07/2020,None
878,IRCT20101219005416N2,IRCT,03/04/2020,24/03/2020,TRUE,Kerman University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of  the effect of traditional  Iranian medicine product on improvement of clinical menifestation of COVID -19,Traditional Medicine (Other),Traditional Medicine,80,Not Available,Not Available,http://en.irct.ir/trial/46775,No Results,No Results,No Results,21/04/2020,22/04/2020,None
879,IRCT20200204046369N1,IRCT,08/04/2020,14/04/2020,FALSE,Shiraz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Methylprednisolone in treatment of COVID-19 patients,Drug,Corticosteroids,48,Not Available,Not Available,http://en.irct.ir/trial/46776,No Results,No Results,No Results,21/04/2020,22/04/2020,None
880,IRCT20140528017891N8,IRCT,28/03/2020,24/03/2020,TRUE,MOM Research and Innovation Center,Not Recruiting,Phase 3,Interventional,Iran,The effect of stem cell transplantation in the treatment of COVID-19,ATMP,Cells (mesenchymal),10,Not Available,Not Available,http://en.irct.ir/trial/46623,No Results,No Results,No Results,21/04/2020,22/04/2020,None
881,NCT04334850,ClinicalTrials.gov,02/04/2020,01/04/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia,Clinical Presentation,Other (Procedure),194,01/07/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04334850,No Results,No Results,No Results,14/04/2020,15/04/2020,EUCTR2020-001324-33
882,ACTRN12620000443998,ANZCTR,06/04/2020,01/05/2020,FALSE,Flinders Medical Centre,Not Recruiting,Not Applicable,Interventional,Australia,Home rehabilitation for people with COVID-19: Implementing telehealth approaches to care,Telehealth,Rehabilitation,58,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000443998.aspx,No Results,No Results,No Results,14/04/2020,04/07/2020,None
883,IRCT20150914024017N1,IRCT,03/04/2020,27/03/2020,TRUE,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,ReciGen for treatment of Covid-19,Drug,Interferon beta,40,Not Available,Not Available,http://en.irct.ir/trial/46665,No Results,No Results,No Results,21/04/2020,22/04/2020,None
884,IRCT20130812014333N145,IRCT,30/03/2020,08/04/2020,FALSE,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparative assessment of the efficacy and safety of add ontreatment with ‚ÄúSofosbuvir standard of care therapeutic regimenVelpatasvir‚Äù to ‚Äústandard of caretherapeutic regimen‚Äù in patients with COVID-19,Drug,"Interventional: Sofosbuvir/Velpatasvir

Both Arms: Hydroxychloroquine + lopinavir/ritonavir",80,Not Available,Not Available,http://en.irct.ir/trial/46790,No Results,No Results,No Results,21/04/2020,22/04/2020,None
885,IRCT20180712040449N2,IRCT,01/04/2020,23/03/2020,TRUE,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of oral multi-herbal preparation on COVID-19,Traditional Medicine (Drug),Traditional Medicine,68,Not Available,Not Available,http://en.irct.ir/trial/46782,No Results,No Results,No Results,21/04/2020,22/04/2020,None
886,ChiCTR2000031772,ChiCTR,09/04/2020,10/01/2020,TRUE,Fujian Provincial Maternity and Child Health Hospital,Recruiting,Not Applicable,Interventional,No Country Given,Impact of WeChat-based parenting education for children with autism spectrum disorder and their mothers during the epidemic of Coronavirus disease 2019 (COVID-19),Other,Health Education,105,Not Available,31/10/2020,http://www.chictr.org.cn/showproj.aspx?proj=52165,No Results,No Results,No Results,13/04/2020,15/04/2020,None
887,IRCT20160310026998N10,IRCT,26/03/2020,20/03/2020,TRUE,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Study of the metformin effect on the survival and recovery rate of patients with COVID-19,Drug,Metformin,200,Not Available,Not Available,http://en.irct.ir/trial/46693,No Results,No Results,No Results,21/04/2020,22/04/2020,None
888,IRCT20161204031229N3,IRCT,08/04/2020,30/03/2020,TRUE,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the Effect of Ticoplanin  in Patients With Coronavirus Disease,Drug,"Interventional: Teicoplanin

Both Arms: Hydroxychloroquine + lopinavir/ritonavir or atazanavir",40,Not Available,Not Available,http://en.irct.ir/trial/46814,No Results,No Results,No Results,21/04/2020,22/04/2020,None
889,IRCT20200318046812N1,IRCT,01/04/2020,01/04/2020,FALSE,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison of the safety and efficacy of Favipiravir and kaletra in COVID-19,Drug,Combination: Favipiravir + hydroxychloroquine vs. Lopinavir/ritonavir + hydroxychloroquine,324,Not Available,Not Available,http://en.irct.ir/trial/46783,No Results,No Results,No Results,21/04/2020,22/04/2020,None
890,IRCT20200324046850N2,IRCT,29/03/2020,18/03/2020,TRUE,Abadan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Comparison of the effect of Sofosbuvir + Daclatasvir (Sovodac) and Ribavirin in Covid-19,Drug,Daclatasvir/sofosbuvir vs. Ribavirin,60,Not Available,Not Available,http://en.irct.ir/trial/46713,No Results,No Results,No Results,21/04/2020,22/04/2020,None
891,IRCT20180802040678N4,IRCT,01/04/2020,31/03/2020,TRUE,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effects of Losartan in patients with corona virus disease 2019,Drug,Losartan vs. amlodipine,100,Not Available,Not Available,http://en.irct.ir/trial/46824,No Results,No Results,No Results,21/04/2020,22/04/2020,None
892,IRCT20151228025732N51,IRCT,08/04/2020,18/03/2020,TRUE,Semnan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,"Effect of Algomed, Menta longifolia, Chamomile, Althaea rosea, Malva sylvestris, Lepidium sativum supplements on the Severity and Consequences of Coronavirus 19 disease (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46828,No Results,No Results,No Results,21/04/2020,22/04/2020,None
893,IRCT20200324046850N1,IRCT,29/03/2020,29/03/2020,FALSE,Abadan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison of vitamin D3 and N-acetylcysteine prescription in COVID-19 patients   and their effect on recovery process,Drug,Combination: Vitamin D vs. N-acetylcysteine vs. Vitamin D + N-acetylcysteine,100,Not Available,Not Available,http://en.irct.ir/trial/46732,No Results,No Results,No Results,21/04/2020,22/04/2020,None
894,IRCT20180610040049N4,IRCT,03/04/2020,07/04/2020,FALSE,Ghoum University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of Tanacetum parthenium (L) Sch syrup on clinical manifestations of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46850,No Results,No Results,No Results,21/04/2020,22/04/2020,None
895,IRCT20200324046850N5,IRCT,04/04/2020,19/04/2020,FALSE,Abadan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Study of the effect of vitamin C in patients with Covid-19,Drug,"Investigational: Vitamin C

All Arms: Hydroxychloroquine or Chloroquine + Lopinavir/Ritonavir",40,Not Available,Not Available,http://en.irct.ir/trial/46751,No Results,No Results,No Results,21/04/2020,22/04/2020,None
896,IRCT20150704023055N2,IRCT,03/04/2020,24/03/2020,TRUE,Babol University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Hemoperfusion in patients with COVID-19,Other (device),Hemoperfusion,10,Not Available,Not Available,http://en.irct.ir/trial/46837,No Results,No Results,No Results,21/04/2020,22/04/2020,None
897,ChiCTR2000031770,ChiCTR,09/04/2020,22/01/2020,TRUE,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Experiences in nursing care for patients with suspected novel coronavirus pneumonia (COVID-19) in Shanghai,Clinical Presentation,No Intervention,119,Not Available,29/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=52148,No Results,No Results,No Results,13/04/2020,15/04/2020,None
898,IRCT20160313027033N2,IRCT,16/04/2020,02/04/2020,TRUE,Kerman University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of MCT Oil on COVID-19,Drug,Medium-chain triglycerides,120,Not Available,Not Available,http://en.irct.ir/trial/46762,No Results,No Results,No Results,21/04/2020,22/04/2020,None
899,IRCT20180725040596N2,IRCT,18/04/2020,29/04/2020,FALSE,Iran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Arbidol in treatment of COVID-19,Drug,Umifenovir + Hydroxychloroquine vs. Lopinavir/ritonavir vs. Hydroxychloroquine,100,Not Available,Not Available,http://en.irct.ir/trial/46897,No Results,No Results,No Results,21/04/2020,22/04/2020,None
900,IRCT20200328046886N1,IRCT,12/04/2020,05/03/2020,TRUE,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effectiveness of Sovodak (sofosbuvir+daclatasvir) in Covid-19 patients,Drug,Daclatasvir/sofosbuvir,48,Not Available,04/05/2020,http://en.irct.ir/trial/46885,No Results,No Results,No Results,21/04/2020,22/04/2020,None
901,IRCT20200317046797N2,IRCT,03/04/2020,08/04/2020,FALSE,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Fingolimod for treatment of COVID-19-induced cytokine storm,Drug,Fingolimod,40,Not Available,Not Available,http://en.irct.ir/trial/46786,No Results,No Results,No Results,21/04/2020,22/04/2020,None
902,IRCT20200404046933N1,IRCT,12/04/2020,20/04/2020,FALSE,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of licorice for treatment of coronavirus,Traditional Medicine (Drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46893,No Results,No Results,No Results,21/04/2020,22/04/2020,None
903,IRCT20200404046947N1,IRCT,15/04/2020,28/03/2020,TRUE,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Methylprednisolone on treatment of COVID-19,Drug,Corticosteroids,40,Not Available,Not Available,http://en.irct.ir/trial/46904,No Results,No Results,No Results,21/04/2020,22/04/2020,None
904,IRCT20200325046860N2,IRCT,01/04/2020,28/03/2020,TRUE,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 1,Interventional,Iran,Mesenchymal Stem Cell therapy in COVID19,ATMP,Cells (mesenchymal),5,Not Available,29/04/2020,http://en.irct.ir/trial/46789,No Results,No Results,No Results,21/04/2020,22/04/2020,None
905,IRCT20130306012728N8,IRCT,12/04/2020,20/04/2020,FALSE,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Post-exposure hydroxycloroquine prophylaxis for Covid 19,Drug (chemoprophylaxis),Hydroxychloroquine,500,Not Available,Not Available,http://en.irct.ir/trial/46932,No Results,No Results,No Results,21/04/2020,22/04/2020,None
906,IRCT20200403046926N1,IRCT,11/04/2020,08/04/2020,TRUE,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of SOVODAK in the treatment of COVID-19 patients,Drug,Combination: Daclatasvir/sofosbuvir + hydroxychloroquine vs. hydroxychloroquine,60,Not Available,Not Available,http://en.irct.ir/trial/46926,No Results,No Results,No Results,21/04/2020,22/04/2020,None
907,IRCT20200319046819N1,IRCT,04/04/2020,02/04/2020,TRUE,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,supplementation in COVID-19,Drug,Combination: Vitamin A + Vitamin D + Vitamin C + Vitamin B,60,Not Available,Not Available,http://en.irct.ir/trial/46838,No Results,No Results,No Results,21/04/2020,22/04/2020,None
908,ChiCTR2000031752,ChiCTR,09/04/2020,01/01/2020,TRUE,the First Affiliated Hospital of Nanjing Medical University,Not Recruiting,Not Applicable,Observational,China,A medical records based observational study for myocardial injury and cardiac function in critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,75,Not Available,15/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52135,No Results,No Results,No Results,13/04/2020,15/04/2020,None
909,IRCT20180429039463N2,IRCT,10/04/2020,20/03/2020,TRUE,Torbate-Heidaria University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"The Impact of Family-Based Empowerment Model on Stress, Anxiety and Satisfaction",Other (psych),Psychological,30,Not Available,Not Available,http://en.irct.ir/trial/46933,No Results,No Results,No Results,21/04/2020,22/04/2020,None
910,IRCT20151228025732N53,IRCT,10/04/2020,20/04/2020,FALSE,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Therapeutic effects of plasma of recovered people from COVID-19 on hospitalized patients with this disease,ATMP,Plasma,12,Not Available,Not Available,http://en.irct.ir/trial/46931,No Results,No Results,No Results,21/04/2020,22/04/2020,None
911,IRCT20130917014693N10,IRCT,08/04/2020,07/04/2020,TRUE,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Hydroxychloroquine administration for COVID-19 prophylaxis,Drug (chemoprophylaxis),Hydroxychloroquine,100,Not Available,Not Available,http://en.irct.ir/trial/46849,No Results,No Results,No Results,21/04/2020,22/04/2020,None
912,IRCT20200406046965N1,IRCT,12/04/2020,20/04/2020,FALSE,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of elderberry syrup against COVID-19 symptoms,Traditional Medicine (Drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46958,No Results,No Results,No Results,21/04/2020,22/04/2020,None
913,IRCT20200404046935N1,IRCT,20/04/2020,18/04/2020,TRUE,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Effect of herbal medicine containing Saatar, Hofarigon and Fennel on COVID-19 patients",Traditional Medicine (Drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46940,No Results,No Results,No Results,21/04/2020,22/04/2020,None
914,IRCT20200401046909N1,IRCT,09/04/2020,15/04/2020,FALSE,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the  efficacy of oral 25-hydroxyvitamin D3 on COVID-19,Drug,Calcifediol,260,Not Available,Not Available,http://en.irct.ir/trial/46875,No Results,No Results,No Results,21/04/2020,22/04/2020,None
915,IRCT20151227025726N14,IRCT,10/04/2020,05/04/2020,TRUE,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Favipiravir in COVID-19 patients,Drug,Favipiravir vs. Lopinavir/ritonavir,84,Not Available,Not Available,http://en.irct.ir/trial/46942,No Results,No Results,No Results,21/04/2020,22/04/2020,None
916,IRCT20200404046948N1,IRCT,15/04/2020,13/04/2020,TRUE,Artesh University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy and safety of convalescent plasma in the treatment of COVID-19,ATMP,Plasma,60,Not Available,Not Available,http://en.irct.ir/trial/46973,No Results,No Results,No Results,21/04/2020,22/04/2020,None
917,IRCT20200402046923N1,IRCT,09/04/2020,05/04/2020,TRUE,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Effect of herbal capsule, Viroherb, and herbal syrup, Fenugreek in treatment of COVID-19",Traditional Medicine (Drug),Traditional Medicine,110,Not Available,Not Available,http://en.irct.ir/trial/46879,No Results,No Results,No Results,21/04/2020,22/04/2020,None
918,IRCT20081019001369N4,IRCT,11/04/2020,20/04/2020,FALSE,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of minocycline on COVID-19,Drug,Minocycline,40,Not Available,Not Available,http://en.irct.ir/trial/46977,No Results,No Results,No Results,21/04/2020,22/04/2020,None
919,IRCT20150808023559N20,IRCT,11/04/2020,29/04/2020,FALSE,Ardabil University of Medical Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in  hospitalized patients with COVID-19,Drug,Favipravir + hydroxychloroquine vs. lopinavir/ritonavir + hydroxychloroquine,100,Not Available,Not Available,http://en.irct.ir/trial/47022,No Results,No Results,No Results,21/04/2020,22/04/2020,None
920,IRCT20200404046937N1,IRCT,09/04/2020,09/04/2020,FALSE,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Marshmallow and Licorice on COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46903,No Results,No Results,No Results,21/04/2020,22/04/2020,None
921,IRCT20200408046992N1,IRCT,14/04/2020,16/04/2020,FALSE,Birjand University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Trifluoperazine in treatment of COVID-19,Drug,Combination: Trifluoprazine + hydroxychloroquine vs. hydroxychloroquine,70,Not Available,Not Available,http://en.irct.ir/trial/47006,No Results,No Results,No Results,21/04/2020,22/04/2020,None
922,IRCT20200217046526N1,IRCT,13/04/2020,15/03/2020,TRUE,Iranian Academic Center for Education Culture and Research,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection,ATMP,Cells (mesenchymal),6,Not Available,25/04/2020,http://en.irct.ir/trial/47030,No Results,No Results,No Results,21/04/2020,22/04/2020,None
923,IRCT20080901001157N16,IRCT,08/04/2020,30/03/2020,TRUE,HomaPharmed  Company,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of IMFLUNA herbal compound on covid-19 pneumonia symptoms,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/46907,No Results,No Results,No Results,21/04/2020,22/04/2020,None
924,IRCT20200404046937N2,IRCT,13/04/2020,13/04/2020,FALSE,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Phyllanthus Emblica on COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/47016,No Results,No Results,No Results,21/04/2020,22/04/2020,None
925,IRCT20200413047053N1,IRCT,15/04/2020,20/04/2020,FALSE,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of asafoetida in the treatment of coronavirus infection,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/47139,No Results,No Results,No Results,21/04/2020,22/04/2020,None
926,IRCT20200406046968N1,IRCT,14/04/2020,21/04/2020,FALSE,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The  effect of IL-6 inhibitor (Tocilizumab) on the prognosis of covid-19 patients with acute respiratory failure hospitalized in Imam Reza Hospital in Tabriz,Drug,Tocilizumab,10,Not Available,Not Available,http://en.irct.ir/trial/47021,No Results,No Results,No Results,21/04/2020,22/04/2020,None
927,ChiCTR2000031751,ChiCTR,08/04/2020,01/04/2020,TRUE,Wuhan Fourth Hospital,Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-2019) patients' prognosis and their influence on heart and lung function,Prognosis,No Intervention,60,Not Available,01/04/2022,http://www.chictr.org.cn/showproj.aspx?proj=52130,No Results,No Results,No Results,13/04/2020,15/04/2020,None
928,IRCT20200405046958N1,IRCT,14/04/2020,13/04/2020,TRUE,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Prevention of Novel Coronavirus Disease by Hydroxychloroquine in cancer patients.,Drug,Hydroxychloroquine,60,Not Available,Not Available,http://en.irct.ir/trial/46946,No Results,No Results,No Results,21/04/2020,22/04/2020,None
929,LBCTR2020043459,LBCTR,16/04/2020,14/04/2020,TRUE,Hôtel-Dieu de France Hospital,Not Recruiting,Not Applicable,Observational,Lebanon,The effect of confinement on the mental health of individuals during the COVID-19 pandemic: an online survey,Other (psych),No Intervention,500,Not Available,18/05/2020,http://lbctr.emro.who.int/Trials/Details/3459,No Results,No Results,No Results,20/04/2020,22/04/2020,None
930,IRCT20200409047007N1,IRCT,12/04/2020,13/04/2020,FALSE,Mashhad University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of COVID 19 survivors plasma in COVID 19 patients with ARDS,ATMP,Plasma,32,Not Available,Not Available,http://en.irct.ir/trial/47058,No Results,No Results,No Results,21/04/2020,22/04/2020,None
931,IRCT20180520039738N2,IRCT,10/04/2020,07/04/2020,TRUE,Saveh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation and comparison of the effectiveness of standard treatment with stand treatment plus Vitamin A in treatment in covid19 patients,Drug,Vitamin A,140,Not Available,Not Available,http://en.irct.ir/trial/46974,No Results,No Results,No Results,21/04/2020,22/04/2020,None
932,PACTR202004693933092,PACTR,12/04/2020,15/04/2020,FALSE,Misr University for Science and Technology,Not Recruiting,Not Applicable,Interventional,Egypt,Effectiveness of Measles Vaccine in Health Care Professionals During COVID-19 Outbreak (Randomized Controlled Trial),ATMP,Vaccine,200,Not Available,30/06/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10953,No Results,No Results,No Results,20/04/2020,22/04/2020,None
933,IRCT20190122042450N4,IRCT,16/04/2020,20/04/2020,FALSE,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of hydroxychloroquine to prevent coronavirus disease,Drug (Chemophrophylaxis),Hydroxychloroquine,1000,Not Available,Not Available,http://en.irct.ir/trial/47090,No Results,No Results,No Results,21/04/2020,22/04/2020,None
934,IRCT20081019001369N3,IRCT,11/04/2020,20/04/2020,FALSE,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of crocetin on COVID-19,Traditional Medicine (Drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46978,No Results,No Results,No Results,21/04/2020,22/04/2020,None
935,PACTR202004761408382,PACTR,13/04/2020,01/05/2020,FALSE,Neimeth International Pharmaceuticals Plc.,Not Recruiting,Not Applicable,Interventional,Nigeria,"Efficacy and safety of IHP Detox Tea (a special blend of Andrographis paniculata, Garcinia kola and Psidium guajava) for treatment of Corona virus disease 2019 (COVID-19): a pilot placebo-controlled randomized trial",Traditional Medicine (Drug),Traditional Medicine,72,Not Available,31/08/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10957,No Results,No Results,No Results,20/04/2020,22/04/2020,None
936,IRCT20200317046797N5,IRCT,19/04/2020,20/04/2020,FALSE,Tabriz University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Treatment of COVID-19-induced cytokine storm by hemoperfusion,Other (device),Hemoperfusion,10,Not Available,Not Available,http://en.irct.ir/trial/47015,No Results,No Results,No Results,21/04/2020,22/04/2020,None
937,IRCT20200411047030N1,IRCT,17/04/2020,14/04/2020,TRUE,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of melatonin on the quality of sleep in COVID-19 patients,Drug,Combination: Melatonin + Hydroxychloroquine + azithormycin vs. Hydroxychloroquine + azithormycin,82,Not Available,Not Available,http://en.irct.ir/trial/47099,No Results,No Results,No Results,21/04/2020,22/04/2020,None
938,IRCT20180923041093N5,IRCT,10/04/2020,15/04/2020,FALSE,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the efficacy of hot foot-bath on COVID-19,Procedure,Foot bath,60,Not Available,Not Available,http://en.irct.ir/trial/47018,No Results,No Results,No Results,21/04/2020,22/04/2020,None
939,RBR-3cbs3w,REBEC,08/04/2020,10/04/2020,FALSE,EMS Pharmaceuticals,Not Recruiting,Phase 3,Interventional,Brazil,Evaluation of Hydroxychloroquine for prevention of hospitalization and respiratory complications in patients with confirmed diagnosis or suspected infection by (COVID-19),Drug,Hydroxychloroquine,1300,Not Available,10/07/2020,http://www.ensaiosclinicos.gov.br/rg/RBR-3cbs3w/,No Results,No Results,No Results,21/04/2020,22/04/2020,None
940,IRCT20200413047056N1,IRCT,17/04/2020,18/04/2020,FALSE,Birjand University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in COVID-19,ATMP,Plasma vs. Immunoglobulin,15,Not Available,Not Available,http://en.irct.ir/trial/47212,No Results,No Results,No Results,21/04/2020,22/04/2020,None
941,IRCT20080901001165N46,IRCT,15/04/2020,30/03/2020,TRUE,Center for Progress and Development of Iran,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Umifenovir in controlling the symptoms of patients with COVID-19,Drug,Umifenovir,200,Not Available,Not Available,http://en.irct.ir/trial/47087,No Results,No Results,No Results,21/04/2020,22/04/2020,None
942,RBR-9d8z6m,REBEC,27/03/2020,30/03/2020,FALSE,Hospital do Coração,Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus,Drug,Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine ,630,Not Available,31/07/2020,http://www.ensaiosclinicos.gov.br/rg/RBR-9d8z6m/,No Results,No Results,No Results,21/04/2020,22/04/2020,None
943,IRCT20191125045492N2,IRCT,18/04/2020,23/04/2020,FALSE,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Ozone therapy in treatment of COVID-19,Drug,Ozone,80,Not Available,Not Available,http://en.irct.ir/trial/47149,No Results,No Results,No Results,21/04/2020,22/04/2020,None
944,JPRN-UMIN000039997,JPRN,01/04/2020,01/04/2020,FALSE,Jichi Medical University,Not Recruiting,Not Applicable,Observational,Japan,"Prevention of COVID-19 infection in a medical institution 
and maintenance of medical system",Other,No Intervention,3700,Not Available,31/12/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045600,No Results,No Results,No Results,20/04/2020,22/04/2020,None
945,ChiCTR2000031707,ChiCTR,07/04/2020,01/03/2020,TRUE,Shanghai Oriental Hospital,Recruiting,Not Applicable,Observational,China,Study for sleep quality of medical teams members moved to Hubei for the fighting of novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,47,Not Available,30/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=52079,No Results,No Results,No Results,13/04/2020,15/04/2020,None
946,TCTR20200404004,TCTR,31/03/2020,27/04/2020,FALSE,Health Systems Research Institute (HSRI),Not Recruiting,Phase 4,Interventional,Thailand,Comparative effectiveness of Chloroquine and Vitamin C prophylaxis in household contacts of confirmed COVID-19 patients,Drug,Chloroquine + Vitamin C,400,31/07/2020,31/07/2020,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5995,No Results,No Results,No Results,21/04/2020,22/04/2020,None
947,TCTR20200409006,TCTR,03/04/2020,01/05/2020,FALSE,King Chulalongkorn Memorial Hospital,Not Recruiting,Not Applicable,Interventional,Thailand,Efficacy of HA330 Hemoperfusion in Critically Ill Patients with Severe COVID-19,Other (device),HA330,206,01/05/2020,01/05/2020,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6016,No Results,No Results,No Results,21/04/2020,22/04/2020,None
948,JPRN-jRCTs031190269,JPRN,27/03/2020,27/03/2020,FALSE,Sugiyama Haruhito,Recruiting,Phase 2,Interventional,Japan,"A multicenter, open-label, randomized controlled trial to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19",Drug,Ciclesonide,100,Not Available,Not Available,https://jrct.niph.go.jp/latest-detail/jRCTs031190269,No Results,No Results,No Results,20/04/2020,22/04/2020,None
949,TCTR20200405001,TCTR,05/04/2020,19/03/2020,TRUE,Chulalongkorn University,Recruiting,Not Applicable,Observational,Thailand,Use of Covid-19 Rapid Test for Hospital Care: GI Procedure,Diagnostics,Diagnostic Test or Assessment,20,30/06/2020,30/06/2020,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6023,No Results,No Results,No Results,21/04/2020,22/04/2020,None
950,JPRN-UMIN000040162,JPRN,15/04/2020,14/04/2020,TRUE,Tokyo University,Recruiting,Not Applicable,Observational,Japan,Multicenter observational study to examine the efficacy of protection during endoscopy examination for Covid-19 infection,Other,No Intervention,1000,Not Available,31/03/2021,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045790,No Results,No Results,No Results,20/04/2020,22/04/2020,None
951,TCTR20200324001,TCTR,21/03/2020,24/03/2020,FALSE,Study Group for Efficiency and Quality of Emergency Departments and Non-Scheduled Activities Departm,Not Recruiting,Not Applicable,Observational,France,Covid-19 preparedness among Emergency Departments: a cross-sectional study in France.,Health System,No Intervention,650,31/03/2020,31/03/2020,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5976,No Results,No Results,No Results,21/04/2020,25/03/2020,None
952,PACTR202004801273802,PACTR,02/04/2020,17/04/2020,FALSE,Lagos State Government,Not Recruiting,Phase 3,Interventional,Nigeria,"Lagos COVID-19 Chloroquine Treatment Trial (LACCTT)
",Drug,Chloroquine vs. Hydroxychloroquine,600,Not Available,16/10/2020,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928,No Results,No Results,No Results,20/04/2020,22/04/2020,None
953,ChiCTR2000031672,ChiCTR,06/04/2020,01/04/2020,TRUE,Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,150,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=51940,No Results,No Results,No Results,13/04/2020,15/04/2020,None
954,TCTR20200321001,TCTR,20/03/2020,20/03/2020,FALSE,Study Group for Efficiency and Quality of Emergency Departments and Non-Scheduled Activities Departm,Not Recruiting,Not Applicable,Observational,France,ED Response against Covid-19 pandemic,Other,No Intervention,5000,14/04/2020,14/04/2020,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5975,No Results,No Results,No Results,21/04/2020,25/03/2020,None
955,RBR-6m69fc,REBEC,02/04/2020,01/04/2020,TRUE,University of Sevilla,Recruiting,Not Applicable,Interventional,Spain,"Therapeutic Pulmonary Telerehabilitation Protocol in patients affected by COVID-19, confined in their homes",Telehealth,Rehabilitation,99,Not Available,15/04/2020,http://www.ensaiosclinicos.gov.br/rg/RBR-6m69fc/,No Results,No Results,No Results,21/04/2020,22/04/2020,None
956,ChiCTR2000030750,ChiCTR,13/03/2020,01/03/2020,TRUE,Shenzhen Third People's Hospital,Not Recruiting,Phase 1/Phase 2,Interventional,China,A clinical study for effectiveness and safety evaluation for recombinant chimeric COVID-19 epitope DC vaccine in the treatment of novel coronavirus pneumonia,ATMP,Vaccine,120,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50928,No Results,No Results,No Results,13/04/2020,18/03/2020,None
957,NCT04244591,ClinicalTrials.gov,23/01/2020,26/01/2020,FALSE,Peking Union Medical College Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,China,Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure,Drug,Corticosteroids,80,13/04/2020,13/04/2020,https://clinicaltrials.gov/show/NCT04244591,No Results,No Results,No Results,27/04/2020,08/03/2020,None
958,RBR-9pgwfc,REBEC,09/04/2020,07/04/2020,TRUE,Hospital Universitário Bettina Ferro de Souza,Recruiting,Not Applicable,Observational,"Colombia, United States, Brazil, Portugal, Chile, Canada, France, United Kingdom, Spain",Psychological effects of social isolation in the coronavirus pandemic,Other (psych),No Intervention,2300,Not Available,30/05/2020,http://www.ensaiosclinicos.gov.br/rg/RBR-9pgwfc/,No Results,No Results,No Results,21/04/2020,22/04/2020,None
959,NCT04252664,ClinicalTrials.gov,31/01/2020,12/02/2020,FALSE,Capital Medical University,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Mild and Moderate COVID-19,Drug,Remdesivir,308,10/04/2020,27/04/2020,https://clinicaltrials.gov/show/NCT04252664,No Results,No Results,No Results,27/04/2020,08/03/2020,None
960,NCT04273321,ClinicalTrials.gov,15/02/2020,14/02/2020,TRUE,"Beijing Chaoyang Hospital, Capital Medical University",Not Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Corticosteroids in COVID-19,Drug,Corticosteroids,400,01/05/2020,30/05/2020,https://clinicaltrials.gov/show/NCT04273321,No Results,No Results,No Results,27/04/2020,08/03/2020,None
961,NCT04252118,ClinicalTrials.gov,27/01/2020,27/01/2020,FALSE,Beijing 302 Hospital,Recruiting,Phase 1,Interventional,China,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,ATMP,Cells (mesenchymal),20,01/12/2020,01/12/2021,https://clinicaltrials.gov/show/NCT04252118,No Results,No Results,No Results,27/04/2020,18/03/2020,None
962,NCT04273646,ClinicalTrials.gov,14/02/2020,20/04/2020,FALSE,"Wuhan Union Hospital, China",Not Recruiting,Not Applicable,Interventional,China,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,ATMP,Cells (mesenchymal),48,30/06/2020,15/02/2022,https://clinicaltrials.gov/show/NCT04273646,No Results,No Results,No Results,27/04/2020,08/03/2020,None
963,RBR-8969zg,REBEC,13/04/2020,14/04/2020,FALSE,University de São Paulo,Not Recruiting,Not Applicable,Interventional,Brazil,Treatment of 2019-nCoV Pneumonia with N-acetylcysteine,Drug,N-acetylcysteine,200,Not Available,14/10/2020,http://www.ensaiosclinicos.gov.br/rg/RBR-8969zg/,No Results,No Results,No Results,21/04/2020,22/04/2020,None
964,NCT04276688,ClinicalTrials.gov,11/02/2020,10/02/2020,TRUE,The University of Hong Kong,Not Recruiting,Phase 2,Interventional,Hong Kong,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",Drug,Combination: Lopinavir/ritonavir + ribavirin + interferon beta,127,30/03/2020,31/03/2020,https://clinicaltrials.gov/show/NCT04276688,Journal Article,08/05/2020,https://doi.org/10.1016/S0140-6736(20)31042-4,27/04/2020,18/03/2020,None
965,NCT04280224,ClinicalTrials.gov,13/02/2020,15/02/2020,FALSE,Xinxiang Medical University,Recruiting,Phase 1,Interventional,China,NK Cells Treatment for COVID-19,ATMP,Cells (NK),30,30/09/2020,30/12/2020,https://clinicaltrials.gov/show/NCT04280224,No Results,No Results,No Results,27/04/2020,18/03/2020,None
966,TCTR20200401002,TCTR,31/03/2020,01/06/2020,FALSE,Wellcome Trust,Not Recruiting,Not Applicable,Observational,"Thailand, Malaysia, Italy, United Kingdom","Social, ethical and behavioural aspects of the novel coronavirus pandemic",Other,No Intervention,2640,31/12/2020,31/12/2020,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5997,No Results,No Results,No Results,21/04/2020,22/04/2020,None
967,NCT04283461,ClinicalTrials.gov,21/02/2020,03/03/2020,FALSE,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection (COVID-19),ATMP,Vaccine,45,20/09/2021,20/09/2021,https://clinicaltrials.gov/show/NCT04283461,No Results,No Results,No Results,20/04/2020,08/03/2020,None
968,NCT04304053,ClinicalTrials.gov,05/03/2020,18/03/2020,TRUE,Fundació Lluita contra la SIDA,Recruiting,Phase 3,Interventional,Spain,Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention,Drug (Chemoprophylaxis),Combination: Darunavir + cobicistat + hydroxychloroquine,3040,15/06/2020,15/06/2020,https://clinicaltrials.gov/show/NCT04304053,No Results,No Results,No Results,27/04/2020,18/03/2020,EUCTR2020-001031-27
969,NCT04312997,ClinicalTrials.gov,16/03/2020,01/04/2020,FALSE,"Pulmotect, Inc.",Not Recruiting,Phase 2,Interventional,United States,The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,Drug,"PUL-042, unspecified immunomodulatory drug",100,01/09/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04312997,No Results,No Results,No Results,27/04/2020,25/03/2020,None
970,NCT04304690,ClinicalTrials.gov,09/03/2020,16/03/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic",Clinical Presentation (Epidemiology),No Intervention,1000,16/07/2020,16/10/2020,https://clinicaltrials.gov/show/NCT04304690,No Results,No Results,No Results,27/04/2020,15/04/2020,None
971,NCT04315896,ClinicalTrials.gov,18/03/2020,14/04/2020,FALSE,"National Institute of Respiratory Diseases, Mexico",Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Drug,Hydroxychloroquine,500,31/10/2020,22/03/2021,https://clinicaltrials.gov/show/NCT04315896,No Results,No Results,No Results,27/04/2020,25/03/2020,None
972,NCT04320953,ClinicalTrials.gov,21/03/2020,16/03/2020,TRUE,Changhai Hospital,Not Recruiting,Not Applicable,Interventional,China,Non-contact Endoscopy at Covid-19 Outbreak,Other (device),Non-contact Endoscopy,5,26/03/2020,09/04/2020,https://clinicaltrials.gov/show/NCT04320953,No Results,No Results,No Results,27/04/2020,04/01/2020,None
973,NCT04324073,ClinicalTrials.gov,25/03/2020,27/03/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2/Phase 3,Interventional,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,Drug,Sarilumab,239,27/03/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04324073,No Results,No Results,No Results,27/04/2020,04/01/2020,None
974,NCT04318015,ClinicalTrials.gov,19/03/2020,14/04/2020,FALSE,"National Institute of Respiratory Diseases, Mexico",Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Drug (Chemoprophylaxis),Hydroxychloroquine,400,31/12/2020,31/03/2021,https://clinicaltrials.gov/show/NCT04318015,No Results,No Results,No Results,27/04/2020,04/01/2020,None
975,NCT04321174,ClinicalTrials.gov,18/03/2020,17/04/2020,FALSE,Darrell Tan,Recruiting,Phase 3,Interventional,Canada,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,Drug,Lopinavir/ritonavir,1220,31/03/2021,31/03/2022,https://clinicaltrials.gov/show/NCT04321174,No Results,No Results,No Results,27/04/2020,04/01/2020,None
976,NCT04288102,ClinicalTrials.gov,24/02/2020,05/03/2020,FALSE,Beijing 302 Hospital,Recruiting,Phase 2,Interventional,China,Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19),ATMP,Cells (mesenchymal),90,15/07/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04288102,No Results,No Results,No Results,20/04/2020,08/03/2020,None
977,NCT04290780,ClinicalTrials.gov,27/02/2020,09/03/2020,FALSE,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,Clinical Presentation,No Intervention,300,10/10/2020,30/10/2020,https://clinicaltrials.gov/show/NCT04290780,No Results,No Results,No Results,20/04/2020,18/03/2020,None
978,NCT04257656,ClinicalTrials.gov,31/01/2020,06/02/2020,FALSE,Capital Medical University,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Severe COVID-19,Drug,Remdesivir,237,30/03/2020,10/04/2020,https://clinicaltrials.gov/show/NCT04257656,Journal Article,29/04/2020,https://doi.org/10.1016/S0140-6736(20)31022-9,27/04/2020,08/03/2020,None
979,NCT04299152,ClinicalTrials.gov,28/02/2020,10/05/2020,FALSE,Tianhe Stem Cell Biotechnologies Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19,ATMP,Cells (stem cells),20,09/10/2020,10/11/2020,https://clinicaltrials.gov/show/NCT04299152,No Results,No Results,No Results,27/04/2020,18/03/2020,None
980,NCT04313023,ClinicalTrials.gov,16/03/2020,01/04/2020,FALSE,"Pulmotect, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,Drug,"PUL-042, unspecified immunomodulatory drug",200,01/09/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04313023,No Results,No Results,No Results,27/04/2020,25/03/2020,None
981,NCT04302766,ClinicalTrials.gov,02/03/2020,01/04/2020,FALSE,U.S. Army Medical Research and Development Command,Not Recruiting,Phase 1,Expanded Access,No Country Given,Expanded Access Remdesivir (RDV; GS-5734‚Ñ¢),Drug,Remdesivir,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04302766,No Results,No Results,No Results,20/04/2020,18/03/2020,None
982,NCT04319315,ClinicalTrials.gov,16/03/2020,11/03/2020,TRUE,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak,Other,No Intervention,400,01/04/2020,16/04/2020,https://clinicaltrials.gov/show/NCT04319315,No Results,No Results,No Results,20/04/2020,04/01/2020,None
983,NCT04323228,ClinicalTrials.gov,23/03/2020,01/05/2020,FALSE,King Saud University,Not Recruiting,Phase 4,Interventional,No Country Given,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19,Supplement,Oral nutrition supplement,30,01/10/2020,30/10/2020,https://clinicaltrials.gov/show/NCT04323228,No Results,No Results,No Results,27/04/2020,04/01/2020,None
984,NCT04315987,ClinicalTrials.gov,18/03/2020,01/04/2020,FALSE,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,NestCell¬Æ Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,ATMP,Cells (mesenchymal),66,01/05/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04315987,No Results,No Results,No Results,27/04/2020,25/03/2020,None
985,NCT04322565,ClinicalTrials.gov,24/03/2020,20/04/2020,FALSE,AOU di Parma,Not Recruiting,Phase 2,Interventional,No Country Given,Colchicine Counteracting Inflammation in COVID-19 Pneumonia,Drug,Colchicine,310,20/06/2020,20/07/2020,https://clinicaltrials.gov/show/NCT04322565,No Results,No Results,No Results,27/04/2020,04/01/2020,None
986,NCT04321265,ClinicalTrials.gov,19/03/2020,19/03/2020,FALSE,Heinrich-Heine University,Recruiting,Not Applicable,Observational,"France, Germany, Norway, Denmark",Outcomes and Prognostic Factors in COVID-19,Prognosis,No Intervention,4000,01/09/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04321265,No Results,No Results,No Results,20/04/2020,04/01/2020,None
987,NCT04322773,ClinicalTrials.gov,24/03/2020,05/04/2020,FALSE,Marius Henriksen,Recruiting,Phase 2,Interventional,Denmark,Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure,Drug,Tocilizumab vs. sarilumab,200,01/06/2021,01/06/2021,https://clinicaltrials.gov/show/NCT04322773,No Results,No Results,No Results,20/04/2020,04/01/2020,None
988,NCT04324190,ClinicalTrials.gov,26/03/2020,08/04/2020,FALSE,Gunther Meinlschmidt,Recruiting,Not Applicable,Interventional,Germany,DIgital Online SuPport for COVID-19 StrEss,Other (psych),Psychological,600,01/06/2020,01/12/2021,https://clinicaltrials.gov/show/NCT04324190,No Results,No Results,No Results,27/04/2020,04/01/2020,None
989,NCT04324736,ClinicalTrials.gov,25/03/2020,10/03/2020,TRUE,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,"""COVID-19 and Diabetes Outcomes""",Clinical Presentation,No Intervention,1000,10/04/2020,08/05/2020,https://clinicaltrials.gov/show/NCT04324736,No Results,No Results,No Results,27/04/2020,22/04/2020,None
990,NCT04324684,ClinicalTrials.gov,25/03/2020,31/03/2020,FALSE,Catholic University of the Sacred Heart,Recruiting,Not Applicable,Observational,Italy,Prognostic Factors Keeping Track for Covid-19 Pneumonia,Prognosis,No Intervention,198,05/05/2020,30/05/2020,https://clinicaltrials.gov/show/NCT04324684,No Results,No Results,No Results,20/04/2020,15/04/2020,None
991,NCT04325893,ClinicalTrials.gov,25/03/2020,01/04/2020,FALSE,"University Hospital, Angers",Recruiting,Phase 3,Interventional,"France, Monaco",Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease,Drug,Hydroxychloroquine,1300,01/09/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04325893,No Results,No Results,No Results,20/04/2020,04/07/2020,None
992,NCT04323345,ClinicalTrials.gov,23/03/2020,15/04/2020,FALSE,Misr University for Science and Technology,Recruiting,Phase 3,Interventional,Egypt,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,Traditional Medicine (Other),Traditional Medicine,1000,15/12/2020,15/01/2021,https://clinicaltrials.gov/show/NCT04323345,No Results,No Results,No Results,27/04/2020,04/01/2020,None
993,NCT04327401,ClinicalTrials.gov,26/03/2020,13/04/2020,FALSE,"Luiz F. L. Reis, Ph.D.",Recruiting,Phase 3,Interventional,Brazil,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,Drug,Dexamethasone,290,30/08/2020,30/08/2020,https://clinicaltrials.gov/show/NCT04327401,No Results,No Results,No Results,27/04/2020,04/07/2020,None
994,NCT04325048,ClinicalTrials.gov,25/03/2020,01/04/2020,FALSE,Cordio Medical,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients,Other (software),eHealth,5000,01/06/2021,01/09/2021,https://clinicaltrials.gov/show/NCT04325048,No Results,No Results,No Results,27/04/2020,22/04/2020,None
995,NCT04326426,ClinicalTrials.gov,26/03/2020,13/04/2020,FALSE,Vanda Pharmaceuticals,Recruiting,Phase 3,Interventional,United States,ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection,Drug,Tradipitant,300,01/08/2020,31/08/2020,https://clinicaltrials.gov/show/NCT04326426,No Results,No Results,No Results,27/04/2020,04/07/2020,None
996,NCT04330300,ClinicalTrials.gov,30/03/2020,30/03/2020,FALSE,"National University of Ireland, Galway",Recruiting,Phase 4,Interventional,Ireland,Coronavirus (COVID-19) ACEi/ARB Investigation,Drug,ACE inhibitors or ARBs vs. Calcium Channel Blockers or Thiazide/Thiazide-like diuretics ,2414,31/01/2021,01/03/2021,https://clinicaltrials.gov/show/NCT04330300,No Results,No Results,No Results,20/04/2020,04/07/2020,None
997,NCT04330495,ClinicalTrials.gov,31/03/2020,06/04/2020,FALSE,Instituto de Investigacin Marqus de Valdecilla,Not Recruiting,Phase 4,Interventional,No Country Given,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection",Drug (Chemoprophylaxis),Hydroxychloroquine,800,06/11/2020,06/11/2020,https://clinicaltrials.gov/show/NCT04330495,No Results,No Results,No Results,20/04/2020,04/07/2020,None
998,NCT04325061,ClinicalTrials.gov,25/03/2020,03/04/2020,TRUE,Dr. Negrin University Hospital,Recruiting,Phase 4,Interventional,Spain,Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19,Drug,Corticosteroids,200,30/10/2020,30/10/2020,https://clinicaltrials.gov/show/NCT04325061,No Results,No Results,No Results,27/04/2020,04/01/2020,EUCTR2020-001278-31
999,NCT04327804,ClinicalTrials.gov,26/03/2020,25/03/2020,TRUE,Dr. Deneen Vojta,Recruiting,Not Applicable,Observational,United States,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,Diagnostics,Diagnostic Test or Assessment,120,03/04/2020,10/04/2020,https://clinicaltrials.gov/show/NCT04327804,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1000,NCT04328961,ClinicalTrials.gov,23/03/2020,31/03/2020,FALSE,University of Washington,Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine for COVID-19 PEP,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Vitamin C,2000,30/09/2020,31/10/2020,https://clinicaltrials.gov/show/NCT04328961,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1001,NCT04329650,ClinicalTrials.gov,31/03/2020,15/04/2020,FALSE,Judit Pich Martínez,Recruiting,Phase 2,Interventional,Spain,Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia,Drug,Siltuximab vs. Corticosteroids,200,20/05/2020,20/05/2020,https://clinicaltrials.gov/show/NCT04329650,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1002,NCT04329533,ClinicalTrials.gov,26/03/2020,13/04/2020,FALSE,University of Arizona,Recruiting,Not Applicable,Interventional,United States,Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic,Other (psych),Psychological,150,30/06/2020,30/07/2020,https://clinicaltrials.gov/show/NCT04329533,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1003,NCT04331366,ClinicalTrials.gov,31/03/2020,08/04/2020,FALSE,Emory University,Recruiting,Not Applicable,Interventional,United States,Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,Other (device),Bidirectional Oxygenation Valve,5,01/05/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04331366,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1004,NCT04331171,ClinicalTrials.gov,30/03/2020,17/03/2020,TRUE,Weprom,Recruiting,Not Applicable,Observational,France,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,Other (device),Other,3000000,31/03/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04331171,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1005,NCT04334252,ClinicalTrials.gov,02/04/2020,17/04/2020,FALSE,Jessa Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia,Diagnostics,Diagnostic Test or Assessment,5000,20/12/2022,20/12/2023,https://clinicaltrials.gov/show/NCT04334252,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1006,NCT04331665,ClinicalTrials.gov,01/04/2020,20/04/2020,FALSE,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,Drug,Ruxolitinib,64,30/10/2020,31/01/2021,https://clinicaltrials.gov/show/NCT04331665,No Results,No Results,No Results,20/04/2020,04/07/2020,None
1007,NCT04332913,ClinicalTrials.gov,26/03/2020,01/04/2020,FALSE,University of L'Aquila,Recruiting,Not Applicable,Observational,Italy,Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia,Drug,Tocilizumab,30,31/12/2020,31/03/2021,https://clinicaltrials.gov/show/NCT04332913,No Results,No Results,No Results,20/04/2020,04/07/2020,None
1008,NCT04328129,ClinicalTrials.gov,23/03/2020,23/03/2020,FALSE,Institut Pasteur,Recruiting,Not Applicable,Interventional,French Guiana,Household Transmission Investigation Study for COVID-19 in French Guiana,Clinical Presentation (Epidemiology),No Intervention,450,23/03/2022,23/03/2022,https://clinicaltrials.gov/show/NCT04328129,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1009,NCT04329611,ClinicalTrials.gov,29/03/2020,13/04/2020,FALSE,Dr. Michael Hill,Recruiting,Phase 3,Interventional,Canada,ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease,Drug,Hydroxychloroquine,1660,31/08/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04329611,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1010,NCT04331886,ClinicalTrials.gov,31/03/2020,01/04/2020,FALSE,"Target PharmaSolutions, Inc.",Not Recruiting,Not Applicable,Observational,United States,An Observational Study of Patients With Coronavirus Disease 2019,Clinical Presentation,No Intervention,5000,01/03/2021,01/03/2021,https://clinicaltrials.gov/show/NCT04331886,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1011,NCT04333732,ClinicalTrials.gov,31/03/2020,01/04/2020,FALSE,Washington University in St. Louis,Not Recruiting,Phase 3,Interventional,"South Africa, United States, Zambia, Canada, Ireland, United Kingdom, Australia",CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION,Drug (Chemoprophylaxis),Chloroquine/hydroxychloroquine,55000,01/02/2021,01/02/2021,https://clinicaltrials.gov/show/NCT04333732,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1012,NCT04333849,ClinicalTrials.gov,01/04/2020,27/03/2020,TRUE,"University Hospital, Angers",Recruiting,Not Applicable,Observational,France,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,Other,Other,100,01/09/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04333849,No Results,No Results,No Results,20/04/2020,04/07/2020,None
1013,NCT04335188,ClinicalTrials.gov,31/03/2020,06/04/2020,FALSE,IHF GmbH - Institut for Herzinfarktforschung,Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry Rhineland-Palatinate (Germany),Clinical Presentation,No Intervention,4000,31/07/2021,30/09/2021,https://clinicaltrials.gov/show/NCT04335188,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1014,NCT04331054,ClinicalTrials.gov,29/03/2020,13/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,Protective Role of Inhaled Steroids for Covid-19 Infection,Drug,Budesonide/formoterol,436,13/07/2020,13/07/2020,https://clinicaltrials.gov/show/NCT04331054,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1015,NCT04333628,ClinicalTrials.gov,01/04/2020,01/04/2020,FALSE,"HaEmek Medical Center, Israel",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Chloroquine for Mild Symptomatic and Asymptomatic COVID-19,Drug,Chloroquine,210,01/04/2021,01/12/2021,https://clinicaltrials.gov/show/NCT04333628,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1016,NCT04336384,ClinicalTrials.gov,30/03/2020,01/03/2020,TRUE,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Impact of Covid-19 in Congenital Heart Disease,Clinical Presentation,No Intervention,5000,01/12/2020,30/12/2020,https://clinicaltrials.gov/show/NCT04336384,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1017,NCT04339634,ClinicalTrials.gov,07/04/2020,07/04/2020,FALSE,Tabula Rasa HealthCare,Not Recruiting,Not Applicable,Observational,United States,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy,Clinical Presentation,No Intervention,12123,07/07/2020,06/04/2021,https://clinicaltrials.gov/show/NCT04339634,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1018,NCT04336215,ClinicalTrials.gov,02/04/2020,07/04/2020,FALSE,Rutgers University,Recruiting,Not Applicable,Observational,United States,Rutgers COVID-19 Cohort Study,Clinical Presentation,No Intervention,750,01/09/2020,21/10/2021,https://clinicaltrials.gov/show/NCT04336215,Pre-Print Article,24/04/2020,https://doi.org/10.1101/2020.04.20.20072470,27/04/2020,15/04/2020,None
1019,NCT04338672,ClinicalTrials.gov,04/04/2020,05/04/2020,FALSE,Sheba Medical Center,Recruiting,Not Applicable,Observational,Israel,The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients,Health System,No Intervention,10000,01/04/2021,01/04/2022,https://clinicaltrials.gov/show/NCT04338672,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1020,NCT04334044,ClinicalTrials.gov,01/04/2020,15/04/2020,FALSE,Grupo Cooperativo Hemopatías Malignas,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Treatment of SARS Caused by COVID-19 With Ruxolitinib,Drug,Ruxolitinib,20,01/06/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04334044,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1021,NCT04334148,ClinicalTrials.gov,02/04/2020,01/04/2020,TRUE,Duke University,Not Recruiting,Phase 3,Interventional,No Country Given,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine,Drug (Chemoprophylaxis),Hydroxychloroquine,15000,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04334148,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1022,NCT04335851,ClinicalTrials.gov,02/04/2020,06/04/2020,FALSE,Biruni University,Not Recruiting,Not Applicable,Interventional,Turkey,Video-Based Exercises and Well-Being During Social Isolation,Other (exercise),Exercise,30,13/05/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04335851,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1023,NCT04336462,ClinicalTrials.gov,25/03/2020,15/02/2020,TRUE,Shanghai Asclepius Meditec Inc.,Recruiting,Not Applicable,Interventional,China,Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19,Drug,Combination: Hydrogen + Oxygen vs Oxygen,100,21/02/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04336462,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1024,NCT04341168,ClinicalTrials.gov,03/04/2020,01/04/2020,TRUE,"University Hospital, Cologne",Not Recruiting,Not Applicable,Observational,Germany,"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults",Clinical Presentation,No Intervention,160,01/10/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04341168,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1025,NCT04341285,ClinicalTrials.gov,30/03/2020,01/06/2020,FALSE,"University Hospital, Tübingen",Not Recruiting,Not Applicable,Interventional,Germany,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID),Drug,Oxygen,200,01/06/2024,01/12/2025,https://clinicaltrials.gov/show/NCT04341285,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1026,NCT04340050,ClinicalTrials.gov,07/04/2020,10/04/2020,FALSE,University of Chicago,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma,ATMP,Plasma,10,31/12/2020,31/12/2021,https://clinicaltrials.gov/show/NCT04340050,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1027,NCT04341142,ClinicalTrials.gov,08/04/2020,09/04/2020,FALSE,Hospices Civils de Lyon,Recruiting,Not Applicable,Interventional,France,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER,Diagnostics,Diagnostic Test or Assessment,400,09/09/2020,09/09/2020,https://clinicaltrials.gov/show/NCT04341142,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1028,NCT04336956,ClinicalTrials.gov,30/03/2020,07/04/2020,FALSE,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,Covid-19 Pediatric Observatory,Clinical Presentation,No Intervention,250,30/06/2021,30/06/2021,https://clinicaltrials.gov/show/NCT04336956,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1029,NCT04338568,ClinicalTrials.gov,04/04/2020,13/04/2020,FALSE,Hasselt University,Recruiting,Not Applicable,Interventional,Belgium,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,Diagnostics,Diagnostic Test or Assessment,50,30/04/2020,30/04/2020,https://clinicaltrials.gov/show/NCT04338568,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1030,NCT04336657,ClinicalTrials.gov,03/04/2020,01/04/2020,TRUE,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease?,Clinical Presentation (Epidemiology),No Intervention,100,01/05/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04336657,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1031,NCT04336904,ClinicalTrials.gov,03/04/2020,25/03/2020,TRUE,Giuliano Rizzardini,Not Recruiting,Phase 3,Interventional,Italy,Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19,Drug,Favipiravir,100,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04336904,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1032,NCT04341870,ClinicalTrials.gov,06/04/2020,11/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 2/Phase 3,Interventional,France,"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO",Drug,Combination: Sarilumab + Azithromycin + Hydroxychloroquine vs Sarilumab,60,08/05/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04341870,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1033,NCT04342806,ClinicalTrials.gov,08/04/2020,10/04/2020,FALSE,Duke University,Recruiting,Not Applicable,Observational,United States,"Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19",Clinical Presentation,No Intervention,100000,31/12/2099,31/12/2099,https://clinicaltrials.gov/show/NCT04342806,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1034,NCT04341441,ClinicalTrials.gov,07/04/2020,07/04/2020,FALSE,Henry Ford Health System,Recruiting,Phase 3,Interventional,United States,Will Hydroxychloroquine Impede or Prevent COVID-19,Drug,Hydroxychloroquine,3000,30/06/2020,30/04/2021,https://clinicaltrials.gov/show/NCT04341441,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1035,NCT04342195,ClinicalTrials.gov,08/04/2020,25/03/2020,TRUE,Columbia University,Recruiting,Not Applicable,Observational,United States,Acquiring Convalescent Specimens for COVID-19 Antibodies,Clinical Presentation,No Intervention,12,01/03/2021,01/03/2021,https://clinicaltrials.gov/show/NCT04342195,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1036,NCT04337151,ClinicalTrials.gov,03/04/2020,01/04/2020,TRUE,Royal National Orthopaedic Hospital NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment,Other,No Intervention,100,01/01/2021,01/03/2021,https://clinicaltrials.gov/show/NCT04337151,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1037,NCT04337190,ClinicalTrials.gov,03/04/2020,03/04/2020,FALSE,"University Hospital, Angers",Recruiting,Not Applicable,Observational,France,Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2),Drug,ARBs,100,06/10/2020,06/12/2020,https://clinicaltrials.gov/show/NCT04337190,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1038,NCT04342728,ClinicalTrials.gov,08/04/2020,08/04/2020,FALSE,The Cleveland Clinic,Recruiting,Not Applicable,Interventional,United States,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,Drug,Combination: Zinc + Vitamin C vs Zinc vs. Vitamin C,520,30/09/2020,30/04/2021,https://clinicaltrials.gov/show/NCT04342728,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1039,NCT04343144,ClinicalTrials.gov,09/04/2020,15/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Nivolumab (Optivo¬Æ) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.",Drug,Nivolumab,92,31/07/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04343144,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1040,NCT04342663,ClinicalTrials.gov,08/04/2020,10/04/2020,FALSE,Washington University in St. Louis,Recruiting,Phase 2,Interventional,United States,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",Drug,Fluvoxamine,152,01/06/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04342663,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1041,NCT04343183,ClinicalTrials.gov,07/04/2020,01/04/2020,TRUE,Ochsner Health System,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,Drug,Oxygen,48,01/06/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04343183,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1042,NCT04343248,ClinicalTrials.gov,08/04/2020,30/04/2020,FALSE,Romark Laboratories L.C.,Not Recruiting,Phase 3,Interventional,No Country Given,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF),Drug (Chemoprophylaxis),Nitazoxanide,600,31/08/2020,31/08/2020,https://clinicaltrials.gov/show/NCT04343248,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1043,NCT04343755,ClinicalTrials.gov,08/04/2020,09/04/2020,FALSE,Hackensack Meridian Health,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection,ATMP,Plasma,55,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04343755,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1044,NCT04338074,ClinicalTrials.gov,06/04/2020,15/04/2020,FALSE,University of Alabama at Birmingham,Not Recruiting,Phase 2,Interventional,United States,TXA and Corona Virus 2019 (COVID19) in Outpatients,Drug,Tranexamic acid,100,15/10/2020,30/10/2020,https://clinicaltrials.gov/show/NCT04338074,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1045,NCT04338100,ClinicalTrials.gov,31/03/2020,06/04/2020,FALSE,"University Hospital, Angers",Not Recruiting,Not Applicable,Observational,No Country Given,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Prognosis,No Intervention,300,29/12/2020,29/01/2021,https://clinicaltrials.gov/show/NCT04338100,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1046,NCT04343768,ClinicalTrials.gov,08/04/2020,05/04/2020,TRUE,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 4,Interventional,Iran,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",Drug,Combination: Hydroxychloroquine + lopinavir/ritonavir + interferon beta 1a vs. hydroxychloroquine + lopinavir/ritonavir + interferon beta 1b vs. hydroxychloroquine + lopinavir/ritonavir ,60,27/04/2020,27/04/2020,https://clinicaltrials.gov/show/NCT04343768,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1047,NCT04343781,ClinicalTrials.gov,09/04/2020,22/03/2020,TRUE,"University Hospital, Angers",Not Recruiting,Not Applicable,Observational,France,National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19,Clinical Presentation,No Intervention,353,05/04/2020,05/04/2020,https://clinicaltrials.gov/show/NCT04343781,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1048,NCT04338945,ClinicalTrials.gov,07/04/2020,15/03/2020,TRUE,Ospedale Policlinico San Martino,Recruiting,Not Applicable,Observational,Italy,Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy,Other,No Intervention,1200,15/04/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04338945,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1049,NCT04339387,ClinicalTrials.gov,06/04/2020,01/03/2020,TRUE,Brigham and Women's Hospital,Recruiting,Not Applicable,Observational,United States,COVID-19 Risk Stratification,Prognosis,No Intervention,1500,15/04/2020,15/04/2020,https://clinicaltrials.gov/show/NCT04339387,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1050,NCT04339608,ClinicalTrials.gov,07/04/2020,02/04/2020,TRUE,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,Max COVID19- Study,Clinical Presentation,No Intervention,10000,30/05/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04339608,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1051,NCT04344002,ClinicalTrials.gov,09/04/2020,15/05/2020,FALSE,Spanish Lung Cancer Group,Not Recruiting,Not Applicable,Observational,Spain,LunG canceR pAtients coVId19 Disease (GRAVID),Clinical Presentation,No Intervention,200,15/05/2021,15/05/2022,https://clinicaltrials.gov/show/NCT04344002,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1052,NCT04344106,ClinicalTrials.gov,08/04/2020,01/04/2020,TRUE,ELHARRAR Xavier,Recruiting,Not Applicable,Interventional,France,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Procedure,Positioning,25,15/04/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04344106,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1053,NCT04343690,ClinicalTrials.gov,09/04/2020,13/04/2020,FALSE,Duke University,Not Recruiting,Not Applicable,Interventional,United States,COPING With COVID-19( CWC-19),Other (psych),Psychological,100,30/06/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04343690,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1054,NCT04343989,ClinicalTrials.gov,09/04/2020,31/03/2020,TRUE,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,90,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04343989,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1055,NCT04343794,ClinicalTrials.gov,20/02/2020,01/04/2020,FALSE,The University of Hong Kong,Recruiting,Not Applicable,Interventional,Hong Kong,Using Biovitals¬Æ Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,Other (device),Biosensors,200,31/12/2021,31/01/2022,https://clinicaltrials.gov/show/NCT04343794,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1056,NCT04344041,ClinicalTrials.gov,09/04/2020,15/04/2020,TRUE,"University Hospital, Angers",Recruiting,Phase 3,Interventional,France,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),Drug,Vitamin D,260,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04344041,No Results,No Results,No Results,27/04/2020,22/04/2020,EUCTR2020-001602-34
1057,NCT04344210,ClinicalTrials.gov,07/04/2020,17/04/2020,FALSE,Federal University of Rio Grande do Sul,Recruiting,Not Applicable,Interventional,Brazil,Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus,Telehealth,Telehealth,149,20/08/2020,30/08/2020,https://clinicaltrials.gov/show/NCT04344210,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1058,NCT04344236,ClinicalTrials.gov,08/04/2020,09/04/2020,FALSE,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19,Other,Povidone/Iodine rinse,48,01/05/2020,09/05/2020,https://clinicaltrials.gov/show/NCT04344236,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1059,NCT04339816,ClinicalTrials.gov,06/04/2020,20/04/2020,FALSE,Frantisek Duska,Not Recruiting,Phase 3,Interventional,No Country Given,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial,Drug,Combination: Hydroxychloroquine + azithromycin vs. hydroxychloroquine,240,31/12/2021,30/06/2022,https://clinicaltrials.gov/show/NCT04339816,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1060,NCT04340479,ClinicalTrials.gov,06/04/2020,01/05/2020,FALSE,"University of Colorado, Denver",Not Recruiting,Not Applicable,Observational,United States,The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation,Diagnostics,Diagnostic Test or Assessment,20,01/05/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04340479,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1061,NCT04344015,ClinicalTrials.gov,09/04/2020,13/04/2020,FALSE,Thomas Jefferson University,Recruiting,Not Applicable,Interventional,United States,COVID-19 Plasma Collection,ATMP,Plasma,2000,12/04/2021,12/04/2021,https://clinicaltrials.gov/show/NCT04344015,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1062,NCT04344119,ClinicalTrials.gov,09/04/2020,09/04/2020,FALSE,CHU de Nice,Recruiting,Not Applicable,Observational,France,Assessment of Chilbains Occuring During Covid-19 Infection,Clinical Presentation,No Intervention,30,30/06/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04344119,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1063,NCT04344288,ClinicalTrials.gov,10/04/2020,01/04/2020,FALSE,Hospices Civils de Lyon,Recruiting,Phase 2,Interventional,France,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection,Drug,Prednisone,304,01/11/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04344288,No Results,No Results,No Results,27/04/2020,22/04/2020,EUCTR2020-001553-48
1064,NCT04344535,ClinicalTrials.gov,10/04/2020,08/04/2020,TRUE,Stony Brook University,Recruiting,Phase 1/Phase 2,Interventional,United States,Convalescent Plasma vs. Standard Plasma for COVID-19,ATMP,Plasma,500,30/04/2021,31/08/2021,https://clinicaltrials.gov/show/NCT04344535,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1065,NCT04340921,ClinicalTrials.gov,03/04/2020,10/04/2020,FALSE,Barts & The London NHS Trust,Not Recruiting,Not Applicable,Observational,No Country Given,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury,Clinical Presentation,No Intervention,140,10/04/2020,10/06/2020,https://clinicaltrials.gov/show/NCT04340921,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1066,NCT04341766,ClinicalTrials.gov,01/04/2020,31/03/2020,TRUE,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19,Clinical Presentation,No Intervention,200,01/05/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04341766,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1067,NCT04344444,ClinicalTrials.gov,10/04/2020,10/04/2020,FALSE,LCMC Health,Recruiting,Phase 3,Interventional,United States,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease,Drug,Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,600,10/04/2021,10/12/2021,https://clinicaltrials.gov/show/NCT04344444,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1068,NCT04344548,ClinicalTrials.gov,10/04/2020,13/04/2020,FALSE,National University of Colombia,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia,ATMP,Cells (NK),10,10/06/2020,10/11/2020,https://clinicaltrials.gov/show/NCT04344548,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1069,NCT04341792,ClinicalTrials.gov,07/04/2020,01/04/2020,TRUE,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient,Clinical Presentation,No Intervention,1000,01/08/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04341792,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1070,NCT04342208,ClinicalTrials.gov,07/04/2020,10/04/2020,FALSE,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluate the Working Environments of Individuals Working From Home During Covid-19 Outbreak,Other,Other,500,01/06/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04342208,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1071,NCT04344561,ClinicalTrials.gov,10/04/2020,20/04/2020,FALSE,Johns Hopkins University,Not Recruiting,Not Applicable,Interventional,No Country Given,Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation,Procedure,Positioning,70,01/05/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04344561,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1072,NCT04344756,ClinicalTrials.gov,09/04/2020,20/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug,Tinzaparin or Heparin,808,31/07/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04344756,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1073,NCT04344834,ClinicalTrials.gov,11/04/2020,01/05/2020,FALSE,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of Covid-19 on Egyptian Health Care Workers and General Population Mental Health,Other (psych),No Intervention,300,01/10/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04344834,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1074,NCT04345159,ClinicalTrials.gov,10/04/2020,01/04/2020,TRUE,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Not Applicable,Observational,France,Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease,Clinical Presentation,No Intervention,1500,01/10/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04345159,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1075,NCT04344730,ClinicalTrials.gov,09/04/2020,10/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia,Drug,"Dexamethasone, Oxygen",550,31/12/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04344730,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1076,NCT04344938,ClinicalTrials.gov,10/04/2020,01/04/2020,TRUE,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality,Other,No Intervention,874,01/06/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04344938,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1077,NCT04342221,ClinicalTrials.gov,08/04/2020,29/03/2020,TRUE,"University Hospital, Tübingen",Recruiting,Phase 3,Interventional,Germany,Hydroxychloroquine for COVID-19,Drug,Hydroxychloroquine,220,01/03/2021,01/02/2022,https://clinicaltrials.gov/show/NCT04342221,No Results,No Results,No Results,20/04/2020,15/04/2020,EUCTR2020-001224-33
1078,NCT04343742,ClinicalTrials.gov,07/04/2020,01/04/2020,TRUE,Genesis Foundation,Recruiting,Not Applicable,Observational,Colombia,Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19,Drug,Chlorine dioxide,20,07/04/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04343742,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1079,NCT04345406,ClinicalTrials.gov,11/04/2020,15/04/2020,FALSE,Tanta University,Not Recruiting,Phase 3,Interventional,Egypt,Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19,Drug,Ace inhibitors,60,01/12/2029,01/12/2029,https://clinicaltrials.gov/show/NCT04345406,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1080,NCT04346043,ClinicalTrials.gov,13/04/2020,20/04/2020,FALSE,Ain Shams University,Not Recruiting,Not Applicable,Observational,Egypt,To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide Database,Genomics,No Intervention,100,01/10/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04346043,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1081,NCT04344782,ClinicalTrials.gov,09/04/2020,15/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,"Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin¬Æ/Zeribev¬Æ) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug,Bevacizumab,130,30/09/2020,30/11/2020,https://clinicaltrials.gov/show/NCT04344782,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1082,NCT04345549,ClinicalTrials.gov,10/04/2020,26/02/2020,TRUE,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,Traditional Medicine (Other),Traditional Medicine,18,30/03/2020,30/03/2020,https://clinicaltrials.gov/show/NCT04345549,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1083,NCT04345315,ClinicalTrials.gov,10/04/2020,27/03/2020,TRUE,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Recruiting,Not Applicable,Observational,Italy,"Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.",Clinical Presentation (Epidemiology),No Intervention,500,01/03/2021,01/03/2022,https://clinicaltrials.gov/show/NCT04345315,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1084,NCT04345445,ClinicalTrials.gov,08/04/2020,15/04/2020,FALSE,University of Malaya,Not Recruiting,Phase 3,Interventional,Malaysia,Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression,Drug,Tocilizumab vs. Corticosteroids,310,31/10/2020,31/10/2020,https://clinicaltrials.gov/show/NCT04345445,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1085,NCT04344197,ClinicalTrials.gov,09/04/2020,02/04/2020,TRUE,University of Rome Tor Vergata,Recruiting,Not Applicable,Observational,Italy,"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey",Clinical Presentation,No Intervention,1200,08/04/2020,15/04/2020,https://clinicaltrials.gov/show/NCT04344197,No Results,No Results,No Results,20/04/2020,22/04/2020,None
1086,ACTRN12620000477921,ANZCTR,16/04/2020,20/04/2020,FALSE,Dr. Michael Soares,Not Recruiting,Not Applicable,Interventional,Australia,The design of an updated iron lung ventilator which can be easily built and used by people with minimal training in situations such as COVID-19 where skilled doctors or normal ventilators are unavailable.,Other (physical),Mechanical ventilation,1,Not Available,20/04/2020,https://anzctr.org.au/ACTRN12620000477921.aspx,No Results,No Results,No Results,20/04/2020,22/04/2020,None
1087,NCT04346056,ClinicalTrials.gov,13/04/2020,14/04/2020,FALSE,Ain Shams University,Recruiting,Not Applicable,Observational,Egypt,Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19,Clinical Presentation,No Intervention,500,01/10/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04346056,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1088,NCT04346082,ClinicalTrials.gov,07/04/2020,01/05/2020,FALSE,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Interventional,Hong Kong,Feasibility of Online Based Mindfulness Interventions During COVID-19 Outbreak,Other (psych),Psychological,30,30/04/2021,30/04/2021,https://clinicaltrials.gov/show/NCT04346082,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1089,ACTRN12620000472976,ANZCTR,15/04/2020,27/04/2020,FALSE,Dr. Simon Joosten,Not Recruiting,Not Applicable,Interventional,Australia,Adapting the Decathlon Group Easybreathe¬Æ snorkelling face mask for the safer administration of oxygen and/or continuous positive airway pressure and in the intra/interhospital transportation of patients with proven or suspected COVID 19 infection.,Other (device),Mask,100,Not Available,27/10/2020,https://anzctr.org.au/ACTRN12620000472976.aspx,No Results,No Results,No Results,20/04/2020,22/04/2020,None
1090,NCT04345536,ClinicalTrials.gov,05/04/2020,15/03/2020,TRUE,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital,Clinical Presentation,No Intervention,400,01/01/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04345536,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1091,NCT04345653,ClinicalTrials.gov,08/04/2020,14/04/2020,FALSE,Hackensack Meridian Health,Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,45,08/04/2021,08/04/2022,https://clinicaltrials.gov/show/NCT04345653,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1092,ACTRN12620000479909,ANZCTR,16/04/2020,01/05/2020,FALSE,The George Institute for Global Health,Not Recruiting,Not Applicable,Observational,"China, Germany, Italy, United States, Australia, Spain",Mental health and wellbeing on general population during the COVID-19 outbreak,Other (psych),No Intervention,3000,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000479909.aspx,No Results,No Results,No Results,20/04/2020,22/04/2020,None
1093,NCT04345640,ClinicalTrials.gov,10/04/2020,14/04/2020,FALSE,"Institute of Liver and Biliary Sciences, India",Recruiting,Not Applicable,Observational,India,The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.,Clinical Presentation,No Intervention,100,30/06/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04345640,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1094,NCT04345887,ClinicalTrials.gov,10/04/2020,21/04/2020,FALSE,Istanbul University-Cerrahpasa,Not Recruiting,Phase 4,Interventional,Turkey,Spironolactone in Covid-19 Induced ARDS,Drug,Spironolactone,60,21/07/2020,21/10/2020,https://clinicaltrials.gov/show/NCT04345887,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1095,NCT04346264,ClinicalTrials.gov,13/04/2020,27/04/2020,FALSE,Ludwig Boltzmann Institute for Lung Health,Recruiting,Not Applicable,Observational,Austria,CoVid-19 - Infection and Antibody Formation in the Viennese Population,Clinical Presentation (Epidemiology),No Intervention,5500,01/06/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04346264,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1096,NCT04346277,ClinicalTrials.gov,13/04/2020,27/04/2020,FALSE,Implicit Bioscience,Not Recruiting,Not Applicable,Expanded Access,Italy,Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19),Drug,IC14,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04346277,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1097,NCT04345991,ClinicalTrials.gov,10/04/2020,14/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort",ATMP,Plasma,120,15/05/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04345991,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1098,NCT04346017,ClinicalTrials.gov,13/04/2020,20/03/2020,TRUE,Francis Corazza,Recruiting,Not Applicable,Interventional,Belgium,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome,Clinical Presentation,No Intervention,200,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04346017,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1099,NCT04346693,ClinicalTrials.gov,08/04/2020,08/04/2020,FALSE,Burnasyan Federal Medical Biophysical Center,Recruiting,Phase 3,Interventional,Russian Federation,An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19,Drug,Combination: Dalargin + Hydroxychloroquine + azithromycin + / - tocilizumab vs. Hydroxychloroquine + azithromycin + / - tocilizumab,320,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04346693,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1100,NCT04346927,ClinicalTrials.gov,13/04/2020,10/04/2020,TRUE,Yasemin Airak,Not Recruiting,Not Applicable,Interventional,No Country Given,Telerehabilitation for Patients Diagnosed With Coronavirus,Telehealth,Rehabilitation,30,10/06/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04346927,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1101,NCT04346121,ClinicalTrials.gov,10/04/2020,15/04/2020,FALSE,Nantes University Hospital,Not Recruiting,Not Applicable,Observational,France,Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis,Other,No Intervention,1000,15/06/2020,15/06/2020,https://clinicaltrials.gov/show/NCT04346121,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1102,NCT04346329,ClinicalTrials.gov,10/04/2020,20/04/2020,FALSE,National University of Colombia,Not Recruiting,Phase 3,Interventional,Colombia,Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,86,01/06/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04346329,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1103,NCT04346953,ClinicalTrials.gov,13/04/2020,20/04/2020,FALSE,Istinye University,Not Recruiting,Not Applicable,Interventional,No Country Given,Video-Based Exercise for Individuals With Social Isolation Due to Coronavirus (COVID-19),Other (exercise),Exercise,128,01/06/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04346953,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1104,NCT04347369,ClinicalTrials.gov,18/03/2020,17/01/2020,TRUE,Xinqiao Hospital of Chongqing,Recruiting,Not Applicable,Observational,China,A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease,Clinical Presentation,No Intervention,1000,30/04/2020,31/05/2020,https://clinicaltrials.gov/show/NCT04347369,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1105,NCT04346199,ClinicalTrials.gov,09/04/2020,24/04/2020,FALSE,AstraZeneca,Not Recruiting,Phase 2,Interventional,Spain,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. CALAVI (Calquence Against the Virus),Drug,Acalabrutinib,428,30/11/2020,30/11/2020,https://clinicaltrials.gov/show/NCT04346199,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1106,NCT04346342,ClinicalTrials.gov,09/04/2020,06/03/2020,TRUE,UMC Amsterdam,Recruiting,Not Applicable,Observational,Netherlands,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),Other (physical),Mechanical ventilation,1000,01/05/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04346342,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1107,ACTRN12620000470998,ANZCTR,14/04/2020,20/04/2020,FALSE,Firebrick Pharma Pty Ltd,Not Recruiting,Not Applicable,Interventional,Australia,Virucidal pilot study of Nasodine¬Æ Antiseptic Nasal Spray (povidone-iodine 0.5%) in people with COVID-19 and confirmed nasal shedding of SARS-CoV-2 virus.,Drug,Povidone-iodine,20,Not Available,30/06/2020,https://anzctr.org.au/ACTRN12620000470998.aspx,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1108,NCT04346355,ClinicalTrials.gov,12/04/2020,31/03/2020,TRUE,Azienda Unit Sanitaria Locale Reggio Emilia,Recruiting,Phase 2,Interventional,Italy,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,Drug,Tocilizumab,398,30/05/2020,30/05/2020,https://clinicaltrials.gov/show/NCT04346355,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1109,NCT04346420,ClinicalTrials.gov,08/04/2020,09/04/2020,FALSE,"University Clinic, UCLouvain",Recruiting,Not Applicable,Interventional,Belgium,Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19,Other (device),Mask,15,30/06/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04346420,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1110,NCT04347174,ClinicalTrials.gov,31/03/2020,20/04/2020,FALSE,Cadila Pharnmaceuticals,Not Recruiting,Not Applicable,Interventional,India,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,Drug,Mycobacterium,40,30/06/2020,30/07/2020,https://clinicaltrials.gov/show/NCT04347174,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1111,NCT04347408,ClinicalTrials.gov,07/04/2020,13/04/2020,FALSE,"Queen's University, Belfast",Not Recruiting,Not Applicable,Observational,United Kingdom,"Rapid Diagnostics, Antibody Testing and Host Response in Children With COVID-19",Diagnostics,Diagnostic Test or Assessment,150,13/12/2020,13/12/2020,https://clinicaltrials.gov/show/NCT04347408,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1112,ChiCTR2000032040,ChiCTR,18/04/2020,01/04/2020,TRUE,Affiliated Hospital of Guangdong Medical University,Recruiting,Not Applicable,Observational,China,A medical records based study for the curative effect of combined traditional Chinese and western medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,30,Not Available,01/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=52529,No Results,No Results,No Results,20/04/2020,22/04/2020,None
1113,NCT04347382,ClinicalTrials.gov,11/04/2020,20/04/2020,FALSE,Sohaib Ashraf,Recruiting,Phase 3,Interventional,Pakistan,Efficacy of Nigella Sativa and Natural Honey Against COVID-19,Traditional Medicine (Drug),Traditional Medicine,30,25/05/2020,30/05/2020,https://clinicaltrials.gov/show/NCT04347382,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1114,NCT04347798,ClinicalTrials.gov,13/04/2020,15/04/2020,FALSE,University of Alberta,Recruiting,Not Applicable,Observational,Canada,IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT,Drug,Hydroxychloroquine or Chloroquine,500,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04347798,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1115,ChiCTR2000032013,ChiCTR,17/04/2020,02/02/2020,TRUE,The Fourth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,The prevention and treatment strategy of the protective respirator related facial pressure injuries among healthcare professionals fighting novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,8,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=52483,No Results,No Results,No Results,20/04/2020,22/04/2020,None
1116,NCT04346628,ClinicalTrials.gov,10/04/2020,01/04/2020,TRUE,Stanford University,Not Recruiting,Phase 2,Interventional,United States,Oral Favipiravir Compared to Standard Supportive Care in Subjects With Mild COVID-19,Drug,Favipiravir,120,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04346628,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1117,NCT04347070,ClinicalTrials.gov,10/04/2020,01/04/2017,TRUE,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Implementation of Physiotherapy on COVID-19 Patients in ICU,Other (physio),Physio,150,01/09/2020,01/12/2022,https://clinicaltrials.gov/show/NCT04347070,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1118,NCT04347850,ClinicalTrials.gov,09/04/2020,01/02/2020,TRUE,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,500,01/12/2022,30/12/2022,https://clinicaltrials.gov/show/NCT04347850,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1119,NCT04347876,ClinicalTrials.gov,14/04/2020,11/04/2020,TRUE,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?,Diagnostics,Diagnostic Test or Assessment,100,16/06/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04347876,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1120,NCT04348214,ClinicalTrials.gov,13/04/2020,20/04/2020,FALSE,Ain Shams University,Not Recruiting,Not Applicable,Observational,Egypt,Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals,Clinical Presentation,No Intervention,3000,01/10/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04348214,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1121,NCT04348227,ClinicalTrials.gov,10/04/2020,01/01/2019,TRUE,Hôpital Universitaire Fattouma Bourguiba,Not Recruiting,Not Applicable,Observational,Tunisia,How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?,Clinical Presentation,No Intervention,120,01/01/2020,04/02/2021,https://clinicaltrials.gov/show/NCT04348227,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1122,NCT04347941,ClinicalTrials.gov,08/04/2020,11/04/2020,FALSE,University College Hospital Galway,Not Recruiting,Not Applicable,Interventional,Ireland,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,Procedure,Positioning,200,11/03/2021,11/05/2021,https://clinicaltrials.gov/show/NCT04347941,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1123,NCT04348383,ClinicalTrials.gov,08/04/2020,08/04/2020,FALSE,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Recruiting,Phase 2,Interventional,Spain,Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.,Drug,Defibrotide,120,08/07/2020,08/08/2020,https://clinicaltrials.gov/show/NCT04348383,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1124,NCT04347538,ClinicalTrials.gov,11/04/2020,01/05/2020,FALSE,Vanderbilt University,Not Recruiting,Not Applicable,Interventional,United States,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,Procedure,Saline Nasal Irrigation,90,01/06/2021,01/06/2022,https://clinicaltrials.gov/show/NCT04347538,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1125,NCT04347980,ClinicalTrials.gov,09/04/2020,01/04/2020,TRUE,Centre Chirurgical Marie Lannelongue,Recruiting,Phase 3,Interventional,France,Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19,Drug,Combination: Dexamethasone + Hydroxychloroquine vs. Hydroxychloroquine,122,01/06/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04347980,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1126,ChiCTR2000032011,ChiCTR,17/04/2020,17/04/2020,FALSE,The Sixth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,Effecacy and Safety of Hyperbaric Oxygen Therapy to patients with novel coronavirus pneumonia (COVID-19),Drug,Oxygen,45,Not Available,17/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=52142,No Results,No Results,No Results,20/04/2020,22/04/2020,None
1127,NCT04348422,ClinicalTrials.gov,13/04/2020,20/04/2020,FALSE,Assaf-Harofeh Medical Center,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluating the Immune Response for COVID-19,Clinical Presentation,No Intervention,1000,01/12/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04348422,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1128,NCT04348448,ClinicalTrials.gov,13/04/2020,01/04/2020,TRUE,AUSL Romagna Rimini,Not Recruiting,Not Applicable,Observational,No Country Given,"Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia",Drug,Canakinumab,100,01/07/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04348448,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1129,NCT04348461,ClinicalTrials.gov,10/04/2020,06/04/2020,TRUE,Instituto de Investigación Sanitaria Fundación Jiménez Díaz,Not Recruiting,Phase 2,Interventional,No Country Given,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,ATMP,Cells (mesenchymal),100,15/09/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04348461,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1130,NCT04348071,ClinicalTrials.gov,13/04/2020,01/04/2020,TRUE,"University of Colorado, Denver",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of Ruxolitinib for COVID-19,Drug,Ruxolitinib,80,01/08/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04348071,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1131,NCT04348396,ClinicalTrials.gov,10/04/2020,01/04/2020,TRUE,Istituto Nazionale di Ricovero e Cura per Anziani,Not Recruiting,Not Applicable,Observational,Italy,Clinical and Biological Predictors of COVID-19 Disease in Older Patients,Clinical Presentation,No Intervention,300,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04348396,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1132,NCT04348500,ClinicalTrials.gov,13/04/2020,21/04/2020,FALSE,Cedars-Sinai Medical Center,Not Recruiting,Phase 2,Interventional,No Country Given,Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease,Drug,Clazakizumab,60,31/12/2020,31/03/2021,https://clinicaltrials.gov/show/NCT04348500,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1133,NCT04349241,ClinicalTrials.gov,13/04/2020,20/04/2020,FALSE,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy and Safety of Favipiravir in Management of COVID-19,Drug,Favipiravir,100,01/10/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04349241,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1134,ChiCTR2000032010,ChiCTR,17/04/2020,01/05/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus pneumonia (COVID-19) Intelligent Assistant Analysis System:A Multi-center Clinical Research,Clinical Presentation,No Intervention,3000,Not Available,30/04/2022,http://www.chictr.org.cn/showproj.aspx?proj=52479,No Results,No Results,No Results,20/04/2020,22/04/2020,None
1135,NCT04348513,ClinicalTrials.gov,09/04/2020,02/05/2020,FALSE,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Not Recruiting,Phase 2,Interventional,Greece,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,Drug,Triiodothyronine,60,02/05/2021,31/05/2021,https://clinicaltrials.gov/show/NCT04348513,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1136,NCT04348695,ClinicalTrials.gov,13/04/2020,12/04/2020,FALSE,Fundación de Investigación HM Hospita​les​,Recruiting,Phase 2,Interventional,Spain,Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.,Drug,Combination: Ruxolitinib + Simvastatin,94,13/05/2020,13/05/2020,https://clinicaltrials.gov/show/NCT04348695,No Results,No Results,No Results,27/04/2020,22/04/2020,EUCTR2020-001405-23
1137,ChiCTR2000031930,ChiCTR,15/04/2020,31/01/2020,TRUE,Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics and therapeutic effect of 9 cases of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,9,Not Available,01/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=51602,No Results,No Results,No Results,20/04/2020,22/04/2020,None
1138,NCT04348864,ClinicalTrials.gov,13/04/2020,16/04/2020,FALSE,Neuroganics LLC,Recruiting,Not Applicable,Interventional,United States,COVID-19 Antibody Self-testing Using Virtual Point-of-care,Diagnostics,Diagnostic Test or Assessment,100,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04348864,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1139,NCT04348877,ClinicalTrials.gov,13/04/2020,20/04/2020,FALSE,Ain Shams University,Not Recruiting,Not Applicable,Interventional,Egypt,Plasma Rich Antibodies From Recovered Patients From COVID19,ATMP,Plasma,20,01/10/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04348877,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1140,NCT04350450,ClinicalTrials.gov,14/04/2020,01/04/2020,TRUE,Montefiore Medical Center,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore,Drug,Hydroxychloroquine,100,01/08/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04350450,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1141,NCT04350684,ClinicalTrials.gov,14/04/2020,15/04/2020,FALSE,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Umifenovir in Hospitalized COVID-19 Patients,Drug,Combination: Umifenovir + Interferon beta + Lopinavir/Ritonavir + Hydroxychloroquine vs. Interferon beta + Lopinavir/Ritonavir + Hydroxycholroquine,40,22/04/2020,24/04/2020,https://clinicaltrials.gov/show/NCT04350684,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1142,ChiCTR2000031888,ChiCTR,13/04/2020,11/02/2020,TRUE,Guangzhou Eighth People's Hospital,Recruiting,Not Applicable,Interventional,China,A medical records based study for ''Guangdong Pneumonia NO.1'' in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,300,Not Available,30/11/2020,http://www.chictr.org.cn/showproj.aspx?proj=52106,No Results,No Results,No Results,20/04/2020,22/04/2020,None
1143,NCT04349371,ClinicalTrials.gov,12/04/2020,01/04/2020,TRUE,Columbia University,Recruiting,Phase 2,Interventional,United States,Saved From COVID-19,Drug (Chemoprophylaxis),Chloroquine,350,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04349371,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1144,NCT04350671,ClinicalTrials.gov,14/04/2020,15/04/2020,FALSE,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Interferon Beta 1a in Hospitalized COVID-19 Patients,Drug,Combination:  Interferon beta + Lopinavir/Ritonavir + Hydroxychlroquine vs. Lopinavir/Ritonavir + Hydroxychloroquine,40,20/04/2020,24/04/2020,https://clinicaltrials.gov/show/NCT04350671,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1145,ChiCTR2000031712,ChiCTR,07/04/2020,01/04/2020,TRUE,The Chinese University of Hong Kong,Recruiting,Not Applicable,Observational,No Country Given,Study for investigation of contamination by novel coronavirus pneumonia (COVID-19) in the clinical environment,Other,Other,60,Not Available,31/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=51650,No Results,No Results,No Results,20/04/2020,15/04/2020,None
1146,NCT04349098,ClinicalTrials.gov,14/04/2020,17/04/2020,TRUE,Karyopharm Therapeutics Inc,Recruiting,Phase 2,Interventional,"United States, Israel, Austria, Spain",Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,Drug,Selinexor,230,31/08/2020,31/08/2020,https://clinicaltrials.gov/show/NCT04349098,No Results,No Results,No Results,27/04/2020,22/04/2020,EUCTR2020-001411-25
1147,NCT04349982,ClinicalTrials.gov,10/04/2020,08/04/2020,TRUE,Medical University of Graz,Recruiting,Not Applicable,Observational,Austria,ICU Trial in Critical Ill COVID-19 Patients,Clinical Presentation,No Intervention,50,30/06/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04349982,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1148,NCT04351243,ClinicalTrials.gov,15/04/2020,01/04/2020,TRUE,Kinevant Sciences GmbH,Recruiting,Phase 2,Interventional,United States,A Study to Assess the Efficacy and Safety of of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19.,Drug,Grimsilumab,270,01/07/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04351243,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1149,NCT04351542,ClinicalTrials.gov,14/04/2020,06/03/2020,TRUE,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda for Flu Like Illness During Covid-19 Outbreak,Traditional Medicine (Drug),Traditional Medicine,32,06/04/2020,12/04/2020,https://clinicaltrials.gov/show/NCT04351542,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1150,NCT04350593,ClinicalTrials.gov,14/04/2020,15/04/2020,FALSE,Saint Luke's Health System,Recruiting,Phase 3,Interventional,United States,Dapagliflozin in Respiratory Failure in Patients With COVID-19,Drug,Dapagliflozin,900,01/10/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04350593,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1151,NCT04351295,ClinicalTrials.gov,15/04/2020,17/04/2020,FALSE,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacy of Faviprevir in COVID-19 Treatment,Drug,Favipiravir,40,01/12/2030,01/12/2030,https://clinicaltrials.gov/show/NCT04351295,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1152,NCT04351633,ClinicalTrials.gov,15/04/2020,01/04/2020,TRUE,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak,Other (psych),No Intervention,50,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04351633,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1153,NCT04351659,ClinicalTrials.gov,16/04/2020,01/04/2020,TRUE,KK Women's and Children's Hospital,Recruiting,Not Applicable,Observational,Singapore,Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,ATMP,Plasma,8,01/08/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04351659,Pre-Print Article,30/04/2020,https://doi.org/10.1101/2020.04.24.20077487,27/04/2020,22/04/2020,None
1154,NCT04351347,ClinicalTrials.gov,15/04/2020,17/04/2020,FALSE,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment,Drug,Combination: Chloroquine + Nitazoxanide vs. Chloroquine + Ivermectin vs. Chloroquine ,60,01/12/2030,01/12/2030,https://clinicaltrials.gov/show/NCT04351347,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1155,NCT04351529,ClinicalTrials.gov,16/04/2020,01/04/2020,TRUE,AGMT,Recruiting,Not Applicable,Observational,Austria,Austrian COVID-19 Registry,Clinical Presentation,No Intervention,1000,01/12/2021,01/12/2021,https://clinicaltrials.gov/show/NCT04351529,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1156,ChiCTR2000029434,ChiCTR,01/02/2020,01/02/2020,FALSE,Hebei Yiling Hospital; Renmin Hospital of Wuhan University,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule /Granule in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,240,Not Available,01/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=48889,No Results,No Results,No Results,20/04/2020,18/03/2020,None
1157,NCT04351490,ClinicalTrials.gov,14/04/2020,01/04/2020,TRUE,"University Hospital, Lille",Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19,Drug,Zinv + Vitamin D,3140,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04351490,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1158,NCT04351711,ClinicalTrials.gov,10/04/2020,01/04/2020,TRUE,CHU de Nimes,Not Recruiting,Not Applicable,Observational,France,Immunological Profiling of Patients With COVID-19 in Respiratory Distress,Clinical Presentation,No Intervention,60,01/10/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04351711,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1159,NCT04351646,ClinicalTrials.gov,07/04/2020,15/04/2020,FALSE,"St. George's, University of London",Not Recruiting,Not Applicable,Observational,United Kingdom,Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak),Diagnostics,Diagnostic Test or Assessment,500,15/04/2022,15/04/2022,https://clinicaltrials.gov/show/NCT04351646,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1160,NCT04351763,ClinicalTrials.gov,14/04/2020,27/04/2020,FALSE,Nicolaus Copernicus University,Recruiting,Phase 2/Phase 3,Interventional,Poland,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms,Drug,Amiodarone or Verapamil,804,02/03/2021,10/04/2021,https://clinicaltrials.gov/show/NCT04351763,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1161,NCT04352400,ClinicalTrials.gov,03/04/2020,01/04/2020,TRUE,University Hospital Padova,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy of Nafamostat in Covid-19 Patients (RACONA Study),Drug,Nafamostat,256,01/12/2021,01/12/2021,https://clinicaltrials.gov/show/NCT04352400,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1162,NCT04352517,ClinicalTrials.gov,10/04/2020,16/03/2020,TRUE,University of Extremadura,Recruiting,Not Applicable,Observational,"Brazil, Chile, Uruguay",Influence Physical Activity Psychological Responses COVID-19 Pandemic,Other (exercise),Exercise,3500,31/08/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04352517,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1163,ChiCTR2000029433,ChiCTR,01/02/2020,01/02/2020,FALSE,Hebei Yiling Hospital; Renmin Hospital of Wuhan University,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule/Granule in the treatment of suspected novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,240,Not Available,01/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=48898,No Results,No Results,No Results,20/04/2020,08/03/2020,None
1164,NCT04352582,ClinicalTrials.gov,13/04/2020,14/04/2020,FALSE,"University Hospital, Geneva",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 and Vaccination Attitudes,Other,No Intervention,1000,30/04/2020,30/04/2020,https://clinicaltrials.gov/show/NCT04352582,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1165,NCT04352803,ClinicalTrials.gov,16/04/2020,01/04/2020,TRUE,Regeneris Medical,Not Recruiting,Phase 1,Interventional,No Country Given,Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease,ATMP,Cells (mesenchymal),20,01/04/2024,01/04/2026,https://clinicaltrials.gov/show/NCT04352803,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1166,NCT04352634,ClinicalTrials.gov,08/04/2020,15/04/2020,FALSE,University of Chile,Not Recruiting,Not Applicable,Observational,"United States, Italy, Spain, Chile",The Covid-19 HEalth caRe wOrkErS (HEROES) Study,Clinical Presentation,No Intervention,2000,31/12/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04352634,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1167,NCT04352842,ClinicalTrials.gov,16/04/2020,19/02/2020,TRUE,RenJi Hospital,Not Recruiting,Not Applicable,Observational,China,Echocardiographic Manifestation in Patient With Coronavirus Disease 2019 (COVID-19),Clinical Presentation,No Intervention,55,04/04/2020,06/04/2020,https://clinicaltrials.gov/show/NCT04352842,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1168,EUCTR2020-001156-18-ES,EU Clinical Trials Register,03/04/2020,27/03/2020,TRUE,Fundación para la investigación Biomédica Hospital Universitario La Paz (FIBHULP),Authorised,Phase 3,Interventional,Spain,Efficacy of different treatments in patients infected with COVID-19,Drug,"Dolquine, Azithromycin, Lopinavir/ritonavir",1000,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001156-18,No Results,No Results,No Results,20/04/2020,22/04/2020,None
1169,NCT04353154,ClinicalTrials.gov,15/04/2020,15/04/2020,FALSE,Ottawa Heart Institute Research Corporation,Not Recruiting,Not Applicable,Observational,No Country Given,The RAPID COVID TRIAGE Algorithm,Diagnostics,Diagnostic Test or Assessment,20,31/08/2020,28/02/2021,https://clinicaltrials.gov/show/NCT04353154,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1170,NCT04354155,ClinicalTrials.gov,13/04/2020,15/05/2020,FALSE,Neil Goldenberg,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial,Drug,Enoxaparin,38,15/09/2022,15/10/2022,https://clinicaltrials.gov/show/NCT04354155,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1171,NCT04352985,ClinicalTrials.gov,15/04/2020,01/05/2020,FALSE,Spectral Diagnostics (US) Inc.,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19,Other (device),Hemoperfusion,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04352985,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1172,NCT04353011,ClinicalTrials.gov,15/04/2020,01/04/2020,TRUE,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak,Other (psych),No Intervention,50,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04353011,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1173,NCT04352933,ClinicalTrials.gov,07/04/2020,01/04/2020,FALSE,Cambridge University Hospitals NHS Foundation Trust,Not Recruiting,Phase 3,Interventional,No Country Given,PROLIFIC ChemoprophylaxisTrial (COVID-19),Drug (chemoprophylaxis),Hydroxychloroquine,1000,31/10/2020,01/04/2021,https://clinicaltrials.gov/show/NCT04352933,No Results,No Results,No Results,27/04/2020,22/04/2020,EUCTR2020-001331-26
1174,NCT04352959,ClinicalTrials.gov,15/04/2020,27/04/2020,FALSE,Claude Bernard University,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses,Drug,Bêta-cyclodextrin + citrox,178,20/05/2020,20/06/2020,https://clinicaltrials.gov/show/NCT04352959,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1175,NCT04354272,ClinicalTrials.gov,10/04/2020,13/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluation of Dental Emergency Treatments During COVID19 Crisis,Clinical Presentation (Epidemiology),No Intervention,840,20/06/2020,20/06/2020,https://clinicaltrials.gov/show/NCT04354272,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1176,NCT04354597,ClinicalTrials.gov,09/04/2020,15/04/2020,FALSE,Iyad Sultan,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients,Drug (Chemoprophylaxis),Combination: Hydroxychloroquine + Azithromycin,200,15/08/2020,15/10/2020,https://clinicaltrials.gov/show/NCT04354597,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1177,NCT04353206,ClinicalTrials.gov,16/04/2020,01/05/2020,FALSE,Noah Merin,Not Recruiting,Phase 1,Interventional,United States,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,ATMP,Plasma,90,01/05/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04353206,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1178,NCT04354753,ClinicalTrials.gov,17/04/2020,28/03/2020,TRUE,Aarogyam UK,Not Recruiting,Not Applicable,Observational,United Kingdom,AiM COVID for Covid 19 Tracking and Prediction,Clinical Presentation (Epidemiology),No Intervention,80,14/04/2020,17/04/2020,https://clinicaltrials.gov/show/NCT04354753,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1179,NCT04353284,ClinicalTrials.gov,16/04/2020,30/04/2020,FALSE,Yale University,Not Recruiting,Phase 2,Interventional,No Country Given,Camostat Mesylate in COVID-19 Outpatients,Drug,Camostat Mesilate,114,31/05/2021,31/05/2021,https://clinicaltrials.gov/show/NCT04353284,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1180,NCT04354558,ClinicalTrials.gov,06/04/2020,01/04/2020,TRUE,CHU de Amiens,Not Recruiting,Not Applicable,Observational,France,French Single Centre Experience of Critically Ill Patients With Covid 19,Clinical Presentation,No Intervention,200,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04354558,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1181,NCT04354805,ClinicalTrials.gov,17/04/2020,01/05/2020,FALSE,Cairo University,Not Recruiting,Phase 1/Phase 2,Interventional,Egypt,Administration of Chloropromazine as a Treatment for COVID-19,Drug,Chlorpromazine,60,01/08/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04354805,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1182,NCT04355247,ClinicalTrials.gov,17/04/2020,14/04/2020,TRUE,Auxilio Mutuo Cancer Center,Recruiting,Phase 2,Interventional,Puerto Rico,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm,Drug (Chemoprophylaxis),Corticosteroids,20,31/07/2020,30/04/2021,https://clinicaltrials.gov/show/NCT04355247,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1183,NCT04354766,ClinicalTrials.gov,17/04/2020,27/04/2020,FALSE,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2,ATMP,Plasma,10,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04354766,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1184,NCT04355624,ClinicalTrials.gov,17/04/2020,15/04/2020,TRUE,CHU de Nice,Recruiting,Not Applicable,Observational,France,Kidney Involvement in COVID-19 Disease (COVKID),Clinical Presentation,No Intervention,80,30/04/2020,30/07/2020,https://clinicaltrials.gov/show/NCT04355624,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1185,NCT04354584,ClinicalTrials.gov,13/04/2020,06/04/2020,TRUE,"Copenhagen University Hospital, Hvidovre",Recruiting,Not Applicable,Observational,Denmark,Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19,Clinical Presentation,No Intervention,20,06/04/2021,06/04/2021,https://clinicaltrials.gov/show/NCT04354584,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1186,NCT04355026,ClinicalTrials.gov,15/04/2020,10/04/2020,TRUE,Celje General Hospital,Recruiting,Phase 4,Interventional,Slovenia,Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia,Drug,Combination: Bromhexine + Hydroxychloroquine vs. Hydroxychloroquine,90,30/06/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04355026,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1187,NCT04355494,ClinicalTrials.gov,17/04/2020,17/04/2020,FALSE,Alexion Pharmaceuticals,Not Recruiting,Not Applicable,Expanded Access,France,SOLIRIS¬Æ (Eculizumab) Treatment of Participants With COVID-19,Drug,Eculizumab,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04355494,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1188,NCT04355676,ClinicalTrials.gov,17/04/2020,30/04/2020,FALSE,Karyopharm Therapeutics Inc,Not Recruiting,Phase 2,Interventional,No Country Given,Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19,Drug,Selinexor,80,30/08/2020,30/08/2020,https://clinicaltrials.gov/show/NCT04355676,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1189,NCT04355767,ClinicalTrials.gov,17/04/2020,01/05/2020,FALSE,Stanford University,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma vs. Placebo in Emergency Room Patients With COVID-19,ATMP,Plasma,206,01/12/2022,01/12/2022,https://clinicaltrials.gov/show/NCT04355767,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1190,NCT04356443,ClinicalTrials.gov,16/04/2020,15/04/2020,TRUE,Massachusetts General Hospital,Recruiting,Not Applicable,Observational,United States,Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection,Other (device),Respiratory Monitor,500,31/12/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04356443,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1191,NCT04355871,ClinicalTrials.gov,19/04/2020,18/03/2020,TRUE,Fundación SEIMC-GESIDA,Not Recruiting,Not Applicable,Observational,Spain,Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain,Clinical Presentation,No Intervention,3000,15/04/2020,17/04/2020,https://clinicaltrials.gov/show/NCT04355871,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1192,NCT04356495,ClinicalTrials.gov,11/04/2020,15/04/2020,FALSE,"University Hospital, Bordeaux",Not Recruiting,Phase 3,Interventional,France,Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19),Drug,Hydroxychloroquine vs. Imatinib vs. Favipiravir vs. Telmisartan vs. Vitamins,1057,31/07/2020,15/08/2020,https://clinicaltrials.gov/show/NCT04356495,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1193,NCT04357314,ClinicalTrials.gov,19/04/2020,27/04/2020,FALSE,French Cardiology Society,Not Recruiting,Not Applicable,Observational,No Country Given,Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study,Clinical Presentation,No Intervention,80,31/07/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04357314,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1194,NCT04357340,ClinicalTrials.gov,13/04/2020,20/04/2020,FALSE,Tehran University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19,Other (physio),Physio,40,20/06/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04357340,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1195,NCT04357847,ClinicalTrials.gov,09/04/2020,09/04/2020,FALSE,"University Hospital, Rouen",Recruiting,Not Applicable,Observational,France,Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection,Clinical Presentation,No Intervention,100,31/07/2020,31/08/2020,https://clinicaltrials.gov/show/NCT04357847,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1196,ChiCTR2000032214,ChiCTR,23/04/2020,01/05/2020,FALSE,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Screening of proprietary Chinese medicines in convalescent rehabilitation of novel coronavirus pneumonia (COVID-19) convalescent patients,Traditional Medicine (Drug),Traditional Medicine,200,Not Available,10/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=52781,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1197,NCT04356534,ClinicalTrials.gov,15/04/2020,19/04/2020,FALSE,Royal College of Surgeons in Ireland - Medical University of Bahrain,Not Recruiting,Not Applicable,Interventional,Bahrain,Convalescent Plasma Trial in COVID -19 Patients,ATMP,Plasma,40,03/05/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04356534,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1198,NCT04357769,ClinicalTrials.gov,16/04/2020,10/04/2020,TRUE,Federico II University,Recruiting,Not Applicable,Observational,Italy,COVID-19 Pandemic Burden in Severe Mental Disease Patients,Other (psych),No Intervention,400,20/04/2020,25/04/2020,https://clinicaltrials.gov/show/NCT04357769,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1199,EUCTR2020-001254-22-BE,EU Clinical Trials Register,24/03/2020,24/03/2020,FALSE,"University Hospital, Ghent",Authorised,Phase 4,Interventional,Belgium,Sargramostim in patients with acute hypoxic respiratory failure due to COVID-19,Drug,Sargramostin,80,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001254-22,No Results,No Results,No Results,20/04/2020,04/01/2020,None
1200,NCT04356508,ClinicalTrials.gov,10/04/2020,14/04/2020,FALSE,Dr. Gerry Gin Wai Kwok,Not Recruiting,Phase 2,Interventional,No Country Given,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1,Drug,Nivolumab,15,30/06/2020,31/08/2021,https://clinicaltrials.gov/show/NCT04356508,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1201,NCT04356937,ClinicalTrials.gov,19/04/2020,27/04/2020,FALSE,Massachusetts General Hospital,Not Recruiting,Phase 3,Interventional,United States,Efficacy of Tocilizumab on Patients With COVID-19,Drug,Tocilizumab,300,30/06/2020,30/08/2020,https://clinicaltrials.gov/show/NCT04356937,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1202,ACTRN12620000486921,ANZCTR,17/04/2020,20/04/2020,FALSE,Royal North Shore Hospital,Not Recruiting,Not Applicable,Observational,Australia,"AUSTRALIAN CARDIOVASCULAR COVID-19 REGISTRY (AUS-COVID) 
",Clinical Presentation,No Intervention,865,Not Available,19/09/2020,https://anzctr.org.au/ACTRN12620000486921.aspx,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1203,ACTRN12620000445976,ANZCTR,06/04/2020,10/04/2020,FALSE,University of Melbourne,Not Recruiting,Phase 3,Interventional,"New Zealand, Australia","To compare the effectiveness of two drugs (hydroxychloroquine and lopinavir/ritonavir alone or combined in treating hospitalized patients with confirmed COVID-19 compared to standard of care

",Drug,Combination: Lopinavir/ritonavir + hydroxychloroquine vs. lopinavir/ritonavir vs. hydroxychloroquine,2500,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000445976.aspx,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1204,ChiCTR2000032161,ChiCTR,21/04/2020,01/02/2020,TRUE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A retrospective study for evolution and clinical outcomes study of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,2000,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=52561,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1205,ACTRN12620000492954,ANZCTR,20/04/2020,01/05/2020,FALSE,University of New South Wales,Not Recruiting,Not Applicable,Interventional,Australia,A Facebook delivered physical activity focused group lifestyle intervention for older adults during the COVID-19 pandemic,Other (exercise),Exercise,20,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000492954.aspx,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1206,ACTRN12620000457943,ANZCTR,08/04/2020,14/04/2020,FALSE,Medical Research Institute of New Zealand,Not Recruiting,Phase 2,Interventional,New Zealand,Hydroxychloroquine for the Community-Based Treatment of COVID-19,Drug,Hydroxychloroquine,70,Not Available,29/01/2021,https://anzctr.org.au/ACTRN12620000457943.aspx,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1207,ISRCTN18348009,ISRCTN,15/04/2020,16/04/2020,FALSE,University of Valladolid,Not Recruiting,Not Applicable,Observational,Spain,Occupational health and safety among health care personnel in a COVID-19 pandemic,Clinical Presentation,No Intervention,80,Not Available,22/04/2020,http://isrctn.com/ISRCTN18348009,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1208,ChiCTR2000032412,ChiCTR,27/04/2020,15/05/2020,FALSE,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for the effectiveness and safety of Xi-Yan-Ping injection combined with conventional protocol in the treatment of common type novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,426,Not Available,22/08/2020,http://www.chictr.org.cn/showproj.aspx?proj=52988,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1209,ISRCTN51255782,ISRCTN,14/04/2020,14/04/2020,FALSE,Labormedizinisches Zentrum Dr. Risch,Recruiting,Not Applicable,Observational,Liechtenstein,Can the Ava fertility tracker device detect early signs of COVID-19?,Diagnostics,Diagnostic Test or Assessment,2170,Not Available,31/12/2021,http://isrctn.com/ISRCTN51255782,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1210,ChiCTR2000032233,ChiCTR,23/04/2020,23/04/2020,FALSE,Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Not Recruiting,Not Applicable,Observational,China,Clinical study for the potential impact of novel coronavirus pneumonia (COVID-19) on endocrine system,Clinical Presentation,No Intervention,28,Not Available,06/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=52796,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1211,ChiCTR2000032239,ChiCTR,23/04/2020,29/01/2020,TRUE,The First People's Hospital of Jiangxia District,Recruiting,Not Applicable,Observational,China,A medical records based study for epidemiological characteristics of 88 patients with new coronavirus pneumonia (COVID-19) and its impact on severe disease,Clinical Presentation (Epidemiology),No Intervention,88,Not Available,16/03/2020,http://www.chictr.org.cn/showproj.aspx?proj=52507,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1212,ISRCTN10077335,ISRCTN,07/04/2020,19/03/2020,TRUE,Klinikum der Universität München,Recruiting,Not Applicable,Observational,Germany,Comparison of lung water in COVID-19 patients and other patients with acute respiratory failure,Clinical Presentation,No Intervention,25,Not Available,30/04/2020,http://isrctn.com/ISRCTN10077335,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1213,ChiCTR2000032205,ChiCTR,23/04/2020,15/04/2020,TRUE,Wuhan Hospital Of Traditional Chinese and Western Medicine,Not Recruiting,Not Applicable,Interventional,China,"A multicenter randomized, double-blind, placebo-controlled trial for Sheng-Mai-Yin for improvement of the pulmonary heart function related symptoms of convalescence patients of new coronavirus pneumonia",Traditional Medicine (Drug),Traditional Medicine,200,Not Available,15/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=52662,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1214,ChiCTR2000032237,ChiCTR,23/04/2020,01/04/2020,TRUE,Ezhou Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,No Country Given,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiang-Sha-Liu-Jun Pill in the treatment of novel coronavirus pneumonia (COVID-19) decline in digestive function during convalescence",Traditional Medicine (Drug),Traditional Medicine,200,Not Available,30/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=52699,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1215,IRCT20170117032004N3,IRCT,29/03/2020,03/04/2020,FALSE,Tabriz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of vitamin A in patients with COVID19,Drug,Vitamin A,30,Not Available,Not Available,http://en.irct.ir/trial/46564,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1216,ChiCTR2000032213,ChiCTR,23/04/2020,23/04/2020,FALSE,The First Affiliated Hospital of Chongqing Medical University,Recruiting,Not Applicable,Observational,China,A medical records based study for the impact of wearing medical masks on oxygen saturation in adult surgical patients after general anaesthesia during novel coronavirus pneumonia (COVID-19) pandemic,Other (device),Masks,151,Not Available,23/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=52788,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1217,ChiCTR2000032165,ChiCTR,21/04/2020,25/04/2020,FALSE,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, parallel-controlled trial for Qi-Mai-Fei-Luo-Ping Mixture in the improvement of lung function of novel coronavirus pneumonia (COVID-19) in the convalescent period",Traditional Medicine (Drug),Traditional Medicine,60,Not Available,31/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=52679,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1218,ISRCTN50189673,ISRCTN,02/04/2020,19/03/2020,TRUE,University of Oxford,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,A randomised trial of treatments to prevent death in patients hospitalised with COVID-19 (coronavirus),Drug,lopinavir/ritonavir vs. interferon beta vs. dexamethasone vs. hydroxychloroquine ,5000,Not Available,30/06/2021,http://isrctn.com/ISRCTN50189673,No Results,No Results,No Results,27/04/2020,04/07/2020,EUCTR2020-001113-21
1219,ISRCTN40092247,ISRCTN,01/04/2020,20/03/2020,TRUE,University of Oxford,Recruiting,Not Applicable,Observational,United Kingdom,UKOSS: Pandemic COVID-19 in pregnancy,Clinical Presentation,No Intervention,500,Not Available,31/12/2022,http://isrctn.com/ISRCTN40092247,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1220,ChiCTR2000032162,ChiCTR,21/04/2020,22/04/2020,FALSE,"Bayi Children's Hospital, Seventh Medical Centre, PLA General Hospital",Not Recruiting,Not Applicable,Observational,China,A medical records based study for ECMO in the rescue therapy of extremely critical novel coronavirus pneumonia (COVID-19) patients,Drug,Oxygen,80,Not Available,21/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=52694,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1221,IRCT20100228003449N29,IRCT,19/03/2020,18/03/2020,TRUE,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Effect of sofosbuvir/ ledipasvir on COVID-19,Drug,Combination: sofosbuvir + ledipasvir vs. hydroxychloroquine + oseltamivir + lopinavir/ritonavir,50,Not Available,Not Available,http://en.irct.ir/trial/46567,No Results,No Results,No Results,21/04/2020,25/03/2020,None
1222,ISRCTN13694948,ISRCTN,01/04/2020,02/04/2020,FALSE,"University Hospital, Bern",Recruiting,Not Applicable,Observational,"Norway, Netherlands, Sweden, Israel, Liechtenstein, Ireland, Czech Republic, Luxembourg, Belgium, Portugal, Croatia, Isle of Man, Bulgaria, New Zealand, United States, Slovakia, French Southern Territories, Greece, Spain, Slovenia, Austria, Italy, Brazil, Switzerland, France, Denmark, United Kingdom, Australia, South Africa, Germany, Lebanon, Turkey, Cyprus, Lithuania, Malta, Finland",Distress and resilience of healthcare professionals during the COVID-19 (coronavirus) pandemic,Other (psych),No Intervention,400,Not Available,01/01/2021,http://isrctn.com/ISRCTN13694948,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1223,EUCTR2020-001244-26-AT,EU Clinical Trials Register,31/03/2020,11/04/2020,FALSE,Medical University of Vienna,Authorised,Phase 2,Interventional,Austria,COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS,Drug,Solnatide,40,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001244-26,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1224,ISRCTN14326006,ISRCTN,14/04/2020,13/04/2020,TRUE,"University Health Network, Toronto",Recruiting,Phase 3,Interventional,Canada,Does taking hydroxychloroquine before and during exposure to patients protect frontline healthcare workers from coronavirus?,Drug (chemoprophylaxis),Hydroxychloroquine,988,Not Available,30/01/2022,http://isrctn.com/ISRCTN14326006,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1225,IRCT20131113015393N6,IRCT,30/03/2020,28/02/2020,TRUE,Sabzevar University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Benson Relaxation on Quality of Life and job stress  in nurses,Other (psych),Psychological,62,Not Available,Not Available,http://en.irct.ir/trial/46609,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1226,IRCT20140911019125N6,IRCT,04/04/2020,04/04/2020,FALSE,Kerman University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of dental pulp mesenchymal stem cells in treatment of  corona disease,ATMP,Cells (mesenchymal),10,Not Available,Not Available,http://en.irct.ir/trial/46668,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1227,ISRCTN80453162,ISRCTN,14/04/2020,09/04/2020,TRUE,University Hospitals Coventry and Warwickshire NHS Trust,Recruiting,Not Applicable,Observational,"Sweden, Estonia, Curacao, Sint Maarten (Dutch part), Mongolia, Reunion, Turks and Caicos Islands, Zimbabwe, South Sudan, Luxembourg, Czech Republic, Falkland Islands, Tunisia, Belgium, China, Jamaica, Portugal, Zambia, Benin, Isle of Man, Bolivia, United Arab Emirates, Algeria, French Southern Territories, French Guiana, Puerto Rico, Somalia, Brazil, Egypt, Panama, Namibia, Mauritania, Korea, North, Yemen, Bhutan, Maldives, Cuba, Haiti, Samoa, Christmas Island, Saint Barthelemy, Palestinian Territory, Wallis and Futuna, Cocos (Keeling) Islands, Guinea, Sri Lanka, Madagascar, Ukraine, Nigeria, Sierra Leone, American Samoa, Costa Rica, Finland, Myanmar, Svalbard and Jan Mayen, Netherlands, Suriname, Israel, Macao, Belarus, Nicaragua, Saudi Arabia, Liechtenstein, Afghanistan, Hong Kong, Martinique, Faroe Islands, United States Minor Outlying Islands, Dominican Republic, Turkmenistan, Lesotho, Nauru, Gabon, Latvia, Niue, Kuwait, Antarctica, Brunei, Senegal, Croatia, Kosovo, Guyana, New Zealand, Paraguay, United States, Bulgaria, Gambia, Micronesia, Federated States of, Anguilla, Poland, India, Cambodia, Guatemala, Saint Martin (French part), Switzerland, Bonaire Saint Eustatius and Saba, Japan, Russian Federation, Mali, United Kingdom, Australia, Burkina Faso, French Polynesia, Aruba, South Africa, Germany, Turkey, Grenada, Guernsey, Norfolk Island, Lithuania, Eritrea, Heard Island and Mcdonald Islands, Tuvalu, Mayotte, Cape Verde, Sao Tome and Principe, Bangladesh, Congo, Saint Vincent and the Grenadines, Virgin Islands, U.S., Chad, Malta, Argentina, Saint Helena, Guinea-Bissau, Norway, Andorra, Bahrain, Barbados, Pakistan, Malaysia, Iceland, Central African Republic, Ecuador, Serbia, Romania, Pitcairn, Georgia, New Caledonia, Armenia, Mexico, Bosnia and Herzegovina, Canada, Netherlands Antilles, Guam, El Salvador, Tajikistan, British Indian Ocean Territory, Greece, Cameroon, Honduras, Slovenia, Syria, Colombia, Qatar, Italy, Austria, Kenya, Indonesia, Nepal, Oman, Tanzania, Albania, Taiwan, Jersey, France, Malawi, Antigua and Barbuda, Holy See (Vatican City State), Vanuatu, Kiribati, Saint Lucia, Gibraltar, Solomon Islands, Kazakhstan, Ethiopia, Kyrgyzstan, Virgin Islands, British, Angola, Botswana, Bouvet Island, Bahamas, Sudan, Saint Kitts and Nevis, Papua New Guinea, Timor-Leste, Uruguay, Libya, Peru, Montserrat, Uzbekistan, Iraq, Western Sahara, Macedonia, Laos, Fiji, Chile, Vietnam, Seychelles, Ireland, Montenegro, Tokelau, Azerbaijan, Jordan, Monaco, Uganda, Korea, South, Hungary, Venezuela, Guadeloupe, Bermuda, Slovakia, Trinidad and Tobago, Cote d'Ivoire, San Marino, Spain, Moldova, Cayman Islands, Northern Mariana Islands, Marshall Islands, Dominica, Niger, Djibouti, Liberia, Denmark, Iran, Mozambique, Congo, Democratic Republic, Mauritius, Comoros, Lebanon, Belize, Palau, South Georgia and the South Sandwich Is, Equatorial Guinea, Philippines, Cyprus, Togo, Morocco, Cook Islands, Greenland, Burundi, Thailand, Singapore, Saint Pierre and Miquelon, Swaziland, Rwanda, Tonga, Ghana","The impact of the COVID-19 pandemic on the provision, practice, and outcomes of vascular surgery (COVER study)",Clinical Presentation,No Intervention,200,Not Available,01/04/2022,http://isrctn.com/ISRCTN80453162,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1228,EUCTR2020-001440-26-ES,EU Clinical Trials Register,20/04/2020,19/04/2020,TRUE,Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI),Authorised,Phase 3,Interventional,Spain,Study for the prevention of COVID-19 infection in healthcare personnel,Drug (Chemoprophylaxis),Hydroxychloroquine,184,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001440-26,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1229,ISRCTN16912075,ISRCTN,06/04/2020,06/04/2020,FALSE,University of Warwick,Recruiting,Not Applicable,Interventional,United Kingdom,"RECOVERY Respiratory Support: Respiratory Strategies in patients with coronavirus COVID-19 ‚Äì CPAP, high-flow nasal oxygen, and standard care",Drug,Oxygen,4002,Not Available,05/05/2021,http://isrctn.com/ISRCTN16912075,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1230,EUCTR2020-001172-15-AT,EU Clinical Trials Register,26/03/2020,10/04/2020,FALSE,Apeiron Biologics,Authorised,Phase 2,Interventional,"Austria, Denmark",Recombinant human angiotensin-converting enzyme 2 (rhACE2) as a treat-ment for patients with COVID-19,Drug,ACE enzyme,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001172-15,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1231,EUCTR2020-001459-42-DK,EU Clinical Trials Register,14/04/2020,22/04/2020,FALSE,Zealand University Hospital,Authorised,Phase 2,Interventional,Denmark,"Ruxolitinib Treatment in Patients with Severe COVID-19 Infection. A Danish Safety and Efficacy Study.
",Drug,Ruxolitinib,40,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001459-42,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1232,EUCTR2020-001391-15-IE,EU Clinical Trials Register,31/03/2020,24/04/2020,FALSE,Royal College of Surgeons Ireland,Authorised,Phase 2,Interventional,Ireland,A randomized double-blind placebo-controlled trial of intravenous plasma-purified alpha-1 antitrypsin for severe COVID-19 illness.,ATMP,Alpha-1-proteinase inhibitor,36,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001391-15,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1233,EUCTR2020-001310-38-DE,EU Clinical Trials Register,31/03/2020,06/04/2020,FALSE,DRK-Bluspendedienst Baden-Württemberg - Hessen gGmbH,Authorised,Phase 2,Interventional,Germany,Clinical Study to assess positive value of blood plasma from donors having built immunity against the new corona virus (SARS-CoV-2) transfused to patients suffering from SARS-CoV-2 infection,ATMP,Plasma,120,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001310-38,No Results,No Results,No Results,29/04/2020,15/04/2020,None
1234,EUCTR2020-001270-29-GB,EU Clinical Trials Register,30/03/2020,02/04/2020,FALSE,Sanofi,Authorised,Phase 2/Phase 3,Interventional,"Germany, Hungary, France, Denmark, Czech Republic, United Kingdom",Hydroxychloroquine for COVID 19 in moderately to severely ill hospitalized patients,Drug,Hydroxychloroquine,350,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001270-29,No Results,No Results,No Results,29/04/2020,04/07/2020,None
1235,EUCTR2020-001614-38-BE,EU Clinical Trials Register,06/04/2020,22/04/2020,FALSE,UZLeuven,Authorised,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",Drug,Azithromycin,240,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001614-38,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1236,EUCTR2020-001327-13-AT,EU Clinical Trials Register,30/03/2020,14/04/2020,FALSE,Medical University of Vienna,Authorised,Phase 2,Interventional,Austria,"A SINGLE-BLINDED RANDOMIZED, PLACEBO-CONTROLLED PHASE II TRIAL OF PROPHYLACTIC TREATMENT WITH ORAL AZITHROMYCIN VERSUS PLACEBO IN CANCER PATIENTS UNDERGOING ANTINEOPLASTIC TREATMENT DURING THE COVID-19 PANDEMIC",Drug,Azithromycin,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001327-13,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1237,EUCTR2020-001622-64-ES,EU Clinical Trials Register,20/04/2020,19/04/2020,TRUE,Dr. Ana Pueyo Bastida,Authorised,Phase 4,Interventional,Spain,OUTPATIENT TREATMENT OF COVID-19 WITH EARLY PULMONARY CORTICOSTEROIDS AS AN OPPORTUNITY TO MODIFY THE COURSE OF THE DISEASE,Drug,Corticosteroids,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001622-64,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1238,NCT04280705,ClinicalTrials.gov,20/02/2020,21/02/2020,TRUE,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 3,Interventional,"United States, Germany, South Korea, Mexico, Japan, United Kingdom, Denmark, Singapore, Greece, Spain",Adaptive COVID-19 Treatment Trial (ACTT),Drug,Remdesivir,800,01/04/2023,01/04/2023,https://clinicaltrials.gov/show/NCT04280705,No Results,No Results,No Results,04/05/2020,18/03/2020,EUCTR2020-001052-18
1240,NCT04256395,ClinicalTrials.gov,01/02/2020,01/02/2020,FALSE,Beijing Tsinghua Chang Gung Hospital,Recruiting,Not Applicable,Observational,China,Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19,Diagnostics,Diagnostic Test or Assessment,300000,31/07/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04256395,No Results,No Results,No Results,04/05/2020,18/03/2020,None
1241,EUCTR2020-001417-21-BE,EU Clinical Trials Register,01/04/2020,12/04/2020,FALSE,Institute of Tropical Medicine,Authorised,Phase 2,Interventional,Belgium,An open label single center randomized controlled trial to evaluate the effect of hydroxychloroquine on viral shedding in mild COVID-19,Drug,Hydroxychloroquine,206,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001417-21,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1242,NCT04320017,ClinicalTrials.gov,20/03/2020,20/03/2020,FALSE,Groupe Hospitalier Pitié Salpêtrière,Recruiting,Not Applicable,Observational,France,Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19,Clinical Presentation,No Intervention,500,20/05/2020,20/05/2020,https://clinicaltrials.gov/show/NCT04320017,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1243,NCT04321096,ClinicalTrials.gov,23/03/2020,04/04/2020,TRUE,Aarhus University,Recruiting,Phase 1/Phase 2,Interventional,Denmark,The Impact of Camostat Mesilate on COVID-19 Infection,Drug,Camostat Mesilate,580,31/12/2020,01/05/2021,https://clinicaltrials.gov/show/NCT04321096,No Results,No Results,No Results,04/05/2020,04/01/2020,EUCTR2020-001200-42
1244,NCT04308668,ClinicalTrials.gov,11/03/2020,17/03/2020,FALSE,University of Minnesota,Recruiting,Phase 3,Interventional,"United States, Canada",Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,Drug (Chemoprophylaxis),Hydroxychloroquine,3000,01/05/2020,14/05/2020,https://clinicaltrials.gov/show/NCT04308668,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1245,NCT04317040,ClinicalTrials.gov,19/03/2020,08/04/2020,FALSE,"OncoImmune, Inc.",Recruiting,Phase 3,Interventional,United States,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment,ATMP,Gene-derived protein,230,01/05/2021,01/05/2022,https://clinicaltrials.gov/show/NCT04317040,No Results,No Results,No Results,04/05/2020,25/03/2020,None
1246,NCT04321278,ClinicalTrials.gov,23/03/2020,28/03/2020,FALSE,Hospital Israelita Albert Einstein,Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),Drug,Combination: hydroxychloroquine + azithromycin vs. hydroxychloroquine,440,30/08/2020,30/08/2020,https://clinicaltrials.gov/show/NCT04321278,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1247,NCT04322682,ClinicalTrials.gov,23/03/2020,23/03/2020,FALSE,Montreal Heart Institute,Recruiting,Phase 3,Interventional,"United States, Canada, Spain",Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),Drug,Colchicine,6000,01/09/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04322682,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1248,NCT04273763,ClinicalTrials.gov,14/02/2020,16/02/2020,FALSE,The Second Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),Drug,Combination: Bromhexine + Umifenovir + Interferon alpha vs. Umifenovir + interferon alpha,18,10/05/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04273763,No Results,No Results,No Results,04/05/2020,08/03/2020,None
1249,NCT04292730,ClinicalTrials.gov,28/02/2020,15/03/2020,TRUE,Gilead Sciences,Recruiting,Phase 3,Interventional,"China, United States, Germany, Italy, South Korea, Netherlands, Sweden, Taiwan, Switzerland, France, Japan, Hong Kong, Singapore, United Kingdom, Iran, Spain",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734‚Ñ¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment,Drug,Remdesivir,1600,01/05/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04292730,No Results,No Results,No Results,04/05/2020,18/03/2020,EUCTR2020-000842-32
1250,NCT04319016,ClinicalTrials.gov,20/03/2020,01/01/2020,TRUE,Federico II University,Recruiting,Not Applicable,Observational,Italy,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,Clinical Presentation,No Intervention,200,30/04/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04319016,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1251,NCT04319445,ClinicalTrials.gov,20/03/2020,22/03/2020,FALSE,Wake Forest University,Recruiting,Not Applicable,Interventional,United States,Mindfulness During COVID-19,Other (psych),Psychological,200,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04319445,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1252,NCT04323761,ClinicalTrials.gov,24/03/2020,27/03/2020,TRUE,Gilead Sciences,Not Recruiting,Not Applicable,Expanded Access,"United States, Germany, Italy, Netherlands, Israel, Canada, Switzerland, France, United Kingdom, Romania, Belgium, Spain",Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19),Drug,Remdesivir,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04323761,No Results,No Results,No Results,04/05/2020,22/04/2020,EUCTR2020-001453-49
1253,NCT04327479,ClinicalTrials.gov,26/03/2020,26/03/2020,FALSE,"University Hospital, Essen",Recruiting,Not Applicable,Observational,Germany,Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,Clinical Presentation,No Intervention,728,25/03/2026,25/03/2026,https://clinicaltrials.gov/show/NCT04327479,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1254,NCT04292899,ClinicalTrials.gov,28/02/2020,06/03/2020,TRUE,Gilead Sciences,Recruiting,Phase 3,Interventional,"China, United States, Germany, Italy, South Korea, Netherlands, Sweden, Taiwan, Switzerland, France, Japan, Hong Kong, Singapore, United Kingdom, Spain",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734‚Ñ¢) in Participants With Severe Coronavirus Disease (COVID-19),Drug,Remdesivir,6000,01/05/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04292899,No Results,No Results,No Results,04/05/2020,18/03/2020,EUCTR2020-000841-15
1255,NCT04312009,ClinicalTrials.gov,13/03/2020,13/04/2020,FALSE,University of Minnesota,Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Requiring Hospitalization,Drug,ARB (Losartan),200,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04312009,No Results,No Results,No Results,04/05/2020,25/03/2020,None
1256,IRCT20160316027081N1,IRCT,31/03/2020,23/03/2020,TRUE,Artesh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Licorice in COVID-19,Traditional Medicine (Drug),Traditional Medicine,374,Not Available,Not Available,http://en.irct.ir/trial/46678,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1257,NCT04321993,ClinicalTrials.gov,24/03/2020,17/04/2020,FALSE,Lisa Barrett,Recruiting,Phase 2,Interventional,Canada,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,Drug,Lopinavir/ritonavir vs. hydroxychloroquine vs. baricitinib vs. sarilumab,1000,01/02/2021,01/07/2021,https://clinicaltrials.gov/show/NCT04321993,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1258,NCT04322123,ClinicalTrials.gov,24/03/2020,01/04/2020,FALSE,Hospital do Coração,Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),Drug,Combination: hydroxychloroquine + azithromycin vs. hydroxychloroquine,630,30/08/2020,30/08/2020,https://clinicaltrials.gov/show/NCT04322123,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1259,NCT04328285,ClinicalTrials.gov,25/03/2020,14/04/2020,TRUE,CHU de Saint Etienne,Recruiting,Phase 3,Interventional,France,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,1200,30/11/2020,30/11/2020,https://clinicaltrials.gov/show/NCT04328285,No Results,No Results,No Results,04/05/2020,04/06/2020,EUCTR2020-001188-96
1260,NCT04328441,ClinicalTrials.gov,27/03/2020,25/03/2020,TRUE,UMC Utrecht,Recruiting,Phase 3,Interventional,Netherlands,Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine,ATMP,Vaccine,1500,25/10/2020,25/12/2020,https://clinicaltrials.gov/show/NCT04328441,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1261,NCT04313946,ClinicalTrials.gov,17/03/2020,18/03/2020,FALSE,Professor Adrian Covic,Recruiting,Not Applicable,Observational,"Romania, United Kingdom, Italy",Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays,Diagnostics,Diagnostic Test or Assessment,200,16/08/2020,18/08/2020,https://clinicaltrials.gov/show/NCT04313946,No Results,No Results,No Results,04/05/2020,25/03/2020,None
1262,NCT04315948,ClinicalTrials.gov,13/03/2020,22/03/2020,TRUE,INSERM,Recruiting,Phase 3,Interventional,"France, Luxembourg",Trial of Treatments for COVID-19 in Hospitalized Adults,Drug,Combination: remdesivir vs. lopinavir/ritonavir vs. lopinavir/ritonavir + interferon beta vs. hydroxychloroquine,3100,01/03/2023,01/03/2023,https://clinicaltrials.gov/show/NCT04315948,No Results,No Results,No Results,04/05/2020,25/03/2020,EUCTR2020-000936-23
1263,NCT04324606,ClinicalTrials.gov,20/03/2020,01/04/2020,TRUE,University of Oxford,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,A Study of a Candidate COVID-19 Vaccine (COV001),ATMP,Vaccine,1112,01/05/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04324606,No Results,No Results,No Results,04/05/2020,04/01/2020,EUCTR2020-001072-15; ISRCTN15281137
1264,NCT04327505,ClinicalTrials.gov,25/03/2020,08/05/2020,FALSE,Karolinska Institutet,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,Drug,Oxygen,200,30/11/2021,31/12/2022,https://clinicaltrials.gov/show/NCT04327505,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1265,IRCT20200324046850N3,IRCT,30/03/2020,28/03/2020,TRUE,Abadan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of naproxen on the healing process of patients with COVID-19,Drug,"Investigational: Naproxen

All Arms: Hydroxychloroquine + Lopinavir/Ritonavir",40,Not Available,Not Available,http://en.irct.ir/trial/46718,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1266,NCT04330599,ClinicalTrials.gov,31/03/2020,05/05/2020,FALSE,Queen Mary University of London,Not Recruiting,Not Applicable,Observational,No Country Given,Longitudinal Population-based Observational Study of COVID-19 in the UK Population,Clinical Presentation,No Intervention,12000,01/04/2025,01/04/2025,https://clinicaltrials.gov/show/NCT04330599,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1267,NCT04330638,ClinicalTrials.gov,31/03/2020,01/04/2020,FALSE,"University Hospital, Ghent",Recruiting,Phase 3,Interventional,Belgium,Treatment of COVID-19 Patients With Anti-interleukin Drugs,Drug,Combination: Anakinta + Siltuximab vs. Tocilizumab + Anakinra vs. Tocilizumab vs. Siltuximab vs. Anakinra,342,01/09/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04330638,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1268,NCT04318444,ClinicalTrials.gov,20/03/2020,29/03/2020,FALSE,Columbia University,Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,1600,01/03/2021,01/03/2022,https://clinicaltrials.gov/show/NCT04318444,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1269,NCT04320056,ClinicalTrials.gov,19/03/2020,20/04/2020,FALSE,Laval University,Recruiting,Not Applicable,Interventional,Canada,Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19),Drug,Oxygen,216,30/04/2021,31/10/2021,https://clinicaltrials.gov/show/NCT04320056,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1270,NCT04329572,ClinicalTrials.gov,29/03/2020,23/04/2020,FALSE,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19,Drug,Combination: Hydroxychloroquine + Azithromycin,400,31/05/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04329572,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1271,NCT04329923,ClinicalTrials.gov,30/03/2020,09/04/2020,FALSE,"Ravi Amaravadi, MD",Recruiting,Phase 2,Interventional,United States,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),Drug,Hydroxychloroquine,400,01/04/2021,01/12/2021,https://clinicaltrials.gov/show/NCT04329923,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1272,IRCT20200324046847N1,IRCT,31/03/2020,28/03/2020,TRUE,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Treatment of patients with Corona virus infection,Drug,Septimeb,30,Not Available,Not Available,http://en.irct.ir/trial/46720,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1273,NCT04321421,ClinicalTrials.gov,23/03/2020,17/03/2020,TRUE,Foundation IRCCS San Matteo Hospital,Recruiting,Not Applicable,Interventional,Italy,Hyperimmune Plasma for Critical Patients With COVID-19,ATMP,Plasma,49,31/05/2020,31/05/2020,https://clinicaltrials.gov/show/NCT04321421,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1274,NCT04323839,ClinicalTrials.gov,24/03/2020,20/03/2020,TRUE,"University of California, San Francisco",Recruiting,Not Applicable,Observational,United States,COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY),Clinical Presentation,No Intervention,2000,31/03/2024,31/03/2024,https://clinicaltrials.gov/show/NCT04323839,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1275,NCT04331808,ClinicalTrials.gov,31/03/2020,30/03/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),Drug,Tocilizumab,228,31/03/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04331808,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1276,NCT04332107,ClinicalTrials.gov,30/03/2020,01/05/2020,FALSE,"University of California, San Francisco",Not Recruiting,Phase 3,Interventional,United States,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,Drug,Azithromycin,2271,30/08/2020,30/08/2021,https://clinicaltrials.gov/show/NCT04332107,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1277,NCT04332380,ClinicalTrials.gov,30/03/2020,01/05/2020,FALSE,Del Rosario University,Not Recruiting,Phase 2,Interventional,Colombia,Convalescent Plasma for Patients With COVID-19: A Pilot Study,ATMP,Plasma,10,31/08/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04332380,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1278,NCT04332835,ClinicalTrials.gov,31/03/2020,01/05/2020,FALSE,Del Rosario University,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,"Convalescent Plasma for Patients With COVID-19: A Randomized, Open Label, Parallel, Controlled Clinical Study",ATMP (+ Drug),Combination: Plasma + Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Azithromycin,80,31/08/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04332835,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1279,NCT04333589,ClinicalTrials.gov,01/04/2020,01/04/2020,FALSE,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,Drug,Favipiravir,210,01/06/2020,15/09/2020,https://clinicaltrials.gov/show/NCT04333589,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1280,NCT04334629,ClinicalTrials.gov,02/04/2020,27/04/2020,FALSE,King's College London,Not Recruiting,Phase 4,Interventional,No Country Given,LIBERATE Trial in COVID-19,Drug,Ibuprofen,230,26/08/2020,26/11/2020,https://clinicaltrials.gov/show/NCT04334629,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1281,NCT04324463,ClinicalTrials.gov,25/03/2020,21/04/2020,FALSE,Population Health Research Institute,Recruiting,Phase 3,Interventional,Canada,Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,Drug,Combination: Chloroquine + azithromycin,1500,30/09/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04324463,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1282,NCT04325646,ClinicalTrials.gov,26/03/2020,13/03/2020,TRUE,Institut Pasteur,Recruiting,Not Applicable,Observational,France,Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France,Clinical Presentation (Epidemiology),No Intervention,1000,28/02/2021,28/02/2023,https://clinicaltrials.gov/show/NCT04325646,Pre-Print Article,23/04/2020,https://doi.org/10.1101/2020.04.18.20071134,04/05/2020,04/01/2020,None
1283,NCT04334928,ClinicalTrials.gov,02/04/2020,15/04/2020,FALSE,Plan Nacional sobre el Sida (PNS),Recruiting,Phase 3,Interventional,Spain,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,Drug,Combination: Emtricitabine/tenofovir disoproxil + hydroxychloroquine vs. hydroxychloroquine vs. Emtricitabine/tenofovir disoproxil,4000,30/06/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04334928,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1284,NCT04335084,ClinicalTrials.gov,02/04/2020,01/04/2020,TRUE,ProgenaBiome,Not Recruiting,Phase 2,Interventional,United States,"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",Drug,Combination: Hydroxychloroquine + vitamin C + vitamin D + zinc,600,01/04/2021,01/07/2021,https://clinicaltrials.gov/show/NCT04335084,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1285,NCT04332991,ClinicalTrials.gov,31/03/2020,02/04/2020,FALSE,Massachusetts General Hospital,Recruiting,Phase 3,Interventional,United States,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,Drug,Hydroxychloroquine,510,01/04/2021,01/07/2021,https://clinicaltrials.gov/show/NCT04332991,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1286,NCT04334980,ClinicalTrials.gov,31/03/2020,30/04/2020,FALSE,Symvivo Corporation,Not Recruiting,Phase 1,Interventional,Canada,"Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",ATMP,Vaccine,84,31/08/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04334980,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1287,NCT04335123,ClinicalTrials.gov,31/03/2020,25/03/2020,TRUE,University of Kansas Medical Center,Recruiting,Phase 1,Interventional,United States,Study of Open Label Losartan in COVID-19,Drug,ARB (Losartan),50,01/09/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04335123,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1288,NCT04335279,ClinicalTrials.gov,01/04/2020,09/04/2020,FALSE,Lady Davis Institute,Recruiting,Not Applicable,Interventional,Canada,Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program,Other (psych),Psychological,195,03/06/2020,03/06/2020,https://clinicaltrials.gov/show/NCT04335279,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1289,NCT04326920,ClinicalTrials.gov,24/03/2020,24/03/2020,FALSE,"University Hospital, Ghent",Recruiting,Phase 4,Interventional,"Belgium, Italy",Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),Drug,Sargramostim,80,31/10/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04326920,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1290,NCT04327388,ClinicalTrials.gov,26/03/2020,29/03/2020,TRUE,Sanofi,Recruiting,Phase 2/Phase 3,Interventional,"Germany, Italy, Israel, Canada, France, Japan, Russian Federation, Spain",Sarilumab COVID-19,Drug,Sarilumab,300,01/07/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04327388,No Results,No Results,No Results,04/05/2020,04/07/2020,EUCTR2020-001162-12
1291,IRCT20180923041093N3,IRCT,28/03/2020,02/04/2020,FALSE,Kerman University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy of the myrtle syrup in the treatment of novel corona,Traditional Medicine (Drug),Traditional Medicine,100,Not Available,Not Available,http://en.irct.ir/trial/46721,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1292,NCT04335032,ClinicalTrials.gov,01/04/2020,13/04/2020,FALSE,S.L.A. Pharma AG,Not Recruiting,Phase 3,Interventional,No Country Given,EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2),Drug,Eicosapentaenoic acid,240,13/07/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04335032,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1293,NCT04335071,ClinicalTrials.gov,02/04/2020,26/04/2020,FALSE,"University Hospital, Bern",Recruiting,Phase 2,Interventional,Switzerland,Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19),Drug,Tocilizumab,100,01/10/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04335071,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1294,NCT04331795,ClinicalTrials.gov,01/04/2020,04/04/2020,FALSE,University of Chicago,Recruiting,Phase 2,Interventional,United States,"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",Drug,Tocilizumab,50,01/07/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04331795,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1295,NCT04331899,ClinicalTrials.gov,27/03/2020,24/04/2020,FALSE,Stanford University,Recruiting,Phase 2,Interventional,United States,Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19,Drug,Interferon lambda,120,31/05/2021,31/05/2022,https://clinicaltrials.gov/show/NCT04331899,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1296,NCT04336345,ClinicalTrials.gov,02/04/2020,01/04/2020,TRUE,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Not Applicable,Observational,Mexico,Outcomes of Patients With COVID-19 in the Intensive Care Unit,Clinical Presentation,No Intervention,150,30/04/2020,30/05/2020,https://clinicaltrials.gov/show/NCT04336345,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1297,NCT04338009,ClinicalTrials.gov,01/04/2020,31/03/2020,TRUE,University of Pennsylvania,Recruiting,Not Applicable,Interventional,United States,Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019,Drug,ACE inhibitors or ARBs,152,31/12/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04338009,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1298,NCT04337008,ClinicalTrials.gov,03/04/2020,03/04/2020,FALSE,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Renin Angiotensin System - CoronaVirus,Clinical Presentation,No Intervention,50,03/06/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04337008,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1299,NCT04339712,ClinicalTrials.gov,01/04/2020,02/04/2020,TRUE,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,Drug,Anakinra or Tocilizumab,40,01/04/2022,01/04/2022,https://clinicaltrials.gov/show/NCT04339712,No Results,No Results,No Results,04/05/2020,15/04/2020,EUCTR2020-001039-29
1300,NCT04333654,ClinicalTrials.gov,01/04/2020,12/04/2020,FALSE,Sanofi,Recruiting,Phase 1,Interventional,"France, United States, Netherlands",Hydroxychloroquine in Outpatient Adults With COVID-19,Drug,Hydroxychloroquine,210,01/05/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04333654,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1301,NCT04334291,ClinicalTrials.gov,01/04/2020,23/03/2020,TRUE,Iván J. Núñez Gil,Recruiting,Not Applicable,Observational,Spain,"International COVID19 Clinical Evaluation Registry,",Clinical Presentation,No Intervention,6000,01/05/2020,05/05/2020,https://clinicaltrials.gov/show/NCT04334291,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1302,NCT04342689,ClinicalTrials.gov,08/04/2020,01/05/2020,FALSE,Yale University,Not Recruiting,Phase 3,Interventional,No Country Given,The Role of Resistant Starch in COVID-19 Infection,Supplement,Resistant Potato Starch,1500,01/05/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04342689,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1303,NCT04342884,ClinicalTrials.gov,08/04/2020,08/04/2020,FALSE,Wake Forest University,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Community Research Partnership,Clinical Presentation,No Intervention,150000,01/12/2021,01/12/2021,https://clinicaltrials.gov/show/NCT04342884,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1304,NCT04335097,ClinicalTrials.gov,01/04/2020,22/04/2020,FALSE,Lars Wik,Recruiting,Not Applicable,Interventional,Norway,Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation,Other (device),Biosensors,214,08/04/2021,20/12/2025,https://clinicaltrials.gov/show/NCT04335097,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1305,NCT04335162,ClinicalTrials.gov,03/04/2020,28/02/2020,TRUE,CHU de Nice,Recruiting,Not Applicable,Observational,France,Cardiovascular Complications and COVID-19 (CovCardioVasc),Clinical Presentation,No Intervention,100,28/08/2020,28/08/2020,https://clinicaltrials.gov/show/NCT04335162,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1306,IRCT20200325046860N1,IRCT,30/03/2020,15/03/2020,TRUE,Darmanara Co.,Recruiting,Not Applicable,Interventional,Iran,Convalescent Plasma therapy for COVID-19 Patients,ATMP,Plasma,200,Not Available,Not Available,http://en.irct.ir/trial/46759,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1307,NCT04339790,ClinicalTrials.gov,08/04/2020,06/05/2020,FALSE,National Institute of Mental Health (NIMH),Recruiting,Not Applicable,Observational,United States,Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers,Other (psych),No Intervention,5000,01/03/2022,01/04/2022,https://clinicaltrials.gov/show/NCT04339790,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1308,NCT04341688,ClinicalTrials.gov,06/04/2020,01/07/2020,FALSE,Aga Khan University,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients,Drug,Mouthwash,50,31/12/2020,31/03/2021,https://clinicaltrials.gov/show/NCT04341688,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1309,NCT04344184,ClinicalTrials.gov,09/04/2020,01/06/2020,FALSE,Virginia Commonwealth University,Not Recruiting,Phase 2,Interventional,United States,Early Infusion of Vitamin C for Treatment of Novel COVID-19 Acute Lung Injury (EVICT-CORONA-ALI),Drug,Vitamin C,200,01/05/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04344184,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1310,NCT04344249,ClinicalTrials.gov,08/04/2020,10/04/2020,FALSE,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic,Clinical Presentation,No Intervention,850,30/09/2020,01/09/2021,https://clinicaltrials.gov/show/NCT04344249,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1311,NCT04342182,ClinicalTrials.gov,31/03/2020,08/04/2020,FALSE,Erasmus Medical Center,Recruiting,Phase 2/Phase 3,Interventional,Netherlands,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),ATMP,Plasma,426,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04342182,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1312,NCT04343092,ClinicalTrials.gov,05/04/2020,18/04/2020,FALSE,University of Baghdad,Recruiting,Phase 1,Interventional,Iraq,Ivermectin Adjuvant to Hydroxychloroquin and Azithromycine in COVID19 Patients,Drug,Combination: Ivermectin + hydroxychloroquine vs. hydroxychloroquine,50,01/08/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04343092,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1313,NCT04336332,ClinicalTrials.gov,31/03/2020,01/04/2020,FALSE,Rutgers University,Recruiting,Phase 2,Interventional,United States,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,Drug,Combination: Hydroxychloroquine + azithromycin vs. hydroxychloroquine,160,30/04/2021,30/04/2021,https://clinicaltrials.gov/show/NCT04336332,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1314,NCT04336410,ClinicalTrials.gov,03/04/2020,03/04/2020,FALSE,Inovio Pharmaceuticals,Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers",Drug,INO-4800,40,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04336410,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1315,IRCT20170611034452N11,IRCT,31/03/2020,30/03/2020,TRUE,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the effectiveness of psychological interventions on mental health,Other (psych),Psychological,60,Not Available,Not Available,http://en.irct.ir/trial/46803,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1316,NCT04344327,ClinicalTrials.gov,09/04/2020,10/04/2020,FALSE,French Cardiology Society,Not Recruiting,Not Applicable,Observational,France,Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF,Clinical Presentation,No Intervention,2878,21/04/2020,21/04/2020,https://clinicaltrials.gov/show/NCT04344327,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1317,NCT04345861,ClinicalTrials.gov,05/04/2020,11/04/2020,FALSE,"University Hospital, Montpellier",Recruiting,Phase 2/Phase 3,Interventional,France,Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial),Drug,Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,150,06/09/2020,06/04/2021,https://clinicaltrials.gov/show/NCT04345861,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1318,NCT04343729,ClinicalTrials.gov,09/04/2020,18/04/2020,FALSE,Fundao de Medicina Tropical Dr. Heitor Vieira Dourado,Recruiting,Phase 2,Interventional,Brazil,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,Drug,Corticosteroids,420,01/09/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04343729,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1319,NCT04343976,ClinicalTrials.gov,09/04/2020,15/05/2020,FALSE,Raymond Chung,Not Recruiting,Phase 2,Interventional,United States,Pegylated Interferon Lambda Treatment for COVID-19,Drug,Interferon lambda,20,01/10/2020,31/12/2021,https://clinicaltrials.gov/show/NCT04343976,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1320,IRCT20190917044805N2,IRCT,31/03/2020,03/04/2020,FALSE,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of High-dose Vitamin C on COVID-19,Drug,Vitamin C,60,Not Available,Not Available,http://en.irct.ir/trial/46804,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1321,NCT04337918,ClinicalTrials.gov,06/04/2020,27/04/2020,FALSE,Sanotize Research and Development corp.,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,Drug,Nitric oxide,200,31/07/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04337918,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1322,NCT04341675,ClinicalTrials.gov,05/04/2020,24/04/2020,FALSE,University of Cincinnati,Recruiting,Phase 2,Interventional,United States,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia,Drug,Sirolimus,30,01/07/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04341675,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1323,IRCT20120225009124N4,IRCT,02/04/2020,18/04/2020,FALSE,Gorgan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Efficacy of dexamethasone, IV-IG and Interferone beta for treatment of patients with severe COVID-19",Drug (+ ATMP),"Intreventional: Dexamethason + Immunoglobulin vs. Dexamethason + Immunoglobulin + interferon beta

All Arms: Hydroxychloroquine + antiviral ",105,Not Available,Not Available,http://en.irct.ir/trial/46810,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1324,NCT04347681,ClinicalTrials.gov,08/04/2020,12/04/2020,FALSE,King Fahad Specialist Hospital,Recruiting,Phase 2,Interventional,Saudi Arabia,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,ATMP,Plasma,40,31/12/2020,11/04/2021,https://clinicaltrials.gov/show/NCT04347681,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1325,NCT04347694,ClinicalTrials.gov,12/04/2020,11/04/2020,TRUE,Medical University of Vienna,Recruiting,Not Applicable,Observational,Austria,Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.,Clinical Presentation,No Intervention,400,11/04/2021,11/04/2021,https://clinicaltrials.gov/show/NCT04347694,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1326,NCT04342897,ClinicalTrials.gov,10/04/2020,20/04/2020,FALSE,Eli Lilly and Company,Recruiting,Phase 2,Interventional,United States,A Study of LY3127804 in Participants With COVID-19,Drug,LY3127804,200,12/06/2020,16/07/2020,https://clinicaltrials.gov/show/NCT04342897,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1327,NCT04343261,ClinicalTrials.gov,08/04/2020,10/04/2020,FALSE,Saint Francis Care,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma in the Treatment of COVID 19,ATMP,Plasma,15,01/12/2020,01/04/2021,https://clinicaltrials.gov/show/NCT04343261,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1328,NCT04344431,ClinicalTrials.gov,09/04/2020,14/04/2020,FALSE,Direction Centrale du Service de Sant des Armes,Recruiting,Phase 2/Phase 3,Interventional,France,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),Drug,Oxygen,100,01/04/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04344431,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1329,NCT04345614,ClinicalTrials.gov,07/04/2020,08/04/2020,FALSE,"CalciMedica, Inc.",Recruiting,Phase 2,Interventional,United States,A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia,Drug,CM4620-Injectable Emulsion,120,01/07/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04345614,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1330,IRCT20200325046859N1,IRCT,02/04/2020,04/04/2020,FALSE,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The efficacy of intravenous immunoglobulin (IVIg) in patients with severe COVID-19 who have not responded to standard three-drug protocol,ATMP,Plasma,50,Not Available,Not Available,http://en.irct.ir/trial/46811,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1331,IRCT20081019001369N2,IRCT,07/04/2020,20/04/2020,FALSE,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of berberine on COVID-19,Traditional Medicine (Drug),Traditional Medicine,40,Not Available,Not Available,http://en.irct.ir/trial/46868,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1332,NCT04345848,ClinicalTrials.gov,07/04/2020,28/04/2020,FALSE,"University Hospital, Geneva",Recruiting,Phase 3,Interventional,Switzerland,Preventing COVID-19 Complications With Low- and High-dose Anticoagulation,Drug,Enoxaparin,200,30/11/2020,30/11/2020,https://clinicaltrials.gov/show/NCT04345848,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1333,NCT04346446,ClinicalTrials.gov,14/04/2020,21/04/2020,FALSE,"Institute of Liver and Biliary Sciences, India",Recruiting,Phase 2,Interventional,India,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients,ATMP,Plasma,20,30/06/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04346446,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1334,NCT04343898,ClinicalTrials.gov,09/04/2020,01/04/2020,TRUE,Brigham and Women's Hospital,Recruiting,Not Applicable,Observational,United States,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,2000,15/06/2020,01/06/2022,https://clinicaltrials.gov/show/NCT04343898,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1335,NCT04344457,ClinicalTrials.gov,08/04/2020,16/04/2020,FALSE,"Perseverance Research Center, LLC",Recruiting,Phase 1/Phase 2,Interventional,United States,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",Drug,Combination: Hydroxychloroquine + Indomethacin + Azithromycin,80,20/06/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04344457,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1336,IRCT20200404046934N1,IRCT,13/04/2020,10/03/2020,TRUE,Qom University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Investigation of the effect of Zufa syrup on clinical symptoms in the with suspected Corona (COVID-19),Traditional Medicine (Drug),Traditional Medicine,130,Not Available,Not Available,http://en.irct.ir/trial/46913,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1337,IRCT20200405046960N1,IRCT,08/04/2020,09/04/2020,FALSE,Ardabil University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,Traditional Medicine (Drug),Traditional Medicine,15,Not Available,Not Available,http://en.irct.ir/trial/46961,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1338,NCT04347226,ClinicalTrials.gov,02/04/2020,16/04/2020,FALSE,Matthew Dallos,Recruiting,Phase 2,Interventional,United States,Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19,Drug,Anti-Interleukin-8,138,01/09/2021,01/09/2022,https://clinicaltrials.gov/show/NCT04347226,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1339,NCT04347993,ClinicalTrials.gov,13/04/2020,27/03/2020,TRUE,Hackensack Meridian Health,Recruiting,Not Applicable,Observational,United States,"A Prospective ""Universal"" Observational Database for COVID-19",Clinical Presentation,No Intervention,5000,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04347993,Pre-Print Article,29/04/2020,https://doi.org/10.1101/2020.04.24.20077388,04/05/2020,22/04/2020,None
1340,NCT04347824,ClinicalTrials.gov,09/04/2020,27/04/2020,FALSE,"University Hospital, Göttingen",Recruiting,Not Applicable,Observational,Germany,Predict Adverse Events by Covid-19 Nephritis,Clinical Presentation,No Intervention,100,31/12/2020,31/12/2021,https://clinicaltrials.gov/show/NCT04347824,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1341,NCT04348942,ClinicalTrials.gov,13/04/2020,20/04/2020,FALSE,ObvioHealth,Not Recruiting,Not Applicable,Observational,No Country Given,"A COVID-19 Symptom, Exposure and Immune Response Registry",Clinical Presentation,No Intervention,10000,01/05/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04348942,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1342,NCT04350476,ClinicalTrials.gov,14/04/2020,01/04/2020,TRUE,Vivek Reddy,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Remote Monitoring,Clinical Presentation,No Intervention,1000,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04350476,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1343,NCT04345601,ClinicalTrials.gov,10/04/2020,01/05/2020,FALSE,Baylor University,Not Recruiting,Phase 1,Interventional,United States,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),ATMP,Cells (mesenchymal),30,01/02/2022,01/02/2022,https://clinicaltrials.gov/show/NCT04345601,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1344,NCT04345679,ClinicalTrials.gov,11/04/2020,14/04/2020,FALSE,Orthosera Kft.,Not Recruiting,Phase 1,Interventional,No Country Given,Anti COVID-19 Convalescent Plasma Therapy,ATMP,Plasma,20,01/06/2020,01/04/2021,https://clinicaltrials.gov/show/NCT04345679,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1345,IRCT20200318046812N2,IRCT,08/04/2020,10/04/2020,FALSE,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,evaluation of Safety and efficacy of anti inflammatory regimens in COVID-19,Drug,Combination: Prednisolone + naproxen + azithromycin + hydroxychloroquine vs. naproxen + azithromycin + hydroxychloroquine vs. hydroxychloroquine + Lopinavit/ritonavir,906,Not Available,Not Available,http://en.irct.ir/trial/46968,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1346,NCT04348305,ClinicalTrials.gov,11/04/2020,17/04/2020,FALSE,Scandinavian Critical Care Trials Group,Recruiting,Phase 3,Interventional,Denmark,Hydrocortisone for COVID-19 and Severe Hypoxia,Drug,Hydrocortisone,1000,30/03/2021,30/12/2021,https://clinicaltrials.gov/show/NCT04348305,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1347,NCT04350320,ClinicalTrials.gov,14/04/2020,20/04/2020,FALSE,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Not Recruiting,Phase 3,Interventional,No Country Given,Trial to Study the Benefit of Colchicine in Patients With COVID-19,Drug,Colchicine,102,20/10/2020,20/11/2020,https://clinicaltrials.gov/show/NCT04350320,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1348,NCT04346212,ClinicalTrials.gov,10/04/2020,14/04/2020,FALSE,Hospital de Matar,Recruiting,Not Applicable,Observational,Spain,Oropharyngeal Dysphagia in Patients With COVID-19,Diagnostics,Diagnostic Test or Assessment,100,01/07/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04346212,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1349,NCT04346615,ClinicalTrials.gov,09/04/2020,01/04/2020,TRUE,"Biohaven Pharmaceuticals, Inc.",Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy Trial of Vazegepant Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen,Drug,Vazegepant,120,01/07/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04346615,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1350,IRCT20200317046797N4,IRCT,14/04/2020,18/04/2020,FALSE,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Bromhexine Hydrochloride on patients with COVID-19,Drug,Bromhexine,60,Not Available,Not Available,http://en.irct.ir/trial/46969,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1351,NCT04350580,ClinicalTrials.gov,08/04/2020,11/04/2020,TRUE,Centre Hospitalier St Anne,Recruiting,Phase 3,Interventional,France,Polyvalent Immunoglobulin in COVID-19 Related ARds,ATMP,Immunoglobulin,138,01/06/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04350580,No Results,No Results,No Results,04/05/2020,22/04/2020,EUCTR2020-001570-30
1352,NCT04350736,ClinicalTrials.gov,14/04/2020,23/04/2020,FALSE,Theravance Biopharma,Recruiting,Phase 1,Interventional,United Kingdom,"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19",Drug,TD-0903,54,01/06/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04350736,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1353,IRCT20200401046909N2,IRCT,11/04/2020,14/04/2020,FALSE,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy of oral 25-hydroxyvitamin D3 on COVID-19,Drug,Calcifediol,540,Not Available,Not Available,http://en.irct.ir/trial/47010,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1354,NCT04347239,ClinicalTrials.gov,13/04/2020,15/04/2020,FALSE,"CytoDyn, Inc.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19),Drug,Leronlimab,390,31/12/2020,01/04/2021,https://clinicaltrials.gov/show/NCT04347239,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1355,NCT04347512,ClinicalTrials.gov,11/04/2020,01/05/2020,FALSE,"University Hospital, Strasbourg",Not Recruiting,Phase 3,Interventional,No Country Given,EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA,Drug,Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,405,01/08/2021,01/08/2021,https://clinicaltrials.gov/show/NCT04347512,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1356,NCT04351516,ClinicalTrials.gov,15/04/2020,21/04/2020,FALSE,"University Hospital, Tübingen",Recruiting,Phase 2/Phase 3,Interventional,Germany,Test and Treat COVID 65plus+,Drug,Hydroxychloroquine,350,31/12/2020,01/05/2021,https://clinicaltrials.gov/show/NCT04351516,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1357,NCT04351724,ClinicalTrials.gov,10/04/2020,16/04/2020,TRUE,Medical University of Vienna,Recruiting,Phase 2/Phase 3,Interventional,Austria,Austrian CoronaVirus Adaptive Clinical Trial (COVID-19),Drug,"Chloroquine or Hydroxychloroquine vs. lopinavir/ritonavir

Substudies: Rovaroxaban, Clazakizumab, Candesartan",500,01/12/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04351724,No Results,No Results,No Results,04/05/2020,22/04/2020,EUCTR2020-001302-30
1358,IRCT20180129038542N1,IRCT,13/04/2020,06/04/2020,TRUE,The University of Baqiyatallah,Not Recruiting,Not Applicable,Interventional,Iran,Early tracheostomy in COVID-19,Other (physical),Mechanical ventilation,30,Not Available,13/04/2020,http://en.irct.ir/trial/47013,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1359,NCT04351854,ClinicalTrials.gov,16/04/2020,20/04/2020,FALSE,University of Cologne,Not Recruiting,Not Applicable,Observational,Germany,Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room,Clinical Presentation,No Intervention,500,31/12/2025,31/08/2026,https://clinicaltrials.gov/show/NCT04351854,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1360,NCT04351906,ClinicalTrials.gov,09/04/2020,01/04/2020,TRUE,University of Giessen,Not Recruiting,Not Applicable,Interventional,Germany,Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome,Other (device),ECCO2R,20,01/07/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04351906,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1361,IRCT20200317046797N3,IRCT,11/04/2020,20/04/2020,FALSE,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Intravenous immunoglobulin (IVIG) in the treatment of COVID-19-induced cytokine storm,ATMP,"Interventional: Immunoglobulin

Both Arms: hydroxychloroquine + ribavirin + lopinavir/ritonavir",100,Not Available,Not Available,http://en.irct.ir/trial/47014,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1362,NCT04347954,ClinicalTrials.gov,13/04/2020,01/05/2020,FALSE,Stanford University,Not Recruiting,Phase 1/Phase 2,Interventional,United States,PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19),Drug,Povidone-iodine,45,01/07/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04347954,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1363,NCT04348240,ClinicalTrials.gov,15/04/2020,16/04/2020,FALSE,National Institute of Dental and Craniofacial Research (NIDCR),Recruiting,Not Applicable,Observational,United States,Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions,Clinical Presentation,No Intervention,60,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04348240,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1364,IRCT20200408046990N1,IRCT,18/04/2020,19/05/2020,FALSE,Mashhad University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of SinaCurcumin capsule efficacy as an supplement therapy for mild to moderate COVID-19 in Mashhad,Traditional Medicine (Drug),Traditional Medicine,60,Not Available,Not Available,http://en.irct.ir/trial/47061,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1365,NCT04352348,ClinicalTrials.gov,31/03/2020,31/03/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being,Prognosis,No Intervention,2000,31/05/2021,31/03/2022,https://clinicaltrials.gov/show/NCT04352348,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1366,NCT04352491,ClinicalTrials.gov,14/04/2020,22/04/2020,FALSE,"Institute of Liver and Biliary Sciences, India",Recruiting,Not Applicable,Observational,India,An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease,Other (psych),No Intervention,1500,30/04/2020,30/04/2020,https://clinicaltrials.gov/show/NCT04352491,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1367,NCT04348656,ClinicalTrials.gov,13/04/2020,27/04/2020,FALSE,Hamilton Health Sciences Corporation,Not Recruiting,Phase 3,Interventional,Canada,CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1),ATMP,Plasma,1200,31/10/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04348656,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1368,NCT04348929,ClinicalTrials.gov,10/04/2020,16/04/2020,FALSE,CHU de Nancy,Recruiting,Not Applicable,Interventional,France,Birth Experience During COVID-19 Confinement,Clinical Presentation,No Intervention,600,16/08/2021,01/11/2021,https://clinicaltrials.gov/show/NCT04348929,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1369,NCT04352751,ClinicalTrials.gov,16/04/2020,01/04/2020,TRUE,Hilton Pharma,Not Recruiting,Not Applicable,Interventional,Pakistan,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020,ATMP,Plasma,2000,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04352751,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1370,NCT04352764,ClinicalTrials.gov,16/04/2020,27/03/2020,TRUE,Texas Cardiac Arrhythmia Research Foundation,Recruiting,Not Applicable,Observational,United States,ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings,Diagnostics,Diagnostic Test or Assessment,5000,31/12/2020,31/01/2021,https://clinicaltrials.gov/show/NCT04352764,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1371,NCT04352608,ClinicalTrials.gov,14/04/2020,16/04/2020,FALSE,"Sinovac Research and Development Co., Ltd.",Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19),ATMP,Vaccine,744,13/08/2020,13/12/2020,https://clinicaltrials.gov/show/NCT04352608,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1372,NCT04353583,ClinicalTrials.gov,06/04/2020,01/04/2020,TRUE,University of Giessen,Not Recruiting,Not Applicable,Observational,Germany,Renal Outcome in Patients With COVID-19,Clinical Presentation,No Intervention,40,01/08/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04353583,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1373,IRCT20200217046526N2,IRCT,13/04/2020,05/04/2020,TRUE,Iranian Academic Center for Education Culture and Research,Recruiting,Phase 2/Phase 3,Interventional,Iran,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection,ATMP,Cells (mesenchymal),60,Not Available,Not Available,http://en.irct.ir/trial/47073,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1374,NCT04352946,ClinicalTrials.gov,16/04/2020,24/04/2020,FALSE,GeoSentinel Foundation,Not Recruiting,Phase 3,Interventional,United States,HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,374,24/06/2020,24/08/2020,https://clinicaltrials.gov/show/NCT04352946,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1375,NCT04353674,ClinicalTrials.gov,07/04/2020,28/04/2020,FALSE,Lawson Health Research Institute,Not Recruiting,Phase 1,Interventional,No Country Given,Modulation of Hyperinflammation in COVID-19,Other (device),Dialysis,40,28/07/2020,01/01/2021,https://clinicaltrials.gov/show/NCT04353674,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1376,NCT04349202,ClinicalTrials.gov,13/04/2020,10/04/2020,TRUE,William Beaumont Hospitals,Recruiting,Not Applicable,Observational,United States,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,Clinical Presentation,No Intervention,50000,01/06/2021,01/06/2021,https://clinicaltrials.gov/show/NCT04349202,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1377,NCT04351581,ClinicalTrials.gov,14/04/2020,01/04/2020,FALSE,"Copenhagen University Hospital, Gentofte",Recruiting,Not Applicable,Interventional,Denmark,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19,Drug,ACE inhibitors or ARBs,215,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04351581,No Results,No Results,No Results,04/05/2020,22/04/2020,EUCTR2020-001544-26
1378,NCT04353609,ClinicalTrials.gov,15/04/2020,18/04/2020,FALSE,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,"Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases",Clinical Presentation,No Intervention,13770,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04353609,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1379,NCT04354701,ClinicalTrials.gov,16/04/2020,17/03/2020,TRUE,Vanderbilt-Ingram Cancer Center,Recruiting,Not Applicable,Observational,United States,COVID-19 and Cancer Consortium Registry,Clinical Presentation,No Intervention,1000,01/12/2021,01/12/2022,https://clinicaltrials.gov/show/NCT04354701,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1380,NCT04354519,ClinicalTrials.gov,06/04/2020,14/03/2020,TRUE,Swansea University,Recruiting,Not Applicable,Observational,United Kingdom,The United Kingdom Multiple Sclerosis Register Covid-19 Substudy,Clinical Presentation,No Intervention,3000,14/07/2021,14/07/2022,https://clinicaltrials.gov/show/NCT04354519,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1381,NCT04354610,ClinicalTrials.gov,14/04/2020,27/04/2020,FALSE,CHU de Nancy,Recruiting,Not Applicable,Interventional,France,Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection,Clinical Presentation,No Intervention,57,18/07/2020,18/10/2020,https://clinicaltrials.gov/show/NCT04354610,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1382,NCT04353037,ClinicalTrials.gov,09/04/2020,07/04/2020,TRUE,UnitedHealth Group,Recruiting,Phase 2,Interventional,United States,PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine,Drug,Hydroxychloroquine,850,01/04/2021,15/06/2021,https://clinicaltrials.gov/show/NCT04353037,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1383,NCT04353128,ClinicalTrials.gov,16/04/2020,01/04/2020,TRUE,Instituto de Investigación Hospital Universitario La Paz,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Drug (Chemoprophylaxis),Melatonin,450,01/04/2021,01/07/2021,https://clinicaltrials.gov/show/NCT04353128,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1384,NCT04354870,ClinicalTrials.gov,16/04/2020,03/04/2020,TRUE,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,COVID-19 PrEP HCW HCQ Study,Drug,Hydroxychloroquine,350,01/08/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04354870,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1385,NCT04355143,ClinicalTrials.gov,14/04/2020,25/04/2020,FALSE,"University of California, Los Angeles",Not Recruiting,Phase 2,Interventional,No Country Given,Colchicine to Reduce Myocardial Injury in COVID-19 (COLHEART-19),Drug,Colchicine,150,25/04/2021,25/04/2021,https://clinicaltrials.gov/show/NCT04355143,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1386,NCT04355338,ClinicalTrials.gov,17/04/2020,15/05/2020,FALSE,Butantan Institute,Not Recruiting,Not Applicable,Observational,No Country Given,Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA),Clinical Presentation (Epidemiology),No Intervention,4100,30/11/2020,15/05/2022,https://clinicaltrials.gov/show/NCT04355338,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1387,NCT04355364,ClinicalTrials.gov,15/04/2020,15/04/2020,FALSE,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Phase 3,Interventional,France,Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alpha Administration in Patients With COVID19-induced ARDS (COVIDORNASE),Drug,Dornase alfa,100,15/04/2020,15/08/2020,https://clinicaltrials.gov/show/NCT04355364,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1388,NCT04353518,ClinicalTrials.gov,16/04/2020,30/04/2020,FALSE,Cadila Pharnmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,Drug,Mycobacterium,4000,30/03/2021,30/05/2021,https://clinicaltrials.gov/show/NCT04353518,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1389,NCT04353596,ClinicalTrials.gov,14/04/2020,15/04/2020,FALSE,Medical University Innsbruck,Recruiting,Phase 4,Interventional,"Germany, Austria",Stopping ACE-inhibitors in COVID-19,Drug,ACE inhibitors or ARBs,208,15/05/2021,15/05/2022,https://clinicaltrials.gov/show/NCT04353596,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1390,NCT04355052,ClinicalTrials.gov,16/04/2020,11/04/2020,TRUE,Sheba Medical Center,Recruiting,Phase 3,Interventional,Israel,"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in SARS CoV 2 Virus",Drug,Combination: Camostat Mesilate + Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,250,11/10/2020,11/12/2020,https://clinicaltrials.gov/show/NCT04355052,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1391,NCT04355429,ClinicalTrials.gov,17/04/2020,05/05/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID),Drug,Captopril,230,01/07/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04355429,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1392,IRCT20200411047025N1,IRCT,14/04/2020,18/04/2020,FALSE,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Intravenous vitamin c in Patients with COVID-19,Drug,Combination: Vitamin C + Hydroxychloroquine + Atazanavir/ritonavir vs. Hydroxychloroquine + Atazanavir/ritonavir,110,Not Available,Not Available,http://en.irct.ir/trial/47078,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1393,NCT04355481,ClinicalTrials.gov,17/04/2020,17/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit,Clinical Presentation,No Intervention,150,17/10/2020,17/12/2020,https://clinicaltrials.gov/show/NCT04355481,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1394,NCT04355637,ClinicalTrials.gov,15/04/2020,21/04/2020,FALSE,Sara Varea,Recruiting,Phase 4,Interventional,Spain,Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia,Drug,Corticosteroids,300,31/08/2020,18/10/2020,https://clinicaltrials.gov/show/NCT04355637,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1395,NCT04355442,ClinicalTrials.gov,16/04/2020,01/04/2020,TRUE,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Evolution of Facial Trauma During COVID Containment Measures,Clinical Presentation,No Intervention,300,01/05/2020,30/05/2020,https://clinicaltrials.gov/show/NCT04355442,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1396,NCT04355715,ClinicalTrials.gov,17/04/2020,01/04/2019,TRUE,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia,Diagnostics,Diagnostic Test or Assessment,200,01/10/2020,20/10/2020,https://clinicaltrials.gov/show/NCT04355715,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1397,NCT04354389,ClinicalTrials.gov,15/04/2020,25/04/2020,FALSE,"Ansun Biopharma, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,Italy,DAS181 for STOP COVID-19,Drug,DAS181,82,30/06/2020,31/10/2020,https://clinicaltrials.gov/show/NCT04354389,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1398,NCT04354714,ClinicalTrials.gov,16/04/2020,30/06/2020,FALSE,Washington University in St. Louis,Not Recruiting,Phase 2,Interventional,United States,Ruxolitinib to Combat COVID-19,Drug,Ruxolitinib,25,31/07/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04354714,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1399,NCT04355884,ClinicalTrials.gov,19/04/2020,20/04/2020,FALSE,The University of Hong Kong,Not Recruiting,Not Applicable,Observational,Hong Kong,Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in Coronavirus Disease 2019 (COVID19) Survivors,Diagnostics,Diagnostic Test or Assessment,100,01/05/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04355884,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1400,NCT04356560,ClinicalTrials.gov,13/04/2020,23/03/2020,TRUE,"Rigshospitalet, Denmark",Recruiting,Not Applicable,Observational,Denmark,COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department,Diagnostics,Diagnostic Test or Assessment,300,30/09/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04356560,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1401,IRCT20200415047089N1,IRCT,19/04/2020,18/04/2020,TRUE,Saveh University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of herbal drugs (Echinacea and Ginger) on Improvement of clinical symptoms and hospitalizations in suspected COVID-19 outpatient cases,Traditional Medicine (Drug),Traditional Medicine,100,Not Available,Not Available,http://en.irct.ir/trial/47234,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1402,NCT04355728,ClinicalTrials.gov,13/04/2020,25/04/2020,FALSE,Camillo Ricordi,Recruiting,Phase 1/Phase 2,Interventional,United States,Use of UC-MSCs for COVID-19 Patients,ATMP,Cells (mesenchymal),24,31/12/2020,01/05/2021,https://clinicaltrials.gov/show/NCT04355728,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1403,NCT04355754,ClinicalTrials.gov,16/04/2020,15/04/2020,TRUE,Medical University of Gdańsk,Recruiting,Not Applicable,Interventional,Poland,Ventil Device Usefulness in Mechanically Ventilated ICU Patients,Other (physical),Mechanical ventilation,40,01/05/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04355754,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1404,NCT04355351,ClinicalTrials.gov,17/04/2020,22/04/2020,FALSE,CHU de Nice,Not Recruiting,Not Applicable,Interventional,France,Study of Immune Response During SARS-CoV-2 Infection - (COVID-19),Clinical Presentation,No Intervention,400,22/10/2020,22/10/2020,https://clinicaltrials.gov/show/NCT04355351,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1405,NCT04355507,ClinicalTrials.gov,17/04/2020,01/04/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Computed Tomography for COVID-19 Diagnosis,Diagnostics,Diagnostic Test or Assessment,10000,01/05/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04355507,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1406,IRCT20200415047092N1,IRCT,20/04/2020,24/04/2020,FALSE,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of azithromycin in treatment of COVID19,Drug,Combination: Azithromycin +  oseltamivir + lopinavir/ritonavir or atazanavir + hydroxychloroquine vs. Oseltamivir + lopinavir/ritonavir or atazanavir + hydroxychloroquine,110,Not Available,Not Available,http://en.irct.ir/trial/47244,No Results,No Results,No Results,21/04/2020,22/04/2020,None
1407,NCT04355793,ClinicalTrials.gov,18/04/2020,15/04/2020,TRUE,Incyte Corporation,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection,Drug,Ruxolitinib,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04355793,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1408,NCT04356677,ClinicalTrials.gov,20/04/2020,01/04/2020,TRUE,"Bausch Health Americas, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,Study to Evaluate the Safety and Efficacy of VIRAZOLE¬Æ in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,Drug,Ribavirin,50,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04356677,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1409,JPRN-JapicCTI-205238,JPRN,27/03/2020,31/03/2020,FALSE,"FUJIFILM Toyama Chemical Co., Ltd.",Recruiting,Phase 3,Interventional,Japan,Phase 3 Clinical Study of Favipiravir in Patients with COVID-19 Non-Severe Pneumonia,Drug,Favipiravir,96,Not Available,Not Available,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205238,No Results,No Results,No Results,20/04/2020,22/04/2020,None
1410,NCT04355702,ClinicalTrials.gov,17/04/2020,01/03/2020,TRUE,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Covid-19 in Lupus Patients,Clinical Presentation,No Intervention,130,01/05/2020,30/05/2020,https://clinicaltrials.gov/show/NCT04355702,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1411,NCT04356365,ClinicalTrials.gov,21/04/2020,31/03/2020,TRUE,University of Oslo,Not Recruiting,Not Applicable,Observational,Norway,The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's),Other (psych),No Intervention,10084,07/04/2020,07/04/2020,https://clinicaltrials.gov/show/NCT04356365,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1412,NCT04357041,ClinicalTrials.gov,17/04/2020,17/04/2020,FALSE,Illinois Institute of Technology,Recruiting,Not Applicable,Observational,United States,"COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being",Clinical Presentation,No Intervention,500,01/12/2020,01/04/2021,https://clinicaltrials.gov/show/NCT04357041,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1413,NCT04357431,ClinicalTrials.gov,21/04/2020,01/04/2020,TRUE,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Among Egyptian Health Care Providers,Other,No Intervention,600,01/05/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04357431,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1414,NCT04357613,ClinicalTrials.gov,20/04/2020,01/05/2020,FALSE,Versailles Hospital,Not Recruiting,Phase 2,Interventional,France,IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.,Drug,Imatinib,99,01/11/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04357613,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1415,JPRN-jRCTs031190226,JPRN,27/02/2020,14/03/2020,FALSE,Tokue Yutaka,Recruiting,Phase 2,Interventional,Japan,Favipiravir in patients infected with COVID-19,Drug,Favipiravir,50,Not Available,Not Available,https://jrct.niph.go.jp/latest-detail/jRCTs031190226,No Results,No Results,No Results,20/04/2020,25/03/2020,None
1416,NCT04356586,ClinicalTrials.gov,17/04/2020,30/04/2020,FALSE,Sciensano,Recruiting,Not Applicable,Observational,Belgium,Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms,Clinical Presentation,No Intervention,300,30/07/2020,30/07/2020,https://clinicaltrials.gov/show/NCT04356586,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1417,NCT04356690,ClinicalTrials.gov,17/04/2020,01/04/2020,TRUE,Boston Medical Center,Not Recruiting,Phase 2,Interventional,No Country Given,Etoposide in Patients With COVID-19 Infection,Drug,Etoposide,134,01/12/2020,01/12/2021,https://clinicaltrials.gov/show/NCT04356690,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1418,NCT04357990,ClinicalTrials.gov,20/04/2020,01/04/2020,TRUE,Kerecis Ltd.,Not Recruiting,Not Applicable,Interventional,No Country Given,Kerecis Oral and Nasal Spray for Treating the Symptoms of COVID-19,Drug,Omega 3,81,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04357990,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1419,NCT04358549,ClinicalTrials.gov,16/04/2020,17/04/2020,FALSE,"Fujifilm Pharmaceuticals U.S.A., Inc.",Recruiting,Phase 2,Interventional,United States,Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19,Drug,Favipiravir,50,01/08/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04358549,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1420,NCT04356885,ClinicalTrials.gov,19/04/2020,01/04/2020,TRUE,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,COVID-19 and Psychotic Symptoms in France,Clinical Presentation,No Intervention,600,30/07/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04356885,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1421,NCT04357028,ClinicalTrials.gov,19/04/2020,01/05/2020,FALSE,Kasr El Aini Hospital,Not Recruiting,Phase 3,Interventional,Egypt,Measles Vaccine in HCW,ATMP,Vaccine,200,01/10/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04357028,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1422,JPRN-jRCTs031190227,JPRN,27/02/2020,01/04/2020,FALSE,Tokue Yutaka,Recruiting,Phase 2,Interventional,Japan,Triple combination therapy in patients infected with COVID-19,Drug,Combination: Lopinavir/ritonavir + hydroxychloroquine (w/ and w/o oseltamivir),50,Not Available,Not Available,https://jrct.niph.go.jp/latest-detail/jRCTs031190227,No Results,No Results,No Results,20/04/2020,25/03/2020,None
1423,NCT04356950,ClinicalTrials.gov,16/04/2020,01/04/2020,TRUE,CHU de Nimes,Not Recruiting,Not Applicable,Observational,France,Analysis of the Coagulopathy Developed by COVID-19 Infected Patients,Clinical Presentation,No Intervention,175,01/10/2020,01/01/2021,https://clinicaltrials.gov/show/NCT04356950,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1424,NCT04357457,ClinicalTrials.gov,20/04/2020,01/04/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 3,Interventional,France,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia,Drug,Almitrine,212,01/06/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04357457,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1425,NCT04358640,ClinicalTrials.gov,21/04/2020,09/04/2020,TRUE,CHU de Nimes,Recruiting,Not Applicable,Observational,France,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey,Other (psych),No Intervention,2000,22/04/2020,22/04/2020,https://clinicaltrials.gov/show/NCT04358640,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1426,NCT04358783,ClinicalTrials.gov,21/04/2020,27/04/2020,FALSE,Hospital Universitario Dr. Jose E. Gonzalez,Not Recruiting,Phase 2,Interventional,Mexico,Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia,ATMP,Plasma,30,01/02/2021,30/05/2021,https://clinicaltrials.gov/show/NCT04358783,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1427,NCT04357418,ClinicalTrials.gov,16/04/2020,01/04/2020,TRUE,Centre Hospitalier de Ville-Evrard,Not Recruiting,Not Applicable,Observational,France,Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives,Other (psych),No Intervention,1320,30/06/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04357418,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1428,NCT04357535,ClinicalTrials.gov,19/04/2020,12/04/2020,TRUE,Hakeam Abdulaziz Hakeam,Recruiting,Not Applicable,Observational,Saudi Arabia,Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives,Drug,ACE inhibitors or ARBs,226,03/05/2020,03/05/2020,https://clinicaltrials.gov/show/NCT04357535,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1429,JPRN-UMIN000039986,JPRN,31/03/2020,28/03/2020,TRUE,Yokohama City University,Not Recruiting,Not Applicable,Other,Japan,Risk factors of death from coronavirus disease 2019,Prognosis,No Intervention,Not Available,Not Available,28/03/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045582,No Results,No Results,No Results,20/04/2020,22/04/2020,None
1430,NCT04357496,ClinicalTrials.gov,20/04/2020,20/04/2020,FALSE,Centogene,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Epidemic Response Study,Clinical Presentation,No Intervention,400,30/10/2020,30/10/2020,https://clinicaltrials.gov/show/NCT04357496,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1431,NCT04357730,ClinicalTrials.gov,18/04/2020,01/04/2020,TRUE,Denver Health and Hospital Authority,Not Recruiting,Phase 2,Interventional,No Country Given,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection: A Phase 2a Clinical Trial,Drug,Alteplase,60,01/08/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04357730,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1432,JPRN-UMIN000040185,JPRN,17/04/2020,17/04/2020,FALSE,Keio University School of Medicine,Recruiting,Not Applicable,Observational,Japan,Multicenter prospective cohort study evaluating outcome of COVID-19 in patients with hepatobiliary-pancreatic disease,Clinical Presentation,No Intervention,600,Not Available,17/04/2020,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045820,No Results,No Results,No Results,20/04/2020,22/04/2020,None
1433,NCT04357639,ClinicalTrials.gov,20/04/2020,30/04/2020,FALSE,Centre Hospitalier Intercommunal Creteil,Not Recruiting,Not Applicable,Observational,France,Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ),Clinical Presentation,No Intervention,794,31/05/2020,31/10/2020,https://clinicaltrials.gov/show/NCT04357639,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1434,NCT04357782,ClinicalTrials.gov,17/04/2020,16/04/2020,TRUE,Veteran Affairs Medical Center,Recruiting,Phase 1/Phase 2,Interventional,United States,Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation,Drug,Vitamin C,20,01/06/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04357782,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1435,NCT04359225,ClinicalTrials.gov,16/04/2020,30/06/2020,FALSE,NHS Greater Glasgow and Clyde,Not Recruiting,Not Applicable,Interventional,United Kingdom,A Comparison of 3D and 2D Telemedicine During Covid 19,Telehealth,Telehealth,80,31/12/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04359225,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1436,NCT04359290,ClinicalTrials.gov,15/04/2020,01/05/2020,FALSE,Philipps University Marburg Medical Center,Not Recruiting,Phase 2,Interventional,No Country Given,Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS,Drug,Ruxolitinib,15,01/09/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04359290,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1437,NCT04358380,ClinicalTrials.gov,18/04/2020,15/04/2020,TRUE,Austral University,Recruiting,Not Applicable,Observational,Argentina,Liver Injury in Patients With COVID-19,Clinical Presentation,No Intervention,34,31/12/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04358380,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1438,NCT04358406,ClinicalTrials.gov,16/04/2020,01/06/2020,FALSE,BioAegis Therapeutics Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Rhu-pGSN for Severe Covid-19 Pneumonia,ATMP,Plasma,60,01/08/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04358406,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1439,NCT04357808,ClinicalTrials.gov,14/04/2020,13/04/2020,TRUE,Maria del Rosario Garcia de Vicua Pinedo,Recruiting,Phase 2,Interventional,Spain,Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID),Drug,Sarilumab,30,01/06/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04357808,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1440,NCT04357886,ClinicalTrials.gov,20/04/2020,01/05/2020,FALSE,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,Turkey,Comparison of New Coronavirus (COVID-19) Awareness in Individuals of Different Age Groups: Analysis of Turkey,Other,No Intervention,1000,01/05/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04357886,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1441,NCT04358588,ClinicalTrials.gov,21/04/2020,01/02/2014,TRUE,Bellerophon,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19,Drug,Nitric oxide,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04358588,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1442,NCT04358614,ClinicalTrials.gov,19/04/2020,16/03/2020,TRUE,Fabrizio Cantini,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Baricitinib Therapy in COVID-19,Drug,Baricitinib,12,05/04/2020,07/04/2020,https://clinicaltrials.gov/show/NCT04358614,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1443,NCT04358627,ClinicalTrials.gov,15/04/2020,15/04/2020,FALSE,Hospital Clinic of Barcelona,Not Recruiting,Not Applicable,Observational,No Country Given,Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 Patients,Drug,Dexmedetomidine,80,30/05/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04358627,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1444,NCT04359316,ClinicalTrials.gov,18/04/2020,20/04/2020,FALSE,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 4,Interventional,Iran,Azithromycin in Hospitalized COVID-19 Patients,Drug,Azithromycin vs. Hydroxychloroquine,40,03/05/2020,05/05/2020,https://clinicaltrials.gov/show/NCT04359316,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1445,NCT04359615,ClinicalTrials.gov,18/04/2020,20/04/2020,FALSE,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 4,Interventional,Iran,Favipiravir in Hospitalized COVID-19 Patients,Drug,Combination: Favipiravir + Hydroxychloroquine vs. Hydroxychloroquine,40,03/05/2020,05/05/2020,https://clinicaltrials.gov/show/NCT04359615,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1446,NCT04358003,ClinicalTrials.gov,20/04/2020,27/04/2020,FALSE,Marker Therapeutics AG,Not Recruiting,Not Applicable,Interventional,No Country Given,Plasma Adsorption in Patients With Confirmed COVID-19,Other (device),Plasma Adsorption Cartridge,2000,01/08/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04358003,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1447,NCT04358029,ClinicalTrials.gov,20/04/2020,09/04/2020,TRUE,Vivek Reddy,Recruiting,Not Applicable,Observational,United States,Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19),Clinical Presentation,No Intervention,10000,01/05/2021,01/12/2021,https://clinicaltrials.gov/show/NCT04358029,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1448,NCT04358809,ClinicalTrials.gov,21/04/2020,30/04/2020,FALSE,Cadila Pharnmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",Drug,Mycobacterium,480,28/02/2021,30/04/2021,https://clinicaltrials.gov/show/NCT04358809,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1449,NCT04358835,ClinicalTrials.gov,16/04/2020,20/04/2020,FALSE,Johns Hopkins University,Not Recruiting,Not Applicable,Interventional,No Country Given,Keto-diet for Intubated Critical Care COVID-19,Other (nutrition),Nutrition,15,01/08/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04358835,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1450,NCT04313127,ClinicalTrials.gov,15/03/2020,16/03/2020,FALSE,CanSino Biologics Inc.,Not Recruiting,Phase 1,Interventional,China,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,ATMP,Adenovirus vector,108,30/12/2020,20/12/2022,https://clinicaltrials.gov/show/NCT04313127,No Results,No Results,No Results,27/04/2020,25/03/2020,None
1451,NCT04359251,ClinicalTrials.gov,13/04/2020,05/03/2020,TRUE,"Southeast University, China",Not Recruiting,Not Applicable,Interventional,China,Different PEEP Settings of COVID-19 Induced ARDS,Other (physical),Mechanical ventilation,20,25/03/2020,25/03/2020,https://clinicaltrials.gov/show/NCT04359251,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1452,NCT04359264,ClinicalTrials.gov,16/04/2020,20/04/2020,FALSE,"St. Michael's Hospital, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial,Other,Other,392,31/12/2020,30/06/2021,https://clinicaltrials.gov/show/NCT04359264,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1453,NCT04320277,ClinicalTrials.gov,20/03/2020,16/05/2020,FALSE,Hospital of Prato,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",Drug,Baricitinib,200,30/06/2020,30/07/2020,https://clinicaltrials.gov/show/NCT04320277,No Results,No Results,No Results,27/04/2020,04/01/2020,None
1454,NCT04322396,ClinicalTrials.gov,23/03/2020,06/04/2020,FALSE,Chronic Obstructive Pulmonary Disease Trial Network,Recruiting,Phase 2,Interventional,Denmark,Proactive Prophylaxis With Azithromycin and Chloroquine in Hospitalized Patients With COVID-19,Drug (Chemoprophylaxis),Combination: hydroxychloroquine + azithromycin,226,31/10/2020,31/03/2021,https://clinicaltrials.gov/show/NCT04322396,No Results,No Results,No Results,27/04/2020,04/01/2020,None
1455,NCT04359667,ClinicalTrials.gov,16/04/2020,16/04/2020,FALSE,"University Hospital for Infectious Diseases, Croatia",Recruiting,Not Applicable,Observational,Croatia,Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab,Drug,Tocilizumab,30,16/04/2020,15/04/2021,https://clinicaltrials.gov/show/NCT04359667,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1456,NCT04359849,ClinicalTrials.gov,20/04/2020,01/05/2020,FALSE,Portsmouth Hospitals NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Sequencing and Tracking of Phylogeny in COVID-19 Study,Genomics,No Intervention,500,01/05/2022,01/09/2022,https://clinicaltrials.gov/show/NCT04359849,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1457,NCT04358211,ClinicalTrials.gov,17/04/2020,01/05/2020,FALSE,Dr. Nakhle Saba,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19,ATMP,Plasma,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04358211,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1458,NCT04358536,ClinicalTrials.gov,20/04/2020,01/04/2020,TRUE,Dascena,Not Recruiting,Not Applicable,Observational,United States,Classification of COVID-19 Infection in Posteroanterior Chest X-rays,Diagnostics,Diagnostic Test or Assessment,230,17/04/2020,17/04/2020,https://clinicaltrials.gov/show/NCT04358536,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1459,NCT04359095,ClinicalTrials.gov,15/04/2020,11/05/2020,FALSE,National University of Colombia,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia,Drug,Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Lopinavir/Ritonavir vs. Hydroxychloroquine,1600,11/10/2020,31/10/2020,https://clinicaltrials.gov/show/NCT04359095,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1460,NCT04359277,ClinicalTrials.gov,20/04/2020,16/04/2020,TRUE,NYU Langone Health,Recruiting,Phase 3,Interventional,United States,A Randomized Trial of Anticoagulation Strategies in COVID-19,Drug,"Enoxaparin, Heparin",1000,16/04/2021,16/04/2021,https://clinicaltrials.gov/show/NCT04359277,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1461,NCT04359459,ClinicalTrials.gov,20/04/2020,01/06/2020,FALSE,University Medical Center Groningen,Not Recruiting,Not Applicable,Observational,No Country Given,Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study,Clinical Presentation,No Intervention,150,01/06/2022,01/06/2022,https://clinicaltrials.gov/show/NCT04359459,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1462,NCT04322487,ClinicalTrials.gov,23/03/2020,08/04/2020,FALSE,Catholic University of the Sacred Heart,Recruiting,Not Applicable,Observational,Italy,"Simple, Safe, Same: Lung Ultrasound for COVID-19",Diagnostics,Diagnostic Test or Assessment,100,31/12/2020,15/01/2021,https://clinicaltrials.gov/show/NCT04322487,No Results,No Results,No Results,27/04/2020,04/01/2020,None
1463,NCT04323787,ClinicalTrials.gov,24/03/2020,30/03/2020,FALSE,Mayo Clinic,Recruiting,Not Applicable,Observational,United States,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry,Clinical Presentation,No Intervention,50000,30/04/2021,30/04/2021,https://clinicaltrials.gov/show/NCT04323787,No Results,No Results,No Results,27/04/2020,04/01/2020,None
1464,NCT04359875,ClinicalTrials.gov,18/04/2020,01/04/2020,TRUE,CHU de Tours,Not Recruiting,Not Applicable,Interventional,France,A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment,Telehealth,Telehealth,22000,01/06/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04359875,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1465,NCT04359992,ClinicalTrials.gov,16/04/2020,17/04/2020,FALSE,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Observational,No Country Given,Study of Hemostasis in Case of Severe COVID-19,Clinical Presentation,No Intervention,50,17/04/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04359992,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1466,NCT04359121,ClinicalTrials.gov,21/04/2020,15/04/2020,TRUE,Medical University of Graz,Recruiting,Not Applicable,Interventional,Austria,COVID-19 and the Developement of Phobic Fears of Disease,Other (psych),No Intervention,600,15/04/2023,15/04/2024,https://clinicaltrials.gov/show/NCT04359121,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1467,NCT04359212,ClinicalTrials.gov,21/04/2020,01/05/2020,FALSE,Quovadis Associazione,Not Recruiting,Not Applicable,Observational,No Country Given,Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19,Drug,Heparin or Fondaparinux,80,01/06/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04359212,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1468,NCT04359680,ClinicalTrials.gov,20/04/2020,30/04/2020,FALSE,Romark Laboratories L.C.,Not Recruiting,Phase 3,Interventional,No Country Given,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- or Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers,Drug (Chemoprophylaxis),Nitazoxanide,800,31/08/2020,31/08/2020,https://clinicaltrials.gov/show/NCT04359680,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1469,NCT04359693,ClinicalTrials.gov,21/04/2020,01/04/2020,TRUE,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections,Clinical Presentation,No Intervention,1071,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04359693,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1470,NCT04325633,ClinicalTrials.gov,26/03/2020,13/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection,Drug,Naproxen,584,13/05/2021,13/07/2021,https://clinicaltrials.gov/show/NCT04325633,No Results,No Results,No Results,27/04/2020,04/01/2020,None
1471,NCT04333420,ClinicalTrials.gov,01/04/2020,31/03/2020,TRUE,InflaRx GmbH,Recruiting,Phase 2/Phase 3,Interventional,Netherlands,"Open-label, Randomized Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",Drug,IFX-1,130,31/10/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04333420,No Results,No Results,No Results,27/04/2020,04/07/2020,None
1472,NCT04360707,ClinicalTrials.gov,22/04/2020,08/04/2020,TRUE,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Solid Organ Transplant Recipients With Covid-19 French Registry,Clinical Presentation,No Intervention,300,08/04/2021,08/04/2021,https://clinicaltrials.gov/show/NCT04360707,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1473,NCT04360733,ClinicalTrials.gov,22/04/2020,20/04/2020,TRUE,University of Bonn,Recruiting,Not Applicable,Observational,Germany,Precision Immunology to Determine the Immune Response in Patients With COVID-19,Clinical Presentation,No Intervention,200,01/04/2022,01/09/2022,https://clinicaltrials.gov/show/NCT04360733,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1474,NCT04359329,ClinicalTrials.gov,21/04/2020,20/04/2020,TRUE,Sharon Nachman,Recruiting,Phase 2,Interventional,United States,Estrogen Patch for COVID-19 Symptoms,Drug,Estradiol,110,15/11/2020,15/11/2020,https://clinicaltrials.gov/show/NCT04359329,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1475,NCT04359511,ClinicalTrials.gov,20/04/2020,01/05/2020,FALSE,CHU de Tours,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Drug,Corticosteroids,210,01/11/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04359511,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1476,NCT04359706,ClinicalTrials.gov,21/04/2020,01/04/2020,TRUE,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19,Clinical Presentation,No Intervention,30,01/09/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04359706,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1477,NCT04359901,ClinicalTrials.gov,20/04/2020,10/04/2020,TRUE,Westyn Branch-Elliman,Recruiting,Phase 2,Interventional,United States,Sarilumab for Patients With Moderate COVID-19 Disease: A Randomized Controlled Trial With a Play-The-Winner Design,Drug,Sarilumab,120,10/04/2022,10/04/2023,https://clinicaltrials.gov/show/NCT04359901,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1478,NCT04334434,ClinicalTrials.gov,02/04/2020,20/04/2020,FALSE,Kubra Koce,Not Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19),Telehealth,Rehabilitation,30,01/06/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04334434,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1479,NCT04335773,ClinicalTrials.gov,03/04/2020,03/04/2020,FALSE,"University Hospital, Akershus",Recruiting,Not Applicable,Observational,Norway,"COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology",Clinical Presentation,No Intervention,350,31/12/2030,31/12/2030,https://clinicaltrials.gov/show/NCT04335773,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1480,NCT04360824,ClinicalTrials.gov,13/04/2020,16/04/2020,FALSE,University of Iowa,Not Recruiting,Phase 4,Interventional,No Country Given,Covid-19 Associated Coagulopathy,Drug,Enoxaparin,170,16/04/2021,16/04/2021,https://clinicaltrials.gov/show/NCT04360824,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1481,NCT04360850,ClinicalTrials.gov,21/04/2020,24/04/2020,FALSE,University of Washington,Recruiting,Not Applicable,Observational,United States,Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic,Telehealth,Telehealth,10000,01/10/2025,01/10/2025,https://clinicaltrials.gov/show/NCT04360850,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1482,NCT04359537,ClinicalTrials.gov,20/04/2020,25/04/2020,FALSE,Shaheed Zulfiqar Ali Bhutto Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19,Drug (Chemoprophylaxis),Hydroxychloroquine,200,25/08/2020,25/09/2020,https://clinicaltrials.gov/show/NCT04359537,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1483,NCT04359654,ClinicalTrials.gov,21/04/2020,01/05/2020,FALSE,"University College, London",Not Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Dornase Alfa for Treatment of COVID-19,Drug,Dornase alfa,50,01/08/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04359654,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1484,NCT04359914,ClinicalTrials.gov,19/04/2020,15/04/2020,TRUE,University of Rostock,Recruiting,Not Applicable,Observational,Germany,Neurocognitive Impairment in Patients With COVID-19,Clinical Presentation,No Intervention,80,31/12/2020,01/04/2021,https://clinicaltrials.gov/show/NCT04359914,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1485,NCT04359927,ClinicalTrials.gov,21/04/2020,20/04/2020,TRUE,Hospital Clinic of Barcelona,Recruiting,Not Applicable,Observational,Spain,Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry,Clinical Presentation,No Intervention,10000,31/08/2021,31/08/2025,https://clinicaltrials.gov/show/NCT04359927,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1486,NCT04339426,ClinicalTrials.gov,07/04/2020,20/04/2020,FALSE,HonorHealth Research Institute,Recruiting,Phase 2,Interventional,United States,Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection,Drug,Combination: Atovaquone + azithromycin,25,01/10/2020,01/04/2021,https://clinicaltrials.gov/show/NCT04339426,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1487,NCT04340466,ClinicalTrials.gov,07/04/2020,03/04/2020,TRUE,CHU de Nimes,Recruiting,Not Applicable,Observational,France,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study,Clinical Presentation,No Intervention,220,30/06/2020,30/04/2021,https://clinicaltrials.gov/show/NCT04340466,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1488,NCT04359836,ClinicalTrials.gov,20/04/2020,16/04/2020,TRUE,ProgenaBiome,Recruiting,Not Applicable,Observational,United States,A Study to Explore the Role of Gut Flora in COVID-19 Infection,Clinical Presentation,No Intervention,250,30/04/2021,31/07/2021,https://clinicaltrials.gov/show/NCT04359836,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1489,NCT04359953,ClinicalTrials.gov,17/04/2020,24/04/2020,TRUE,"University Hospital, Strasbourg",Not Recruiting,Phase 3,Interventional,France,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19",Drug,Combination: Hydroxychloroquine + Telmisartan + Azithromycin,1600,01/06/2021,01/06/2021,https://clinicaltrials.gov/show/NCT04359953,No Results,No Results,No Results,04/05/2020,22/04/2020,EUCTR2020-001303-16
1490,NCT04360122,ClinicalTrials.gov,15/04/2020,20/04/2020,FALSE,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19,Drug (Chemoprophylaxis),Combination: Levamisole + Isoprinosine vs. Levamisole vs. Isoprinosine,100,01/11/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04360122,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1491,NCT04360356,ClinicalTrials.gov,19/04/2020,01/05/2020,FALSE,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Ivermectin and Nitazoxanide Combination Therapy for COVID-19,Drug,Combination: Ivermectin + Nitazoxanide,100,01/10/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04360356,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1492,NCT04361032,ClinicalTrials.gov,22/04/2020,04/05/2020,FALSE,Abderrahmane Mami Hospital,Not Recruiting,Phase 3,Interventional,Tunisia,"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia",Drug,Tocilizumab,260,04/09/2020,04/10/2020,https://clinicaltrials.gov/show/NCT04361032,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1493,NCT04361474,ClinicalTrials.gov,22/04/2020,25/04/2020,FALSE,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Phase 3,Interventional,No Country Given,Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,Drug,Budesonide,120,25/04/2020,25/05/2021,https://clinicaltrials.gov/show/NCT04361474,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1494,NCT04341584,ClinicalTrials.gov,07/04/2020,01/04/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection,Drug,Anakinra,240,01/05/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04341584,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1495,NCT04342156,ClinicalTrials.gov,08/04/2020,01/04/2020,TRUE,Tan Tock Seng Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,1200,01/08/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04342156,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1496,NCT04360096,ClinicalTrials.gov,21/04/2020,01/06/2020,FALSE,"NeuroRx, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Inhaled Aviptadil for the Treatment of Non-Acute Lung Injury in COVID-19,Drug,Aviptadil,144,01/08/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04360096,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1497,NCT04360278,ClinicalTrials.gov,22/04/2020,21/04/2020,TRUE,National Institutes of Health Clinical Center (CC),Recruiting,Not Applicable,Observational,United States,Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19,ATMP,Plasma,1500,14/04/2030,14/04/2030,https://clinicaltrials.gov/show/NCT04360278,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1498,NCT04360551,ClinicalTrials.gov,21/04/2020,01/07/2020,FALSE,University of Hawaii,Not Recruiting,Phase 2,Interventional,United States,Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients,Drug,Telmisartan,40,30/06/2021,30/06/2021,https://clinicaltrials.gov/show/NCT04360551,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1499,NCT04360759,ClinicalTrials.gov,22/04/2020,01/05/2020,FALSE,University of Cape Town,Not Recruiting,Phase 3,Interventional,South Africa,Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19,Drug,Chloroquine or hydroxychloroquine,560,31/05/2021,31/07/2021,https://clinicaltrials.gov/show/NCT04360759,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1500,NCT04361500,ClinicalTrials.gov,22/04/2020,15/04/2020,TRUE,Hannover Medical School,Recruiting,Not Applicable,Observational,Germany,Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter,Other (device),Blood filter,100,01/10/2020,01/10/2021,https://clinicaltrials.gov/show/NCT04361500,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1501,NCT04361591,ClinicalTrials.gov,22/04/2020,01/03/2020,TRUE,Hospital Clinic of Barcelona,Recruiting,Not Applicable,Observational,Spain,COVID-19 in Liver Transplant Recipients,Clinical Presentation,No Intervention,200,01/03/2021,01/03/2021,https://clinicaltrials.gov/show/NCT04361591,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1502,NCT04360486,ClinicalTrials.gov,20/04/2020,01/06/2020,FALSE,U.S. Army Medical Research and Development Command,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP),ATMP,Plasma,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04360486,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1503,NCT04360538,ClinicalTrials.gov,16/04/2020,08/04/2020,TRUE,University of Chicago,Recruiting,Not Applicable,Observational,United States,Long Term Outcomes of Patients With COVID-19,Clinical Presentation,No Intervention,500,01/07/2021,30/12/2021,https://clinicaltrials.gov/show/NCT04360538,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1504,NCT04342169,ClinicalTrials.gov,07/04/2020,14/04/2020,FALSE,University of Utah,Recruiting,Phase 2,Interventional,United States,University of Utah COVID-19 Hydrochloroquine Trial,Drug,Hydroxychloroquine,400,01/04/2022,01/04/2023,https://clinicaltrials.gov/show/NCT04342169,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1505,NCT04342637,ClinicalTrials.gov,07/04/2020,10/04/2020,FALSE,Al-Azhar University,Recruiting,Not Applicable,Observational,"United States, Iran, Egypt",COVID-19 Endoscopy Survey,Other,Other,40,10/10/2020,10/12/2020,https://clinicaltrials.gov/show/NCT04342637,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1506,NCT04360980,ClinicalTrials.gov,22/04/2020,20/03/2020,TRUE,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection,Drug,Colchicine,80,20/05/2020,30/05/2020,https://clinicaltrials.gov/show/NCT04360980,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1507,NCT04361019,ClinicalTrials.gov,22/04/2020,16/04/2020,TRUE,Basque Country University,Recruiting,Not Applicable,Observational,Spain,Physical Activity in University Students Around COVID-19 Confinement,Other (exercise),No Intervention,25000,20/10/2020,20/10/2020,https://clinicaltrials.gov/show/NCT04361019,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1508,NCT04360811,ClinicalTrials.gov,22/04/2020,17/04/2020,TRUE,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic",Diagnostics,Diagnostic Test or Assessment,3600,01/04/2021,01/04/2022,https://clinicaltrials.gov/show/NCT04360811,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1509,NCT04360837,ClinicalTrials.gov,22/04/2020,01/05/2020,FALSE,Szeged University,Not Recruiting,Not Applicable,Interventional,No Country Given,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients,Diagnostics,Diagnostic Test or Assessment,10,19/04/2021,19/04/2021,https://clinicaltrials.gov/show/NCT04360837,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1510,NCT04361916,ClinicalTrials.gov,14/04/2020,21/04/2020,FALSE,Mario Negri Institute for Pharmacological Research,Recruiting,Not Applicable,Interventional,Italy,Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino),Other,Other,425,31/10/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04361916,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1511,NCT04361942,ClinicalTrials.gov,17/04/2020,01/04/2020,TRUE,Red de Terapia Celular,Recruiting,Phase 2,Interventional,Spain,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),ATMP,Cells (mesenchymal),24,30/11/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04361942,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1512,NCT04342650,ClinicalTrials.gov,04/04/2020,08/04/2020,FALSE,Fundao de Medicina Tropical Dr. Heitor Vieira Dourado,Recruiting,Phase 2,Interventional,Brazil,Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection,Drug,Chloroquine,210,01/09/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04342650,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1513,NCT04343001,ClinicalTrials.gov,08/04/2020,01/04/2020,TRUE,London School of Hygiene and Tropical Medicine,Not Recruiting,Phase 3,Interventional,"Pakistan, Nigeria",Coronavirus Response - Active Support for Hospitalised Covid-19 Patients,Drug,"Monotherapy and all Combinations of: ARB (Losartan), simvastatin, and aspirin",10000,01/04/2021,01/08/2021,https://clinicaltrials.gov/show/NCT04343001,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1514,NCT04360863,ClinicalTrials.gov,22/04/2020,24/04/2020,FALSE,The University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong,Other,No Intervention,150,30/06/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04360863,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1515,NCT04360954,ClinicalTrials.gov,20/04/2020,27/04/2020,FALSE,Washington University in St. Louis,Recruiting,Not Applicable,Observational,United States,Evaluation of Antibody Tests for COVID-19,Diagnostics,Diagnostic Test or Assessment,1000,27/10/2020,27/10/2020,https://clinicaltrials.gov/show/NCT04360954,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1516,NCT04361214,ClinicalTrials.gov,22/04/2020,01/04/2020,TRUE,University of Chicago,Not Recruiting,Phase 1,Interventional,United States,Leflunomide in Mild COVID-19 Patients,Drug,Leflunomide,20,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04361214,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1517,NCT04361422,ClinicalTrials.gov,21/04/2020,21/04/2020,FALSE,Tanta University,Not Recruiting,Phase 3,Interventional,No Country Given,Isotretinoin in Treatment of COVID-19,Drug,Isotretinoin,300,01/06/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04361422,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1518,NCT04362059,ClinicalTrials.gov,20/04/2020,27/04/2020,FALSE,University Hospital Southampton NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,Drug,Bovactant,24,27/07/2020,02/11/2020,https://clinicaltrials.gov/show/NCT04362059,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1519,NCT04362124,ClinicalTrials.gov,21/04/2020,01/04/2020,TRUE,University of Antioquia,Not Recruiting,Phase 3,Interventional,Colombia,Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of SARS-COV-2 Infection,ATMP,Vaccine,1000,01/06/2021,01/11/2021,https://clinicaltrials.gov/show/NCT04362124,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1520,NCT04361435,ClinicalTrials.gov,12/04/2020,01/05/2020,FALSE,St. Justine's Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Lung Recruitment Device for COVID-19,Other (physio),Physio,50,31/07/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04361435,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1521,NCT04361448,ClinicalTrials.gov,20/04/2020,20/04/2020,FALSE,Jessa Hospital,Not Recruiting,Not Applicable,Interventional,Belgium,Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR,Diagnostics,Diagnostic Test or Assessment,30,20/05/2020,20/05/2020,https://clinicaltrials.gov/show/NCT04361448,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1522,NCT04343339,ClinicalTrials.gov,08/04/2020,08/04/2020,FALSE,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment,Other (psych),No Intervention,100,30/07/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04343339,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1523,NCT04343664,ClinicalTrials.gov,09/04/2020,12/04/2020,FALSE,Tjhin Wiguna,Not Recruiting,Not Applicable,Observational,Indonesia,Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,Other (psych),No Intervention,10000,30/06/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04343664,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1524,NCT04361253,ClinicalTrials.gov,23/04/2020,01/04/2020,TRUE,Brigham and Women's Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy,ATMP,Plasma,220,01/06/2021,01/12/2021,https://clinicaltrials.gov/show/NCT04361253,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1525,NCT04361396,ClinicalTrials.gov,22/04/2020,01/05/2020,FALSE,Centre Hospitalier Ren Dubos,Recruiting,Not Applicable,Interventional,France,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients,Clinical Presentation,No Intervention,40,01/10/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04361396,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1526,NCT04361461,ClinicalTrials.gov,22/04/2020,04/05/2020,FALSE,Apsen Farmaceutica S.A.,Not Recruiting,Phase 3,Interventional,Brazil,Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19),Drug,Combination: Hydroxychloroquine + Azythromycin vs. Hydroxychloroquine,500,04/11/2020,04/11/2020,https://clinicaltrials.gov/show/NCT04361461,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1527,NCT04361643,ClinicalTrials.gov,23/04/2020,27/04/2020,FALSE,Hospital Universitario Getafe,Not Recruiting,Phase 4,Interventional,Spain,Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial,Drug,Lenalidomide,120,31/08/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04361643,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1528,NCT04343963,ClinicalTrials.gov,09/04/2020,04/04/2020,TRUE,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2/Phase 3,Interventional,Mexico,Pyridostigmine in Severe SARS-CoV-2 Infection,Drug,Pyridostigmine,436,30/09/2020,30/04/2021,https://clinicaltrials.gov/show/NCT04343963,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1529,NCT04344145,ClinicalTrials.gov,09/04/2020,16/04/2020,FALSE,Université Libre de Bruxelles,Recruiting,Not Applicable,Observational,Belgium,Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population,Other (psych),No Intervention,200,15/06/2020,15/07/2020,https://clinicaltrials.gov/show/NCT04344145,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1530,NCT04362150,ClinicalTrials.gov,23/04/2020,21/04/2020,TRUE,"University of California, San Francisco",Recruiting,Not Applicable,Observational,United States,Long-term Impact of Infection With Novel Coronavirus (COVID-19),Clinical Presentation,No Intervention,800,31/12/2022,21/12/2024,https://clinicaltrials.gov/show/NCT04362150,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1531,NCT04362267,ClinicalTrials.gov,23/04/2020,01/04/2020,TRUE,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital,Clinical Presentation (Epidemiology),No Intervention,150,01/09/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04362267,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1532,NCT04361877,ClinicalTrials.gov,20/04/2020,30/03/2020,TRUE,Klinikum der Universität München,Recruiting,Not Applicable,Observational,Germany,Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial),Clinical Presentation,No Intervention,1900,20/04/2020,20/04/2020,https://clinicaltrials.gov/show/NCT04361877,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1533,NCT04362085,ClinicalTrials.gov,20/04/2020,01/04/2020,TRUE,"St. Michael's Hospital, Toronto",Not Recruiting,Phase 3,Interventional,No Country Given,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,Drug,Heparin,462,01/11/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04362085,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1534,NCT04362332,ClinicalTrials.gov,20/04/2020,14/04/2020,TRUE,UMC Utrecht,Recruiting,Phase 4,Interventional,Netherlands,"Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19",Drug,Chloroquine vs. hydroxychloroquine,950,14/04/2021,14/05/2021,https://clinicaltrials.gov/show/NCT04362332,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1535,NCT04362358,ClinicalTrials.gov,21/04/2020,01/05/2020,FALSE,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Interventional,No Country Given,Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic,Other (psych),Psychological,120,01/10/2021,01/10/2021,https://clinicaltrials.gov/show/NCT04362358,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1536,NCT04344171,ClinicalTrials.gov,10/04/2020,30/03/2020,TRUE,ClarData,Recruiting,Not Applicable,Observational,"Romania, Germany",CovidDB: The Covid-19 Inpatient Database,Clinical Presentation,No Intervention,5000,31/12/2022,30/06/2023,https://clinicaltrials.gov/show/NCT04344171,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1537,NCT04344964,ClinicalTrials.gov,10/04/2020,15/04/2020,FALSE,Austin Health,Not Recruiting,Not Applicable,Observational,No Country Given,Endoscopy-related Phone Consultation During the COVID-19 Outbreak,Telehealth,Telehealth,150,15/06/2020,15/06/2020,https://clinicaltrials.gov/show/NCT04344964,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1538,NCT04361604,ClinicalTrials.gov,20/04/2020,01/04/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Clinical Characterisation Protocol for COVID-19 in People Living With HIV,Clinical Presentation,No Intervention,270,01/10/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04361604,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1539,NCT04361838,ClinicalTrials.gov,16/04/2020,01/05/2020,FALSE,Kansas City Heart Rhythm Institute,Not Recruiting,Not Applicable,Interventional,No Country Given,The COVID-19 ICU PRAYER Study,Other,Other,1000,31/08/2020,31/08/2020,https://clinicaltrials.gov/show/NCT04361838,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1540,NCT04361903,ClinicalTrials.gov,14/04/2020,25/04/2020,FALSE,Azienda Unit Sanitaria Locale Toscana Nord Ovest,Not Recruiting,Not Applicable,Observational,No Country Given,Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection,Drug,Ruxolitinib,13,24/05/2020,31/05/2020,https://clinicaltrials.gov/show/NCT04361903,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1541,NCT04362137,ClinicalTrials.gov,22/04/2020,30/04/2020,TRUE,Novartis Pharmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,"Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)",Drug,Ruxolitinib,402,10/07/2020,13/07/2020,https://clinicaltrials.gov/show/NCT04362137,No Results,No Results,No Results,04/05/2020,05/05/2020,EUCTR2020-001591-15
1542,NCT04362137,ClinicalTrials.gov,22/04/2020,30/04/2020,TRUE,Novartis Pharmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,"Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)",Drug,Ruxolitinib,402,10/07/2020,13/07/2020,https://clinicaltrials.gov/show/NCT04362137,No Results,No Results,No Results,04/05/2020,05/05/2020,EUCTR2020-001662-11
1543,NCT04362111,ClinicalTrials.gov,21/04/2020,01/05/2020,FALSE,University of Alabama at Birmingham,Not Recruiting,Phase 3,Interventional,No Country Given,Early Identification and Treatment of Cytokine Storm Syndrome in Covid-19,Drug,Anakinra,20,01/07/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04362111,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1544,NCT04362319,ClinicalTrials.gov,23/04/2020,01/05/2020,FALSE,University of Malaya,Not Recruiting,Not Applicable,Observational,No Country Given,Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic,Other (psych),No Intervention,88,31/05/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04362319,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1545,NCT04363008,ClinicalTrials.gov,21/04/2020,30/03/2020,TRUE,University of British Columbia,Recruiting,Not Applicable,Observational,Canada,COVID 19 Biomarkers,Diagnostics,Diagnostic Test or Assessment,150,30/04/2020,30/09/2021,https://clinicaltrials.gov/show/NCT04363008,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1546,NCT04363034,ClinicalTrials.gov,23/04/2020,01/10/2020,FALSE,University of Arkansas,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program,ATMP,Plasma,Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04363034,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1547,NCT04362930,ClinicalTrials.gov,24/04/2020,24/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences),Clinical Presentation,No Intervention,2000,24/04/2022,24/04/2022,https://clinicaltrials.gov/show/NCT04362930,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1548,NCT04362943,ClinicalTrials.gov,22/04/2020,20/04/2020,TRUE,Complejo Hospitalario Universitario de Albacete,Recruiting,Not Applicable,Observational,Spain,Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults,Drug,Baricitinib or Anakinra,576,15/05/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04362943,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1549,NCT04362345,ClinicalTrials.gov,20/04/2020,09/04/2020,TRUE,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia,Clinical Presentation,No Intervention,100,17/05/2020,17/05/2020,https://clinicaltrials.gov/show/NCT04362345,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1550,NCT04362813,ClinicalTrials.gov,24/04/2020,30/04/2020,TRUE,Novartis Pharmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia,Drug,Canakinumab,450,10/07/2020,16/10/2020,https://clinicaltrials.gov/show/NCT04362813,No Results,No Results,No Results,04/05/2020,05/05/2020,EUCTR2020-001370-30
1551,NCT04345276,ClinicalTrials.gov,10/04/2020,18/03/2020,TRUE,Huo-Shen-Shan Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug,Combination: Danoprevir + Ritonavir,40,30/04/2020,31/05/2020,https://clinicaltrials.gov/show/NCT04345276,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1552,NCT04345289,ClinicalTrials.gov,10/04/2020,20/04/2020,TRUE,Thomas Benfield,Not Recruiting,Phase 3,Interventional,Denmark,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,Drug (+ ATMP),Plamsa vs. Sarilumab vs. Hydroxychloroquine vs. Baricitinib,1500,15/06/2021,15/06/2021,https://clinicaltrials.gov/show/NCT04345289,No Results,No Results,No Results,27/04/2020,22/04/2020,EUCTR2020-001367-88
1553,NCT04363099,ClinicalTrials.gov,23/04/2020,01/03/2020,TRUE,Maison de Santé Pluridisciplinaire de Creil,Recruiting,Not Applicable,Observational,France,Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.,Clinical Presentation (Epidemiology),No Intervention,1000,30/06/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04363099,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1554,NCT04363216,ClinicalTrials.gov,23/04/2020,01/04/2020,TRUE,Thomas Jefferson University,Not Recruiting,Phase 2,Interventional,No Country Given,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,Drug,Vitamin C,66,01/05/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04363216,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1555,NCT04362995,ClinicalTrials.gov,22/04/2020,23/04/2020,FALSE,St. Jude Children's Research Hospital,Recruiting,Not Applicable,Observational,United States,St. Jude Tracking of Viral and Host Factors Associated With COVID-19,Clinical Presentation,No Intervention,1517,20/04/2021,20/03/2025,https://clinicaltrials.gov/show/NCT04362995,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1556,NCT04363203,ClinicalTrials.gov,23/04/2020,01/04/2020,TRUE,Dr. Salomeh Keyhani,Not Recruiting,Phase 4,Interventional,No Country Given,VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL),Drug,Hydroxychloroquine vs. Azithromycin,600,01/03/2021,01/08/2021,https://clinicaltrials.gov/show/NCT04363203,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1557,NCT04362956,ClinicalTrials.gov,21/04/2020,01/05/2020,FALSE,Fundación Infant,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection,Clinical Presentation,No Intervention,200,30/09/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04362956,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1558,NCT04362969,ClinicalTrials.gov,23/04/2020,01/04/2020,TRUE,"Hospital San Carlos, Madrid",Not Recruiting,Not Applicable,Observational,No Country Given,"COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador",Clinical Presentation,No Intervention,300,01/05/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04362969,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1559,NCT04363372,ClinicalTrials.gov,24/04/2020,01/05/2020,FALSE,4D Pharma,Not Recruiting,Phase 2,Interventional,No Country Given,A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19,Drug,MRx-4DP0004,90,01/08/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04363372,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1560,NCT04345510,ClinicalTrials.gov,12/04/2020,20/04/2020,FALSE,German Cancer Research Center,Not Recruiting,Not Applicable,Observational,No Country Given,Testing for COVID-19 Infection in Asymptomatic Persons,Clinical Presentation (Epidemiology),No Intervention,500,31/05/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04345510,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1561,NCT04345523,ClinicalTrials.gov,02/04/2020,03/04/2020,FALSE,Cristina Avendao Sol,Recruiting,Phase 2,Interventional,Spain,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients,ATMP,Plasma,278,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04345523,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1562,NCT04363333,ClinicalTrials.gov,19/04/2020,27/04/2020,FALSE,Ko University,Recruiting,Not Applicable,Observational,Turkey,Obstructive Sleep Apnea & Covid-19 Outcomes,Clinical Presentation,No Intervention,275,30/11/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04363333,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1563,NCT04363450,ClinicalTrials.gov,23/04/2020,27/04/2020,FALSE,Louisiana State University Health Sciences Center in New Orleans,Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),Drug (chemoprophylaxis),Hydroxychloroquine,1700,06/07/2020,03/08/2020,https://clinicaltrials.gov/show/NCT04363450,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1564,NCT04363346,ClinicalTrials.gov,23/04/2020,04/05/2020,FALSE,University of Minnesota,Not Recruiting,Phase 1,Interventional,United States,Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia,Drug,FT516,12,01/01/2022,01/01/2022,https://clinicaltrials.gov/show/NCT04363346,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1565,NCT04363437,ClinicalTrials.gov,23/04/2020,26/04/2020,FALSE,Maimonides Medical Center,Recruiting,Phase 2,Interventional,United States,COlchicine in Moderate Severity Hospitalized Patients Before ARDS to Treat COVID-19,Drug,Colchicine,70,31/05/2020,14/06/2020,https://clinicaltrials.gov/show/NCT04363437,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1566,NCT04345692,ClinicalTrials.gov,09/04/2020,26/03/2020,TRUE,Queen's Medical Centre,Recruiting,Phase 3,Interventional,United States,A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients,Drug,Hydroxychloroquine,350,31/12/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04345692,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1567,NCT04346147,ClinicalTrials.gov,07/04/2020,13/04/2020,FALSE,Hospital Universitario de Fuenlabrada,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19,Drug,"Lopinavir/ritonavir vs. Imatinib vs. Baricitinib

All in comibination with Hydroxychloroquine ",165,01/08/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04346147,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1568,NCT04363385,ClinicalTrials.gov,21/04/2020,01/05/2020,FALSE,Centre Hospitalier Intercommunal Creteil,Not Recruiting,Not Applicable,Interventional,France,Collection of Biological Samples With Clinical Characterization of Covid-19 Patients,Clinical Presentation,No Intervention,500,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04363385,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1569,NCT04363593,ClinicalTrials.gov,24/04/2020,04/05/2020,FALSE,Centre Hospitalier de Cornouaille,Not Recruiting,Not Applicable,Interventional,France,Serology COVID-19 From the Cornwall Hospital Union,Clinical Presentation (Epidemiology),No Intervention,3200,04/11/2020,04/11/2020,https://clinicaltrials.gov/show/NCT04363593,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1570,NCT04363463,ClinicalTrials.gov,22/04/2020,01/05/2020,FALSE,Centre Hospitalier Rgional d'Orlans,Not Recruiting,Not Applicable,Interventional,France,Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress,Procedure,Positioning,400,01/05/2022,01/05/2022,https://clinicaltrials.gov/show/NCT04363463,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1571,NCT04363528,ClinicalTrials.gov,23/04/2020,27/04/2020,FALSE,Versailles Hospital,Not Recruiting,Not Applicable,Interventional,France,Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,Clinical Presentation,No Intervention,50,30/10/2020,30/10/2020,https://clinicaltrials.gov/show/NCT04363528,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1572,NCT04363541,ClinicalTrials.gov,23/04/2020,01/04/2020,TRUE,Instituto Nacional de Perinatología,Not Recruiting,Not Applicable,Interventional,No Country Given,Local Thermotherapy for Patients With Moderate Symptoms of COVID-19,Other (device),Heating pad,298,01/09/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04363541,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1573,NCT04363749,ClinicalTrials.gov,20/04/2020,27/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities,Other,Other,30,27/04/2021,27/11/2021,https://clinicaltrials.gov/show/NCT04363749,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1574,NCT04363606,ClinicalTrials.gov,24/04/2020,01/04/2020,TRUE,CHU de Saint Etienne,Not Recruiting,Not Applicable,Interventional,France,Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability,Clinical Presentation,No Intervention,52,01/04/2021,01/12/2021,https://clinicaltrials.gov/show/NCT04363606,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1575,NCT04363814,ClinicalTrials.gov,19/04/2020,10/05/2020,FALSE,Inmunotek S.L.,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,Drug,Bactek-R,100,01/07/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04363814,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1576,NCT04363671,ClinicalTrials.gov,21/04/2020,01/05/2020,FALSE,Hôpital Cochin,Not Recruiting,Not Applicable,Observational,France,Adolescents and Health Professionals Faced With the Necessity for Changing to Remote Care During the COVID-19 Outbreak Quarantine (AdoPro-Cov19),Other (psych),No Intervention,30,01/06/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04363671,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1577,NCT04363788,ClinicalTrials.gov,23/04/2020,28/02/2020,TRUE,Lazarski University,Not Recruiting,Not Applicable,Observational,Poland,Needle Stick Injuries in Emergency Medical Service Practice,Procedure,Double Gloves,300,24/04/2020,24/04/2020,https://clinicaltrials.gov/show/NCT04363788,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1578,NCT04346160,ClinicalTrials.gov,10/04/2020,14/04/2020,FALSE,D'Annunzio University of Chieti–Pescara,Not Recruiting,Not Applicable,Observational,Italy,"A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease",Diagnostics,Diagnostic Test or Assessment,25,30/04/2020,30/04/2020,https://clinicaltrials.gov/show/NCT04346160,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1579,NCT04346186,ClinicalTrials.gov,11/04/2020,15/04/2020,FALSE,"Copenhagen University Hospital, Herlev Hospital",Not Recruiting,Not Applicable,Observational,Denmark,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Diagnostics,Diagnostic Test or Assessment,30000,01/10/2020,01/08/2021,https://clinicaltrials.gov/show/NCT04346186,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1580,NCT04363827,ClinicalTrials.gov,24/04/2020,01/05/2020,FALSE,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Not Recruiting,Phase 2,Interventional,Italy,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),Drug (+ chemoprophylaxis),Hydroxychloroquine,2300,01/09/2020,01/03/2021,https://clinicaltrials.gov/show/NCT04363827,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1581,NCT04363840,ClinicalTrials.gov,24/04/2020,01/05/2020,FALSE,Louisiana State University Health Sciences Center in New Orleans,Not Recruiting,Phase 2,Interventional,No Country Given,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations",Drug,Combination: Aspirin + Vitamin D vs. Aspirin,1080,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04363840,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1582,NCT04363866,ClinicalTrials.gov,24/04/2020,01/05/2020,FALSE,Oregon Health and Science University,Not Recruiting,Phase 4,Interventional,United States,A Pilot Study to Assess Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19),Drug,Hydroxychloroquine,40,01/12/2020,01/06/2021,https://clinicaltrials.gov/show/NCT04363866,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1583,NCT04364984,ClinicalTrials.gov,23/04/2020,01/04/2020,TRUE,Medical Practice Prof D. Ivanov,Recruiting,Not Applicable,Observational,Ukraine,"ARB, ACEi, DRi in COVID-19",Drug,ACE inhibitors,10,01/04/2021,01/08/2021,https://clinicaltrials.gov/show/NCT04364984,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1584,NCT04363853,ClinicalTrials.gov,17/04/2020,01/04/2020,TRUE,Instituto Nacional de Cancerología,Recruiting,Phase 2,Interventional,Mexico,Tocilizumab Treatment in Patients With COVID-19,Drug,Tocilizumab,200,01/06/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04363853,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1585,NCT04364737,ClinicalTrials.gov,22/04/2020,17/04/2020,TRUE,Albert Einstein College of Medicine,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients,ATMP,Plasma,300,31/01/2023,30/04/2023,https://clinicaltrials.gov/show/NCT04364737,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1586,NCT04346368,ClinicalTrials.gov,23/03/2020,01/04/2020,FALSE,Guangzhou Institute of Respiratory Disease,Not Recruiting,Phase 1/Phase 2,Interventional,China,Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),ATMP,Cells (mesenchymal),20,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04346368,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1587,NCT04346589,ClinicalTrials.gov,09/04/2020,01/04/2020,TRUE,A.O. Ospedale Papa Giovanni XXIII,Not Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients,ATMP,Plasma,10,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04346589,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1588,NCT04365166,ClinicalTrials.gov,19/04/2020,20/04/2020,FALSE,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19),Clinical Presentation,No Intervention,100,20/04/2022,20/04/2022,https://clinicaltrials.gov/show/NCT04365166,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1589,NCT04365309,ClinicalTrials.gov,24/04/2020,10/02/2020,TRUE,Xijing Hospital,Recruiting,Phase 2/Phase 3,Interventional,China,Protective Effect of Aspirin on COVID-19 Patients,Drug,Aspirin,128,01/04/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04365309,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1590,NCT04364022,ClinicalTrials.gov,23/04/2020,01/04/2020,TRUE,Calmy Alexandra,Recruiting,Phase 3,Interventional,Switzerland,Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland,Drug (chemoprophylaxis),Hydroxychloroquine vs. Lopinavir/Ritonavir,420,01/10/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04364022,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1591,NCT04364698,ClinicalTrials.gov,24/04/2020,01/04/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Observational Cohort of COVID-19 Patients at Raymond-Poincare,Clinical Presentation,No Intervention,500,01/05/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04364698,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1592,NCT04346810,ClinicalTrials.gov,08/04/2020,15/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Burnout Among Caregivers Facing COVID-19 Health Crisis at a Non-conventional Intensive Care Unit Compared to a Conventional Intensive Care Unit,Other (psych),No Intervention,100,15/08/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04346810,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1593,NCT04347278,ClinicalTrials.gov,03/04/2020,15/04/2020,FALSE,Instituto de Investigacin Marqus de Valdecilla,Not Recruiting,Not Applicable,Observational,No Country Given,Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry,Drug,Unspecified,100,15/10/2020,01/01/2021,https://clinicaltrials.gov/show/NCT04347278,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1594,NCT04364763,ClinicalTrials.gov,20/04/2020,01/06/2020,FALSE,"Renibus Therapuetics, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Effect of RBT-9 on Preventing Progression of COVID-19 in High-Risk Individuals,Drug,Stannous protoporphyrin,252,30/06/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04364763,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1595,NCT04365530,ClinicalTrials.gov,26/04/2020,01/04/2020,TRUE,Groupe Hospitalier Paris Saint-Joseph,Recruiting,Not Applicable,Observational,France,Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City,Clinical Presentation,No Intervention,2000,01/04/2022,31/12/2022,https://clinicaltrials.gov/show/NCT04365530,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1596,NCT04365517,ClinicalTrials.gov,14/04/2020,30/04/2020,FALSE,University of Milan,Not Recruiting,Phase 3,Interventional,Italy,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients,Drug,Sitagliptin,170,30/05/2020,30/12/2020,https://clinicaltrials.gov/show/NCT04365517,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1597,NCT04365608,ClinicalTrials.gov,24/04/2020,20/03/2020,TRUE,Lazarski University,Recruiting,Not Applicable,Interventional,Poland,Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment,Other (physical),Mechanical ventilation,90,20/05/2020,20/05/2020,https://clinicaltrials.gov/show/NCT04365608,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1598,NCT04364711,ClinicalTrials.gov,20/04/2020,01/05/2020,FALSE,UMC Utrecht,Not Recruiting,Not Applicable,Observational,No Country Given,EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19,Clinical Presentation,No Intervention,2000,30/04/2022,30/04/2022,https://clinicaltrials.gov/show/NCT04364711,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1599,NCT04364893,ClinicalTrials.gov,07/04/2020,06/04/2020,TRUE,D'Or Institute for Research and Education,Recruiting,Not Applicable,Interventional,Brazil,Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19,Drug,ACE inhibitors or ARBs,500,01/10/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04364893,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1600,NCT04365595,ClinicalTrials.gov,24/04/2020,01/05/2020,FALSE,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir),Clinical Presentation,No Intervention,200,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04365595,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1601,NCT04365738,ClinicalTrials.gov,26/04/2020,11/03/2020,TRUE,Istanbul Bilgi University,Not Recruiting,Not Applicable,Interventional,Turkey,Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection,Other (physio),Physio,270,10/04/2020,26/04/2020,https://clinicaltrials.gov/show/NCT04365738,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1602,NCT04365634,ClinicalTrials.gov,25/04/2020,02/02/2020,TRUE,Tongji Hospital,Not Recruiting,Not Applicable,Observational,China,A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients.,Clinical Presentation,No Intervention,306,15/03/2020,01/04/2020,https://clinicaltrials.gov/show/NCT04365634,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1603,NCT04365699,ClinicalTrials.gov,25/04/2020,08/04/2020,TRUE,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Cardiovascular Effects of COVID-19,Drug,AT-001,500,31/12/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04365699,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1604,NCT04365101,ClinicalTrials.gov,22/04/2020,30/04/2020,FALSE,Celularity Incorporated,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19),ATMP,Cells (NK),86,30/11/2020,30/11/2021,https://clinicaltrials.gov/show/NCT04365101,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1605,NCT04365127,ClinicalTrials.gov,24/04/2020,27/04/2020,FALSE,Sara Ghandehari,Recruiting,Phase 1,Interventional,United States,Progesterone for the Treatment of COVID-19 in Hospitalized Men,Drug,Progesterone,40,01/09/2020,17/04/2021,https://clinicaltrials.gov/show/NCT04365127,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1606,NCT04365725,ClinicalTrials.gov,25/04/2020,01/04/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,"Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections",Drug,Remdesivir,200,01/04/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04365725,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1607,NCT04365816,ClinicalTrials.gov,24/04/2020,01/05/2020,FALSE,"University Hospital, Grenoble",Not Recruiting,Not Applicable,Observational,No Country Given,NutriCovid30 : Nutritional Evaluation for Covid-19 Infection at D30,Clinical Presentation,No Intervention,600,01/07/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04365816,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1608,NCT04366063,ClinicalTrials.gov,20/04/2020,05/04/2020,TRUE,Royan Institute,Recruiting,Phase 2/Phase 3,Interventional,Iran,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),60,06/06/2020,10/12/2020,https://clinicaltrials.gov/show/NCT04366063,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1609,NCT04366154,ClinicalTrials.gov,16/04/2020,15/04/2020,TRUE,Centre Francois Baclesse,Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers,Other (psych),No Intervention,385,01/07/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04366154,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1610,NCT04347460,ClinicalTrials.gov,08/04/2020,27/03/2020,TRUE,Technische Universität München,Recruiting,Not Applicable,Observational,Germany,Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH,Clinical Presentation,No Intervention,20,01/07/2020,31/08/2020,https://clinicaltrials.gov/show/NCT04347460,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1611,NCT04347889,ClinicalTrials.gov,13/04/2020,20/04/2020,FALSE,Stony Brook University,Not Recruiting,Phase 2,Interventional,No Country Given,Preventing COVID-19 in Healthcare Workers With HCQ: A RCT,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Vitamin C,1212,30/12/2020,30/12/2020,https://clinicaltrials.gov/show/NCT04347889,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1612,NCT04365153,ClinicalTrials.gov,24/04/2020,24/04/2020,FALSE,The Cleveland Clinic,Recruiting,Phase 2,Interventional,United States,Canakinumab to Reduce Deterioration of Cardiac and Respiratory Function Due to COVID-19,Drug,Canakinumab,45,31/12/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04365153,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1613,NCT04365322,ClinicalTrials.gov,25/04/2020,20/04/2020,TRUE,CHU de Besançon,Recruiting,Not Applicable,Observational,France,Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,60,01/06/2020,20/04/2025,https://clinicaltrials.gov/show/NCT04365322,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1614,NCT04365959,ClinicalTrials.gov,21/04/2020,20/03/2020,TRUE,University of Milano Bicocca,Not Recruiting,Not Applicable,Observational,Italy,The Prone Position in Covid-19 Affected Patients,Procedure,Positioning,56,09/04/2020,31/05/2020,https://clinicaltrials.gov/show/NCT04365959,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1615,NCT04366050,ClinicalTrials.gov,24/04/2020,01/04/2020,TRUE,"University of California, San Diego",Not Recruiting,Phase 2,Interventional,No Country Given,Ramipril for the Treatment of COVID-19,Drug,Ramipril,560,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04366050,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1616,NCT04365335,ClinicalTrials.gov,24/04/2020,01/04/2020,TRUE,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic,Other (psych),No Intervention,60,01/06/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04365335,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1617,NCT04365348,ClinicalTrials.gov,25/04/2020,27/04/2020,FALSE,The University of Hong Kong,Not Recruiting,Not Applicable,Observational,Hong Kong,The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families,Other (psych),No Intervention,300,31/03/2021,30/06/2021,https://clinicaltrials.gov/show/NCT04365348,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1618,NCT04347915,ClinicalTrials.gov,14/04/2020,24/04/2020,FALSE,Bukwang Pharmaceutical,Not Recruiting,Phase 2,Interventional,No Country Given,The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19,Drug,Clevudine vs. Hydroxychloroquine,60,30/09/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04347915,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1619,NCT04347928,ClinicalTrials.gov,08/04/2020,01/04/2020,TRUE,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19,Clinical Presentation,No Intervention,15,01/09/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04347928,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1620,NCT04366180,ClinicalTrials.gov,27/04/2020,24/04/2020,TRUE,Biosearch S.A.,Recruiting,Not Applicable,Interventional,Spain,Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers,Supplement,Probiotics,314,01/06/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04366180,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1621,NCT04366245,ClinicalTrials.gov,22/04/2020,01/04/2020,TRUE,Andalusian Network for Design and Translation of Advanced Therapies,Recruiting,Phase 1/Phase 2,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection,ATMP (+ Drug),Combination: Plasma vs. Hydroxychloroquine + Azithromycin or Hydroxychloroquine + Interferon beta + Lopinavir/ritonavir,72,01/12/2021,01/12/2021,https://clinicaltrials.gov/show/NCT04366245,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1622,NCT04366141,ClinicalTrials.gov,24/04/2020,01/05/2020,FALSE,University of British Columbia,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box Randomized Controlled Trial,Other (device),Barrier,120,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04366141,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1623,NCT04366167,ClinicalTrials.gov,24/04/2020,18/04/2020,TRUE,Barts & The London NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Patient Recovery From Heart Surgery During the Covid-19 Pandemic,Clinical Presentation,No Intervention,100,19/04/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04366167,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1624,NCT04365361,ClinicalTrials.gov,25/04/2020,26/04/2020,FALSE,The University of Hong Kong,Not Recruiting,Not Applicable,Observational,No Country Given,The Psychological Impact of the COVID-19 on Students.,Other (psych),No Intervention,300,30/12/2020,31/03/2021,https://clinicaltrials.gov/show/NCT04365361,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1625,NCT04365582,ClinicalTrials.gov,23/04/2020,28/04/2020,FALSE,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Phase 3,Interventional,France,OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome,Drug,Hydroxychloroquine vs. Azithromycin vs. Lopinavir/ritonavir,640,28/07/2020,28/01/2021,https://clinicaltrials.gov/show/NCT04365582,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1626,NCT04348552,ClinicalTrials.gov,13/04/2020,15/04/2020,FALSE,Nantes University Hospital,Not Recruiting,Not Applicable,Observational,France,Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study,Other,No Intervention,1000,15/06/2020,15/06/2020,https://clinicaltrials.gov/show/NCT04348552,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1627,NCT04349410,ClinicalTrials.gov,11/04/2020,11/04/2020,FALSE,The Camelot Foundation,Recruiting,Phase 2/Phase 3,Interventional,United States,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,Drug (+ ATMP),Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Doxycycline vs. Hydroxychloroquine + Clindamycin vs. Hydroxychloroquine  + Clindamycin + Primaquine vs. Remdesivir vs. Tocilizumab vs. Corticosteroids vs. Interferon alpha vs. Losartan vs. Plasma,500,11/10/2020,11/11/2020,https://clinicaltrials.gov/show/NCT04349410,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1628,NCT04366271,ClinicalTrials.gov,23/04/2020,24/04/2020,FALSE,Hospital Infantil Universitario Niño Jesús,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,ATMP,Cells (mesenchymal),106,31/07/2020,31/05/2021,https://clinicaltrials.gov/show/NCT04366271,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1629,NCT04366830,ClinicalTrials.gov,24/04/2020,01/04/2020,TRUE,Mesoblast International Srl,Not Recruiting,Not Applicable,Expanded Access,United States,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection",ATMP,Cells (mesenchymal),Not Available,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04366830,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1630,NCT04365764,ClinicalTrials.gov,25/04/2020,14/03/2020,TRUE,Groupe Hospitalier Pitié Salpêtrière,Recruiting,Not Applicable,Observational,France,Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study,Drug,Unspecified Drug,400,31/05/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04365764,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1631,NCT04365972,ClinicalTrials.gov,24/04/2020,23/04/2020,TRUE,Tel Aviv University,Recruiting,Not Applicable,Interventional,Israel,Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic,Other (psych),Psychological,20,30/04/2020,30/04/2020,https://clinicaltrials.gov/show/NCT04365972,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1632,NCT04366791,ClinicalTrials.gov,24/04/2020,23/04/2020,TRUE,Emory University,Recruiting,Phase 1/Phase 2,Interventional,United States,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,Other,Radiation,10,01/06/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04366791,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1633,NCT04366817,ClinicalTrials.gov,20/04/2020,01/04/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact,Other (psych),No Intervention,120,01/04/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04366817,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1634,NCT04349618,ClinicalTrials.gov,08/04/2020,14/04/2020,FALSE,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Interventional,France,Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia,Other (physical),Mechanical ventilation,200,14/07/2021,14/04/2022,https://clinicaltrials.gov/show/NCT04349618,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1635,NCT04350086,ClinicalTrials.gov,13/04/2020,20/04/2020,FALSE,"University Hospital, Limoges",Not Recruiting,Phase 4,Interventional,France,Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection,Drug,Dexmedetomidine,10,20/11/2020,20/11/2020,https://clinicaltrials.gov/show/NCT04350086,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1636,NCT04365985,ClinicalTrials.gov,26/04/2020,01/04/2020,TRUE,William Beaumont Hospitals,Not Recruiting,Phase 2,Interventional,United States,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,Drug,"Ketamine, Naltrexone",500,01/05/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04365985,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1637,NCT04366024,ClinicalTrials.gov,21/04/2020,17/01/2020,TRUE,Xinqiao Hospital of Chongqing,Recruiting,Not Applicable,Observational,China,A Novel Nomogram to Predict Severity of COVID-19,Prognosis,No Intervention,1000,30/05/2020,31/12/2021,https://clinicaltrials.gov/show/NCT04366024,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1638,NCT04366921,ClinicalTrials.gov,17/04/2020,10/04/2020,TRUE,Maastricht University Medical Center,Recruiting,Not Applicable,Observational,"Netherlands, Sweden, Israel, Belgium, Portugal, Hungary, Greece, Poland, Spain, Austria, Italy, Switzerland, France, Russian Federation, Denmark, United Kingdom, Germany, Lithuania, Czechia",European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO,Drug,Oxygen,150,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04366921,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1639,NCT04366947,ClinicalTrials.gov,23/04/2020,14/04/2020,TRUE,Lazarski University,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access in Suspected/Confirmed COVID-19 Patient,Other (device),Intraosseous/Intravenous access device,60,20/05/2020,20/05/2020,https://clinicaltrials.gov/show/NCT04366947,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1640,NCT04366908,ClinicalTrials.gov,25/04/2020,28/04/2020,FALSE,Maimonides Biomedical Research Institute of Cordoba,Not Recruiting,Phase 2,Interventional,No Country Given,Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome,Drug,Calcifediol,1008,28/07/2020,28/08/2020,https://clinicaltrials.gov/show/NCT04366908,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1641,NCT04366934,ClinicalTrials.gov,22/04/2020,30/04/2020,FALSE,Institut Pasteur,Not Recruiting,Not Applicable,Observational,France,Study of the Pathogenesis of Olfactory Disorders in COVID-19,Clinical Presentation,No Intervention,24,15/09/2022,15/09/2022,https://clinicaltrials.gov/show/NCT04366934,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1642,NCT04350099,ClinicalTrials.gov,11/04/2020,15/04/2020,FALSE,"University Hospital, Limoges",Not Recruiting,Not Applicable,Observational,France,Emotional Burden of Healthcare Professionals and Covid Infection 19,Other (psych),No Intervention,200,15/12/2020,15/06/2021,https://clinicaltrials.gov/show/NCT04350099,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1643,NCT04350281,ClinicalTrials.gov,13/04/2020,09/04/2020,TRUE,The University of Hong Kong,Recruiting,Phase 2,Interventional,Hong Kong,Double Therapy With IFN-beta 1b and Hydroxychloroquine,Drug,Combination: Interferon beta + Hydroxychloroquine vs. Hydroxychloroquine,80,31/03/2022,31/07/2022,https://clinicaltrials.gov/show/NCT04350281,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1644,NCT04366206,ClinicalTrials.gov,19/04/2020,14/03/2020,TRUE,Centre Hospitalier Intercommunal Robert Ballanger,Recruiting,Not Applicable,Observational,France,Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est,Clinical Presentation,No Intervention,143,31/07/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04366206,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1645,NCT04366232,ClinicalTrials.gov,27/04/2020,01/05/2020,FALSE,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,Not Recruiting,Phase 2,Interventional,France,Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation (JAKINCOV),Drug,Combination: Anakinra + Ruxolitinib vs. Anakinra,50,31/08/2020,31/08/2020,https://clinicaltrials.gov/show/NCT04366232,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1646,NCT04367142,ClinicalTrials.gov,27/04/2020,01/05/2020,FALSE,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Rapid Detection of COVID-19 by Portable and Connected Biosensor,Diagnostics,Diagnostic Test or Assessment,200,01/09/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04367142,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1647,NCT04367350,ClinicalTrials.gov,28/04/2020,20/03/2020,TRUE,"University Hospital, Tübingen",Recruiting,Not Applicable,Observational,Germany,Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement,Clinical Presentation,No Intervention,500,31/03/2021,31/03/2022,https://clinicaltrials.gov/show/NCT04367350,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1648,NCT04367129,ClinicalTrials.gov,16/04/2020,14/04/2020,TRUE,"University Hospital, Ferrara",Recruiting,Not Applicable,Observational,Italy,Electrocardiogram Analysis in COVID-19 Patients,Clinical Presentation,No Intervention,1000,01/12/2020,01/12/2021,https://clinicaltrials.gov/show/NCT04367129,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1649,NCT04367337,ClinicalTrials.gov,28/04/2020,25/03/2020,TRUE,"University of Social Sciences and Humanities, Warsaw",Recruiting,Not Applicable,Observational,"China, Germany, Italy, Portugal, Israel, Canada, Malaysia, Switzerland, France, Singapore, Gambia, Romania, Australia, Poland",Health Behavior Change During COVID-19 Pandemic,Other,No Intervention,5600,24/03/2021,24/03/2021,https://clinicaltrials.gov/show/NCT04367337,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1650,NCT04366856,ClinicalTrials.gov,26/04/2020,01/04/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study),Procedure,Positioning,500,01/05/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04366856,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1651,NCT04366882,ClinicalTrials.gov,22/04/2020,14/04/2020,TRUE,Jessa Hospital,Recruiting,Not Applicable,Interventional,Belgium,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,Clinical Presentation,No Intervention,45,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04366882,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1652,NCT04350931,ClinicalTrials.gov,13/04/2020,20/04/2020,FALSE,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19,ATMP,Vaccine,900,01/10/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04350931,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1653,NCT04351152,ClinicalTrials.gov,15/04/2020,01/05/2020,FALSE,"Humanigen, Inc.",Not Recruiting,Phase 3,Interventional,No Country Given,Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia,Drug,Lenzilumab,238,01/09/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04351152,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1654,NCT04367064,ClinicalTrials.gov,26/04/2020,25/04/2020,TRUE,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study),Clinical Presentation,No Intervention,1000,25/06/2020,25/07/2020,https://clinicaltrials.gov/show/NCT04367064,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1655,NCT04367077,ClinicalTrials.gov,27/04/2020,01/05/2020,FALSE,"Athersys, Inc",Recruiting,Phase 2/Phase 3,Interventional,United States,MultiStem Administration for COVID-19 Induced ARDS (MACoVIA),ATMP,Cells (stem cells),400,01/09/2021,01/08/2022,https://clinicaltrials.gov/show/NCT04367077,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1656,NCT04367792,ClinicalTrials.gov,27/04/2020,01/04/2020,TRUE,A.O. Ospedale Papa Giovanni XXIII,Recruiting,Not Applicable,Observational,Italy,Cardiac Injury in COVID-19: a Pathology Study,Clinical Presentation,No Intervention,50,01/10/2020,01/03/2021,https://clinicaltrials.gov/show/NCT04367792,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1657,NCT04367896,ClinicalTrials.gov,27/04/2020,24/03/2020,TRUE,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Observational,Italy,COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY,Clinical Presentation,No Intervention,1819,17/04/2020,17/04/2020,https://clinicaltrials.gov/show/NCT04367896,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1658,NCT04367714,ClinicalTrials.gov,27/04/2020,15/03/2020,TRUE,Region MidtJylland,Recruiting,Not Applicable,Observational,Denmark,Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19,Clinical Presentation,No Intervention,300,01/12/2020,01/12/2021,https://clinicaltrials.gov/show/NCT04367714,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1659,NCT04367740,ClinicalTrials.gov,27/04/2020,28/04/2020,FALSE,"University of North Carolina, Chapel Hill",Recruiting,Not Applicable,Observational,United States,"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19",Diagnostics,Diagnostic Test or Assessment,10000,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04367740,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1660,NCT04351399,ClinicalTrials.gov,14/04/2020,01/04/2020,TRUE,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak,Other (psych),No Intervention,100,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04351399,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1661,NCT04351620,ClinicalTrials.gov,14/04/2020,01/04/2020,TRUE,University of Chicago,Recruiting,Phase 1,Interventional,United States,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,Drug,Hydroxychloroquine,20,01/06/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04351620,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1662,NCT04367363,ClinicalTrials.gov,17/04/2020,08/03/2020,TRUE,Jean Liu,Recruiting,Not Applicable,Observational,Singapore,Social Media and COVID-19,Other,No Intervention,150,31/05/2020,31/05/2020,https://clinicaltrials.gov/show/NCT04367363,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1663,NCT04367545,ClinicalTrials.gov,27/04/2020,01/04/2020,TRUE,"University Hospital, Rouen",Recruiting,Not Applicable,Interventional,France,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic,Diagnostics,Diagnostic Test or Assessment,50,01/05/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04367545,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1664,NCT04368013,ClinicalTrials.gov,27/04/2020,28/04/2020,FALSE,Johan Normark,Not Recruiting,Not Applicable,Interventional,Sweden,"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial",Prognosis,No Intervention,400,14/04/2026,14/04/2026,https://clinicaltrials.gov/show/NCT04368013,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1665,NCT04368221,ClinicalTrials.gov,24/04/2020,01/04/2020,TRUE,Rennes University Hospital,Not Recruiting,Not Applicable,Observational,France,Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU,Clinical Presentation,No Intervention,250,01/05/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04368221,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1666,NCT04351789,ClinicalTrials.gov,11/04/2020,01/04/2020,TRUE,"Copenhagen University Hospital, Hvidovre",Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark,Other (psych),Psychological,66,01/04/2023,01/04/2023,https://clinicaltrials.gov/show/NCT04351789,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1667,NCT04351802,ClinicalTrials.gov,16/04/2020,20/04/2020,FALSE,University Hospital Plymouth NHS Trust,Not Recruiting,Not Applicable,Observational,No Country Given,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study,Diagnostics,Diagnostic Test or Assessment,180,20/01/2021,20/01/2021,https://clinicaltrials.gov/show/NCT04351802,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1668,NCT04368156,ClinicalTrials.gov,20/04/2020,20/04/2020,FALSE,Carlos Tornero,Recruiting,Not Applicable,Interventional,Spain,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Other (device),Vagus nerve stimulation,90,31/07/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04368156,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1669,NCT04368208,ClinicalTrials.gov,28/04/2020,01/05/2020,FALSE,Poitiers University Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression,Other (psych),No Intervention,900,01/05/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04368208,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1670,NCT04367662,ClinicalTrials.gov,16/04/2020,09/04/2020,TRUE,"University Hospital, Rouen",Recruiting,Not Applicable,Interventional,France,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,Clinical Presentation,No Intervention,100,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04367662,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1671,NCT04367805,ClinicalTrials.gov,27/04/2020,27/04/2020,FALSE,CHU de Amiens,Recruiting,Not Applicable,Observational,France,COVID-19 Infection in Patients With Hepatocellular Carcinoma,Diagnostics,Diagnostic Test or Assessment,50,01/10/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04367805,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1672,NCT04352699,ClinicalTrials.gov,14/04/2020,15/03/2020,TRUE,CHU de Nice,Recruiting,Not Applicable,Observational,France,Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All?,Clinical Presentation,No Intervention,120,17/04/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04352699,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1673,NCT04353141,ClinicalTrials.gov,16/04/2020,20/04/2020,FALSE,KU Leuven,Not Recruiting,Not Applicable,Observational,"United Kingdom, Belgium, Italy",International Lung UltraSound Analysis (ILUSA) Study,Diagnostics,Diagnostic Test or Assessment,1850,31/05/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04353141,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1674,NCT04368338,ClinicalTrials.gov,28/04/2020,28/04/2020,FALSE,CHU de Amiens,Recruiting,Not Applicable,Observational,France,Lung Ultrasound to Diagnose COVID-19,Diagnostics,Diagnostic Test or Assessment,100,28/09/2020,28/09/2020,https://clinicaltrials.gov/show/NCT04368338,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1675,NCT04368871,ClinicalTrials.gov,29/04/2020,28/04/2020,TRUE,Max Healthcare Insititute Limited,Not Recruiting,Not Applicable,Observational,India,Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study,Clinical Presentation,No Intervention,200,30/06/2020,30/05/2021,https://clinicaltrials.gov/show/NCT04368871,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1676,NCT04368377,ClinicalTrials.gov,23/04/2020,06/04/2020,TRUE,University of Milan,Not Recruiting,Phase 2,Interventional,Italy,Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19,Drug,Combination: Tirofiban + Clopidogrel + Aspirin + Fondaparinux,5,23/04/2020,23/04/2020,https://clinicaltrials.gov/show/NCT04368377,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1677,NCT04368390,ClinicalTrials.gov,28/04/2020,03/04/2020,TRUE,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Neuroradiolological Analysis of COVID-19 Patients,Clinical Presentation,No Intervention,100,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04368390,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1678,NCT04368000,ClinicalTrials.gov,24/04/2020,01/04/2020,TRUE,University of Utah,Not Recruiting,Not Applicable,Interventional,No Country Given,Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization,Procedure,Positioning,60,01/12/2020,01/01/2021,https://clinicaltrials.gov/show/NCT04368000,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1679,NCT04368143,ClinicalTrials.gov,27/04/2020,01/04/2020,TRUE,Institute of Tropical Medicine,Recruiting,Not Applicable,Observational,Belgium,COVID-19 Immune Repertoire Sequencing,Genomics,No Intervention,100,30/06/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04368143,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1680,NCT04353323,ClinicalTrials.gov,15/04/2020,25/04/2020,FALSE,"University Hospital, Limoges",Not Recruiting,Not Applicable,Observational,France,COVID 19-Caregivers IGg Seroconversion,Clinical Presentation (Epidemiology),No Intervention,130,25/06/2020,25/12/2020,https://clinicaltrials.gov/show/NCT04353323,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1681,NCT04353336,ClinicalTrials.gov,15/04/2020,17/04/2020,FALSE,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacay of Chloroquine in COVID-19 Treatment,Drug,Chloroquine,40,01/12/2030,01/12/2030,https://clinicaltrials.gov/show/NCT04353336,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1682,NCT04368897,ClinicalTrials.gov,27/04/2020,01/05/2020,FALSE,"Applied Biology, Inc.",Not Recruiting,Not Applicable,Observational,Spain,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity,Diagnostics,Diagnostic Test or Assessment,200,01/09/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04368897,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1683,NCT04368988,ClinicalTrials.gov,24/04/2020,15/05/2020,FALSE,Novavax,Not Recruiting,Phase 1,Interventional,Australia,Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant,ATMP,Vaccine,131,31/12/2020,31/07/2021,https://clinicaltrials.gov/show/NCT04368988,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1684,NCT04368234,ClinicalTrials.gov,27/04/2020,05/05/2020,FALSE,Duke University,Recruiting,Not Applicable,Observational,United States,Duke COVID-19 Shared Data and Specimen Repository,Clinical Presentation,No Intervention,100000,30/04/2025,30/04/2025,https://clinicaltrials.gov/show/NCT04368234,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1685,NCT04368260,ClinicalTrials.gov,24/04/2020,24/04/2020,FALSE,University of Virginia,Recruiting,Not Applicable,Interventional,United States,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic,Diagnostics,Diagnostic Test or Assessment,40,31/07/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04368260,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1686,NCT04368637,ClinicalTrials.gov,26/04/2020,30/04/2020,FALSE,Jordan Collaborating Cardiology Group,Not Recruiting,Not Applicable,Observational,No Country Given,Acute Cardiovascular Events Triggered by COVID-19-Related Stress,Clinical Presentation,No Intervention,50,30/07/2020,30/08/2020,https://clinicaltrials.gov/show/NCT04368637,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1687,NCT04368845,ClinicalTrials.gov,20/04/2020,30/04/2020,FALSE,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,Not Recruiting,Not Applicable,Interventional,No Country Given,Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study,Telehealth,Rehabilitation,100,31/07/2020,01/03/2021,https://clinicaltrials.gov/show/NCT04368845,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1688,NCT04354428,ClinicalTrials.gov,16/04/2020,16/04/2020,FALSE,University of Washington,Recruiting,Phase 2/Phase 3,Interventional,United States,Treatment for SARS-CoV-2 in High-Risk Adult Outpatients,Drug,Combo: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine vs. Vitamin C + Folic Acid,630,01/07/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04354428,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1689,NCT04354441,ClinicalTrials.gov,14/04/2020,01/05/2020,FALSE,Sir Mortimer B. Davis - Jewish General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women,Drug,Hydroxychloroquine,600,01/11/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04354441,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1690,NCT04368351,ClinicalTrials.gov,27/04/2020,01/03/2020,TRUE,Giancarlo Ceccarelli,Not Recruiting,Not Applicable,Observational,Italy,Bacteriotherapy in the Treatment of COVID-19,Drug,Combination: Bacteriotherapy + Azithromycin + Hydroxychloroquine vs. Azithromycin + Hydrixychloroquine,70,30/06/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04368351,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1691,NCT04368676,ClinicalTrials.gov,26/04/2020,10/05/2020,FALSE,Lawson Health Research Institute,Not Recruiting,Phase 1,Interventional,Canada,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness,Traditional Medicine (other),Traditional Medicine,60,30/06/2021,30/06/2021,https://clinicaltrials.gov/show/NCT04368676,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1692,NCT04369456,ClinicalTrials.gov,27/04/2020,22/04/2020,TRUE,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,Clinical Presentation,No Intervention,115,22/10/2020,22/10/2020,https://clinicaltrials.gov/show/NCT04369456,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1693,NCT04369989,ClinicalTrials.gov,28/04/2020,14/04/2020,TRUE,OSF Healthcare System,Recruiting,Not Applicable,Observational,United States,Observational Study of COVID-19 Treatment Efficacy,Clinical Presentation,No Intervention,1000,14/04/2021,14/04/2021,https://clinicaltrials.gov/show/NCT04369989,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1694,NCT04368884,ClinicalTrials.gov,29/04/2020,22/04/2020,TRUE,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,Observational Study to Assess the Seroconversion Status of Health Care Workers and Suspected or Confirmed Cases of COVID-19 Patients,Clinical Presentation (Epidemiology),No Intervention,1000,30/06/2020,30/07/2020,https://clinicaltrials.gov/show/NCT04368884,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1695,NCT04368975,ClinicalTrials.gov,27/04/2020,12/03/2020,TRUE,Hospital Clinic of Barcelona,Recruiting,Not Applicable,Observational,Spain,ARDS Caused by COVID-19,Clinical Presentation,No Intervention,500,21/04/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04368975,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1696,NCT04354857,ClinicalTrials.gov,17/04/2020,27/03/2020,TRUE,CHU de Nimes,Recruiting,Not Applicable,Observational,France,Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection,Clinical Presentation,No Intervention,454,01/07/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04354857,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1697,NCT04355741,ClinicalTrials.gov,15/04/2020,01/04/2020,TRUE,University Nova de Lisboa,Not Recruiting,Not Applicable,Observational,Portugal,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease",Clinical Presentation,No Intervention,60,01/07/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04355741,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1698,NCT04369066,ClinicalTrials.gov,27/04/2020,28/04/2020,FALSE,Institut Curie,Recruiting,Not Applicable,Interventional,France,"COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie",Clinical Presentation,No Intervention,2500,28/10/2020,28/01/2021,https://clinicaltrials.gov/show/NCT04369066,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1699,NCT04369274,ClinicalTrials.gov,23/04/2020,01/05/2020,FALSE,Massachusetts General Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent,Other (physical),Mechanical ventilation,30,01/11/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04369274,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1700,NCT04370171,ClinicalTrials.gov,27/04/2020,01/05/2020,FALSE,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Observational,No Country Given,Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic,Telehealth,Telehealth,200,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04370171,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1701,NCT04370197,ClinicalTrials.gov,29/04/2020,03/03/2020,TRUE,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Covid-19 Epidemic on Acute Stroke Management,Clinical Presentation,No Intervention,300,30/04/2020,30/04/2020,https://clinicaltrials.gov/show/NCT04370197,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1702,NCT04356417,ClinicalTrials.gov,17/04/2020,01/04/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse,Drug,Synthetic anti-malarials,6000000,01/06/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04356417,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1703,NCT04357275,ClinicalTrials.gov,15/04/2020,13/03/2020,TRUE,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,The RIsk Stratification in COVID-19 Patients in the ICU Registry,Clinical Presentation,No Intervention,10000,01/03/2021,01/03/2022,https://clinicaltrials.gov/show/NCT04357275,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1704,NCT04369300,ClinicalTrials.gov,28/04/2020,24/04/2020,TRUE,Max Healthcare Insititute Limited,Not Recruiting,Not Applicable,Observational,No Country Given,Anxiety And Depression During COVID-19 IN INDIA,Other (psych),No Intervention,1000,24/11/2020,24/02/2021,https://clinicaltrials.gov/show/NCT04369300,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1705,NCT04369742,ClinicalTrials.gov,25/04/2020,15/04/2020,TRUE,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Treating COVID-19 With Hydroxychloroquine (TEACH),Drug,Hydroxychloroquine,626,01/06/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04369742,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1706,NCT04369469,ClinicalTrials.gov,28/04/2020,01/05/2020,FALSE,Alexion Pharmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia,Drug,Ravulizumab,270,01/11/2020,01/02/2021,https://clinicaltrials.gov/show/NCT04369469,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1707,NCT04369690,ClinicalTrials.gov,20/04/2020,03/04/2020,TRUE,University of Ottawa,Recruiting,Not Applicable,Observational,Canada,"The Psychological, Social, and Economic Impacts of COVID-19",Other (psych),No Intervention,1000,03/04/2021,03/04/2021,https://clinicaltrials.gov/show/NCT04369690,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1708,ACTRN12620000417987,ANZCTR,30/03/2020,30/03/2020,FALSE,Australian Defence Force Malaria and Infectious Disease Institute,Recruiting,Phase 4,Interventional,Australia,Chloroquine Chemorophylaxis Countermeasure against COVID-19,Drug,Chloroquine,680,Not Available,28/09/2020,https://anzctr.org.au/ACTRN12620000417987.aspx,No Results,No Results,No Results,27/04/2020,04/01/2020,None
1709,NCT04370288,ClinicalTrials.gov,29/04/2020,19/04/2020,TRUE,Mashhad University of Medical Sciences,Recruiting,Phase 1,Interventional,Iran,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,Drug,Combination: Methylene blue + Vitamin C + N-acetyl cysteine,20,20/09/2020,21/09/2020,https://clinicaltrials.gov/show/NCT04370288,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1710,NCT04370821,ClinicalTrials.gov,27/04/2020,27/04/2020,FALSE,Villanova University,Not Recruiting,Not Applicable,Observational,United States,"COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers",Other (psych),No Intervention,20000,27/04/2040,27/04/2040,https://clinicaltrials.gov/show/NCT04370821,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1711,NCT04369859,ClinicalTrials.gov,29/04/2020,23/04/2020,TRUE,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Observational,France,Obstetric and Perinatal Outcomes of Women With COVID-19,Clinical Presentation,No Intervention,1300,22/04/2021,22/04/2021,https://clinicaltrials.gov/show/NCT04369859,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1712,NCT04370210,ClinicalTrials.gov,29/04/2020,01/05/2020,FALSE,Centre Hospitalier Ren Dubos,Not Recruiting,Not Applicable,Observational,France,Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry,Other (psych),No Intervention,464,01/06/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04370210,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1713,ACTRN12620000482965,ANZCTR,17/04/2020,17/03/2020,TRUE,Juan Pedro Fuentes García,Not Recruiting,Not Applicable,Interventional,Spain,"Impact of high intensity interval training and aerobic training on stress, depression symptoms, anxiety and resilience in self-isolated people during the COVID-19 health emergency in Spain",Other (exercise),Exercise,34,Not Available,26/04/2020,https://anzctr.org.au/ACTRN12620000482965.aspx,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1714,NCT04370782,ClinicalTrials.gov,26/04/2020,28/04/2020,FALSE,"St. Francis Hospital, New York",Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting,Drug,Combination: Hydroxychloroquine + Azithromycin + Zinc vs. Hydroxychloroquine + Doxycycline + Zinc,750,30/09/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04370782,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1715,NCT04370808,ClinicalTrials.gov,26/04/2020,01/04/2020,TRUE,University of Lisbon,Not Recruiting,Not Applicable,Observational,Portugal,BREATH: Vitamin D Polymorphisms and Severity of COVID-19 Infection,Clinical Presentation,No Intervention,500,01/10/2020,01/03/2021,https://clinicaltrials.gov/show/NCT04370808,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1716,ACTRN12620000501943,ANZCTR,22/04/2020,28/04/2020,FALSE,Walter and Eliza Hall Institute of Medical Research,Not Recruiting,Phase 2 / Phase 3,Interventional,Australia,COVID-19 prophylaxis with hydroxychloroquine in Front-line Health and Allied-Health Care Workers: The COVID-SHIELD Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,2250,Not Available,30/11/2020,https://anzctr.org.au/ACTRN12620000501943.aspx,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1717,NCT04370275,ClinicalTrials.gov,29/04/2020,23/04/2020,TRUE,Latisana Hospital,Recruiting,Not Applicable,Observational,Italy,Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia,Diagnostics,Diagnostic Test or Assessment,235,23/05/2020,31/05/2020,https://clinicaltrials.gov/show/NCT04370275,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1718,NCT04370834,ClinicalTrials.gov,30/04/2020,01/05/2020,FALSE,National Cancer Institute (NCI),Not Recruiting,Phase 2,Interventional,No Country Given,Tocilizumab for Patients With Cancer and COVID-19 Disease,Drug,Tocilizumab,200,01/01/2022,01/01/2022,https://clinicaltrials.gov/show/NCT04370834,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1719,NCT04370938,ClinicalTrials.gov,29/04/2020,29/04/2020,FALSE,University of Pittsburgh,Recruiting,Not Applicable,Interventional,United States,Provider Burnout During COVID-19,Other (psych),Psychological,250,29/10/2020,29/10/2020,https://clinicaltrials.gov/show/NCT04370938,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1720,NCT04371289,ClinicalTrials.gov,28/04/2020,01/04/2020,TRUE,Istituto Auxologico Italiano,Not Recruiting,Not Applicable,Observational,Italy,Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up,Clinical Presentation,No Intervention,5500,10/07/2020,10/09/2020,https://clinicaltrials.gov/show/NCT04371289,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1721,ACTRN12620000498998,ANZCTR,20/04/2020,22/04/2020,FALSE,Tenon Hospital,Not Recruiting,Not Applicable,Observational,France,Retrospective Study on surgical outcomes among surgical patients during the COVID-19 (SARS-CoV-2) Pandemic,Clinical Presentation,No Intervention,700,Not Available,07/04/2021,https://anzctr.org.au/ACTRN12620000498998.aspx,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1722,NCT04371029,ClinicalTrials.gov,28/04/2020,01/04/2020,TRUE,"University Hospital, Bordeaux",Not Recruiting,Not Applicable,Interventional,France,Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS,Other,Polysomnography,25,01/06/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04371029,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1723,NCT04371419,ClinicalTrials.gov,28/04/2020,08/05/2020,FALSE,"National Bureau of Economic Research, Inc.",Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Health Messaging to Underserved Communities,Other,Health Education,20000,31/05/2021,30/06/2021,https://clinicaltrials.gov/show/NCT04371419,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1724,ACTRN12620000493943,ANZCTR,20/04/2020,07/04/2020,TRUE,Albury Wodonga Health,Recruiting,Not Applicable,Observational,Australia,Study evaluating Front-line health care workers serial blood COVID-19 antibody results in relation to symptom presentation,Clinical Presentation,No Intervention,50,Not Available,07/04/2021,https://anzctr.org.au/ACTRN12620000493943.aspx,No Results,No Results,No Results,27/04/2020,22/04/2020,None
1725,ACTRN12620000500954,ANZCTR,22/04/2020,01/05/2020,FALSE,Western Health,Not Recruiting,Not Applicable,Interventional,Australia,A reusable personalised ventilation hood: A phase 1 safety study of a new device (McMonty) in patients with suspected or confirmed COVID-19.,Other (device),Hood,20,Not Available,01/06/2020,https://anzctr.org.au/ACTRN12620000500954.aspx,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1726,NCT04371432,ClinicalTrials.gov,29/04/2020,06/05/2020,FALSE,National Human Genome Research Institute (NHGRI),Recruiting,Not Applicable,Observational,United States,Genetics of COVID-19 Susceptibility and Manifestations,Genomics,No Intervention,2500,01/06/2025,01/06/2025,https://clinicaltrials.gov/show/NCT04371432,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1727,NCT04371640,ClinicalTrials.gov,28/04/2020,01/05/2020,FALSE,Walter K. Kraft,Recruiting,Phase 1,Interventional,United States,Sirolimus in COVID-19 Phase 1,Drug,Sirolimus,40,Not Available,Not Available,https://clinicaltrials.gov/show/NCT04371640,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1728,NCT04371406,ClinicalTrials.gov,29/04/2020,02/05/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients,Drug,Combination: Hydroxychloroquine + Azithromycin,2770,02/08/2020,02/09/2020,https://clinicaltrials.gov/show/NCT04371406,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1729,NCT04371471,ClinicalTrials.gov,30/04/2020,01/03/2020,TRUE,Groupe Hospitalier La Rochelle,Not Recruiting,Not Applicable,Observational,France,Covid-19 Pandemic Triage Score,Diagnostics,Diagnostic Test or Assessment,50,30/04/2020,30/04/2020,https://clinicaltrials.gov/show/NCT04371471,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1730,NCT04371302,ClinicalTrials.gov,29/04/2020,01/05/2020,FALSE,University of Malaya,Not Recruiting,Not Applicable,Observational,No Country Given,Nursing Perspective on Burnout and Medical Errors in the Intensive Care Unit During Covid-19 Pandemic,Other (psych),No Intervention,145,30/06/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04371302,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1731,NCT04371367,ClinicalTrials.gov,29/04/2020,27/04/2020,TRUE,Assistance Publique – Hôpitaux de Marseille,Recruiting,Phase 2,Interventional,France,"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )",Drug,Avdoralimab,108,27/06/2020,27/10/2020,https://clinicaltrials.gov/show/NCT04371367,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1732,NCT04371822,ClinicalTrials.gov,29/04/2020,01/05/2020,FALSE,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,No Country Given,Efficacy of Sn-protoporphyrin IX (SnPPIX) and Sulfonated Tetranaphthyl Porphyrin Against Covid-19,Drug,"SnPP Protoporphyrin, Porphyrin",56,01/06/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04371822,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1733,NCT04371848,ClinicalTrials.gov,22/04/2020,16/04/2020,TRUE,Laval University,Not Recruiting,Not Applicable,Observational,Canada,Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQu√©bec Sub-study,Other (nutrition),No Intervention,2465,07/05/2020,07/05/2020,https://clinicaltrials.gov/show/NCT04371848,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1734,NCT04371393,ClinicalTrials.gov,28/04/2020,01/04/2020,TRUE,Icahn School of Medicine at Mount Sinai,Not Recruiting,Phase 3,Interventional,No Country Given,MSCs in COVID-19 ARDS,ATMP,Cells (mesenchymal),300,01/04/2021,01/04/2022,https://clinicaltrials.gov/show/NCT04371393,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1735,NCT04371510,ClinicalTrials.gov,28/04/2020,22/04/2020,TRUE,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients,Clinical Presentation,No Intervention,115,22/10/2020,22/02/2021,https://clinicaltrials.gov/show/NCT04371510,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1736,NCT04371679,ClinicalTrials.gov,30/04/2020,01/04/2020,TRUE,Hasselt University,Recruiting,Not Applicable,Observational,Belgium,Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients,Clinical Presentation,No Intervention,40,01/10/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04371679,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1737,NCT04372030,ClinicalTrials.gov,22/04/2020,01/05/2020,FALSE,UCLouvain,Not Recruiting,Not Applicable,Interventional,No Country Given,Health Care Use During the Covid19 Crisis,Health System,No Intervention,10000,30/06/2020,31/10/2021,https://clinicaltrials.gov/show/NCT04372030,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1738,NCT04372056,ClinicalTrials.gov,29/04/2020,30/04/2020,FALSE,Oslo University Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,The COVID-ICU Healthcare Professional Study,Other,No Intervention,2200,06/05/2021,06/05/2021,https://clinicaltrials.gov/show/NCT04372056,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1739,NCT04371601,ClinicalTrials.gov,25/03/2020,01/03/2020,TRUE,Fuzhou General Hospital,Not Recruiting,Phase 1,Interventional,China,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,ATMP (+ Drug),Combination: Cells (mesenchymal) + Oseltamivir + Oxygen + Hormones vs. Oseltamivir + Oxygen + Hormones,60,31/12/2021,31/12/2022,https://clinicaltrials.gov/show/NCT04371601,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1740,NCT04371692,ClinicalTrials.gov,28/04/2020,01/04/2020,TRUE,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence of COVID-19 Infection Among HCW in a French University Hospital,Clinical Presentation (Epidemiology),No Intervention,100,01/09/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04371692,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1741,ChiCTR2000032400,ChiCTR,27/04/2020,01/01/2020,TRUE,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Not Applicable,Interventional,China,"the efficacy and safety of high dose intravenous vitamin C in the treatment of novel coronavirus pneumonia (COVID-19): a prospective, randomize, controlled trial",Drug,Vitamin C,120,Not Available,01/06/2020,http://www.chictr.org.cn/showproj.aspx?proj=52958,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1742,NCT04372082,ClinicalTrials.gov,30/04/2020,01/05/2020,FALSE,"University Hospital, Lille",Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19,Drug,Hydroxychloroquine vs. Diltiazem/Niclosamide,480,01/05/2023,01/05/2023,https://clinicaltrials.gov/show/NCT04372082,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1743,ACTRN12620000527965,ANZCTR,29/04/2020,01/05/2020,FALSE,Hunter New England Local Health District,Not Recruiting,Not Applicable,Observational,Australia,Neonatal CoVID-19 Study to evaluate the population health impacts of COVID-19 in mothers and their newborn infants cared for in tertiary and non-tertiary hospitals in Australia.,Clinical Presentation,No Intervention,1000,Not Available,30/11/2022,https://anzctr.org.au/ACTRN12620000527965.aspx,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1744,ACTRN12620000516987,ANZCTR,27/04/2020,02/06/2020,FALSE,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Testing a wellbeing app to support wellbeing during the Covid-19 pandemic,Other (psych),Psychological,90,Not Available,Not Available,https://anzctr.org.au/ACTRN12620000516987.aspx,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1745,ChiCTR2000032399,ChiCTR,27/04/2020,20/04/2020,TRUE,Xiaogan Traditional Chinese Medicine Hospital,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiaoyao capsule in the improvement of sleep mood disorder of convalescence patients of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,200,Not Available,01/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=52942,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1746,NCT04371835,ClinicalTrials.gov,28/04/2020,15/05/2020,FALSE,Kirby Institute,Not Recruiting,Not Applicable,Observational,No Country Given,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,Clinical Presentation,No Intervention,1500,31/12/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04371835,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1747,NCT04371926,ClinicalTrials.gov,29/04/2020,01/06/2020,FALSE,Texas Cardiac Arrhythmia Research Foundation,Not Recruiting,Not Applicable,Interventional,No Country Given,Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk,Drug (chemoprophylaxis),Hydroxychloroquine,64,01/06/2021,01/07/2021,https://clinicaltrials.gov/show/NCT04371926,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1748,ACTRN12620000524998,ANZCTR,28/04/2020,28/04/2020,FALSE,South Eastern Sydney Local Health District,Not Recruiting,Not Applicable,Interventional,Australia,Evaluation of a remote monitoring smartphone application and care model of COVID-19 patients in the community  (ReCOVER),Other (software),eHealth,2000,Not Available,30/04/2021,https://anzctr.org.au/ACTRN12620000524998.aspx,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1749,ISRCTN17898730,ISRCTN,23/04/2020,07/04/2020,TRUE,Psychosocial Innovation Network,Recruiting,Not Applicable,Interventional,Serbia,Expressive writing for the reduction of psychological difficulties during the COVID-19 pandemic,Other (psych),Psychological,150,Not Available,20/12/2020,http://isrctn.com/ISRCTN17898730,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1750,NCT04371952,ClinicalTrials.gov,27/04/2020,01/05/2020,FALSE,Nantes University Hospital,Not Recruiting,Phase 3,Interventional,France,DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19),Drug,Doxycycline,330,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04371952,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1751,NCT04372017,ClinicalTrials.gov,25/04/2020,30/04/2020,FALSE,Sanford Health,Not Recruiting,Phase 3,Interventional,No Country Given,"Randomized, Double-Blind,Controlled Trial of Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection",Drug (chemoprophylaxis),Hydroxychloroquine,1739,20/04/2022,20/04/2023,https://clinicaltrials.gov/show/NCT04372017,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1752,ISRCTN43900695,ISRCTN,08/04/2020,04/05/2020,FALSE,Northumbria University,Recruiting,Not Applicable,Interventional,United Kingdom,Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic,Other,Sleep aids,75,Not Available,06/04/2022,http://isrctn.com/ISRCTN43900695,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1753,ISRCTN10666798,ISRCTN,23/04/2020,18/03/2020,TRUE,North Bristol NHS Trust,Recruiting,Not Applicable,Observational,"United Kingdom, Ireland",The COVID-19 Emergency Response Assessment Study: a survey of the psychological health of frontline doctors in the UK and Ireland during the coronavirus pandemic,Other (psych),No Intervention,6000,Not Available,01/10/2020,http://isrctn.com/ISRCTN10666798,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1754,ChiCTR2000032368,ChiCTR,26/04/2020,15/04/2020,TRUE,China-Japan Friendship Hospital,Not Recruiting,Not Applicable,Health services research,China,Investigation on the mental health status and intervention of the medical staff of the national rescue medical team in hubei province during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,116,Not Available,31/10/2020,http://www.chictr.org.cn/showproj.aspx?proj=52933,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1755,NCT04372043,ClinicalTrials.gov,29/04/2020,30/04/2020,FALSE,Saint-Joseph University,Not Recruiting,Not Applicable,Observational,Lebanon,Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period.,Other (psych),No Intervention,1200,30/09/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04372043,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1756,ACTRN12620000512921,ANZCTR,27/04/2020,29/04/2020,FALSE,Gold Coast University Hospital,Not Recruiting,Not Applicable,Observational,Australia,SARS-CoV2 in children presenting to hospital: A repeating point prevalence study during the COVID-19 pandemic in South East Queensland,Clinical Presentation (Epidemiology),No Intervention,400,Not Available,18/09/2020,https://anzctr.org.au/ACTRN12620000512921.aspx,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1757,ChiCTR2000032573,ChiCTR,03/05/2020,02/05/2020,TRUE,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, controlled trial for Bu-Fei-Huo-Xue Capsule in the treatment of novel coronavirus pneumonia (COVID-19) convalescence patient with ''Fei-Pi-Qi-Xu zhen''",Traditional Medicine (Drug),Traditional Medicine,120,Not Available,01/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=53225,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1758,ChiCTR2000031327,ChiCTR,27/03/2020,01/04/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and death risk factors in severe novel coronavirus pneumonia (COVID-19) patients: a single-center respective analysis based on medical records,Clinical Presentation,No Intervention,120,Not Available,10/04/2020,http://www.chictr.org.cn/showproj.aspx?proj=51669,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1759,ACTRN12620000487910,ANZCTR,20/04/2020,07/04/2020,TRUE,Albury Wodonga Health,Recruiting,Not Applicable,Observational,Australia,Study evaluating Coronavirus (COVID-19) nasal/oral swab results compared to blood antibody results in COVID-19 clinic patients.,Diagnostics,Diagnostic Test or Assessment,500,Not Available,07/04/2021,https://anzctr.org.au/ACTRN12620000487910.aspx,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1760,ChiCTR2000032487,ChiCTR,29/04/2020,26/03/2020,TRUE,Shanghai Public Health Clinical Center,Not Recruiting,Phase 4,Interventional,China,Study for using sulfate in the prevention and control of novel coronavirus pneumonia (COVID-19) in high and low prevalence communities,Drug (chemoprophylaxis),Hydroxychloroquine,2000,Not Available,30/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=52394,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1761,ChiCTR2000032460,ChiCTR,29/04/2020,20/01/2020,TRUE,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Not Recruiting,Not Applicable,Diagnostic test,China,Early warning model and new biomarker of severe novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,76,Not Available,30/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=52875,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1762,ACTRN12620000517976,ANZCTR,27/04/2020,21/05/2020,FALSE,"St. Vincents Hospital, Melbourne",Not Recruiting,Phase 3,Interventional,Australia,COVID-19: Can Nebulised HepArin Reduce Time to Extubation in SARS-CoV-2 patients requiring mechanical ventilation (CHARTER Study),Drug,Heparin,172,Not Available,25/07/2021,https://anzctr.org.au/ACTRN12620000517976.aspx,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1763,NL8535,Netherlands Trial Register,15/04/2020,30/03/2020,TRUE,CIRO,Recruiting,Not Applicable,Observational,Netherlands,Functional status and health status in COVID-19 patients pre and post rehabilitation,Other (physio),Physio,30,Not Available,30/11/2020,https://trialregister.nl/trial/8535,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1764,ChiCTR2000031174,ChiCTR,23/03/2020,23/03/2020,FALSE,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Interventional,China,Effectiveness and safety of hydroxychloroquine sulfate in the preventive treatment of novel coronavirus pneumonia (COVID-19),Drug (chemoprophylaxis),Hydroxychloroquine,1000,Not Available,30/09/2020,http://www.chictr.org.cn/showproj.aspx?proj=51437,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1765,ChiCTR2000032367,ChiCTR,26/04/2020,19/02/2020,TRUE,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19):  a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,186,Not Available,31/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=52972,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1766,NL8512,Netherlands Trial Register,02/04/2020,18/03/2020,TRUE,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,"The use of ACE2 receptor increasing medication at hospital admission and
mortality rates in COVID-19 pati√´nts 
",Drug,ACE inhibitors,400,Not Available,18/09/2020,https://trialregister.nl/trial/8512,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1767,ISRCTN68026880,ISRCTN,30/04/2020,01/01/2020,TRUE,Imperial College London,Recruiting,Not Applicable,Observational,"Netherlands, Estonia, Chile, Israel, Ecuador, Czech Republic, Ireland, Romania, Belgium, Tunisia, Latvia, Uganda, Bosnia and Herzegovina, Mexico, Portugal, Hungary, Canada, United States, United Arab Emirates, Peru, Greece, Spain, India, Colombia, Austria, Italy, Qatar, Brazil, Indonesia, Egypt, Guatemala, Japan, Russian Federation, United Kingdom, Australia, South Africa, Germany, Lebanon, Thailand, Nigeria, Malta, Argentina","A global registry of women affected by COVID-19 in pregnancy and their babies, to guide treatment and prevention",Clinical Presentation,No Intervention,1000,Not Available,30/09/2021,http://isrctn.com/ISRCTN68026880,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1768,NL8513,Netherlands Trial Register,07/04/2020,13/04/2020,FALSE,Reade Research BV,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 in rheumatic patients: a prospective cohort study,Clinical Presentation,No Intervention,8000,Not Available,13/04/2021,https://trialregister.nl/trial/8513,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1769,NL8562,Netherlands Trial Register,21/04/2020,01/04/2020,TRUE,None (investigator initiated study),Not Recruiting,Not Applicable,Observational,Netherlands,Bioelectric Impedance Analysis in COVID-19 positive patients. A prospective prevalence study,Clinical Presentation,No Intervention,50,Not Available,30/04/2020,https://trialregister.nl/trial/8562,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1770,ISRCTN13311119,ISRCTN,24/04/2020,30/04/2020,FALSE,Eminentlabs GmbH,Recruiting,Phase 2,Interventional,India,START (Siddha Treatment Accelerating Recovery from SARS-CoV-2 Test) trial of Siddha treatment for patients with novel coronavirus infectious disease (COVID-19),Traditional Medicine (Drug),Traditional Medicine,116,Not Available,26/06/2020,http://isrctn.com/ISRCTN13311119,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1771,ChiCTR2000032346,ChiCTR,26/04/2020,21/04/2020,TRUE,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"Lingnan Fire-Needle Therapy Improves the Quality of Life in General Population Under the Pandemic of novel coronavirus pneumonia (COVID-19): A Prospective, Randomized Controlled Trial",Traditional Medicine (Other),Traditional Medicine,120,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=52692,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1772,NL8483,Netherlands Trial Register,26/03/2020,16/03/2020,TRUE,Fred Foundation; Noaber Foundation,Recruiting,Not Applicable,Interventional,Netherlands,A weapon against COVID-19: (Social) media and influencers,Other,Other,17000,Not Available,29/03/2020,https://trialregister.nl/trial/8483,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1773,ChiCTR2000032632,ChiCTR,04/05/2020,20/03/2020,TRUE,The First Affiliated Hospital of Xinjiang Medical University,Recruiting,Not Applicable,Interventional,China,The influence of COVID-19 pandemic on cardiovascular patients,Clinical Presentation,No Intervention,100,Not Available,22/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53190,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1774,ChiCTR2000032574,ChiCTR,03/05/2020,01/01/2020,TRUE,Ganzhou People's Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Diagnostic value of chest CT in outpatient for novel coronavirus pneumonia (COVID-19) compared to RT-PCR,Diagnostics,Diagnostic Test or Assessment,248,Not Available,29/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=53122,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1775,NL8570,Netherlands Trial Register,29/04/2020,10/05/2020,FALSE,Franciscus Gasthuis & Vlietland,Not Recruiting,Not Applicable,Observational,Netherlands,COVID-19 infections in health care workers,Clinical Presentation,No Intervention,300,Not Available,31/12/2020,https://trialregister.nl/trial/8570,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1776,NL8491,Netherlands Trial Register,31/03/2020,31/03/2020,FALSE,UMC Amsterdam,Recruiting,Not Applicable,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection (CounterCovid) study,Drug,Imatinib,386,Not Available,30/06/2020,https://trialregister.nl/trial/8491,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1777,ChiCTR2000032314,ChiCTR,25/04/2020,01/03/2020,TRUE,West China Hospital of Sichuan University,Recruiting,Not Applicable,Interventional,China,A randomized clinical trial for the efficacy and safety of Aliskiren and Nifedipine in novel coronavirus pneumonia (COVID-19) patients with hypertension,Drug,Aliskiren vs. Nifedipine,242,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=52867,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1778,ChiCTR2000032514,ChiCTR,01/05/2020,05/05/2020,FALSE,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Basic Science,China,Direct evidence of rectal cancer patient infected with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,13,Not Available,16/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53181,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1779,DRKS00021516,German Clinical Trials Register,22/04/2020,22/04/2020,FALSE,Kantonsspital Aarau,Recruiting,Not Applicable,Observational,Switzerland,Dysosmia and Dysgeusia in COVID-19 patients,Clinical Presentation,No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021516,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1780,NL8543,Netherlands Trial Register,18/04/2020,14/04/2020,TRUE,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,COVID19 ultrasound triage,Diagnostics,Diagnostic Test or Assessment,50,Not Available,01/06/2020,https://trialregister.nl/trial/8543,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1781,ChiCTR2000032480,ChiCTR,29/04/2020,29/04/2020,FALSE,China Academy of Chinese Medical Sciences,Not Recruiting,Not Applicable,Observational,China,Study on data management and diagnosis-treatment mode of TCM intervention for novel coronavirus pneumonia (COVID-19)  convalescence,Traditional Medicine (Other),Traditional Medicine,1000,Not Available,22/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=52698,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1782,ChiCTR2000032313,ChiCTR,25/04/2020,01/05/2020,FALSE,"Beijing University of Chinese Medicine, Third Affiliated Hospital",Not Recruiting,Not Applicable,Interventional,China,Study for efficacy and safety of Jie-Xing-Jun-Zi granules in the Treatment of convalescent patients of novel coronavious pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,60,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=52916,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1783,ChiCTR2000032478,ChiCTR,29/04/2020,03/02/2020,TRUE,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences",Recruiting,Not Applicable,Observational,China,TCM Intervention study for novel coronavirus pneumonia (COVID-19) patient during home/designate-unit isolation based on community prevention and control,Traditional Medicine (Other),Traditional Medicine,3000,Not Available,01/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=52777,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1784,ChiCTR2000032242,ChiCTR,24/04/2020,24/04/2020,FALSE,Mudanjiang Kang'an Hospital,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of oral kolimycin in the treatment of patients with new coronavirus pneumonia (CoVID-19)",Traditional Medicine (Drug),Traditional Medicine,350,Not Available,01/05/2021,http://www.chictr.org.cn/showproj.aspx?proj=52824,No Results,No Results,No Results,27/04/2020,29/04/2020,None
1785,ChiCTR2000032461,ChiCTR,29/04/2020,06/05/2020,FALSE,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for effect of applying individualized Chinese herbal medicine in treatment of patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,500,Not Available,31/07/2020,http://www.chictr.org.cn/showproj.aspx?proj=52482,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1786,DRKS00021521,German Clinical Trials Register,22/04/2020,22/04/2020,FALSE,Zentrum für Infektionskrankheiten,Recruiting,Not Applicable,Observational,Germany,Prevalence of COVID-19 in children aged 1-10 years in Baden-W√ºrttemberg,Clinical Presentation (Epidemiology),No Intervention,2000,Not Available,Not Available,http://www.drks.de/DRKS00021521,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1787,ChiCTR2000032459,ChiCTR,29/04/2020,29/04/2020,FALSE,Henan Provincial Center for Disease Control and Prevention,Recruiting,Phase 1/Phase 2,Interventional,China,A phase I/II clinical trial for inactivated novel coronavirus (2019-CoV) vaccine (Vero cells),ATMP,Vaccine,288,Not Available,28/11/2021,http://www.chictr.org.cn/showproj.aspx?proj=53003,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1788,NL8485,Netherlands Trial Register,27/03/2020,27/03/2020,FALSE,Mxima MC,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 during pregnancy: a prospective observational cohort,Clinical Presentation,No Intervention,20,Not Available,31/12/2020,https://trialregister.nl/trial/8485,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1789,ISRCTN77353041,ISRCTN,07/04/2020,08/04/2020,FALSE,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,Cohort study for predicting severe disease courses in patients presenting for coronavirus testing to the University of Zurich COVID-19 Testing Center,Clinical Presentation,No Intervention,2000,Not Available,31/12/2020,http://isrctn.com/ISRCTN77353041,No Results,No Results,No Results,27/04/2020,15/04/2020,None
1790,DRKS00021523,German Clinical Trials Register,27/04/2020,28/04/2020,FALSE,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,The influence of proton pump inhibitor therapy on the clinical course of COVID-19,Drug,Proton pump inhibitor,200,Not Available,Not Available,http://www.drks.de/DRKS00021523,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1791,ChiCTR2000032135,ChiCTR,20/04/2020,22/04/2020,FALSE,Shanghai Public Health Clinical Center,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of ulinastatin in the Treatment of novel coronavirus pneumonia (COVID-19),Drug,Ulinastatin,50,Not Available,31/12/2020,http://www.chictr.org.cn/showproj.aspx?proj=52506,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1792,NL8497,Netherlands Trial Register,31/03/2020,15/03/2020,TRUE,Radboud University Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Lung ultrasound vs CT scan in COVID-19 disease,Diagnostics,Diagnostic Test or Assessment,200,Not Available,30/06/2020,https://trialregister.nl/trial/8497,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1793,ISRCTN86534580,ISRCTN,22/03/2020,25/03/2020,TRUE,University of Oxford,Recruiting,Phase 3,Interventional,United Kingdom,A trial evaluating treatments for suspected coronavirus infection in people aged 50 years and above with pre-existing conditions and those aged 65 years and above,Drug,Hydroxychloroquine,3000,Not Available,24/03/2021,http://isrctn.com/ISRCTN86534580,No Results,No Results,No Results,27/04/2020,25/03/2020,EUCTR2020-001209-22
1794,DRKS00021575,German Clinical Trials Register,29/04/2020,03/05/2020,FALSE,"University Hospital, Halle (Saale)",Not Recruiting,Not Applicable,Observational,Germany,Covid-19 HOspitalized patients RegisTry,Clinical Presentation,No Intervention,750,Not Available,Not Available,http://www.drks.de/DRKS00021575,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1795,NL8551,Netherlands Trial Register,23/04/2020,23/04/2020,FALSE,Zuyderland Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Covid High-intensity Immunosuppression in Cytokine release syndrome,Drug,Corticosteroids + Tocilizumab,160,Not Available,31/07/2020,https://trialregister.nl/trial/8551,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1796,DRKS00021578,German Clinical Trials Register,28/04/2020,24/04/2020,TRUE,Universität Konstanz,Recruiting,Not Applicable,Observational,Germany,Validation of new detection methods for SARS CoV-2 in suspected COVID-19,Diagnostics,Diagnostic Test or Assessment,300,Not Available,Not Available,http://www.drks.de/DRKS00021578,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1797,EUCTR2020-001329-30-AT,EU Clinical Trials Register,03/04/2020,09/04/2020,FALSE,Massachusetts General Hospital,Authorised,Phase 4,Interventional,"China, United States, Austria",Therapy with Inhaled Nitric Oxide for Patients Infected with Coronavirus Suffering form Lung Failure,Drug,Nitric oxide,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001329-30,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1798,NL8501,Netherlands Trial Register,01/04/2020,23/03/2020,TRUE,Interactive Studios,Recruiting,Not Applicable,Observational,Netherlands,"Using eHealth to support COVID-19 education, self-assessment and symptom tracking.",Other (software),eHealth,2000,Not Available,30/06/2020,https://trialregister.nl/trial/8501,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1799,DRKS00021537,German Clinical Trials Register,30/04/2020,17/04/2020,TRUE,Stuttgart Hospital,Recruiting,Not Applicable,Observational,Germany,Long term Analysis and Evaluation of morphologic and clinical Parameters in COVID-19 Patients: prospective development of a practical risk score,Clinical Presentation,No Intervention,150,Not Available,Not Available,http://www.drks.de/DRKS00021537,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1800,DRKS00021447,German Clinical Trials Register,27/04/2020,01/05/2020,FALSE,Charité University,Not Recruiting,Phase 2,Interventional,Germany,CytoResc - CytoSorb Rescue for COVID-19 Cytokine Storm,Other (device),Cytokine Adsorber,100,Not Available,Not Available,http://www.drks.de/DRKS00021447,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1801,DRKS00021522,German Clinical Trials Register,22/04/2020,21/04/2020,TRUE,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,Local and systemic markers of inflammation and circadian rhythmicity in COVID-19 disease and their role in the prediction of clinical outcome,Clinical Presentation,No Intervention,50,Not Available,Not Available,http://www.drks.de/DRKS00021522,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1802,DRKS00021585,German Clinical Trials Register,29/04/2020,24/04/2020,TRUE,Vivantes Humboldt Klinikum,Recruiting,Not Applicable,Interventional,Germany,Lung Ultrasound in Covid-19 Pneumonia,Diagnostics,Diagnostic Test or Assessment,220,Not Available,Not Available,http://www.drks.de/DRKS00021585,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1803,EUCTR2020-001375-32-NL,EU Clinical Trials Register,03/04/2020,03/04/2020,TRUE,University Medical Center Groningen,Authorised,Phase 2,Interventional,Netherlands,Early intervention with Tocilizumab in patients with COVID-19 and hypoxia,Drug,Tocilizumab,354,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001375-32,No Results,No Results,No Results,29/04/2020,29/04/2020,NL8504
1804,NL8523,Netherlands Trial Register,13/04/2020,26/04/2020,FALSE,UMC Utrecht,Not Recruiting,Not Applicable,Interventional,Netherlands,Volatile Anaesthetics in COVID-19 ‚Äì a pilot study,Drug,Isoflurane,20,Not Available,31/05/2020,https://trialregister.nl/trial/8523,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1805,NL8563,Netherlands Trial Register,22/04/2020,22/04/2020,FALSE,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Patient‚Äôs knowledge And behavior oN the COVID-19 disease and as DEterMInants of Contamination,Other,No Intervention,170,Not Available,21/08/2020,https://trialregister.nl/trial/8563,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1806,DRKS00021527,German Clinical Trials Register,24/04/2020,14/04/2020,TRUE,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of online support during the coronavirus (COVID-19) pandemic: a group chat program in the psychiatric outpatient clinic of the Leipzig University Hospital,Other (psych),Psychological,100,Not Available,Not Available,http://www.drks.de/DRKS00021527,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1807,DRKS00021255,German Clinical Trials Register,28/04/2020,01/05/2020,FALSE,Private Universitt Witten/Herdecke gGmbH,Not Recruiting,Not Applicable,Observational,Germany,Point-of-care coagulation testing in patients suffering from COVID-19,Diagnostics,Diagnostic Test or Assessment,20,Not Available,Not Available,http://www.drks.de/DRKS00021255,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1808,NL8529,Netherlands Trial Register,14/04/2020,01/05/2020,FALSE,MCC Omnes (Sittard),Not Recruiting,Not Applicable,Observational,Netherlands,General practice cooperative COVID-19 centre Urmond,Health System,No Intervention,2000,Not Available,03/01/2022,https://trialregister.nl/trial/8529,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1809,DRKS00021514,German Clinical Trials Register,24/04/2020,26/04/2020,FALSE,Forschung in der Operativen Medizin (IFOM),Not Recruiting,Not Applicable,Observational,Germany,Database for diagnosis and therapy of COVID-19 infected patients,Clinical Presentation,No Intervention,150,Not Available,Not Available,http://www.drks.de/DRKS00021514,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1810,NL8572,Netherlands Trial Register,30/04/2020,19/04/2020,TRUE,University Medical Center Groningen,Recruiting,Not Applicable,Observational,Netherlands,Prevalence of asymptomatic deep vein thrombosis in admitted COVID-19 patients,Clinical Presentation,No Intervention,100,Not Available,19/04/2021,https://trialregister.nl/trial/8572,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1811,DRKS00021254,German Clinical Trials Register,03/04/2020,05/04/2020,FALSE,Universitätsklinikum Schleswig-Holstein,Recruiting,Not Applicable,Observational,Germany,"Investigation of the influence of the new coronavirus pandemic (COVID-19) on pain, mood and everyday life of patients with painful polyneuropathy",Other (psych),No Intervention,50,Not Available,Not Available,http://www.drks.de/DRKS00021254,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1812,EUCTR2020-001527-14-NL,EU Clinical Trials Register,06/04/2020,21/04/2020,FALSE,Erasmus MC,Authorised,Phase 4,Interventional,Netherlands,COVID-19: addition of azithromycin to chloroquine treatment,Drug,Combination: Chloroquine + Azithromycin,60,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001527-14,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1813,NL8547,Netherlands Trial Register,22/04/2020,16/04/2020,TRUE,Radboud University Medical Centre,Recruiting,Not Applicable,Interventional,Netherlands,"REDUCING HOSPITAL ADMISSION OF ELDERLY IN SARS-CoV-2 PANDEMIC VIA THE INDUCTION OF TRAINED IMMUNITY BY BACILLUS CALMETTE-GU√âRIN VACCINATION, A RANDOMIZED CONTROLLED TRIAL",ATMP,Vaccine,1600,Not Available,18/04/2022,https://trialregister.nl/trial/8547,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1814,DRKS00021573,German Clinical Trials Register,27/04/2020,30/04/2020,FALSE,"University Hospital, Heidelberg",Not Recruiting,Phase 1,Interventional,Germany,"Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Covid-19",Drug,Combination: Proton pump inhibitor + Hydoxychloroquine + Midazolam + Yohimbine vs. Hydoxychloroquine + Midazolam + Yohimbine,24,Not Available,Not Available,http://www.drks.de/DRKS00021573,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1815,DRKS00021220,German Clinical Trials Register,01/04/2020,05/04/2020,FALSE,"University Hospital, Heidelberg",Not Recruiting,Not Applicable,Observational,Germany,Evaluation of the performance of novel rapid diagnostics for COVID-19 at point-of-care,Diagnostics,Diagnostic Test or Assessment,2000,Not Available,Not Available,http://www.drks.de/DRKS00021220,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1816,NL8526,Netherlands Trial Register,14/04/2020,26/04/2020,FALSE,Zuyderland Medical Centre,Not Recruiting,Not Applicable,Observational,Netherlands,Neuroinvasion in COVID-19,Clinical Presentation,No Intervention,10,Not Available,26/06/2020,https://trialregister.nl/trial/8526,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1817,DRKS00021214,German Clinical Trials Register,01/04/2020,06/04/2020,FALSE,"University Hospital, Schleswig-Holstein",Not Recruiting,Not Applicable,Interventional,Germany,Improvement of the nutritional status regarding nicotinamide (vitamin B3) and the course of COVID-19 disease,Drug,Vitamin B3,1300,Not Available,Not Available,http://www.drks.de/DRKS00021214,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1818,EUCTR2020-001363-85-DK,EU Clinical Trials Register,17/04/2020,23/04/2020,FALSE,Odense University Hospital,Authorised,Phase 3,Interventional,Denmark,Medication for prevention of Corona-virus for Danish nursing home residents,Drug (Chemoprophylaxis),Hydroxychloroquine,206,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001363-85,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1819,DRKS00021145,German Clinical Trials Register,08/04/2020,16/03/2020,TRUE,Deutsches Zentrum für Infektionsforschung (DZIF) e. V.,Recruiting,Not Applicable,Observational,"Germany, Austria, Italy, Portugal, Iceland, Switzerland, France, Ireland, United Kingdom, Belgium, Spain","Lean European Open Survey on 
SARS-CoV-2 (COVID-19)",Clinical Presentation,No Intervention,20000,Not Available,Not Available,http://www.drks.de/DRKS00021145,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1820,NL8460,Netherlands Trial Register,16/03/2020,16/03/2020,FALSE,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Biomarkers for prognosis in critically ill COVID-19 patients : a prospective cohort study,Prognosis,No Intervention,100,Not Available,16/08/2020,https://trialregister.nl/trial/8460,No Results,No Results,No Results,04/05/2020,25/03/2020,None
1821,DRKS00021166,German Clinical Trials Register,27/03/2020,30/03/2020,FALSE,University Hospital Leipzig,Not Recruiting,Not Applicable,Observational,Germany,Development of a test to measure the immune response in patients with Covid-19,Clinical Presentation,No Intervention,15,Not Available,Not Available,http://www.drks.de/DRKS00021166,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1822,EUCTR2020-001255-40-ES,EU Clinical Trials Register,20/04/2020,16/04/2020,TRUE,Clínica Universidad de Navarra,Authorised,Phase 2,Interventional,Spain,Sarilumab Treatment In cytoKinE storm caused by infection with COVID-19.,Drug,Sarilumab,60,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001255-40,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1823,NL8473,Netherlands Trial Register,23/03/2020,23/03/2020,FALSE,National Institute for Public Health and the Environment (RIVM),Not Recruiting,Not Applicable,Observational,Netherlands,Immunity against SARS-CoV-2 in Dutch population,Clinical Presentation,No Intervention,4000,Not Available,23/09/2021,https://trialregister.nl/trial/8473,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1824,EUCTR2020-001659-42-ES,EU Clinical Trials Register,20/04/2020,18/04/2020,TRUE,Fundación para la Investigación Biomédica de Córdoba,Authorised,Phase 2,Interventional,Spain,Study of antithrombin as prophylaxis of acute respiratory disease in patients with COVID-19,Drug (Chemoprophylaxis),Antithrombin,46,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001659-42,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1825,DRKS00021152,German Clinical Trials Register,07/04/2020,05/04/2020,TRUE,Medizinische Hochschule Hannover,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Contact Study - Immunoreaction after possible SARS-CoV-2 / COVID-19 contact,Clinical Presentation (Epidemiology),No Intervention,1000,Not Available,Not Available,http://www.drks.de/DRKS00021152,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1826,NL8490,Netherlands Trial Register,31/03/2020,12/04/2020,FALSE,UMC Utrecht,Not Recruiting,Not Applicable,Interventional,Netherlands,"An open label randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19
",Drug,Chloroquine vs. hydroxychloroquine,950,Not Available,12/04/2021,https://trialregister.nl/trial/8490,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1827,DRKS00021161,German Clinical Trials Register,07/04/2020,15/02/2020,TRUE,Abteilung für Krankenhaushygiene,Recruiting,Not Applicable,Observational,Germany,Demographic and epidemiological characteristics of Covid-19 disease in Helios-Hospital and determinants of clinical course,Clinical Presentation (Epidemiology),No Intervention,1000,Not Available,Not Available,http://www.drks.de/DRKS00021161,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1828,DRKS00021443,German Clinical Trials Register,28/04/2020,23/04/2020,TRUE,University of Oldenburg,Recruiting,Not Applicable,Observational,Germany,Feasibility and usability of video-based physical therapy for older people in the context of the COVID-19 pandemic,Other (physio),Physio,30,Not Available,Not Available,http://www.drks.de/DRKS00021443,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1829,DRKS00021186,German Clinical Trials Register,26/03/2020,26/03/2020,FALSE,KKH Bergstraße Abteilung,Recruiting,Not Applicable,Observational,Germany,"prospective observational study to evaluate transpulmonary pressure, end expiratory lung volume and intraabdominal pressure in mechanical ventilated patients with Covid-19",Clinical Presentation,No Intervention,45,Not Available,Not Available,http://www.drks.de/DRKS00021186,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1830,DRKS00021605,German Clinical Trials Register,28/04/2020,27/04/2020,TRUE,Klinikum Konstanz II. Medizin,Recruiting,Not Applicable,Observational,Germany,"COVID-19 in an academic teaching hospital in Konstanz/Germany - evaluation of the ""double rule out - single rule in"" concept (DURO-SIN)",Prognosis,No Intervention,200,Not Available,Not Available,http://www.drks.de/DRKS00021605,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1831,EUCTR2020-001536-98-ES,EU Clinical Trials Register,20/04/2020,18/04/2020,TRUE,Mútua Terrassa University Hospital,Authorised,Phase 3,Interventional,Spain,"Prophylaxis of COVID-19 infection with hydroxychloroquine in healthcare
personnel with high risk of infection.",Drug (Chemoprophylaxis),Hydroxychloroquine,300,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001536-98,No Results,No Results,No Results,29/04/2020,29/04/2020,None
1832,EUCTR2020-001678-31-FR,EU Clinical Trials Register,17/04/2020,28/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 3,Interventional,France,"Randomized controlled trial evaluating the efficacy of vaccination with Bacillus Calmette and Gu√©rin (BCG) in the Prevention of COVID-19 via the strengthening of innate immunity in Health Care Workers.‚Äù
COVID-BCG",ATMP,Vaccine,1120,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001678-31,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1833,DRKS00021301,German Clinical Trials Register,16/04/2020,23/04/2020,FALSE,Universität Duisburg-Essen,Not Recruiting,Not Applicable,Interventional,Germany,An e-Mental Health Intervention to Support burdened People in Times of the COVID-19 pandemic: CoPE It,Other (psych),Psychological,90,Not Available,Not Available,http://www.drks.de/DRKS00021301,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1834,EUCTR2020-001734-36-FR,EU Clinical Trials Register,15/04/2020,20/04/2020,FALSE,CHU de Tours,Authorised,Phase 3,Interventional,France,Efficacy and safety of ANAkinra during Adult ¬´ COVID-19 ¬ª with Aggravating respiratory symptoms: a multicenter open-label controlled randomized trial,Drug,Anakinra,240,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001734-36,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1835,DRKS00021416,German Clinical Trials Register,30/04/2020,29/04/2020,TRUE,Klinik for Ophthalmologie,Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 in tears in patients with COVID-19,Clinical Presentation,No Intervention,30,Not Available,Not Available,http://www.drks.de/DRKS00021416,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1836,DRKS00021300,German Clinical Trials Register,08/04/2020,29/03/2020,TRUE,"University Hospital, Freiburg",Recruiting,Phase 2/Phase 3,Interventional,Germany,Cytokine adsorption in severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation,Drug,Oxygen,30,Not Available,Not Available,http://www.drks.de/DRKS00021300,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1837,EUCTR2020-001722-66-ES,EU Clinical Trials Register,27/04/2020,23/04/2020,TRUE,Fundació Clínic per a la Recerca Biomèdica,Authorised,Phase 2,Interventional,Spain,Plasma turnover in patients with COVID-19 disease and invasive mechanical ventilation,ATMP,Plasma,116,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001722-66,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1838,DRKS00021276,German Clinical Trials Register,06/04/2020,12/04/2020,FALSE,"University Hospital, Rostock",Not Recruiting,Not Applicable,Observational,Germany,Dynamics of regional lung aeration non-invasive determined by electrical impedance tomography in patients with COVID 19,Clinical Presentation,No Intervention,24,Not Available,Not Available,http://www.drks.de/DRKS00021276,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1839,DRKS00021395,German Clinical Trials Register,17/04/2020,20/04/2020,FALSE,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,The effects of the COVID-19 pandemic on mental health,Other (psych),No Intervention,60,Not Available,Not Available,http://www.drks.de/DRKS00021395,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1840,EUCTR2020-001500-41-BE,EU Clinical Trials Register,04/04/2020,03/04/2020,TRUE,"University Hospital, Ghent",Authorised,Phase 3,Interventional,Belgium,Treatment of COVID-19 patients with anti-interleukin drugs,Drug,Anakinra or tocilizumab or siltuximab,342,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001500-41,No Results,No Results,No Results,29/04/2020,04/07/2020,None
1841,EUCTR2020-001505-22-ES,EU Clinical Trials Register,27/04/2020,23/04/2020,TRUE,Banc de Sang i Teixits,Authorised,Phase 1/Phase 2,Interventional,Spain,Efficacy and safety evaluation of umbilical cord mesenchymal stem cells for the treatment of patients with respiratory failure due to coronavirus (COVID-19),ATMP,Cells (mesenchymal),30,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001505-22,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1842,NCT04303507,ClinicalTrials.gov,06/03/2020,01/04/2020,FALSE,University of Oxford,Not Recruiting,Not Applicable,Interventional,No Country Given,Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting,Drug,Chloroquine or Hydroxychloroquine,40000,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04303507,No Results,No Results,No Results,04/05/2020,18/03/2020,None
1843,DRKS00021270,German Clinical Trials Register,15/04/2020,14/04/2020,TRUE,Krankenhaus Reinbek St. Adolf-Stift,Not Recruiting,Not Applicable,Observational,Germany,Prospective molecular biological and serological examination for the detection of SARS-CoV-2 (COVID-19) in employees of a hospital of regular care in Germany,Clinical Presentation,No Intervention,800,Not Available,Not Available,http://www.drks.de/DRKS00021270,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1844,DRKS00021591,German Clinical Trials Register,27/04/2020,03/05/2020,FALSE,Bundeswehrkrankenhaus Berlin,Not Recruiting,Not Applicable,Observational,Germany,Identification of predictive biomarkers for severe progression of COVID-19,Clinical Presentation,No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021591,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1845,EUCTR2020-001541-39-ES,EU Clinical Trials Register,27/04/2020,24/04/2020,TRUE,Fundación para la Investigación Biomédica de Córdoba,Authorised,Phase 2,Interventional,Spain,Pilot study of bevacizumab as a treatment for respiratory distress in patients with COVID-19,Drug,Bevacizumab,22,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001541-39,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1846,NCT04311177,ClinicalTrials.gov,13/03/2020,09/04/2020,FALSE,University of Minnesota,Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Not Requiring Hospitalization,Drug,ARB (Losartan),580,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04311177,No Results,No Results,No Results,04/05/2020,25/03/2020,None
1847,NCT04311697,ClinicalTrials.gov,14/03/2020,01/04/2020,FALSE,"NeuroRx, Inc.",Not Recruiting,Phase 2,Interventional,"United States, Israel",Intravenous Aviptadil for COVID-19 Associated Acute Respiratory Distress,Drug,Aviptadil,120,01/08/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04311697,No Results,No Results,No Results,04/05/2020,25/03/2020,None
1848,EUCTR2020-001618-39-ES,EU Clinical Trials Register,27/04/2020,24/04/2020,TRUE,Oryzon Genomics S. A.,Authorised,Phase 2,Interventional,Spain,Study to evaluate the efficacy and tolerability of treatment with vafidemstat in combination with standard of care treatment to prevent Acute Respiratory Distress Syndrome in adult severely ill patients with COVID-19.,Drug,Vafidemstat,40,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001618-39,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1849,DRKS00021206,German Clinical Trials Register,30/03/2020,26/03/2020,TRUE,Universitäts-Herzzentrum Freiburg Bad Krozingen,Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry Freiburg,Clinical Presentation,No Intervention,400,Not Available,Not Available,http://www.drks.de/DRKS00021206,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1850,NCT04318301,ClinicalTrials.gov,20/03/2020,21/03/2020,FALSE,Zhenhua Zen,Not Recruiting,Not Applicable,Observational,China,Hypertension in Patients Hospitalized With COVID-19,Clinical Presentation,No Intervention,275,28/03/2020,30/03/2020,https://clinicaltrials.gov/show/NCT04318301,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1851,NCT04320472,ClinicalTrials.gov,22/03/2020,23/03/2020,FALSE,Ictal Group,Recruiting,Not Applicable,Observational,"France, United States, Spain",Acute Encephalopathy in Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,250,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04320472,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1852,NCT04320615,ClinicalTrials.gov,23/03/2020,03/04/2020,TRUE,Roche,Recruiting,Phase 3,Interventional,"United States, Germany, Italy, Netherlands, Canada, France, Denmark, United Kingdom, Spain",A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia,Drug,Tocilizumab,330,31/08/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04320615,No Results,No Results,No Results,04/05/2020,04/01/2020,EUCTR2020-001154-22
1853,DRKS00021134,German Clinical Trials Register,19/03/2020,20/03/2020,FALSE,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Observational,Germany,Identification of host cell respiratory tract cell gene expression and epigenetic pattern after human SARS-CoV-2 infection (COVID-19),Genomics,No Intervention,60,Not Available,Not Available,http://www.drks.de/DRKS00021134,No Results,No Results,No Results,04/05/2020,25/03/2020,None
1854,DRKS00021208,German Clinical Trials Register,31/03/2020,03/04/2020,FALSE,Vorstand der Deutschen Gesellschaft for Perinatale Medizin (DGPM),Recruiting,Not Applicable,Observational,Germany,COVID-19 related obstetric and neonatal outcome study (CRONOS),Clinical Presentation,No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021208,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1855,NCT04320862,ClinicalTrials.gov,23/03/2020,03/04/2020,FALSE,Duke University,Recruiting,Not Applicable,Observational,United States,COVID-19 Pandemic Response Network,Clinical Presentation (Epidemiology),No Intervention,200000,31/12/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04320862,No Results,No Results,No Results,04/05/2020,04/01/2020,None
1856,NCT04325906,ClinicalTrials.gov,26/03/2020,02/04/2020,FALSE,Rush University Medical Center,Recruiting,Not Applicable,Interventional,United States,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,Other (device),high flow nasal cannula (HFNC),346,31/05/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04325906,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1857,EUCTR2020-001686-36-FR,EU Clinical Trials Register,14/04/2020,23/04/2020,FALSE,Assistance Publique – Hôpitaux de Marseille,Authorised,Phase 2,Interventional,France,"A double-blind, randomized study versus placebo of avdoralimab (IPH5401), an anti-C5aR antibody, in patients with COVID-19 induced pneumonia",Drug,Avdoralimab,116,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001686-36,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1858,DRKS00021225,German Clinical Trials Register,01/04/2020,02/04/2020,FALSE,Klinikum der Universität München,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry of the LMU Hospital Munich,Clinical Presentation,No Intervention,1500,Not Available,Not Available,http://www.drks.de/DRKS00021225,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1859,DRKS00021231,German Clinical Trials Register,02/04/2020,03/04/2020,FALSE,Paracelsus Medical University ,Not Recruiting,Not Applicable,Observational,"Germany, Austria",Accompanying monitoring of primary care in GP practices during the COVID-19 pandemic,Health System,No Intervention,2000,Not Available,Not Available,http://www.drks.de/DRKS00021231,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1860,DRKS00021153,German Clinical Trials Register,06/04/2020,07/04/2020,FALSE,Leuphana Universität Lüneburg,Recruiting,Not Applicable,Interventional,Germany,get.calm and move.on ‚Äì tackling worries and finding strength for the crisis (COVID-19) in 10 steps,Other (psych),Psychological,352,Not Available,Not Available,http://www.drks.de/DRKS00021153,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1861,EUCTR2020-001717-20-ES,EU Clinical Trials Register,27/04/2020,20/04/2020,TRUE,Fundación para la Investigación Biomédica de Córdoba,Authorised,Phase 2,Interventional,Spain,Prevention and treatment with Calcifediol of respiratory problems caused by COVID-19,Drug,Calcifediol,1008,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001717-20,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1862,NCT04328480,ClinicalTrials.gov,30/03/2020,17/04/2020,FALSE,Estudios Clínicos Latino América,Recruiting,Phase 3,Interventional,Argentina,The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.,Drug,Colchicine,2500,30/06/2020,30/08/2020,https://clinicaltrials.gov/show/NCT04328480,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1863,NCT04328493,ClinicalTrials.gov,27/03/2020,07/04/2020,FALSE,University of Oxford,Recruiting,Phase 2,Interventional,Vietnam,The Vietnam Chloroquine Treatment on COVID-19,Drug,Chloroquine,250,01/04/2021,01/04/2022,https://clinicaltrials.gov/show/NCT04328493,No Results,No Results,No Results,04/05/2020,04/07/2020,None
1864,DRKS00021268,German Clinical Trials Register,09/04/2020,20/04/2020,FALSE,"University Hospital, Erlangen",Not Recruiting,Not Applicable,Observational,Germany,VOICE: Online-Survey on distress and mental resources of medical health care workers during Covid-19-pandemic,Other (psych),No Intervention,2000,Not Available,Not Available,http://www.drks.de/DRKS00021268,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1865,NCT04333914,ClinicalTrials.gov,01/04/2020,15/04/2020,TRUE,Centre Leon Berard,Recruiting,Phase 2,Interventional,France,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection,Drug,Chloroquine + Nivolumab + Tocilizumab,273,01/06/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04333914,No Results,No Results,No Results,04/05/2020,04/06/2020,EUCTR2020-001373-70
1866,DRKS00021273,German Clinical Trials Register,20/04/2020,25/04/2020,FALSE,Goethe University Frankfurt,Recruiting,Not Applicable,Interventional,"Germany, Austria, Italy, Brazil, Chile, France, Singapore, Spain, Argentina",Effects of digital home exercise programs on physical and mental well-being during the COVID-19 pandemic: a multi-center trial,Other (exercise),Exercise,544,Not Available,Not Available,http://www.drks.de/DRKS00021273,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1867,NCT04334265,ClinicalTrials.gov,01/04/2020,01/04/2020,FALSE,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,Traditional Medicine (Drug),Traditional Medicine,750,01/06/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04334265,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1868,NCT04335305,ClinicalTrials.gov,31/03/2020,14/04/2020,FALSE,MedSIR,Recruiting,Phase 2,Interventional,Spain,Checkpoint Blockade in COVID-19 Pandemic,Drug,Combination: Tocilizumab + Pembrolizumab,24,15/05/2020,15/05/2020,https://clinicaltrials.gov/show/NCT04335305,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1869,DRKS00021612,German Clinical Trials Register,30/04/2020,30/03/2020,TRUE,Technische Universität München,Recruiting,Not Applicable,Observational,Germany,CORRECT: COvid (Covid-19) Registry REChts der Isar intensive care Trial,Clinical Presentation,No Intervention,500,Not Available,Not Available,http://www.drks.de/DRKS00021612,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1870,EUCTR2020-001770-30-BE,EU Clinical Trials Register,15/04/2020,21/04/2020,FALSE,CHU Ambroise Paré,Authorised,Phase 2,Interventional,Belgium,Experimental use of tocilizumab in COVID-19 related pneumonia.,Drug,Tocilizumab,60,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001770-30,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1871,NCT04335786,ClinicalTrials.gov,02/04/2020,01/04/2020,TRUE,Radboud University,Recruiting,Phase 4,Interventional,Netherlands,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,Drug,Valsartan,651,01/10/2020,01/10/2021,https://clinicaltrials.gov/show/NCT04335786,No Results,No Results,No Results,04/05/2020,15/04/2020,EUCTR2020-001320-34
1872,NCT04338932,ClinicalTrials.gov,07/04/2020,17/04/2020,FALSE,Jessa Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 and Deep Venous Thrombosis,Clinical Presentation,No Intervention,12,30/09/2020,30/12/2020,https://clinicaltrials.gov/show/NCT04338932,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1873,EUCTR2020-001198-55-DK,EU Clinical Trials Register,21/03/2020,03/04/2020,FALSE,Chronic Obstructive Pulmonary Disease Trial Network,Authorised,Phase 2,Interventional,Denmark,Early Treatment to Patients with Coronavirus (COVID),Drug,Combination: Hydroxychloroquine + Azithromycin,226,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001198-55,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1874,EUCTR2020-001408-41-DE,EU Clinical Trials Register,07/04/2020,21/04/2020,TRUE,"University Hospital, Freiburg",Authorised,Phase 2,Interventional,Germany,Evaluation of efficacy and safety of an tocilizumab treatment in patients with severe COVID-19 pneumonia,Drug,Tocilizumab,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001408-41,No Results,No Results,No Results,04/05/2020,29/04/2020,DRKS00021238
1875,EUCTR2020-001823-15-FR,EU Clinical Trials Register,15/04/2020,28/04/2020,FALSE,CHU de Saint Etienne,Authorised,Phase 4,Interventional,France,Evaluation of the concentration-effect relationship of enoxaparin for thromboembolic prevention in COVID-19 resuscitation patients. COV-ENOX study,Drug,Enoxaparine,200,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001823-15,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1876,NCT04338958,ClinicalTrials.gov,07/04/2020,22/04/2020,FALSE,University of Jena,Recruiting,Phase 2,Interventional,Germany,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,Drug,Ruxolitinib,200,31/01/2021,31/08/2021,https://clinicaltrials.gov/show/NCT04338958,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1877,NCT04341116,ClinicalTrials.gov,04/04/2020,11/04/2020,FALSE,I-Mab Biopharma Co. Ltd.,Recruiting,Phase 1/Phase 2,Interventional,United States,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),Drug,TJ003234,144,01/09/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04341116,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1878,NCT04341389,ClinicalTrials.gov,07/04/2020,12/04/2020,FALSE,"Insitute of Biotechnology, Academy of Military Medical Sciences, PLA of China",Not Recruiting,Phase 2,Interventional,China,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),ATMP,Vaccine,500,31/01/2021,31/01/2021,https://clinicaltrials.gov/show/NCT04341389,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1879,NCT04341493,ClinicalTrials.gov,07/04/2020,06/04/2020,TRUE,Hugo Mendieta Zeron,Recruiting,Phase 4,Interventional,Mexico,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,Drug,Hydroxychloroquine vs. Nitazoxanide,86,30/08/2020,30/12/2020,https://clinicaltrials.gov/show/NCT04341493,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1880,NCT04343651,ClinicalTrials.gov,31/03/2020,01/04/2020,FALSE,"CytoDyn, Inc.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19,Drug,Leronlimab,75,04/12/2020,04/04/2021,https://clinicaltrials.gov/show/NCT04343651,No Results,No Results,No Results,04/05/2020,15/04/2020,None
1881,NCT04344587,ClinicalTrials.gov,08/04/2020,01/04/2020,TRUE,Boston University,Recruiting,Not Applicable,Interventional,United States,COVID-19 smArtphone-based Trial of Non-ICU Admission Prone Positioning,Procedure,Positioning,380,01/09/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04344587,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1882,NCT04344977,ClinicalTrials.gov,13/04/2020,15/05/2020,FALSE,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,"United States Minor Outlying Islands, United States",Collection of Anti-SARS-CoV-2 Immune Plasma,ATMP,Plasma,1500,01/07/2024,01/04/2025,https://clinicaltrials.gov/show/NCT04344977,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1883,NCT04345419,ClinicalTrials.gov,11/04/2020,30/04/2020,FALSE,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,A Real-life Experience on Treatment of Patients With COVID 19,Drug,Chloroquine vs. Favipiravir vs. Nitazoxanide vs. Ivermectin vs. Niclosamide,120,01/12/2029,01/12/2029,https://clinicaltrials.gov/show/NCT04345419,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1884,NCT04346667,ClinicalTrials.gov,13/04/2020,14/04/2020,FALSE,"Government of Punjab, Specialized Healthcare and Medical Education Department",Recruiting,Phase 4,Interventional,Pakistan,Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Chloroquine ,400,30/05/2020,30/06/2021,https://clinicaltrials.gov/show/NCT04346667,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1885,NCT04346797,ClinicalTrials.gov,06/04/2020,16/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 2,Interventional,France,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort",Drug,Eculizumab,120,30/09/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04346797,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1886,NCT04348370,ClinicalTrials.gov,30/03/2020,20/04/2020,FALSE,Texas A&M University,Recruiting,Phase 4,Interventional,United States,BCG Vaccine for Health Care Workers as Defense Against COVID 19,ATMP,Vaccine,1800,01/05/2021,01/11/2021,https://clinicaltrials.gov/show/NCT04348370,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1887,NCT04348409,ClinicalTrials.gov,03/04/2020,12/04/2020,FALSE,Azidus Brasil,Recruiting,Not Applicable,Interventional,Brazil,Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19,Drug,Nitazoxanide,50,31/05/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04348409,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1888,NCT04348435,ClinicalTrials.gov,14/04/2020,23/04/2020,FALSE,Hope Biosciences,Recruiting,Phase 2,Interventional,United States,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",ATMP,Cells (mesenchymal),100,31/12/2020,30/04/2021,https://clinicaltrials.gov/show/NCT04348435,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1889,NCT04348474,ClinicalTrials.gov,13/04/2020,20/04/2020,FALSE,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19,Drug,Combination: Hydroxychloroquine + Azithromycin ,200,30/06/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04348474,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1890,NCT04349631,ClinicalTrials.gov,06/04/2020,07/05/2020,FALSE,Hope Biosciences,Recruiting,Phase 2,Interventional,United States,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,ATMP,Cells (mesenchymal),56,31/12/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04349631,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1891,NCT04350073,ClinicalTrials.gov,14/04/2020,20/04/2020,FALSE,Duke University,Recruiting,Not Applicable,Interventional,United States,Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID),Clinical Presentation,No Intervention,120,01/10/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04350073,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1892,NCT04351139,ClinicalTrials.gov,15/04/2020,01/04/2020,TRUE,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Pandemic in Gynecological Oncology,Clinical Presentation,No Intervention,400,01/05/2020,01/05/2020,https://clinicaltrials.gov/show/NCT04351139,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1893,NCT04351191,ClinicalTrials.gov,14/04/2020,15/04/2020,FALSE,"Government of Punjab, Specialized Healthcare and Medical Education Department",Recruiting,Phase 4,Interventional,Pakistan,PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Chloroquine ,400,30/05/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04351191,No Results,No Results,No Results,04/05/2020,22/04/2020,None
1894,NCT04351503,ClinicalTrials.gov,15/04/2020,09/04/2020,TRUE,"University Hospital, Basel",Recruiting,Not Applicable,Observational,Switzerland,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19,Clinical Presentation (Epidemiology),No Intervention,10000,01/04/2022,01/04/2022,https://clinicaltrials.gov/show/NCT04351503,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1895,NCT04352465,ClinicalTrials.gov,15/04/2020,01/05/2020,FALSE,Azidus Brasil,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients,Drug,Methotrexate,42,30/06/2020,30/11/2020,https://clinicaltrials.gov/show/NCT04352465,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1896,NCT04353180,ClinicalTrials.gov,10/04/2020,01/04/2020,TRUE,Kafrelsheikh University,Not Recruiting,Phase 3,Interventional,Egypt,Assessment the Activity Value of 13- Cis-Retinoic Acid (Isotretinoin) in the Treatment of COVID-19 (Randomized),Drug,Isotretinoin,45,01/06/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04353180,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1897,NCT04353271,ClinicalTrials.gov,25/03/2020,17/04/2020,FALSE,University of South Alabama,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Trial of Hydroxychloroquine In Covid-19 Kinetics,Drug,Hydroxychloroquine,58,01/07/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04353271,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1898,NCT04354259,ClinicalTrials.gov,16/04/2020,21/04/2020,FALSE,"University Health Network, Toronto",Not Recruiting,Phase 2,Interventional,Canada,Interferon Lambda for Immediate Antiviral Therapy at Diagnosis,Drug,Interferon lambda,140,01/08/2020,30/11/2020,https://clinicaltrials.gov/show/NCT04354259,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1899,NCT04354792,ClinicalTrials.gov,16/04/2020,25/04/2020,FALSE,Kasr El Aini Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Asymptomatic COVID-19 Infection Among Healthcare Workers,Diagnostics,Diagnostic Test or Assessment,1000,30/06/2020,10/07/2020,https://clinicaltrials.gov/show/NCT04354792,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1900,NCT04354818,ClinicalTrials.gov,16/04/2020,27/04/2020,FALSE,Kirby Institute,Not Recruiting,Not Applicable,Observational,No Country Given,Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA),Clinical Presentation,No Intervention,1000,27/04/2022,27/04/2022,https://clinicaltrials.gov/show/NCT04354818,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1901,NCT04354831,ClinicalTrials.gov,14/04/2020,01/05/2020,FALSE,Medical College of Wisconsin,Not Recruiting,Phase 2,Interventional,No Country Given,A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection,ATMP,Plasma,131,01/05/2022,01/05/2023,https://clinicaltrials.gov/show/NCT04354831,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1902,NCT04355234,ClinicalTrials.gov,17/04/2020,24/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,"Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns",Clinical Presentation (Epidemiology),No Intervention,2200,31/08/2021,31/08/2021,https://clinicaltrials.gov/show/NCT04355234,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1903,NCT04355533,ClinicalTrials.gov,17/04/2020,01/04/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19,Diagnostics,Diagnostic Test or Assessment,1920,01/04/2020,01/07/2021,https://clinicaltrials.gov/show/NCT04355533,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1904,NCT04355611,ClinicalTrials.gov,17/04/2020,20/04/2020,FALSE,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Epidemiological Characteristics of COVID-19 in Patients With MS or NMO,Clinical Presentation (Epidemiology),No Intervention,2000,20/04/2022,20/04/2022,https://clinicaltrials.gov/show/NCT04355611,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1905,NCT04355897,ClinicalTrials.gov,15/04/2020,01/04/2020,TRUE,The Christ Hospital,Recruiting,Phase 1,Interventional,United States,CoVID-19 Plasma in Treatment of COVID-19 Patients,ATMP,Plasma,100,01/07/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04355897,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1906,NCT04355936,ClinicalTrials.gov,17/04/2020,01/04/2020,TRUE,Laboratorio Elea,Recruiting,Phase 2,Interventional,Argentina,Telmisartan for Treatment of COVID-19 Patients,Drug,Telmisartan,400,01/10/2020,01/10/2020,https://clinicaltrials.gov/show/NCT04355936,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1907,NCT04355962,ClinicalTrials.gov,26/03/2020,23/04/2020,FALSE,University of Zurich,Recruiting,Phase 3,Interventional,Switzerland,Sevoflurane in COVID-19 ARDS (SevCov),Drug,Sevoflurane,64,31/03/2021,31/03/2021,https://clinicaltrials.gov/show/NCT04355962,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1908,NCT04356482,ClinicalTrials.gov,17/04/2020,01/05/2020,FALSE,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19,ATMP,Plasma,90,01/11/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04356482,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1909,NCT04356833,ClinicalTrials.gov,14/04/2020,22/04/2020,TRUE,"University College, London",Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Rt-PA for ARDS Due to COVID-19,Drug,Recombinant Tissue-Plasminogen Activator,24,14/01/2021,14/01/2021,https://clinicaltrials.gov/show/NCT04356833,No Results,No Results,No Results,04/05/2020,29/04/2020,EUCTR2020-001640-26
1910,NCT04357106,ClinicalTrials.gov,14/04/2020,13/04/2020,TRUE,Centro de Hematologia y Medicina Interna,Recruiting,Phase 2,Interventional,Mexico,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,ATMP,Plasma,10,01/07/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04357106,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1911,NCT04357327,ClinicalTrials.gov,15/04/2020,16/04/2020,FALSE,Università degli Studi dell'Insubria,Recruiting,Not Applicable,Interventional,Italy,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19),Diagnostics,Diagnostic Test or Assessment,100,31/05/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04357327,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1912,NCT04357366,ClinicalTrials.gov,20/04/2020,15/04/2020,TRUE,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE),Drug,Combination: Anakinra + trimethoprim/sulfamethoxazole,100,15/04/2022,15/04/2022,https://clinicaltrials.gov/show/NCT04357366,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1913,NCT04357574,ClinicalTrials.gov,20/04/2020,14/04/2020,TRUE,Duke University,Recruiting,Not Applicable,Observational,United States,Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19,Telehealth,Telehealth,1000,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04357574,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1914,NCT04357834,ClinicalTrials.gov,17/04/2020,01/05/2020,FALSE,"University Hospital, Bern",Not Recruiting,Not Applicable,Observational,Switzerland,WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories,Other (device),Smartwatch,100,31/07/2020,31/07/2020,https://clinicaltrials.gov/show/NCT04357834,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1915,NCT04357860,ClinicalTrials.gov,20/04/2020,27/04/2020,TRUE,Maimonides Biomedical Research Institute of Cordoba,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Sarilumab in Adults With COVID-19,Drug,Sarilumab,120,27/07/2020,27/07/2020,https://clinicaltrials.gov/show/NCT04357860,No Results,No Results,No Results,04/05/2020,29/04/2020,EUCTR2020-001531-27
1916,NCT04358042,ClinicalTrials.gov,08/04/2020,25/04/2020,FALSE,Nantes University Hospital,Not Recruiting,Not Applicable,Observational,France,PSYCHIATRIC Disorders and Covid-19,Other (psych),No Intervention,250,01/01/2022,01/01/2023,https://clinicaltrials.gov/show/NCT04358042,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1917,NCT04358068,ClinicalTrials.gov,20/04/2020,01/05/2020,FALSE,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 2,Interventional,No Country Given,Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19,Drug,Combination: Hydroxychloroquine + Azithromycin,2000,09/10/2020,05/03/2021,https://clinicaltrials.gov/show/NCT04358068,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1918,NCT04358081,ClinicalTrials.gov,08/04/2020,30/04/2020,FALSE,Novartis Pharmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease,Drug,Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,444,21/07/2020,21/07/2020,https://clinicaltrials.gov/show/NCT04358081,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1919,NCT04358510,ClinicalTrials.gov,20/04/2020,01/04/2020,TRUE,Dascena,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Mortality Prediction Model,Prognosis,No Intervention,114,17/04/2020,17/04/2020,https://clinicaltrials.gov/show/NCT04358510,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1920,NCT04358926,ClinicalTrials.gov,21/04/2020,26/04/2020,FALSE,Assaf-Harofeh Medical Center,Not Recruiting,Not Applicable,Interventional,No Country Given,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19),Drug,Oxygen,30,30/06/2020,30/07/2020,https://clinicaltrials.gov/show/NCT04358926,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1921,NCT04358939,ClinicalTrials.gov,16/04/2020,27/04/2020,FALSE,CHU de Tours,Recruiting,Not Applicable,Interventional,France,Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19),Procedure,Positioning,248,10/11/2020,24/11/2020,https://clinicaltrials.gov/show/NCT04358939,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1922,NCT04359602,ClinicalTrials.gov,21/04/2020,08/04/2020,TRUE,"University of California, Los Angeles",Recruiting,Not Applicable,Observational,United States,COVID-19 Recovered Volunteer Research Participant Pool Registry,Other,No Intervention,10000,20/04/2022,20/04/2042,https://clinicaltrials.gov/show/NCT04359602,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1923,NCT04359797,ClinicalTrials.gov,20/04/2020,27/04/2020,FALSE,Vanderbilt University,Recruiting,Not Applicable,Interventional,United States,COVID-19 Patient Positioning Pragmatic Trial,Procedure,Positioning,300,01/04/2021,01/06/2021,https://clinicaltrials.gov/show/NCT04359797,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1924,NCT04359810,ClinicalTrials.gov,21/04/2020,21/04/2020,FALSE,Max R. O'Donnell,Recruiting,Phase 2,Interventional,United States,Plasma Therapy of COVID-19 in Critically Ill Patients,ATMP,Plasma,105,01/12/2020,01/04/2021,https://clinicaltrials.gov/show/NCT04359810,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1925,NCT04360876,ClinicalTrials.gov,22/04/2020,01/05/2020,FALSE,"University of Colorado, Denver",Not Recruiting,Phase 2,Interventional,No Country Given,Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial,Drug,Corticosteroids,90,30/09/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04360876,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1926,NCT04361123,ClinicalTrials.gov,22/04/2020,01/04/2020,TRUE,Dr. Michael Runyon,Recruiting,Not Applicable,Observational,United States,Atrium COVID-19 Syndromic and Serologic Surveillance,Clinical Presentation (Epidemiology),No Intervention,450000,01/12/2021,01/12/2021,https://clinicaltrials.gov/show/NCT04361123,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1927,NCT04361318,ClinicalTrials.gov,18/04/2020,01/05/2020,FALSE,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19,Drug,Combination: Hydroxychloroquine + Nitazoxanide,100,01/10/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04361318,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1928,NCT04361344,ClinicalTrials.gov,16/04/2020,05/05/2020,FALSE,Centre Hospitalier de Pau,Not Recruiting,Not Applicable,Interventional,No Country Given,Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection,Clinical Presentation,No Intervention,30,05/01/2021,05/01/2021,https://clinicaltrials.gov/show/NCT04361344,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1929,NCT04361526,ClinicalTrials.gov,21/04/2020,17/04/2020,TRUE,Manuel Castell,Recruiting,Not Applicable,Interventional,Spain,Pilot Study on Cytokine Filtration in COVID-19 ARDS,Other (device),Cytokine Adsorber,40,01/07/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04361526,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1930,NCT04361552,ClinicalTrials.gov,07/04/2020,30/05/2020,FALSE,Emory University,Recruiting,Phase 3,Interventional,United States,Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection),Drug,Tocilizumab,180,30/05/2022,30/05/2022,https://clinicaltrials.gov/show/NCT04361552,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1931,NCT04361565,ClinicalTrials.gov,22/04/2020,20/03/2020,TRUE,CHU de Nice,Recruiting,Not Applicable,Observational,France,Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients,Clinical Presentation,No Intervention,50,10/04/2020,31/05/2020,https://clinicaltrials.gov/show/NCT04361565,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1932,NCT04361786,ClinicalTrials.gov,17/04/2020,01/04/2020,TRUE,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection,Clinical Presentation,No Intervention,10,30/06/2020,30/10/2020,https://clinicaltrials.gov/show/NCT04361786,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1933,NCT04361981,ClinicalTrials.gov,23/04/2020,01/04/2020,TRUE,Sociedad Española de Angiología y Cirugía Vascular (SEACV),Not Recruiting,Not Applicable,Observational,Spain,Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study,Diagnostics,Diagnostic Test or Assessment,50,31/08/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04361981,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1934,NCT04362176,ClinicalTrials.gov,21/04/2020,24/04/2020,FALSE,Vanderbilt University,Not Recruiting,Phase 3,Interventional,United States,Passive Immunity Trial of Nashville II,ATMP,Plasma,500,01/04/2021,01/04/2021,https://clinicaltrials.gov/show/NCT04362176,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1935,NCT04362189,ClinicalTrials.gov,21/04/2020,15/05/2020,FALSE,Hope Biosciences,Not Recruiting,Phase 2,Interventional,United States,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,ATMP,Cells (mesenchymal),110,31/10/2020,31/10/2020,https://clinicaltrials.gov/show/NCT04362189,No Results,No Results,No Results,04/05/2020,29/04/2020,None
1936,NCT04362865,ClinicalTrials.gov,24/04/2020,27/04/2020,FALSE,National Cancer Institute (NCI),Recruiting,Not Applicable,Observational,United States,Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection,Clinical Presentation,No Intervention,150,01/12/2023,01/12/2024,https://clinicaltrials.gov/show/NCT04362865,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1937,NCT04363047,ClinicalTrials.gov,20/04/2020,01/05/2020,FALSE,University of Manchester,Not Recruiting,Not Applicable,Observational,United Kingdom,"Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19",Clinical Presentation,No Intervention,125,01/05/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04363047,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1938,NCT04363060,ClinicalTrials.gov,23/04/2020,30/04/2020,FALSE,Nantes University Hospital,Not Recruiting,Phase 3,Interventional,France,Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit,Drug,Combination: Azithromycin + Amoxicillin/Clavulanate vs. Amoxicillin/Clavulanate,104,30/07/2020,30/07/2020,https://clinicaltrials.gov/show/NCT04363060,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1939,NCT04363268,ClinicalTrials.gov,23/04/2020,20/04/2020,TRUE,Medable Inc.,Recruiting,Not Applicable,Observational,United States,ACCESS A Master Digital Surveillance Protocol for COVID-19,Clinical Presentation (Epidemiology),No Intervention,1000000,20/04/2030,01/10/2031,https://clinicaltrials.gov/show/NCT04363268,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1940,NCT04363489,ClinicalTrials.gov,23/04/2020,27/04/2020,FALSE,King's College London,Not Recruiting,Not Applicable,Observational,No Country Given,The CEDiD Study (COVID-19 Early Diagnosis in Doctors),Diagnostics,Diagnostic Test or Assessment,30,27/05/2020,27/05/2020,https://clinicaltrials.gov/show/NCT04363489,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1941,NCT04363502,ClinicalTrials.gov,23/04/2020,01/04/2020,TRUE,Johns Hopkins University,Not Recruiting,Phase 2,Interventional,No Country Given,Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,30,01/08/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04363502,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1942,NCT04363736,ClinicalTrials.gov,21/04/2020,04/05/2020,FALSE,Roche,Not Recruiting,Phase 2,Interventional,No Country Given,A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia,Drug,Tocilizumab,100,11/06/2020,03/08/2020,https://clinicaltrials.gov/show/NCT04363736,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1943,NCT04364594,ClinicalTrials.gov,22/04/2020,26/03/2020,TRUE,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Interventional,Italy,COVID-19 Search in Conjunctival Cells,Diagnostics,Diagnostic Test or Assessment,50,30/04/2020,30/05/2020,https://clinicaltrials.gov/show/NCT04364594,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1944,NCT04364802,ClinicalTrials.gov,25/04/2020,01/05/2020,FALSE,Alexandra Kejner,Not Recruiting,Phase 2,Interventional,United States,COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients,Drug,Povidone-iodine,250,01/05/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04364802,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1945,NCT04364815,ClinicalTrials.gov,22/04/2020,01/04/2020,TRUE,University of the Philippines,Not Recruiting,Phase 3,Interventional,No Country Given,The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial,Drug (chemoprophylaxis),Hydroxychloroquine,960,01/05/2021,01/05/2021,https://clinicaltrials.gov/show/NCT04364815,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1946,NCT04364828,ClinicalTrials.gov,22/04/2020,01/04/2020,TRUE,"University Hospital, Tübingen",Not Recruiting,Not Applicable,Interventional,No Country Given,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,Diagnostics,Diagnostic Test or Assessment,1000,01/04/2021,01/08/2021,https://clinicaltrials.gov/show/NCT04364828,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1947,NCT04365231,ClinicalTrials.gov,23/04/2020,01/04/2020,TRUE,"Hospital St. Joseph, Marseille",Not Recruiting,Phase 3,Interventional,France,Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial,Drug,Combination: Hydroxychloroquine + Azithromycin,50,01/06/2020,01/01/2021,https://clinicaltrials.gov/show/NCT04365231,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1948,NCT04365257,ClinicalTrials.gov,24/04/2020,01/04/2020,TRUE,Johns Hopkins University,Not Recruiting,Phase 2,Interventional,United States,Prazosin to Prevent COVID-19 (PREVENT-COVID Trial),Drug,Prazosin,220,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04365257,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1949,NCT04365439,ClinicalTrials.gov,18/04/2020,27/04/2020,FALSE,Enos Bernasconi,Not Recruiting,Not Applicable,Interventional,No Country Given,Convalescent Plasma for COVID-19,ATMP,Plasma,10,30/05/2020,30/06/2020,https://clinicaltrials.gov/show/NCT04365439,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1950,NCT04365881,ClinicalTrials.gov,26/04/2020,31/03/2020,TRUE,Modum Bad,Not Recruiting,Not Applicable,Observational,Norway,Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology,Other (psych),No Intervention,10084,07/04/2020,07/04/2020,https://clinicaltrials.gov/show/NCT04365881,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1951,NCT04366089,ClinicalTrials.gov,22/04/2020,26/03/2020,TRUE,Dr. Roberto Poscia,Recruiting,Phase 2,Interventional,Italy,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,Drug,Oxygen,152,30/10/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04366089,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1952,NCT04366115,ClinicalTrials.gov,26/04/2020,01/06/2020,FALSE,AVM Biotechnology LLC,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Evaluating AVM0703 for Treatment of COVID-19,Drug,AVM0703,126,01/06/2022,01/06/2023,https://clinicaltrials.gov/show/NCT04366115,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1953,NCT04366297,ClinicalTrials.gov,23/04/2020,12/01/2020,TRUE,Lazarski University,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access of COVID-19 Patient Under Personal Protective Equipment,Other (device),Intraosseous/Intravenous access device,41,25/02/2020,25/02/2020,https://clinicaltrials.gov/show/NCT04366297,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1954,NCT04366323,ClinicalTrials.gov,22/04/2020,01/04/2020,TRUE,Andalusian Network for Design and Translation of Advanced Therapies,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,ATMP,Cells (mesenchymal),26,01/10/2021,01/10/2021,https://clinicaltrials.gov/show/NCT04366323,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1955,NCT04366739,ClinicalTrials.gov,24/04/2020,29/04/2020,FALSE,Centre Hospitalier St Anne,Not Recruiting,Phase 3,Interventional,France,Repurposing of Chlorpromazine in Covid-19 Treatment,Drug,Chlorpromazine,40,30/08/2020,30/09/2020,https://clinicaltrials.gov/show/NCT04366739,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1956,NCT04366752,ClinicalTrials.gov,27/04/2020,22/04/2020,TRUE,CHU de Amiens,Recruiting,Not Applicable,Observational,France,Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy,Clinical Presentation,No Intervention,100,22/08/2020,22/09/2020,https://clinicaltrials.gov/show/NCT04366752,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1957,NCT04366765,ClinicalTrials.gov,06/04/2020,19/03/2020,TRUE,"University Hospital, Basel",Recruiting,Not Applicable,Observational,Switzerland,COVID-19 Survival - The COVIVA Study,Clinical Presentation (Epidemiology),No Intervention,1500,30/06/2021,30/06/2021,https://clinicaltrials.gov/show/NCT04366765,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1958,NCT04366778,ClinicalTrials.gov,23/04/2020,01/05/2020,FALSE,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Thrombosis and Covid-19,Diagnostics,Diagnostic Test or Assessment,300,01/12/2020,01/12/2020,https://clinicaltrials.gov/show/NCT04366778,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1959,NCT04366960,ClinicalTrials.gov,24/04/2020,01/05/2020,FALSE,Niguarda Hospital,Not Recruiting,Phase 3,Interventional,Italy,Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients,Drug,Enoxaparin,2712,01/08/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04366960,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1960,NCT04366986,ClinicalTrials.gov,23/04/2020,01/05/2020,FALSE,Pregistry,Not Recruiting,Not Applicable,Observational,United States,International Registry of Coronavirus (COVID-19) Exposure in Pregnancy,Clinical Presentation,No Intervention,25000,30/04/2024,30/04/2024,https://clinicaltrials.gov/show/NCT04366986,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1961,NCT04367207,ClinicalTrials.gov,27/04/2020,01/05/2020,FALSE,University of Cape Town,Not Recruiting,Not Applicable,Observational,No Country Given,African Covid-19 Critical Care Outcomes Study,Clinical Presentation,No Intervention,2000,01/12/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04367207,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1962,NCT04367402,ClinicalTrials.gov,17/04/2020,30/03/2020,TRUE,Azienda Ospedaliera San Paolo,Recruiting,Not Applicable,Observational,Italy,"COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)",Diagnostics,Diagnostic Test or Assessment,600,24/04/2020,01/09/2020,https://clinicaltrials.gov/show/NCT04367402,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1963,NCT04367636,ClinicalTrials.gov,20/04/2020,20/04/2020,FALSE,University of Ghent,Not Recruiting,Not Applicable,Interventional,Belgium,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19,Other (psych),Psychological,100,01/08/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04367636,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1964,NCT04367831,ClinicalTrials.gov,27/04/2020,01/05/2020,FALSE,Columbia University,Not Recruiting,Phase 4,Interventional,United States,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19,Drug,Enoxaparin,100,01/11/2020,01/04/2021,https://clinicaltrials.gov/show/NCT04367831,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1965,NCT04367857,ClinicalTrials.gov,28/04/2020,18/04/2020,TRUE,Columbia University,Recruiting,Not Applicable,Observational,United States,ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,1000,01/10/2021,01/10/2021,https://clinicaltrials.gov/show/NCT04367857,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1966,NCT04367870,ClinicalTrials.gov,28/04/2020,01/05/2020,FALSE,UNICANCER,Not Recruiting,Not Applicable,Observational,France,COVID-19 Detection Test in Oncology,Clinical Presentation (Epidemiology),No Intervention,2500,01/08/2020,01/05/2021,https://clinicaltrials.gov/show/NCT04367870,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1967,NCT04368065,ClinicalTrials.gov,28/04/2020,02/04/2020,TRUE,Iqvia Pty Ltd,Recruiting,Not Applicable,Observational,United States,Registry to Study Factors That May Impact COVID-19 Occurrence and Severity,Clinical Presentation,No Intervention,100000,31/12/2021,01/06/2022,https://clinicaltrials.gov/show/NCT04368065,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1968,NCT04368299,ClinicalTrials.gov,25/04/2020,01/05/2020,FALSE,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Interventional,No Country Given,Telemedicine for Follow-up of Systemic Lupus Erythematosus,Telehealth,Telehealth,150,31/10/2021,31/12/2021,https://clinicaltrials.gov/show/NCT04368299,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1969,NCT04368312,ClinicalTrials.gov,09/04/2020,06/05/2020,FALSE,"University Hospital, Essen",Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impairment Due to Covid-19,Other (psych),No Intervention,100,30/05/2020,30/05/2020,https://clinicaltrials.gov/show/NCT04368312,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1970,NCT04368728,ClinicalTrials.gov,27/04/2020,28/04/2020,FALSE,Biontech SE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,"Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults",ATMP,Vaccine,8640,27/01/2023,27/01/2023,https://clinicaltrials.gov/show/NCT04368728,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1971,NCT04368923,ClinicalTrials.gov,24/04/2020,15/03/2020,TRUE,Cairo University,Not Recruiting,Not Applicable,Interventional,Egypt,Management of Covid-19 Patients During Home Isolation,Drug,Oxygen,60,15/05/2020,20/05/2020,https://clinicaltrials.gov/show/NCT04368923,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1972,NCT04369365,ClinicalTrials.gov,27/04/2020,27/04/2020,FALSE,Dr. Matthias Preusser,Recruiting,Phase 2,Interventional,Austria,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic",Drug (chemoprophylaxis),Azithromycin,200,27/08/2020,27/12/2020,https://clinicaltrials.gov/show/NCT04369365,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1973,NCT04369378,ClinicalTrials.gov,24/04/2020,02/05/2020,FALSE,Lake Erie College of Osteopathic Medicine,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic,Other (psych),Psychological,100,15/09/2020,31/10/2020,https://clinicaltrials.gov/show/NCT04369378,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1974,NCT04369599,ClinicalTrials.gov,28/04/2020,01/05/2020,FALSE,Emory University,Not Recruiting,Not Applicable,Interventional,United States,Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest,Other (device),Thoracic Manipulation Vest,24,01/03/2021,01/03/2021,https://clinicaltrials.gov/show/NCT04369599,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1975,NCT04369794,ClinicalTrials.gov,27/04/2020,01/06/2020,FALSE,"University of Campinas, Brazil",Not Recruiting,Phase 4,Interventional,Brazil,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement",ATMP,Vaccine,1000,01/06/2021,01/05/2022,https://clinicaltrials.gov/show/NCT04369794,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1976,NCT04369807,ClinicalTrials.gov,22/04/2020,21/04/2020,TRUE,Perspectum Diagnostics Ltd,Recruiting,Not Applicable,Observational,United Kingdom,Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection,Clinical Presentation,No Intervention,507,31/05/2023,31/05/2023,https://clinicaltrials.gov/show/NCT04369807,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1977,NCT04369820,ClinicalTrials.gov,29/04/2020,31/03/2020,TRUE,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,C5a Receptor Expression - COVID-19 (C5-COV),Clinical Presentation,No Intervention,70,01/09/2020,01/11/2020,https://clinicaltrials.gov/show/NCT04369820,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1978,NCT04370015,ClinicalTrials.gov,27/04/2020,01/04/2020,TRUE,"Services Institute of Medical Sciences, Pakistan",Not Recruiting,Not Applicable,Interventional,No Country Given,Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers: Randomised Control Trial,Drug (chemoprophylaxis),Hydroxychloroquine,374,30/06/2020,15/10/2020,https://clinicaltrials.gov/show/NCT04370015,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1979,NCT04370223,ClinicalTrials.gov,27/04/2020,04/05/2020,FALSE,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,Not Recruiting,Phase 3,Interventional,Spain,Ozone Auto-hemotherapy for COVID-19 Pneumonia,Drug,Ozone,208,25/10/2020,25/12/2020,https://clinicaltrials.gov/show/NCT04370223,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1980,NCT04370236,ClinicalTrials.gov,29/04/2020,01/06/2020,FALSE,"Inmune Bio, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,XPro1595 for the Treatment of Pulmonary Complications From COVID-19,Drug,XPro1595,150,01/01/2021,01/01/2021,https://clinicaltrials.gov/show/NCT04370236,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1981,NCT04370249,ClinicalTrials.gov,28/04/2020,09/04/2020,TRUE,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19,Clinical Presentation,No Intervention,400,01/06/2020,01/06/2020,https://clinicaltrials.gov/show/NCT04370249,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1982,NCT04370262,ClinicalTrials.gov,27/04/2020,07/04/2020,TRUE,Northwell Health,Recruiting,Phase 3,Interventional,United States,Multi-site Adaptive Trials Using Hydroxycholoroquine for COVID-19,Drug,Combination: Hydroxychloroquine + Famotidine vs. Hydroxychloroquine,1170,07/09/2020,07/04/2021,https://clinicaltrials.gov/show/NCT04370262,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1983,NCT04370678,ClinicalTrials.gov,24/04/2020,17/04/2020,TRUE,Region Zealand,Not Recruiting,Not Applicable,Observational,Denmark,Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures,Other,No Intervention,79,24/04/2020,24/04/2020,https://clinicaltrials.gov/show/NCT04370678,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1984,NCT04370886,ClinicalTrials.gov,28/04/2020,30/04/2020,FALSE,Guangzhou Blood Center,Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19,Other,No Intervention,394578,30/04/2020,10/05/2020,https://clinicaltrials.gov/show/NCT04370886,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1985,NCT04371315,ClinicalTrials.gov,24/04/2020,27/04/2020,FALSE,St. Jude Children's Research Hospital,Recruiting,Not Applicable,Observational,United States,"Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children",Clinical Presentation,No Intervention,400,01/06/2021,30/06/2022,https://clinicaltrials.gov/show/NCT04371315,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1986,NCT04371354,ClinicalTrials.gov,28/04/2020,27/04/2020,TRUE,Fundación Miguel Servet,Not Recruiting,Not Applicable,Observational,No Country Given,Outcomes of Covid Protective Measures in Endoscopy,Clinical Presentation,No Intervention,100,14/06/2020,27/07/2020,https://clinicaltrials.gov/show/NCT04371354,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1987,NCT04371523,ClinicalTrials.gov,28/04/2020,01/05/2020,FALSE,St. Joseph's Healthcare Hamilton,Not Recruiting,Phase 3,Interventional,Canada,Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers,Drug (chemoprophylaxis),Hydroxychloroquine,1100,31/07/2020,30/08/2020,https://clinicaltrials.gov/show/NCT04371523,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1988,NCT04371562,ClinicalTrials.gov,30/04/2020,01/03/2020,TRUE,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Observational,Italy,PREDICTING ICU ADMISSION AND DEATH FOR COVID-19 PATIENTS,Prognosis,No Intervention,300,31/03/2020,15/04/2020,https://clinicaltrials.gov/show/NCT04371562,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1989,NCT04371744,ClinicalTrials.gov,30/04/2020,17/04/2020,TRUE,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Observational,France,QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19,Other (software),Other,100,04/05/2020,11/05/2020,https://clinicaltrials.gov/show/NCT04371744,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1990,NCT04371965,ClinicalTrials.gov,29/04/2020,01/05/2020,FALSE,Poitiers University Hospital,Not Recruiting,Phase 2,Interventional,France,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19",Drug,Povidone-iodine,24,01/07/2020,01/08/2020,https://clinicaltrials.gov/show/NCT04371965,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1991,NCT04371978,ClinicalTrials.gov,30/04/2020,15/05/2020,FALSE,Rabin Medical Center,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19,Drug,Linagliptin,100,30/06/2021,30/09/2021,https://clinicaltrials.gov/show/NCT04371978,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1992,NCT04372004,ClinicalTrials.gov,29/04/2020,01/05/2020,FALSE,Texas Cardiac Arrhythmia Research Foundation,Not Recruiting,Not Applicable,Interventional,No Country Given,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19),Diagnostics,Diagnostic Test or Assessment,100,01/05/2021,01/06/2021,https://clinicaltrials.gov/show/NCT04372004,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1993,NCT04372186,ClinicalTrials.gov,29/04/2020,08/05/2020,FALSE,"Genentech, Inc.",Not Recruiting,Phase 3,Interventional,No Country Given,A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia,Drug,Tocilizumab,379,05/08/2020,05/10/2020,https://clinicaltrials.gov/show/NCT04372186,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1994,NCT04372199,ClinicalTrials.gov,29/04/2020,29/04/2020,FALSE,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Recruiting,Not Applicable,Observational,Italy,SEVERITY SCORE FOR COVID-19 PNEUMONIA,Clinical Presentation,No Intervention,248,27/05/2020,27/05/2020,https://clinicaltrials.gov/show/NCT04372199,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1995,ISRCTN83971151,ISRCTN,25/03/2020,26/03/2020,TRUE,World Health Organization,Recruiting,Phase 3,Interventional,"Norway, Israel, Malaysia, Saudi Arabia, Ireland, Canada, Peru, Honduras, Spain, India, Qatar, Italy, Kenya, Indonesia, Brazil, Switzerland, Iran, South Africa, Lebanon, Germany, Philippines, Thailand, Argentina",Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients,Drug,Remdesivir vs. chloroquine/hydroxychloroquine vs. lopinavir/ritonavir vs. interferon beta,10000,Not Available,25/03/2021,http://isrctn.com/ISRCTN83971151,No Results,No Results,No Results,04/05/2020,04/01/2020,EUCTR2020-001366-11; NCT04330690; PER-010-20; IRCT20200405046953N1; NCT04321616; EUCTR2020-000982-18
1996,ChiCTR2000032527,ChiCTR,01/05/2020,01/05/2020,FALSE,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"Developing and validating of clinical prediction model for novel coronavirus pneumonia (COVID-19) patients progressing to critical type, acute respiratory distress syndrome and death: a medical records based study",Prognosis,No Intervention,8500,Not Available,30/04/2021,http://www.chictr.org.cn/showproj.aspx?proj=53196,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1997,ChiCTR2000032476,ChiCTR,29/04/2020,23/03/2020,TRUE,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,Analysis of clinical features of novel coronavirus  pneumonia (COVID-19): a medical records based study,Clinical Presentation,No Intervention,500,Not Available,23/03/2021,http://www.chictr.org.cn/showproj.aspx?proj=53094,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1998,ChiCTR2000032458,ChiCTR,29/04/2020,29/02/2020,TRUE,Department of Science and Technology of Guizhou Province,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study: Leukopenia is more common in asymptomatic patients less than 18 years old with novel coronavirus pneumonia (COVID-19) in convalescence,Clinical Presentation,No Intervention,25,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=52779,No Results,No Results,No Results,04/05/2020,05/05/2020,None
1999,ChiCTR2000032457,ChiCTR,29/04/2020,01/05/2020,FALSE,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Application of pulmonary rehabilitation exercise in the treatment of novel coronavirus pneumonia (COVID-19) patients during convalescence period.,Other (physio),Physio,60,Not Available,31/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=52925,No Results,No Results,No Results,04/05/2020,05/05/2020,None
2000,ChiCTR2000032456,ChiCTR,29/04/2020,01/03/2020,TRUE,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Interventional,No Country Given,A Randomized Controlled Trial for the Effects of Low-Oxygen Consumption Instruction on the Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,100,Not Available,01/05/2020,http://www.chictr.org.cn/showproj.aspx?proj=53048,No Results,No Results,No Results,04/05/2020,05/05/2020,None
2001,ChiCTR2000032455,ChiCTR,29/04/2020,28/04/2020,TRUE,Ningxia Ning'an Hospital,Recruiting,Not Applicable,Interventional,China,A study for the mental health status of novel coronavirus pneumonia (COVID-19) convalescent patients and first-line medical staff and Isolate residents and Hospital staffand the intervention strategy of psychological crisis in Ningxia,Other (psych),No Intervention,140,Not Available,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=53050,No Results,No Results,No Results,04/05/2020,05/05/2020,None
2002,ChiCTR2000031896,ChiCTR,14/04/2020,05/02/2020,TRUE,Fujian Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Study for the influence of novel coronavirus pneumonia (COVID-19) on mental health of Chinese public hospital stuffs,Other (psych),No Intervention,923,Not Available,10/02/2020,http://www.chictr.org.cn/showproj.aspx?proj=52332,No Results,No Results,No Results,04/05/2020,22/04/2020,None
2003,ChiCTR2000030262,ChiCTR,26/02/2020,01/02/2020,TRUE,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Clinical study of novel coronavirus (SARS-Cov-2) infection treated with aerosol inhalation (IFN-? plus anti-inflammatory factor TFF2),Drug,Combination: interferon kappa + trefoil factor 2 (a gene-derived protein),140,Not Available,31/01/2021,http://www.chictr.org.cn/showproj.aspx?proj=50136,No Results,No Results,No Results,04/05/2020,08/03/2020,None
2004,NL8536,Netherlands Trial Register,15/04/2020,28/04/2020,FALSE,Zuyderland Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Neurological Manifestations of COVID-19 and Indications of an Association with Respiratory Failure,Clinical Presentation,No Intervention,285,Not Available,31/07/2020,https://trialregister.nl/trial/8536,No Results,No Results,No Results,04/05/2020,29/04/2020,None
2005,NL8521,Netherlands Trial Register,13/04/2020,18/04/2020,FALSE,UMC Amsterdam,Not Recruiting,Not Applicable,Interventional,Netherlands,Continuous positive airway pressure in severe Covid-19 pneumonia,Drug,Oxygen,13,Not Available,18/07/2020,https://trialregister.nl/trial/8521,No Results,No Results,No Results,04/05/2020,22/04/2020,None
2006,NL8522,Netherlands Trial Register,12/04/2020,08/04/2020,TRUE,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,The Digital Doc in the Emergency Department: The solution for patient care in the Covid-19 pandemic?,Telehealth,Telehealth,50,Not Available,01/09/2020,https://trialregister.nl/trial/8522,No Results,No Results,No Results,04/05/2020,29/04/2020,None
2007,NL8528,Netherlands Trial Register,15/04/2020,22/04/2020,FALSE,UMC Utrecht,Not Recruiting,Not Applicable,Observational,Netherlands,Control of COVID-19 in hospitals,Clinical Presentation (Epidemiology),No Intervention,2000,Not Available,31/08/2020,https://trialregister.nl/trial/8528,No Results,No Results,No Results,04/05/2020,29/04/2020,None
2008,NL8538,Netherlands Trial Register,17/04/2020,17/04/2020,FALSE,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,Netherlands,Sleep position related to hospital length of stay in admitted COVID-19 patients,Procedure,Positioning,342,Not Available,17/04/2021,https://trialregister.nl/trial/8538,No Results,No Results,No Results,04/05/2020,29/04/2020,None
2009,NL8498,Netherlands Trial Register,31/03/2020,15/03/2020,TRUE,Radboud University Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Lung ultrasound (LUS) as a tool to determine the clinical course in COVID-19 patients,Clinical Presentation,No Intervention,20,Not Available,31/05/2020,https://trialregister.nl/trial/8498,No Results,No Results,No Results,04/05/2020,15/04/2020,None
2010,RPCEC00000306,RPCEC,13/04/2020,27/03/2020,TRUE,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Phase 1/Phase 2,Interventional,Cuba,CIGB 2020 in contacts and SARS-CoV-2 infection suspects,ATMP,Vaccine,80,Not Available,15/07/2020,http://rpcec.sld.cu/en/trials/RPCEC00000306-En,No Results,No Results,No Results,04/05/2020,22/04/2020,None
2011,RPCEC00000307,RPCEC,14/04/2020,10/04/2020,TRUE,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Phase 2,Interventional,Cuba,ESPERANZA study,Drug,Interferon alpha,120,Not Available,30/07/2020,http://rpcec.sld.cu/en/trials/RPCEC00000307-En,No Results,No Results,No Results,04/05/2020,05/05/2020,None
2012,RPCEC00000308,RPCEC,03/05/2020,04/05/2020,FALSE,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1,Interventional,Cuba,Pharmacodynamics of the Nasalferon in healthy volunteers.,Drug,Nasalferon,30,Not Available,09/06/2020,http://rpcec.sld.cu/en/trials/RPCEC00000308-En,No Results,No Results,No Results,04/05/2020,05/05/2020,None
2013,DRKS00021439,German Clinical Trials Register,20/04/2020,20/04/2020,FALSE,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,COVID-19 associated brainstem encephalitis - is SARS-CoV-2 a neurotropic agent?,Clinical Presentation,No Intervention,70,Not Available,Not Available,http://www.drks.de/DRKS00021439,No Results,No Results,No Results,04/05/2020,05/05/2020,None
2014,DRKS00021420,German Clinical Trials Register,16/04/2020,01/04/2020,TRUE,Technische Universität München,Recruiting,Phase 1,Interventional,Germany,Observational clinical trial for the evaluation of an automated nasal and pharyngeal swab exam to test COVID-19 patients,Diagnostics,Diagnostic Test or Assessment,30,Not Available,Not Available,http://www.drks.de/DRKS00021420,No Results,No Results,No Results,04/05/2020,22/04/2020,None
2015,DRKS00021399,German Clinical Trials Register,20/04/2020,12/04/2020,TRUE,Dortmund Hospital,Recruiting,Not Applicable,Observational,Germany,Prospective gas chromatographic and spectrometric analysis of the exhalation of healthy test persons and of SARS-CoV2 infected patients as well as  of patients suffering from COVID-19 at the Klinikum Dortmund,Clinical Presentation,No Intervention,450,Not Available,Not Available,http://www.drks.de/DRKS00021399,No Results,No Results,No Results,04/05/2020,05/05/2020,None
2016,DRKS00021506,German Clinical Trials Register,22/04/2020,18/03/2020,TRUE,"University Hospital Carl Gustav Carus, Dresden",Recruiting,Not Applicable,Observational,Germany,Registry of hospitalized pediatric Patients mit SARS-CoV-2 infection (COVID-19),Clinical Presentation,No Intervention,1000,Not Available,Not Available,http://www.drks.de/DRKS00021506,No Results,No Results,No Results,04/05/2020,05/05/2020,None
2017,DRKS00021581,German Clinical Trials Register,27/04/2020,27/04/2020,FALSE,Klinikum der Universität München,Recruiting,Not Applicable,Observational,Germany,Alterations in  inflammatory and coagulation variables in COVID-19 patients,Clinical Presentation,No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021581,No Results,No Results,No Results,04/05/2020,05/05/2020,None
2018,DRKS00021164,German Clinical Trials Register,27/03/2020,16/03/2020,TRUE,Universität Duisburg-Essen,Recruiting,Not Applicable,Observational,Germany,Psychological distress of the COVID-19 pandemic: A comparison between cancer patients and healthy controls,Other (psych),No Intervention,220,Not Available,Not Available,http://www.drks.de/DRKS00021164,No Results,No Results,No Results,04/05/2020,22/04/2020,None
2019,DRKS00021306,German Clinical Trials Register,14/04/2020,31/03/2020,TRUE,University Hospital Bonn,Recruiting,Not Applicable,Observational,Germany,Covid-19 Case-Cluster-Study,Clinical Presentation (Epidemiology),No Intervention,1400,Not Available,Not Available,http://www.drks.de/DRKS00021306,No Results,No Results,No Results,04/05/2020,22/04/2020,None
2020,DRKS00021289,German Clinical Trials Register,14/04/2020,31/03/2020,TRUE,Performa Nord,Recruiting,Not Applicable,Observational,Germany,Study on SARS-CoV-2-Serology (COVID-19) in Bremen's public sector,Clinical Presentation (Epidemiology),No Intervention,100,Not Available,Not Available,http://www.drks.de/DRKS00021289,No Results,No Results,No Results,04/05/2020,22/04/2020,None
2021,EUCTR2020-001723-13-FR,EU Clinical Trials Register,08/04/2020,17/04/2020,FALSE,Groupe Hospitalier Paris Saint-Joseph,Authorised,Phase 3,Interventional,France,A randomized trial of efficacy and safety of an early OUTpatient treatment of COVID-19 in patients with risk factor for poor outcome : a strategy to prevent hospitalization : OUTCOV Study,Drug,"Azithromycin, Hydroxychloroquine, Lopinavir/Ritonavir",640,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001723-13,No Results,No Results,No Results,04/05/2020,05/05/2020,None
2022,EUCTR2020-001364-29-ES,EU Clinical Trials Register,27/04/2020,20/04/2020,TRUE,Red Andaluza de Diseño y Traslación de Terapias Avanzadas,Authorised,Phase 1/Phase 2,Interventional,Spain,"Study with stem cells from allogenic adipose tissue, in patients with coronavirus severe pneumonia",ATMP,Cells (mesenchymal) vs. Hydroxychloroquine + Azithromycin or Lopinavir/ritonavir + Interferon beta,26,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001364-29,No Results,No Results,No Results,04/05/2020,05/05/2020,None
2023,EUCTR2020-001888-90-DK,EU Clinical Trials Register,16/04/2020,30/04/2020,FALSE,University of Southern Denmark,Authorised,Phase 3,Interventional,Denmark,BCG vaccine for healthcare workers against COVID-19,ATMP,Vaccine,1500,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001888-90,No Results,No Results,No Results,04/05/2020,05/05/2020,None
2024,EUCTR2020-001345-38-GR,EU Clinical Trials Register,31/03/2020,02/04/2020,FALSE,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Authorised,Phase 2,Interventional,Greece,CHROLOQUINE PHOSPHATE AGAINST INFECTION BY THE NOVEL CORONAVIRUS,Drug,Chloroquine,60,Not Available,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001345-38,No Results,No Results,No Results,04/05/2020,04/07/2020,None
2025,NCT04307459,ClinicalTrials.gov,10/03/2020,19/03/2020,FALSE,University of Milan,Not Recruiting,Not Applicable,Observational,Italy,Acute Respiratory Failure and SARS-CoV-2 Infection in Real Life,Clinical Presentation,No Intervention,50,01/05/2020,31/12/2020,https://clinicaltrials.gov/show/NCT04307459,No Results,No Results,No Results,16/03/2020,18/03/2020,None
2026,NCT04323527,ClinicalTrials.gov,13/03/2020,23/03/2020,FALSE,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,Recruiting,Phase 2,Interventional,Brazil,Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 (CloroCOVID19),Drug,Chloroquine,440,31/08/2020,31/08/2020,https://clinicaltrials.gov/ct2/show/NCT04323527,Journal Article,24/04/2020,https://doi.org/10.1001/jamanetworkopen.2020.8857,14/04/2020,06/04/2020,None
2027,NCT04335552,ClinicalTrials.gov,03/04/2020,17/04/2020,FALSE,Duke University,Recruiting,Phase 2,Interventional,United States,"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection",Drug,Combination: Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine vs. Azithormycin,500,01/08/2020,01/08/2020,https://clinicaltrials.gov/ct2/show/NCT04335552,No Results,No Results,No Results,24/04/2020,22/04/2020,None
2028,NCT04336748,ClinicalTrials.gov,04/04/2020,01/04/2020,TRUE,Medical University of Vienna,Not Recruiting,Phase 3,Interventional,No Country Given,HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers,Drug,Hydroxychloroquine,440,01/07/2020,01/08/2020,https://clinicaltrials.gov/ct2/show/NCT04336748,No Results,No Results,No Results,07/04/2020,22/04/2020,None
2029,NCT04341727,ClinicalTrials.gov,04/04/2020,04/04/2020,FALSE,Washington University in St. Louis,Recruiting,Phase 3,Interventional,United States,"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection (WU352)",Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin vs. Chloroquine vs. Chloroquine + Azithormycin,500,01/04/2021,01/08/2021,https://clinicaltrials.gov/ct2/show/NCT04341727,No Results,No Results,No Results,10/04/2020,22/04/2020,None
2030,RBR-9ktwx6,REBEC,27/03/2020,20/03/2020,FALSE,Socidade Brasileira de Reumatologia,Recruiting,Not Applicable,Observational,Brazil,Evaluation of the effect of chronic use of Antimalarials on the frequency of infection with the New Corona Virus 2019 (Severe Acute Respiratory Syndrome Coronavirus 2 - SARS-CoV-2) in patients with Immunomedical Rheumatic Diseases,Drug,Hydroxychloroquine or Chloroquine,6000,Not Available,30/07/2020,http://www.ensaiosclinicos.gov.br/rg/RBR-9ktwx6/,No Results,No Results,No Results,09/04/2020,22/04/2020,None
2031,NCT04357444,ClinicalTrials.gov,10/04/2020,01/04/2020,TRUE,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19,Drug,ILT101,30,01/05/2020,01/07/2020,https://clinicaltrials.gov/show/NCT04357444,No Results,No Results,No Results,27/04/2020,29/04/2020,EUCTR2020-001571-32